Kondáš Michal
Kondáš Michal
2015-12-18T09:19:26Z
2015-12-01T07:56:24Z
14.00
7995
9000
105
105
False
False
ATC |
|
OL |
|
Názov |
Doplnok |
ŠDL |
JD |
|
|
|
|
|
|
|
|
UZP2 |
Podmienená |
Dočasná |
Uhr./Špec. |
Kód |
GP |
PL |
Typ lieku |
|
|
CRP |
Štát |
ŠDL počet |
Konečná c. |
UZP |
s.u. |
DOP |
DOP% |
PDOP Limit |
PO |
IO |
kateg. |
kateg. |
skupina |
A03AD02 |
|
|
|
Drotaverín |
parent. 20 mg/ml |
0.1 |
g |
|
|
|
|
|
|
|
|
1.0649999999999999 |
|
|
|
02552 |
|
|
O |
NO-SPA |
sol inj 5x2 ml/40 mg |
CHN |
HU |
2 |
2.13 |
2.13 |
A |
0 |
0 |
0 |
|
|
|
|
|
A03BA01 |
|
|
|
Atropín |
parent. 0,5 mg/ml |
1.5 |
mg |
|
|
|
|
|
|
|
|
0.84299999999999997 |
|
|
|
00392 |
|
|
G |
ATROPIN BIOTIKA 0,5 mg |
sol inj 10x1 ml/0,5 mg |
HBS |
SK |
3.3330000000000002 |
2.81 |
2.81 |
A |
0 |
0 |
0 |
|
|
|
|
|
A03BA01 |
|
|
|
Atropín |
parent. 1 mg/ml |
1.5 |
mg |
|
|
|
|
|
|
|
|
0.84299999999999997 |
|
|
|
00394 |
|
|
G |
ATROPIN BIOTIKA 1 mg |
sol inj 10x1 ml/1 mg |
HBS |
SK |
6.6669999999999998 |
3.44 |
3.44 |
A |
0 |
0 |
0 |
|
|
|
|
|
A03BB01 |
|
|
|
Butylskopolamín |
parent. 20 mg/ml |
60 |
mg |
|
|
|
|
|
|
|
|
1.72 |
|
|
|
98169 |
|
|
O |
BUSCOPAN |
sol inj 5x1 ml/20 mg |
BOE |
ES |
1.667 |
2.86 |
2.86 |
A |
0 |
0 |
0 |
|
|
|
|
|
A03DA02 |
|
|
|
Pitofenón kombinovaný s analgetikami |
parent. 2 mg/ml |
2 |
DF |
|
|
|
|
|
|
|
|
2.02 |
|
|
|
88709 |
|
|
O |
ANALGIN inj |
sol inj 5x5 ml |
BTA |
SK |
2.5 |
5.03 |
5.03 |
A |
0 |
0 |
0 |
|
|
|
|
|
A04AA01 |
|
|
|
Ondasetrón |
p.o. 8 mg (10 ks) |
16 |
mg |
|
|
|
|
|
|
|
|
2.93 |
|
|
|
95221 |
X |
|
G |
Onsetrogen 8 mg |
tbl flm 10x8 mg |
GNS |
GB |
5 |
14.61 |
14.61 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
A04AA01 |
|
|
|
Ondasetrón |
parent. 2 mg/ml |
16 |
mg |
|
|
|
|
|
|
|
|
3.95 |
|
|
|
35816 |
|
|
G |
Ondansetron Kabi 2 mg/ml |
sol inj 5x4 ml |
FRK |
DE |
2.5 |
9.84 |
9.84 |
A |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
20654 |
|
|
G |
Ondasetron Accord 2 mg/ml injekčný alebo infúzny roztok |
sol ijf 5x4 ml/8 mg (amp.skl.) |
ACC |
GB |
2.5 |
9.84 |
9.84 |
A |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
95220 |
|
|
G |
Onsetrogen 2 mg/ml |
sol inj 5x4 ml |
GNS |
GB |
2.5 |
9.84 |
9.84 |
A |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
A04AA02 |
|
|
|
Granisetrón |
p.o. 1 mg (10 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
5.2619999999999996 |
|
|
|
35777 |
X |
|
G |
Emegar 1 mg |
tbl flm 10x1 mg |
STD |
GB |
5 |
26.31 |
26.31 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
76410 |
X |
|
G |
Granegis 1 mg |
tbl flm 10x1 mg (blis. PVC/AI) |
EGI |
HU |
5 |
26.31 |
26.31 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
36399 |
X |
|
G |
Granisetron Mylan 1 mg |
tbl flm 10x1 mg |
GNS |
GB |
5 |
26.31 |
26.31 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
77279 |
X |
|
G |
Rasetron 1 mg |
tbl flm 10x1 mg (blis.PVC/Al) |
ACT |
IS |
5 |
26.31 |
26.31 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
A04AA02 |
|
|
|
Granisetrón |
p.o. 2 mg (5 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
5.2619999999999996 |
|
|
|
35796 |
X |
|
G |
Emegar 2 mg |
tbl flm 5x2 mg |
STD |
DE |
5 |
26.31 |
26.31 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
76412 |
X |
|
G |
Granegis 2 mg |
tbl flm 5x2 mg (blis. PVC/AI) |
EGI |
HU |
5 |
26.31 |
26.31 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
A04AA02 |
|
|
|
Granisetrón |
p.o. 2 mg (10 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
5.2619999999999996 |
|
|
|
35799 |
X |
|
G |
Emegar 2 mg |
tbl flm 10x2 mg |
STD |
DE |
10 |
52.62 |
52.62 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
77469 |
X |
|
G |
Rasetron 2 mg |
tbl flm 10x2 mg (blis.PVC/Al) |
ACT |
IS |
10 |
52.62 |
52.62 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
A04AA02 |
|
|
|
Granisetrón |
parent. 1 mg/ml |
3 |
mg |
|
|
|
|
|
|
|
|
8.0399999999999991 |
|
|
|
58987 |
|
|
G |
Granisetron Kabi 1 mg/ml |
con ijf 5x3 ml/3 mg |
FRK |
CZ |
5 |
37.450000000000003 |
37.450000000000003 |
A |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
49905 |
|
|
G |
Granisetron-Teva 3 mg/3 ml injekčný roztok |
con ijf 5x3 mg/3 ml (inj.liek.) |
PHM |
NL |
5 |
37.450000000000003 |
37.450000000000003 |
A |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
A04AA05 |
|
|
|
Palonosetrón |
p.o. 500 mcg (1 ks) |
100 |
mcg |
|
|
|
|
|
|
|
|
15.04 |
|
|
|
89919 |
|
|
O |
Aloxi 500 mcg mäkké kapsuly |
cps mol 1x500 mcg /blis.PA/Al/PVC/ |
HHC |
IE |
5 |
75.180000000000007 |
75.180000000000007 |
I |
0 |
0 |
0 |
HEM, ONK, PLM |
ind.obm. |
|
|
|
A04AA05 |
|
|
|
Palonosetrón |
parent. 50 mcg/ml |
50 |
mcg |
|
|
|
|
|
|
|
|
13.893000000000001 |
|
|
|
90114 |
|
|
O |
ALOXI |
sol inj 1x5 ml (250 mcg v amp.) |
HLS |
IE |
5 |
69.47 |
69.47 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
A04AD12 |
|
|
|
Aprepitant |
p.o. 80 mg (2 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
21.7 |
|
|
|
40848 |
X |
|
O |
EMEND |
cps dur 2x80 mg |
MSD |
GB |
2 |
43.37 |
43.37 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
A04AD12 |
|
|
|
Aprepitant |
p.o. 1x125 mg + 2x80 mg |
95 |
mg |
|
|
|
|
|
|
|
|
18.600000000000001 |
|
|
|
40852 |
X |
|
O |
EMEND |
cps dur 1x125 mg+ 2x80 mg |
MSD |
GB |
3 |
55.79 |
55.79 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
A05AA02 |
|
|
|
Kyselina ursodeoxycholínová |
p.o. 250 mg ( 100 ks) |
0.75 |
g |
|
|
|
|
|
|
|
|
0.78500000000000003 |
|
|
|
91017 |
X |
|
O |
URSOFALK |
cps 100x250 mg |
FAK |
DE |
33.332999999999998 |
26.09 |
26.09 |
I |
0 |
0 |
0 |
GER, GIT, HEP, INF, INT, KLF |
|
|
|
|
A05AA02 |
|
|
|
Kyselina ursodeoxycholínová |
p.o. 500 mg ( 100 ks) |
0.75 |
g |
|
|
|
|
|
|
|
|
0.92300000000000004 |
|
|
|
89458 |
X |
|
O |
Ursofalk |
tbl flm 100x500mg |
FAK |
DE |
66.667000000000002 |
61.47 |
61.47 |
I |
0 |
0 |
0 |
GER, GIT, HEP, INF, INT, KLF |
|
|
|
|
A06AG10 |
|
|
|
Dokusát sodný, vrátane kombinácií |
p.rect. 0,01 g (10 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
6.9539999999999997 |
|
|
|
92489 |
|
|
G |
YAL |
sol rec 10x67,5 ml |
TRM |
DE |
5 |
34.770000000000003 |
34.770000000000003 |
A |
0 |
0 |
0 |
CCH, CHI, GER, GIT, GYN, INT, KLF, ONK, PLM |
ind.obm. |
|
|
|
A06AH01 |
|
|
|
Metylnaltrexóniumbromid |
parent. 20 mg/ml |
12 |
mg |
|
|
|
|
|
|
|
|
25.283000000000001 |
|
|
|
51897 |
|
|
O |
RELISTOR |
sol inj 7 x 0,6 ml/12 mg |
TMC |
GB |
7 |
176.98 |
176.98 |
I |
0 |
0 |
0 |
AGG, ONK, PLM |
ind.obm. |
|
|
|
A06AX05 |
|
|
|
Prukaloprid |
p.o. 1 mg (28 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
3.6139999999999999 |
|
|
|
81447 |
|
|
O |
Resolor 1 mg filmom obalené tablety |
tbl flm 28x1x1 mg (blis.Al/Al) |
SHP-IE |
IE |
14 |
50.49 |
50.49 |
I |
0 |
0 |
0 |
GER, GIT, GYN, INT |
ind.obm. |
|
|
|
A06AX05 |
|
|
|
Prukaloprid |
p.o. 2 mg (28 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
2.71 |
|
|
|
81448 |
|
|
O |
Resolor 2 mg filmom obalené tablety |
tbl flm 28x1x2 mg (blis.Al/Al) |
SHP-IE |
IE |
28 |
75.67 |
75.67 |
I |
0 |
0 |
0 |
GER, GIT, GYN, INT |
ind.obm. |
|
|
|
A07EC01 |
|
|
|
Sulfasalazín |
p.o. 500 mg (100 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.53110000000000002 |
|
|
|
04304 |
X |
|
G |
SULFASALAZIN-EN |
tbl 100x578 mg |
KRK |
SI |
28.9 |
15.31 |
15.31 |
I |
0 |
0 |
0 |
GER, GIT, INT, KLF, REU |
|
|
|
|
A07EC02 |
|
|
|
Mesalazín |
p.o. 250 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
93235 |
X |
|
G |
SALOFALK 250 |
tbl ent 100x250 mg |
FAK |
DE |
16.666 |
15.66 |
15.66 |
I |
0 |
0 |
0 |
GER, GIT, INT, KLF |
|
|
|
U73 |
A07EC02 |
|
|
|
Mesalazín |
p.o. 500 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
75567 |
X |
|
G |
SALOFALK 500 |
tbl ent 100x500 mg |
FAK |
DE |
33.332999999999998 |
24.54 |
24.54 |
I |
0 |
0 |
0 |
GER, GIT, INT, KLF |
|
|
|
U73 |
A07EC02 |
|
|
|
Mesalazín |
p.rect. sus rec 1000 mg |
1.5 |
g |
|
|
|
|
|
|
|
|
4.641 |
|
|
|
45744 |
|
|
O |
PENTASA 1 G |
sus rec 7x1 g |
FEI |
DK |
4.6669999999999998 |
21.66 |
21.66 |
I |
0 |
0 |
0 |
GER, GIT, INT, KLF |
|
|
|
|
A07EC02 |
|
|
|
Mesalazín |
p.rect. sus rec 4000 mg |
1.5 |
g |
|
|
|
|
|
|
|
|
1.79 |
|
|
|
93770 |
|
|
O |
SALOFALK KLYSMEN |
sus rec 7x4 g/60 ml |
FAK |
DE |
18.667000000000002 |
33.26 |
33.26 |
I |
0 |
0 |
0 |
GER, GIT, INT, KLF |
|
|
|
|
A10AB01 |
|
|
|
Inzulín humánny |
parent. rýchle pôsobiaci 100 IU/ml |
40 |
UT |
|
|
|
|
|
|
|
|
0.55000000000000004 |
|
|
|
28593 |
|
|
O |
INSUMAN RAPID 100 IU/ml (liekovka) |
sol inj 1x5 ml/500 IU (100 IU/ml) (skl. liek.) |
AVT-D |
DE |
12.5 |
6.72 |
6.72 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10AB01 |
|
|
|
Inzulín humánny |
parent. rýchle pôsobiaci náplne 100 IU/ml (5 ks) |
40 |
UT |
|
|
|
|
|
|
|
|
0.59 |
|
|
|
66114 |
|
|
O |
Insuman Rapid |
sol inj 5x3 ml/300 IU (SoloStar-skl.nápl.v naplnen..pere) |
SAV-D |
DE |
37.5 |
21.99 |
21.99 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AB04 |
|
|
|
Inzulín lispro |
parent. pôsobiace krátkodobo 100 IU/ml |
40 |
UT |
|
|
|
|
|
|
|
|
0.78 |
|
|
|
89134 |
|
|
O |
HUMALOG 100 IU |
sol inj 1x10 ml |
LIL |
FR |
25 |
19.420000000000002 |
19.420000000000002 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AB06 |
|
|
|
Inzulín glulizín |
parent. SoloStar 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
0.81 |
|
|
|
36550 |
|
|
O |
APIDRA (SoloStar) |
sol inj 5x3 ml (100 IU/ml) (napl.pero-sklo-SoloStar) |
SAV-D |
DE |
37.5 |
29.86 |
29.86 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AC01 |
|
|
|
Inzulín humánny |
parent. strednodobo pôsobiaci 100 IU/ml |
40 |
UT |
|
|
|
|
|
|
|
|
0.61 |
|
|
|
28589 |
|
|
O |
INSUMAN BASAL 100 IU/ml (liekovka) |
sus inj 1x5 ml/500 IU (100 IU/ml) (skl. liek.) |
AVT-D |
DE |
12.5 |
7.5 |
7.5 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10AC01 |
|
|
|
Inzulín humánny |
parent. strednodobo pôsobiaci náplne 100 IU/ml (5ks) |
40 |
UT |
|
|
|
|
|
|
|
|
0.63500000000000001 |
|
|
|
28591 |
|
|
O |
INSUMAN BASAL 100 IU/ml (pre Optipen) |
sus inj 5x3 ml/300 IU (100 IU/ml) (napl. skl.) |
AVT-D |
DE |
37.5 |
23.47 |
23.47 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
66120 |
|
|
O |
Insuman Basal |
sus inj 5x3 ml/300 IU (SoloStar-skl.nápl.v naplnen.pere) |
SAV-D |
DE |
37.5 |
23.8 |
23.8 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AC01 |
|
|
|
Inzulín humánny |
parent. strednodobo pôsobiaci náplne 100 IU/ml (10 ks) |
40 |
UT |
|
|
|
|
|
|
|
|
0.63500000000000001 |
|
|
|
0196B |
|
|
O |
Humulin N (NPH) Cartridge |
sus inj 10 ( 2x5) x 3 ml/300IU (náplň skl.) |
LIL |
CZ |
75 |
47.5 |
47.5 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AD01 |
|
|
|
Inzulín humánny |
parent. komb. stred. a rých. pôsobiaci 100 IU/ml |
40 |
UT |
|
|
|
|
|
|
|
|
0.69 |
|
|
|
28581 |
|
|
O |
INSUMAN COMB 25 |
sus inj 1x5 ml/500 IU (100 IU/ml) (skl. liek.) |
AVT-D |
DE |
12.5 |
8.48 |
8.48 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10AD01 |
|
|
|
Inzulín humánny |
parent. komb. stred. a rých. pôsobiaci náplne 100 IU/ml |
40 |
UT |
|
|
|
|
|
|
|
|
0.63500000000000001 |
|
|
|
28583 |
|
|
O |
INSUMAN COMB 25 (pre Optipen) |
inj 5x3 ml/300 IU (100 IU/ml) (napl.skl.) |
AVT-D |
DE |
37.5 |
23.48 |
23.48 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
0197B |
|
|
O |
Humulin M3(30/70) Cartridge |
sus inj 10 (2x5) x 3 ml/300 IU (náplň skl.) |
LIL |
CZ |
75 |
47.5 |
47.5 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
66133 |
|
|
O |
Insuman Comb 25 |
sus inj 5x3 ml/300 IU (SoloStar-skl.nápl.v naplnen..pere) |
SAV-D |
DE |
37.5 |
23.8 |
23.8 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AE04 |
|
|
|
Inzulín glargín |
parent. pôsobiace dlhodobo náplň 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
1.1419999999999999 |
|
|
|
3137B |
|
|
B |
ABASAGLAR 100 jednotiek/ml injekčný roztok v náhradnej náplni |
sol inj 10x3 ml (náplň skl.) |
LIL - AT |
AT |
75 |
85.6 |
85.6 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10AE04 |
|
|
|
Inzulín glargín |
parent. pôsobiace dlhodobo SoloStar 100 IU/ml |
40 |
IU |
|
|
|
|
|
|
|
|
1.1299999999999999 |
|
|
|
2151B |
|
|
B |
ABASAGLAR 100 jednotiek/ml injekčný roztok naplnený v injekčnom pere |
sol inj 10(2x5)x3 ml (pero napl. skl.- KwikPen- multibal) |
LIL - AT |
AT |
75 |
84.58 |
84.58 |
I |
0 |
0 |
0 |
DIA, ENP |
ind.obm. |
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. 500 mg (50-60 ks) |
2 |
g |
|
|
|
|
|
|
|
|
7.5300000000000006E-2 |
|
|
|
76266 |
X |
|
G |
Metformín Bluefish 500 mg |
tbl flm 60x500 mg (blis. PVC/PVDC/Al) |
BLR |
SE |
15 |
1.1299999999999999 |
1.1299999999999999 |
I |
0 |
0 |
0 |
|
|
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. 850 mg (120 ks) |
2 |
g |
|
|
|
|
|
|
|
|
5.96E-2 |
|
|
|
76294 |
X |
|
G |
Metformín Bluefish 850 mg |
tbl flm 120x850 mg (blis. PVC/PVDC/Al) |
BLR |
SE |
51 |
3.04 |
3.04 |
I |
0 |
0 |
0 |
|
|
|
|
|
A10BA02 |
|
|
|
Metformín |
p.o. 1000 mg (120 ks) |
2 |
g |
|
|
|
|
|
|
|
|
0.08 |
|
|
|
85957 |
X |
|
G |
Metformin Mylan 1000 mg filmom obalené tablety (blis. PVC/Al) |
tbl flm 120x1000 mg |
GNS |
GB |
60 |
4.6500000000000004 |
4.6500000000000004 |
I |
0 |
0 |
0 |
|
|
|
|
|
9244A |
X |
|
G |
Diareg 1000 mg filmom obalené tablety |
tbl flm 120x1000 mg (blis.PVC/AL) |
MRG |
CR |
60 |
4.8 |
4.8 |
I |
0 |
0 |
0 |
|
|
|
|
|
A10BB01 |
|
|
|
Glibenklamid |
p.o. 5 mg (120 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
3.6499999999999998E-2 |
|
|
|
91880 |
X |
|
G |
MANINIL 5 |
tbl 120x5 mg |
BCE |
DE |
60 |
2.1800000000000002 |
2.1800000000000002 |
I |
0 |
0 |
0 |
|
|
|
|
|
A10BB01 |
|
|
|
Glibenklamid |
p.o. mikrokryšt. 3,5 mg (120 ks) |
7 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
18703 |
X |
|
G |
MANINIL 3,5 |
tbl 120x3,5 mg |
BCE |
DE |
60 |
2.64 |
2.64 |
I |
0 |
0 |
0 |
|
|
|
|
|
A10BB09 |
|
|
|
Gliklazid |
p.o. predĺžené uvoľňovanie 30 mg (120ks) |
60 |
mg |
|
|
|
|
|
|
|
|
0.1517 |
|
|
|
78487 |
X |
|
G |
Gliclazid Mylan 30 mg |
tbl mod 120x30 mg |
GNC |
GB |
60 |
7.61 |
7.61 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
47664 |
X |
|
G |
Gliclada 30 mg |
tbl mod 120x30 mg (blis.) |
KRK |
SI |
60 |
7.71 |
7.71 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 1 mg (30 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
92856 |
X |
|
G |
Glimepirid Sandoz 1 mg |
tbl 30x1 mg |
SAN |
AT |
15 |
0.99 |
0.99 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
35083 |
X |
|
G |
Glibezid 1 |
tbl 30x1 mg |
PRW |
CZ |
15 |
1.5 |
1.5 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 1 mg (120 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
35088 |
X |
|
G |
Glibezid 1 |
tbl 120x1 mg |
PRW |
CZ |
60 |
3.96 |
3.96 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 2 mg (30 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
6.9000000000000006E-2 |
|
|
|
92869 |
X |
|
G |
Glimepirid Sandoz 2 mg |
tbl 30x2 mg |
SAN |
AT |
30 |
1.92 |
1.92 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 2 mg (60 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
6.9000000000000006E-2 |
|
|
|
35059 |
X |
|
G |
Melyd 2 mg tablety |
tbl 60x2 mg |
STD |
DE |
60 |
4.1399999999999997 |
4.1399999999999997 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 2 mg (120 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
6.9000000000000006E-2 |
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 3 mg (30 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
92887 |
X |
|
G |
Glimepirid Sandoz 3 mg |
tbl 30x3 mg |
SAN |
AT |
45 |
3.04 |
3.04 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 4 mg (120 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
5.5E-2 |
|
|
|
36653 |
X |
|
G |
Glibezid 4 |
tbl 120x4 mg (blis.) |
PRW |
CZ |
240 |
12.54 |
12.54 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
35075 |
X |
|
G |
Melyd 4 mg tablety |
tbl 120x4 mg (blister PVC/Al) |
STD |
DE |
240 |
12.54 |
12.54 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 6 mg (30 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
0.12 |
|
|
|
36628 |
X |
|
G |
Oltar 6 mg |
tbl 30 x 6 mg |
MNR |
LU |
90 |
10.79 |
10.79 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BB12 |
|
|
|
Glimepirid |
p.o. 6 mg (120 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
0.12 |
|
|
|
36672 |
X |
|
G |
Glibezid 6 |
tbl 120x6 mg (bli.AI/PVC/PVDc) |
PRW |
CZ |
360 |
42.7 |
42.7 |
I |
0 |
0 |
0 |
DIA, ENP, GER, INT, KLF |
|
|
|
|
A10BD07 |
|
|
|
Sitagliptín a metformín |
p.o. 50 mg/1000 mg (56 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.5049999999999999 |
|
|
|
52215 |
|
|
O |
JANUMET |
tbl flm 56 x 50 mg/1000 mg |
MSD |
GB |
28 |
39.950000000000003 |
39.950000000000003 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD07 |
|
|
|
Sitagliptín a metformín |
p.o. 50 mg/1000 mg (168-196 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.5049999999999999 |
|
|
|
76789 |
|
|
O |
JANUMET |
tbl flm 196 x 50 mg/1000 mg |
MSD |
GB |
98 |
146.85 |
146.85 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD08 |
|
|
|
Vildagliptín a metformín |
p.o. 50 mg/1000 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.48 |
|
|
|
5891A |
|
|
O |
Eucreas 50mg/1000mg |
tbl flm 60x50mg/1000mg (blis.PCTFE/PVC/AI) |
NEH |
GB |
30 |
43.23 |
43.23 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD09 |
|
|
|
Pioglitazón a alogliptín |
p.o. 25 mg/30 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
1.325 |
|
|
|
7317A |
|
|
O |
Incresync 25 mg/30 mg filmom obalené tablety |
tbl flm 28x25 mg/30 mg (blis.NYL/Al/PVC) |
TAA |
DK |
28 |
37.090000000000003 |
37.090000000000003 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD10 |
|
|
|
Saxagliptín a metformín |
p.o. 2,5 mg/1000 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.444 |
|
|
|
30899 |
|
|
O |
Komboglyze 2,5 mg/1000 mg filmom obalené tablety |
tbl flm 60x2,5 mg/1000 mg (blis.Al/Al) |
BMS-GB-3 |
GB |
30 |
43.23 |
43.23 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD11 |
|
|
|
Linagliptín a metformín |
p.o. 2,5 mg/850 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.476 |
|
|
|
2270A |
|
|
O |
Jentadueto 2,5mg/850 mg filmom obalené tablety |
tbl flm 60x1x2,5 mg/850 mg (blis.Al/PVC/PCTFE/PVC-perf.) |
BOE |
DE |
30 |
43.36 |
43.36 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD11 |
|
|
|
Linagliptín a metformín |
p.o. 2,5 mg/850 mg (180 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.476 |
|
|
|
3746A |
|
|
O |
Jentadueto 2,5 mg/850 mg filmom obalené tablety |
tbl flm 180(2x90x1)x2,5 mg/850 mg (blis.Al/PVC/PCTFE/PVC-perf.viacpoč.) |
BOE |
DE |
90 |
131.72 |
131.72 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD11 |
|
|
|
Linagliptín a metformín |
p.o. 2,5 mg/1000 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.52 |
|
|
|
2284A |
|
|
O |
Jentadueto 2,5mg/1000 mg filmom obalené tablety |
tbl flm 60x1x2,5 mg/1000 mg (blis.Al/PVC/PCTFE/PVC-perf.) |
BOE |
DE |
30 |
43.36 |
43.36 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD11 |
|
|
|
Linagliptín a metformín |
p.o. 2,5 mg/1000 mg (180 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.52 |
|
|
|
3749A |
|
|
O |
Jentadueto 2,5 mg/1000 mg filmom obalené tablety |
tbl flm 180(2x90x1)x2,5 mg/1000 mg (blis.Al/PVC/PCTFE/PVC-perf.viacpoč.) |
BOE |
DE |
90 |
131.72 |
131.72 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD13 |
|
|
|
Metformín a alogliptín |
p.o. 12,5 mg/850 mg (56 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.325 |
|
|
|
7337A |
|
|
O |
Vipdomet 12,5 mg/850 mg filmom obalené tablety |
tbl flm 56x12,5 mg/850 mg (blis.PCTFE/PVC/Al) |
TAA |
DK |
28 |
36.85 |
36.85 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD13 |
|
|
|
Metformín a alogliptín |
p.o. 12,5 mg/1000 mg (56 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.325 |
|
|
|
7349A |
|
|
O |
Vipdomet 12,5 mg/1000 mg filmom obalené tablety |
tbl flm 56x12,5 mg/1000 mg (blis.PCTFE/PVC/Al) |
TAA |
DK |
28 |
36.85 |
36.85 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD16 |
|
|
|
Metformín a kanagliflozín |
p.o. 50 mg / 850 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.6910000000000001 |
|
|
|
9956A |
|
|
O |
Vokanamet 50 mg/850 mg filmom obalené tablety |
tbl flm 60x50 mg/850 mg (fľ.HDPE) |
JNS |
BE |
30 |
50.72 |
50.72 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD16 |
|
|
|
Metformín a kanagliflozín |
p.o. 50 mg / 1000 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
1.7350000000000001 |
|
|
|
9959A |
|
|
O |
Vokanamet 50 mg/1000 mg filmom obalené tablety |
tbl flm 60x50 mg/1000 mg (fľ.HDPE) |
JNS |
BE |
30 |
52.05 |
52.05 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD16 |
|
|
|
Metformín a kanagliflozín |
p.o. 150 mg / 850 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.8370000000000002 |
|
|
|
9962A |
|
|
O |
Vokanamet 150 mg/850 mg filmom obalené tablety |
tbl flm 60x150 mg/850 mg (fľ.HDPE) |
JNS |
BE |
30 |
85.11 |
85.11 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BD16 |
|
|
|
Metformín a kanagliflozín |
p.o. 150 mg / 1000 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.8370000000000002 |
|
|
|
9965A |
|
|
O |
Vokanamet 150 mg/1000 mg filmom obalené tablety |
tbl flm 60x150 mg/1000 mg (fľ.HDPE) |
JNS |
BE |
30 |
85.11 |
85.11 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BX09 |
|
|
|
Dapagliflozín |
p.o. 10 mg (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.544 |
|
|
|
3303A |
|
|
O |
Forxiga 10 mg filmom obalené tablety |
tbl flm 28x10 mg (blis.Al/Al-kalend.bal) |
BMS/AZ |
GB |
28 |
43.23 |
43.23 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BX09 |
|
|
|
Dapagliflozín |
p.o. 10 mg (98 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.544 |
|
|
|
3304A |
|
|
O |
Forxiga 10 mg filmom obalené tablety |
tbl flm 98x10 mg (blis.Al/Al-kalend.bal) |
BMS/AZ |
GB |
98 |
151.31 |
151.31 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BX11 |
|
|
|
Kanagliflozín |
p.o. 100 mg (100 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
1.6120000000000001 |
|
|
|
8116A |
|
|
O |
Invokana 100 mg filmom obalené tablety |
tbl flm 100x1x100 mg (blis.PVC/Al-perf.) |
JNS |
BE |
100 |
161.13 |
161.13 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BX12 |
|
|
|
Empagliflozín |
p.o. 10 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
1.52 |
|
|
|
0694B |
|
|
O |
Jardiance 10 mg filmom obalené tablety |
tbl flm 30x1x10 mg (blis PVC/Al.-perf.) |
BOE |
DE |
30 |
45.58 |
45.58 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BX12 |
|
|
|
Empagliflozín |
p.o. 10 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
1.52 |
|
|
|
0697B |
|
|
O |
Jardiance 10 mg filmom obalené tablety |
tbl flm 90x1x10 mg (blis PVC/Al.-perf.) |
BOE |
DE |
90 |
136.74 |
136.74 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BX12 |
|
|
|
Empagliflozín |
p.o. 25 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
1.52 |
|
|
|
0685B |
|
|
O |
Jardiance 25 mg filmom obalené tablety |
tbl flm 30x1x25 mg (blis PVC/Al.-perf.) |
BOE |
DE |
30 |
45.58 |
45.58 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A10BX12 |
|
|
|
Empagliflozín |
p.o. 25 mg (90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
1.52 |
|
|
|
0688B |
|
|
O |
Jardiance 25 mg filmom obalené tablety |
tbl flm 90x1x25 mg (blis PVC/Al.-perf.) |
BOE |
DE |
90 |
136.74 |
136.74 |
I |
0 |
0 |
0 |
DIA |
ind.obm. |
|
|
|
A11CC01 |
|
|
|
Ergokalciferol |
p.o. vitamín D a jeho analógy 300 KU (1 ks) |
6 |
KU |
|
|
|
|
|
|
|
|
2.9899999999999999E-2 |
|
|
|
00353 |
X |
|
G |
VITAMIN D SLOVAKOFARMA |
cps 1x300 KU |
ZNT |
SK |
50 |
1.37 |
1.37 |
I |
0 |
0 |
0 |
|
|
|
|
|
A11CC05 |
|
|
|
Cholekalciferol |
p.o. 0,5 mg/ml (10 ml) |
0.5 |
mg |
|
|
|
|
|
|
|
|
0.1593 |
|
|
|
12023 |
X |
|
O |
VIGANTOL OIL |
sol 10 ml 500 ug/ ml |
MEC |
DE |
10 |
1.57 |
1.57 |
I |
0 |
0 |
0 |
|
|
|
|
|
A12AA03 |
|
|
|
Glukonát vápenatý |
parent. 100 mg/ml |
3 |
g |
|
|
|
|
|
|
|
|
2.65 |
|
|
|
00407 |
|
|
G |
CALCIUM BIOTIKA |
sol inj 10x10 ml/1 g |
HBS |
SK |
3.3330000000000002 |
8.81 |
8.81 |
A |
0 |
0 |
0 |
|
|
|
|
|
A12AA07 |
|
|
|
Chlorid vápenatý |
parent. 100 mg/ml |
0.2 |
g |
|
|
|
|
|
|
|
|
0.14000000000000001 |
|
|
|
00409 |
|
|
G |
CALCIUM CHLORATUM BIOTIKA |
sol inj 5x10 ml 10% |
HBS |
SK |
25 |
3.2 |
3.2 |
A |
0 |
0 |
0 |
|
|
|
|
|
A12BA |
|
|
|
Draslík, horčík |
p.o. 175 mg (100 tbl) |
1 |
g |
|
|
|
|
|
|
|
|
1.1817 |
|
|
|
88356 |
X |
|
G |
CARDILAN |
tbl 100x175 mg |
ZNT |
SK |
3.798 |
4.46 |
4.46 |
I |
0 |
0 |
0 |
|
|
|
|
|
A12BA |
|
|
|
Draslík, horčík |
parent. |
3 |
DF |
|
|
|
|
|
|
|
|
1.8062 |
|
|
|
02132 |
|
|
G |
CARDILAN |
sol inj 10x10 ml |
HBS |
SK |
3.3330000000000002 |
6.02 |
6.02 |
A |
0 |
0 |
0 |
|
|
|
|
|
A12CC02 |
|
|
|
Síran horečnatý |
parent. 10 % |
1 |
g |
|
|
|
|
|
|
|
|
0.87 |
|
|
|
00498 |
|
|
G |
MAGNESIUM SULFURICUM BIOTIKA |
sol inj 5x10 ml 10% |
HBS |
SK |
5 |
4.3499999999999996 |
4.3499999999999996 |
A |
0 |
0 |
0 |
|
|
|
|
|
A12CC02 |
|
|
|
Síran horečnatý |
parent. 20 % |
1 |
g |
|
|
|
|
|
|
|
|
0.45200000000000001 |
|
|
|
00499 |
|
|
G |
MAGNESIUM SULFURICUM BIOTIKA |
sol inj 5x10 ml 20% |
HBS |
SK |
10 |
4.5199999999999996 |
4.5199999999999996 |
A |
0 |
0 |
0 |
|
|
|
|
|
A16AA01 |
|
|
|
Levokarnitín |
parent. 200 mg/ml |
2 |
g |
|
|
|
|
|
|
|
|
11.4 |
|
|
|
75602 |
|
|
O |
L-CARNITIN 'Fresenius' 1 g |
sol inj 5x5 ml/1 g |
FRK |
AT |
2.5 |
28.5 |
28.5 |
A |
0 |
0 |
0 |
GER, INT, KLF, NEF, PED |
|
|
|
|
A16AB02 |
|
|
|
Imigluceráza |
parent. 40 IU/ml |
300 |
IU |
|
|
|
|
|
|
|
|
1111.42 |
|
|
|
40761 |
|
|
O |
CEREZYME |
plv ifo 1x400 UT (40 IU/ ml) (skl. liekov.) |
GZE |
NL |
1.333 |
1481.52 |
1481.52 |
A |
0 |
0 |
0 |
PED |
ind.obm., ZP |
|
|
|
A16AB04 |
|
|
|
Agalzydáza beta |
parent. 5 mg/ml |
5 |
mg |
|
|
|
|
|
|
|
|
442.66399999999999 |
|
|
|
32646 |
|
|
O |
FABRAZYME 35 mg |
plc ifo 1x35 mg |
GBZ |
GB |
7 |
3098.65 |
3098.65 |
A |
0 |
0 |
0 |
PED |
ind.obm., ZP |
|
|
|
A16AB05 |
|
|
|
Laronidáza |
parent. 100 IU/ml |
100 |
IU |
|
|
|
|
|
|
|
|
123.59 |
|
|
|
40757 |
|
|
O |
ALDURAZYME |
con inf 1x5 ml (100 IU/ ml) (skl. liekov.) |
GZE |
NL |
5 |
617.94000000000005 |
617.94000000000005 |
A |
0 |
0 |
0 |
PED |
ind.obm., ZP |
|
|
|
A16AB07 |
|
|
|
Aglukozidáza |
parent. 50 mg (1ks) |
800 |
mg |
|
|
|
|
|
|
|
|
8427.83 |
|
|
|
98891 |
|
|
O |
Myozyme |
plc ifo 1x50 mg |
GZE |
NL |
0.06 |
505.67 |
505.67 |
A |
0 |
0 |
0 |
|
ind.obm., ZP |
|
|
|
A16AX01 |
|
|
|
Kyselina tioktová |
parent. 12 mg/ml (10 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
1.75 |
|
|
|
10890 |
|
|
G |
THIOGAMMA TURBO-SET |
sol inf 10x50 ml/600 mg |
WGP |
DE |
30 |
52.38 |
52.38 |
A |
0 |
0 |
0 |
ANG, DIA, GER, INT, KLF, NEU |
ind.obm. |
|
|
|
A16AX01 |
|
|
|
Kyselina tioktová |
parent. 25 mg/ml (5 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
1.82 |
|
|
|
86092 |
|
|
O |
THIOCTACID 600 T |
sol inj 5x24 ml/600 mg |
MDM |
DE |
15 |
26.95 |
26.95 |
A |
0 |
0 |
0 |
ANG, DIA, GER, INT, KLF, NEU |
ind.obm. |
|
|
|
A16AX06 |
|
|
|
Miglustat |
p.o. 100 mg (84 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
227.18 |
|
|
|
41411 |
|
|
O |
Zavesca 100 mg tvrdé kapsuly |
cps dur 84x100 mg (blis.Aclar/Al) |
ACB |
GB |
28 |
6360.95 |
6360.95 |
I |
0 |
0 |
0 |
|
ind.obm., ZP |
|
|
|
A16AX07 |
|
|
|
Sapropterin |
p.o. 100 mg (120 ks) |
20 |
mg/kg/deň |
|
|
|
|
|
|
|
|
4.8899999999999997 |
|
|
|
59281 |
|
|
O |
Kuvan |
tbl sol 120 x 100 mg |
MEC |
DE |
600 |
2932.32 |
2932.32 |
I |
0 |
0 |
0 |
|
ind.obm., ZP |
|
|
|
B01AA03 |
|
|
|
Warfarín |
p.o. 5 mg (100 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
9.5000000000000001E-2 |
|
|
|
24663 |
|
|
O |
WARFARIN ORION 5 mg |
tbl 100x5 mg |
ORN |
FI |
66.667000000000002 |
5.83 |
5.83 |
I |
0 |
0 |
0 |
|
|
|
|
U4 |
B01AB01 |
|
|
|
Heparín |
parent. 5 KU/ml |
10 |
KU |
|
|
|
|
|
|
|
|
3.5030000000000001 |
|
|
|
93746 |
|
|
O |
HEPARIN LÉČIVA |
sol inj 1x10 ml/50 KU |
ZNT |
CZ |
5 |
17.52 |
17.52 |
A |
0 |
0 |
0 |
|
|
|
|
|
B01AB04 |
|
|
|
Dalteparín |
parent. 25 KU/ml |
3 |
KU |
|
|
|
|
|
|
|
|
1.73 |
|
|
|
14825 |
|
|
O |
FRAGMIN 7500 IU (anti-Xa)/0,3 ml |
sol inj 10x0,3 ml (striek.inj.napl.jednor.) |
PFI-GB-3 |
GB |
25 |
36.270000000000003 |
36.270000000000003 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
14817 |
|
|
O |
FRAGMIN 5000 IU (anti-Xa)/0,2 ml |
sol inj 10x0,2 ml (striek.inj.napl.jednor.) |
PFI-GB-3 |
GB |
16.667000000000002 |
27.55 |
27.55 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
B01AB05 |
|
|
|
Enoxaparín |
parent. 150 mg/ml |
3 |
KU |
|
|
|
|
|
|
|
|
1.73 |
|
|
|
58810 |
|
|
O |
CLEXANE FORTE |
sol inj 10x1,0ml/150 mg |
AVT |
FR |
50 |
83.38 |
83.38 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
B01AB06 |
|
|
|
Nadroparín |
parent. 9,5 KU/ml |
3 |
KU |
|
|
|
|
|
|
|
|
1.73 |
|
|
|
62402 |
|
|
O |
FRAXIPARINE |
sol inj 10x0,8 ml/7,6 ku |
GLA |
GB |
25.332999999999998 |
37.450000000000003 |
37.450000000000003 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
96986 |
|
|
O |
FRAXIPARINE |
sol inj 10x0,6 ml/5,7 ku |
GLA |
GB |
19 |
29.84 |
29.84 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
97858 |
|
|
O |
FRAXIPARINE |
sol inj 10x0,4 ml/3,8 ku |
GLA |
GB |
12.667 |
20.149999999999999 |
20.149999999999999 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
96970 |
|
|
O |
FRAXIPARINE |
sol inj 10x0,3 ml/2,85 ku |
GLA |
GB |
9.5 |
15.73 |
15.73 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
B01AB06 |
|
|
|
Nadroparín |
parent. 9,5 KU/ml (10 ml) |
3 |
KU |
|
|
|
|
|
|
|
|
1.395 |
|
|
|
96988 |
|
|
O |
FRAXIPARINE |
sol inj 10x1 ml/9,5 ku |
GLA |
GB |
31.667000000000002 |
43.98 |
43.98 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
B01AB06 |
|
|
|
Nadroparín |
parent. 19 KU/ml |
3 |
KU |
|
|
|
|
|
|
|
|
1.73 |
|
|
|
59810 |
|
|
O |
FRAXIPARINE FORTE (19KU) |
sol inj 10x1,0 ml |
GLA |
GB |
63.332999999999998 |
91.58 |
91.58 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
59806 |
|
|
O |
FRAXIPARINE FORTE (11,4KU) |
sol inj 10x0,6 ml |
GLA |
GB |
38 |
56.56 |
56.56 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
59808 |
|
|
O |
FRAXIPARINE FORTE (15,2KU) |
sol inj 10x0,8 ml |
GLA |
GB |
50.667000000000002 |
80.22 |
80.22 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
B01AC11 |
|
|
|
Iloprost |
inhal.10 mcg/ml |
30 |
mcg |
|
|
|
|
|
|
|
|
36.871000000000002 |
|
|
|
40892 |
|
|
O |
VENTAVIS |
sol neb 30x2 ml/20 mcg |
BAS |
DE |
20 |
737.41 |
737.41 |
I |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
B01AC21 |
|
|
|
Treprostinil |
parent. 1mg/ml |
1 |
DF |
|
|
|
|
|
|
|
|
184.61 |
|
|
|
93637 |
|
|
O |
REMODULIN 1 mg/ml |
sol inf 1x20 ml/20 mg |
UNT |
GB |
15 |
2769.13 |
2769.13 |
A |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
B01AC21 |
|
|
|
Treprostinil |
parent. 2,5 mg/ml |
1 |
DF |
|
|
|
|
|
|
|
|
162.83000000000001 |
|
|
|
93639 |
|
|
O |
REMODULIN 2,5 mg/ml |
sol inf 1x20 ml/50 mg |
UNT |
GB |
37.5 |
6105.94 |
6105.94 |
A |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
B01AC21 |
|
|
|
Treprostinil |
parent. 5 mg/ml |
1 |
DF |
|
|
|
|
|
|
|
|
145.78 |
|
|
|
93638 |
|
|
O |
REMODULIN 5 mg/ml |
sol inf 1x20 ml/100 mg |
UNT |
GB |
75 |
10933.29 |
10933.29 |
A |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
B01AD11 |
|
|
|
Tenektepláza |
parent. 5 mg/ml (10 ml) |
10 |
KU |
|
|
|
|
|
|
|
|
811 |
|
|
|
40738 |
|
|
O |
METALYSE 10 KU |
plv iol 1x10 KU (50 mg) (1 liek. + 1 napln. striek. plast. 10 ml) |
BOE |
DE |
1 |
811 |
811 |
A |
0 |
0 |
0 |
ANS, INT, KAR, KLF, URM |
ind.obm. |
|
|
|
B01AE07 |
|
|
|
Dabigatranetexilát |
p.o. 110 mg (180 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
08300 |
X |
|
O |
Pradaxa 110 mg tvrdé kapsuly |
cps dur 180(3x60x1)x110 mg (blis.Al/Al) |
BOE |
DE |
90 |
213.99 |
213.99 |
I |
0 |
0 |
0 |
ANG, CCH, HEM, INT, KAR, NEU, ORT, UCH |
ind.obm. |
|
|
U5 |
B01AE07 |
|
|
|
Dabigatranetexilát |
p.o. 150 mg (180 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
08298 |
X |
|
O |
Pradaxa 150 mg tvrdé kapsuly |
cps dur 180(3x60x1)x150 mg (blis.Al/Al) |
BOE |
DE |
90 |
213.99 |
213.99 |
I |
0 |
0 |
0 |
ANG, CCH, HEM, INT, KAR, NEU |
ind.obm. |
|
|
U5 |
B01AF02 |
|
|
|
Apixabán |
p.o. 2,5 mg (168 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
3808A |
|
|
O |
Eliquis 2,5 mg filmom obalené tablety |
tbl flm 168x2,5 mg (blis.PVC/PVDC/Al) |
BMS-GB-4 |
GB |
84 |
199.75 |
199.75 |
I |
0 |
0 |
0 |
ANG, CCH, HEM, INT, KAR, NEU, ORT, UCH |
ind.obm. |
|
|
U5 |
B01AF02 |
|
|
|
Apixabán |
p.o. 5 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
3804A |
|
|
O |
ELIQUIS 5 mg filmom obalené tablety |
tbl flm 60x5 mg (blis.PVC/PVDC/Al) |
BMS-GB-4 |
GB |
30 |
71.290000000000006 |
71.290000000000006 |
I |
0 |
0 |
0 |
ANG, CCH, HEM, INT, KAR, NEU |
ind.obm. |
|
|
U5 |
B01AF02 |
|
|
|
Apixabán |
p.o. 5 mg (168 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
3806A |
|
|
O |
Eliquis 5 mg filmom obalené tablety |
tbl flm 168x5 mg (blis.PVC/PVDC/Al) |
BMS-GB-4 |
GB |
84 |
199.75 |
199.75 |
I |
0 |
0 |
0 |
ANG, CCH, HEM, INT, KAR, NEU |
ind.obm. |
|
|
U5 |
B01AX06 |
|
|
|
Rivaroxaban |
p.o. 15 mg (42 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
2.38 |
|
|
|
30833 |
|
|
O |
Xarelto 15 mg filmom obalené tablety |
tbl flm 42x15 mg (blis.PP/AI) |
BYE |
DE |
42 |
99.86 |
99.86 |
I |
0 |
0 |
0 |
ANG, HEM, INT, KAR, NEU, CCH |
ind.obm. |
|
|
U5 |
B02AA03 |
|
|
|
Kyselina aminometylbenzoová |
parent. 10 mg/ml |
0.25 |
g |
|
|
|
|
|
|
|
|
6.63 |
|
|
|
69793 |
|
|
G |
PAMBA |
sol inj 5x5 ml/50 mg |
CWO |
DE |
1 |
6.63 |
6.63 |
I |
0 |
0 |
0 |
|
|
|
|
|
B02BA01 |
|
|
|
Fytomenadión |
p.o. 20 mg/ml |
20 |
mg |
|
|
|
|
|
|
|
|
0.82799999999999996 |
|
|
|
00720 |
X |
|
G |
KANAVIT |
gte por 5 ml 20 mg/ ml |
ZNT |
SK |
5 |
4.1399999999999997 |
4.1399999999999997 |
I |
0 |
0 |
0 |
|
|
|
|
|
B02BA01 |
|
|
|
Fytomenadión |
parent. 10 mg/ml |
20 |
mg |
|
|
|
|
|
|
|
|
0.88629999999999998 |
|
|
|
00489 |
|
|
O |
KANAVIT |
sol inj 5x1 ml/10 mg |
HBS |
SK |
2.5 |
2.2200000000000002 |
2.2200000000000002 |
I |
0 |
0 |
0 |
|
|
|
|
|
B02BC |
|
|
|
Fibrínový lepiaci systém |
loc. |
1 |
ml |
|
|
|
|
|
|
|
|
98.53 |
|
|
|
14209 |
|
|
O |
Beriplast P Combi-Set 3 ml |
plv gtv 1x3 ml (liek.inj.skl.) |
CSL |
DE |
3 |
223.73 |
223.73 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
14208 |
|
|
O |
BERIPLAST P COMBI-SET |
plv gtv 1x1 ml |
CSL |
DE |
1 |
91.28 |
91.28 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD01 |
|
|
|
Koagulačné faktory IX., II.,VII. a X. v kombinácii |
parent. 500 IU |
350 |
UT |
|
|
|
|
|
|
|
|
278.43 |
|
|
|
36360 |
|
|
O |
Octaplex |
plv iol 1x 500 I.U. |
OPU |
AT |
1 |
249.32 |
249.32 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD02 |
|
|
|
Faktor VIII. |
parent. 250 IU |
500 |
UT |
|
|
|
|
|
|
|
|
211.12 |
|
|
|
58278 |
|
|
O |
OCTANATE 250 IU |
plv iol 1x250 UT+ sol. |
OCP |
AT |
0.5 |
91.31 |
91.31 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD02 |
|
|
|
Faktor VIII. |
parent. rekomb. 250 IU |
500 |
UT |
|
|
|
|
|
|
|
|
354.69 |
|
|
|
36432 |
|
|
O |
KOGENATE Bayer |
plv iol 1x250 IU (1x skl. liek. – powder +1x skl. naplnená striek. - solv. + 1x adaptér pre liek.) |
BAS |
DE |
0.5 |
177.34 |
177.34 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
13143 |
|
|
O |
ReFacto AF 250 IU, prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x250 IU (liek.skl.)+4 ml solv. |
PFI-GB-1 |
GB |
0.5 |
177.34 |
177.34 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD02 |
|
|
|
Faktor VIII. |
parent. 500 IU |
500 |
UT |
|
|
|
|
|
|
|
|
178.8 |
|
|
|
58279 |
|
|
O |
OCTANATE 500 IU |
plv iol 1x500 UT+ sol. |
OCP |
AT |
1 |
175.13 |
175.13 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD02 |
|
|
|
Faktor VIII. |
parent. rekomb. 500 IU |
500 |
UT |
|
|
|
|
|
|
|
|
346.06 |
|
|
|
36433 |
|
|
O |
KOGENATE Bayer |
plv iol 1x500 IU (1x skl. liek. – powder +1x skl. naplnená striek. - solv. + 1x adaptér pre liek.) |
BAS |
DE |
1 |
346.06 |
346.06 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
13142 |
|
|
O |
ReFacto AF 500 IU, prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x500 IU (liek.skl.)+4 ml solv. |
PFI-GB-1 |
GB |
1 |
346.06 |
346.06 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD02 |
|
|
|
Faktor VIII. |
parent. nad 500 IU |
500 |
UT |
|
|
|
|
|
|
|
|
163.58000000000001 |
|
|
|
15009 |
|
|
O |
OCTANATE 1000 IU |
plv iol 1x1000 UT+ sol. |
OCP |
AT |
2 |
327.14 |
327.14 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD02 |
|
|
|
Faktor VIII. |
parent. rekomb. nad 500 IU |
500 |
UT |
|
|
|
|
|
|
|
|
346.06 |
|
|
|
36434 |
|
|
O |
KOGENATE Bayer |
plv iol 1x1000 IU (1x skl. liek. – powder +1x skl. naplnená striek. - solv. + 1x adaptér pre liek.) |
BAS |
DE |
2 |
682.29 |
682.29 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
13141 |
|
|
O |
ReFacto AF 1000 IU, prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x1000 IU (liek.skl.)+4 ml solv. |
PFI-GB-1 |
GB |
2 |
682.29 |
682.29 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD03 |
|
|
|
Faktor VIII. |
parent. inhibitor bypassing. aktivity 500 IU |
10 |
KU |
|
|
|
|
|
|
|
|
7.81 |
|
|
|
85676 |
|
|
O |
FEIBA NF |
plo jof 1x500 ut+solv. |
BXG |
AT |
50 |
390.27 |
390.27 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD03 |
|
|
|
Faktor VIII. |
parent. inhibitor bypassing. aktivity 1000 IU |
10 |
KU |
|
|
|
|
|
|
|
|
9.02 |
|
|
|
85677 |
|
|
O |
FEIBA NF |
plo jof 1x1000 ut + solv. |
BXG |
AT |
100 |
900.56 |
900.56 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD04 |
|
|
|
Faktor IX. |
parent. 500 IU |
350 |
UT |
|
|
|
|
|
|
|
|
150.82 |
|
|
|
14110 |
|
|
O |
OCTANINE F 500 IU |
plv iol 1x500 UT+ sol. |
OCP |
AT |
1.4 |
211.14 |
211.14 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD04 |
|
|
|
Faktor IX. |
parent. 1000 IU |
350 |
UT |
|
|
|
|
|
|
|
|
115.01300000000001 |
|
|
|
14112 |
|
|
O |
OCTANINE F 1000 IU |
plv iol 1x1000 UT+ sol. |
OCP |
AT |
2.9 |
333.54 |
333.54 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD04 |
|
|
|
Faktor IX. |
parent. 1200 IU |
350 |
UT |
|
|
|
|
|
|
|
|
130.38999999999999 |
|
|
|
75080 |
|
|
O |
IMMUNINE 1200I.E. |
plv iio 1,2 ku+10 ml |
BXG |
AT |
3.4289999999999998 |
447.1 |
447.1 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD05 |
|
|
|
Faktor VII. |
parent. |
6 |
KU |
|
|
|
|
|
|
|
|
3890.3613999999998 |
|
|
|
90099 |
|
|
O |
FACTOR VII NF Baxter |
plv iol 600 ut+solv. |
BAX |
AT |
8.3000000000000004E-2 |
322.89999999999998 |
322.89999999999998 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD06 |
|
|
|
Faktor VIII. a VWF |
parent. 250 IU |
500 |
UT |
|
|
|
|
|
|
|
|
255.67 |
|
|
|
89027 |
|
|
O |
IMMUNATE BAXTER 250 |
plv iol 1x250 IU+ 5 ml solv. |
BXG |
AT |
0.5 |
95.2 |
95.2 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
87238 |
|
|
O |
FANHDI 25 I.U./ml |
plv iol 1x250 UT + sol. |
GFO |
ES |
0.5 |
123.46 |
123.46 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD06 |
|
|
|
Faktor VIII. a VWF |
parent. 500 IU |
500 |
UT |
|
|
|
|
|
|
|
|
221.84 |
|
|
|
89028 |
|
|
O |
IMMUNATE BAXTER 500 |
plv iol 1x500 IU+ 5 ml solv. |
BXG |
AT |
1 |
174.76 |
174.76 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
87239 |
|
|
O |
FANHDI 50 I.U./ml |
plv iol 1x500 UT + sol. |
GFO |
ES |
1 |
207.91 |
207.91 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD06 |
|
|
|
Faktor VIII. a VWF |
parent. 1000 IU |
500 |
UT |
|
|
|
|
|
|
|
|
216.36 |
|
|
|
89029 |
|
|
O |
IMMUNATE BAXTER 1000 |
plv iol 1x1000 IU+10 ml solv. |
BAX |
AT |
2 |
343.21 |
343.21 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
87240 |
|
|
O |
FANHDI 100 I.U./ml |
plv iol 1x1 KU + sol. |
GFO |
ES |
2 |
409.45 |
409.45 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD06 |
|
|
|
Faktor VIII. a VWF |
parent. 1500 IU |
500 |
UT |
|
|
|
|
|
|
|
|
248.63 |
|
|
|
92698 |
|
|
O |
FANHDI 100 IU/ml |
plv iol 1x1500 IU+15 ml sol. |
GFO |
ES |
3 |
745.86 |
745.86 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD08 |
|
|
|
Eptakog alfa aktivovaný |
parent. termostabilný 50 KIU |
2500 |
U |
|
|
|
|
|
|
|
|
32.53 |
|
|
|
50726 |
|
|
O |
NovoSeven 1mg (50KIU) |
plv iol 1x1mg+solv. (skl. liek.) |
NOO |
DK |
20 |
650.39 |
650.39 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD08 |
|
|
|
Eptakog alfa aktivovaný |
parent. termostabilný 100 KIU |
2500 |
U |
|
|
|
|
|
|
|
|
32.290999999999997 |
|
|
|
50727 |
|
|
O |
NovoSeven 2mg (100KIU) |
plv iol 1x2mg+solv. (skl. liek.) |
NOO |
DK |
40 |
1291.6300000000001 |
1291.6300000000001 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BD10 |
|
|
|
Von Willebrandov faktor |
parent. 1000 IU |
1000 |
IU |
|
|
|
|
|
|
|
|
901.56 |
|
|
|
05883 |
|
|
O |
Willfact |
plv io 1x1000 IU + 1x10 ml solv. (liek.inj.skl.) |
LFM |
FR |
1 |
901.56 |
901.56 |
A |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
B02BX04 |
|
|
|
Romiplostim |
parent. 500 mcg/ml |
30 |
mcg |
|
|
|
|
|
|
|
|
72.881 |
|
|
|
86037 |
|
|
O |
Nplate |
plv iol 1x(250 mcg+0,72 ml solv.)(liek.skl.+napl.inj.striek.) |
AMG |
NL |
8.3330000000000002 |
607.32000000000005 |
607.32000000000005 |
A |
0 |
0 |
0 |
HEM |
ind.obm., ZP |
|
|
|
B02BX05 |
|
|
|
Eltrombopag |
p.o. 25 mg (28 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
68.77 |
|
|
|
87601 |
|
|
O |
Revolade |
tbl flm 28x25 mg |
NEH-1 |
GB |
14 |
962.71 |
962.71 |
I |
0 |
0 |
0 |
HEM |
ind.obm., ZP |
|
|
|
B02BX05 |
|
|
|
Eltrombopag |
p.o. 50 mg (28 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
69.293000000000006 |
|
|
|
87609 |
|
|
O |
Revolade |
tbl flm 28x50mg |
NEH-1 |
GB |
28 |
1940.2 |
1940.2 |
I |
0 |
0 |
0 |
HEM |
ind.obm., ZP |
|
|
|
B03AC02 |
|
|
|
Sacharózový komplex s trojmocným železom |
parent. na prvkové železo i.v. 20 mg/ml |
0.1 |
g |
|
|
|
|
|
|
|
|
12.56 |
|
|
|
07620 |
|
|
O |
Venofer |
sol inj 5 x 5 ml/100 mg |
VIF |
CH |
5 |
62.79 |
62.79 |
A |
0 |
0 |
0 |
|
|
|
|
|
B03AE10 |
|
|
|
Rôzne kombinácie |
p.o. 100 mg (50 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.1008 |
|
|
|
97402 |
|
|
G |
SORBIFER DURULES |
tbl flm 50x100 mg |
EGI |
HU |
50 |
4.53 |
4.53 |
I |
0 |
0 |
0 |
|
|
|
|
|
B03BA01 |
|
|
|
Kyanokobalamín |
parent. 0,3 mg/ml |
0.02 |
mg |
|
|
|
|
|
|
|
|
0.06 |
|
|
|
00641 |
|
|
O |
VITAMIN B12 LÉČIVA |
sol inj 5x1 ml/300 ug |
ZNT |
CZ |
75 |
1.7 |
1.7 |
I |
0 |
0 |
0 |
|
|
|
|
|
B03BA01 |
|
|
|
Kyanokobalamín |
parent. 1 mg/ml |
0.02 |
mg |
|
|
|
|
|
|
|
|
0.01 |
|
|
|
00643 |
|
|
O |
VITAMIN B12 LÉČIVA |
sol inj 5x1 ml/1000 ug |
ZNT |
CZ |
250 |
2.2799999999999998 |
2.2799999999999998 |
I |
0 |
0 |
0 |
|
|
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 2000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
6.3 |
|
|
|
28689 |
|
|
O |
NEORECORMON 2000 IU |
sol inj 6x 0,3 ml/2000 IU (predp.inj.striek.) |
HLR |
GB |
12 |
75.510000000000005 |
75.510000000000005 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 3000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
6.54 |
|
|
|
14548 |
|
|
O |
NEORECORMON 3000 IU |
sol inj 6x 0,3 ml/3000 IU (predp.inj.striek.) |
HLR |
GB |
18 |
117.54 |
117.54 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 4000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
6.09 |
|
|
|
06221 |
|
|
O |
NEORECORMON 4000 IU |
sol inj 6x0,3 ml/4000 IU(predp.inj.striek.) |
HLR |
GB |
24 |
145.99 |
145.99 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 5000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
7.17 |
|
|
|
28690 |
|
|
O |
NEORECORMON 5000 IU |
sol inj 6x 0,3 ml/5000 IU (predp.inj.striek.) |
HLR |
GB |
30 |
214.86 |
214.86 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 6000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
6.48 |
|
|
|
41488 |
|
|
O |
NEORECORMON 6000 IU |
sol inj 6x0,3 ml/6000 IU(predp.inj.striek.) |
HLR |
GB |
36 |
232.79 |
232.79 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 10 000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
4.4000000000000004 |
|
|
|
45105 |
|
|
O |
Binocrit 10 000IU/1 ml injekčný roztok v naplnenej injekčnej striekačke |
sol inj 6x1,0 ml/10000 IU |
SAN |
AT |
60 |
263.93 |
263.93 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
81634 |
|
|
O |
Biopoin 10000 IU/1 ml injekčný roztok v naplnenej injekčnej striekačke |
sol inj, 6x1,0 ml/10000 IU (striek.skl.napl.s bezpeč.zar.) |
CTA |
DE |
60 |
263.93 |
263.93 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 20 000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
4.93 |
|
|
|
81640 |
|
|
O |
Biopoin 20000 IU/1 ml injekčný roztok v naplnenej injekčnej striekačke |
sol inj, 6x1,0 ml/20000 IU (striek.skl.napl.s bezpeč.zar.) |
CTA |
DE |
120 |
574.76 |
574.76 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 30 000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
4.3099999999999996 |
|
|
|
05752 |
|
|
O |
Binocrit |
sol iru 6x0,75 ml/30000 IU (striek.inj.skl.napl.+ochr.kryt ihly) |
SAN |
AT |
180 |
774 |
774 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
81646 |
|
|
O |
Biopoin 30000 IU/1 ml injekčný roztok v naplnenej injekčnej striekačke |
sol inj, 6x1,0 ml/30000 IU (striek.skl.napl.s bezpeč.zar.) |
CTA |
DE |
180 |
774 |
774 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
65691 |
|
|
B |
Retacrit |
sol inj 6x0,75 ml/30 000 IU |
HSP |
GB |
180 |
774 |
774 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA01 |
|
|
|
Erytropoetín |
parent. 40 000 IU |
1 |
KU |
|
|
|
|
|
|
|
|
4.83 |
|
|
|
05754 |
|
|
O |
Binocrit |
sol iru 6x1 ml/40000 IU (striek.inj.skl.napl.+ochr.kryt ihly) |
SAN |
AT |
240 |
1159.1400000000001 |
1159.1400000000001 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
65693 |
|
|
B |
Retacrit |
sol inj 6x1 ml/40 000 IU |
HSP |
GB |
240 |
1159.1400000000001 |
1159.1400000000001 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
B03XA02 |
|
|
|
Darbepoetín alfa |
parent. 10 mcg |
4.5 |
mcg |
|
|
|
|
|
|
|
|
8.3109999999999999 |
|
|
|
40697 |
|
|
O |
Aranesp 10 mcg |
sol inj 1x0,4 ml/10 µg (napl.skl.striek.- blistr.bal.) |
AMG |
NL |
2.222 |
18.47 |
18.47 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA02 |
|
|
|
Darbepoetín alfa |
parent. 20 mcg |
4.5 |
mcg |
|
|
|
|
|
|
|
|
7.4539999999999997 |
|
|
|
76210 |
|
|
O |
Aranesp 20 mcg |
sol inj 1x0,5 ml/20 mcg (napl. skl.striek.+ kryt ihly - blistr.bal.) |
AMG |
NL |
4.444 |
33.130000000000003 |
33.130000000000003 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA02 |
|
|
|
Darbepoetín alfa |
parent. 60 mcg |
4.5 |
mcg |
|
|
|
|
|
|
|
|
6.84 |
|
|
|
76238 |
|
|
O |
Aranesp 60 mcg |
sol inj 1x0,3 ml/60 mcg (napl. skl.striek.+ kryt ihly - blistr.bal.) |
AMG |
NL |
13.333 |
91.14 |
91.14 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA02 |
|
|
|
Darbepoetín alfa |
parent. 80 mcg |
4.5 |
mcg |
|
|
|
|
|
|
|
|
6.9640000000000004 |
|
|
|
76247 |
|
|
O |
Aranesp 80 mcg |
sol inj 1x0,4 ml/80 mcg (napl. skl.striek.+ kryt ihly - blistr.bal.) |
AMG |
NL |
17.777999999999999 |
123.81 |
123.81 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA02 |
|
|
|
Darbepoetín alfa |
parent. 100 mcg |
4.5 |
mcg |
|
|
|
|
|
|
|
|
7.2750000000000004 |
|
|
|
76249 |
|
|
O |
Aranesp 100 mcg |
sol inj 1x0,5 ml/100 mcg (napl. skl.striek.+ kryt ihly - blistr.bal.) |
AMG |
NL |
22.222000000000001 |
161.65 |
161.65 |
A |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA02 |
|
|
|
Darbepoetín alfa |
parent. 150 mcg |
4.5 |
mcg |
|
|
|
|
|
|
|
|
6.782 |
|
|
|
76253 |
|
|
O |
Aranesp 150 mcg |
sol inj 1x0,3 ml/150 mcg (napl. skl.striek.+ kryt ihly - blistr.bal.) |
AMG |
NL |
33.332999999999998 |
225.86 |
225.86 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA02 |
|
|
|
Darbepoetín alfa |
parent. 300 mcg |
4.5 |
mcg |
|
|
|
|
|
|
|
|
6.7 |
|
|
|
76255 |
|
|
O |
Aranesp 300 mcg |
sol inj 1x0,6 ml/300 mcg (napl. skl.striek.+ kryt ihly) |
AMG |
NL |
66.667000000000002 |
446.59 |
446.59 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA02 |
|
|
|
Darbepoetín alfa |
parent. 500 mcg |
4.5 |
mcg |
|
|
|
|
|
|
|
|
6.7830000000000004 |
|
|
|
76257 |
|
|
O |
Aranesp 500 mcg |
sol inj 1x1 ml/500 mcg (napl. skl.striek.+ kryt ihly) |
AMG |
NL |
111.111 |
753.62 |
753.62 |
I |
0 |
0 |
0 |
HEM, NEF, ONK, PED |
ind.obm. |
|
|
|
B03XA03 |
|
|
|
Metoxypolyetylénglykol epoetín beta |
parent. 30 mcg |
4 |
mcg |
|
|
|
|
|
|
|
|
7.5430000000000001 |
|
|
|
53298 |
|
|
O |
MIRCERA 30 mcg/0,3 ml |
sol inj 1x0,3 ml/30 mcg (napl. inj. striek.) |
HLR |
GB |
7.5 |
56.56 |
56.56 |
A |
0 |
0 |
0 |
HEM, NEF |
ind.obm. |
|
|
|
B03XA03 |
|
|
|
Metoxypolyetylénglykol epoetín beta |
parent. 50 mcg |
4 |
mcg |
|
|
|
|
|
|
|
|
7.27 |
|
|
|
44653 |
|
|
O |
MIRCERA 50 mcg/0,3 ml |
sol inj 1x0,3 ml/50 mcg (napl. inj. striek.) |
HLR |
GB |
12.5 |
90.84 |
90.84 |
A |
0 |
0 |
0 |
HEM, NEF |
ind.obm. |
|
|
|
B03XA03 |
|
|
|
Metoxypolyetylénglykol epoetín beta |
parent. 75 mcg |
4 |
mcg |
|
|
|
|
|
|
|
|
7.1420000000000003 |
|
|
|
44654 |
|
|
O |
MIRCERA 75 mcg/0,3 ml |
sol inj 1x0,3 ml/75 mcg (napl. inj. striek.) |
HLR |
GB |
18.8 |
134.27000000000001 |
134.27000000000001 |
A |
0 |
0 |
0 |
HEM, NEF |
ind.obm. |
|
|
|
B03XA03 |
|
|
|
Metoxypolyetylénglykol epoetín beta |
parent. 100 mcg |
4 |
mcg |
|
|
|
|
|
|
|
|
7.11 |
|
|
|
44660 |
|
|
O |
MIRCERA 100 mcg/0,3 ml |
sol inj 1x0,3 ml/100 mcg (napl. inj. striek.) |
HLR |
GB |
25 |
177.69 |
177.69 |
A |
0 |
0 |
0 |
HEM, NEF |
ind.obm. |
|
|
|
B03XA03 |
|
|
|
Metoxypolyetylénglykol epoetín beta |
parent. 120 mcg |
4 |
mcg |
|
|
|
|
|
|
|
|
7.1630000000000003 |
|
|
|
53301 |
|
|
O |
MIRCERA 120 mcg/0,3 ml |
sol inj 1x0,3 ml/120 mcg (napl. inj. striek.) |
HLR |
GB |
30 |
214.89 |
214.89 |
A |
0 |
0 |
0 |
HEM, NEF |
ind.obm. |
|
|
|
B03XA03 |
|
|
|
Metoxypolyetylénglykol epoetín beta |
parent. 150 mcg |
4 |
mcg |
|
|
|
|
|
|
|
|
7.05 |
|
|
|
44661 |
|
|
O |
MIRCERA 150 mcg/0,3 ml |
sol inj 1x0,3 ml/150 mcg (napl. inj. striek.) |
HLR |
GB |
37.5 |
264.24 |
264.24 |
A |
0 |
0 |
0 |
HEM, NEF |
ind.obm. |
|
|
|
B03XA03 |
|
|
|
Metoxypolyetylénglykol epoetín beta |
parent. 200 mcg |
4 |
mcg |
|
|
|
|
|
|
|
|
7.0149999999999997 |
|
|
|
44662 |
|
|
O |
MIRCERA 200 mcg/0,3 ml |
sol inj 1x0,3 ml/200 mcg (napl. inj. striek.) |
HLR |
GB |
50 |
350.69 |
350.69 |
A |
0 |
0 |
0 |
HEM, NEF |
ind.obm. |
|
|
|
B03XA03 |
|
|
|
Metoxypolyetylénglykol epoetín beta |
parent. 250 mcg |
4 |
mcg |
|
|
|
|
|
|
|
|
7.0750000000000002 |
|
|
|
44663 |
|
|
O |
MIRCERA 250 mcg/0,3 ml |
sol inj 1x0,3 ml/250 mcg (napl. inj. striek.) |
HLR |
GB |
62.5 |
442.16 |
442.16 |
A |
0 |
0 |
0 |
HEM, NEF |
ind.obm. |
|
|
|
B05AA01 |
|
|
|
Albumín |
parent. 5% |
20 |
g |
|
|
|
|
|
|
|
|
76.3 |
|
|
|
97907 |
|
|
O |
HUMAN ALBUMIN GRIFOLS 5% I.V. |
sol inf 1x250 ml |
GFO |
ES |
0.625 |
47.68 |
47.68 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05AA01 |
|
|
|
Albumín |
parent. 20% |
20 |
g |
|
|
|
|
|
|
|
|
64.319999999999993 |
|
|
|
62471 |
|
|
O |
HUMAN ALBUMIN 20% IMMUNO |
sol inf 1x100 ml |
BXG |
AT |
1 |
64.31 |
64.31 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05AA06 |
|
|
|
Želatína |
parent. 4 % (500 ml) |
27.5 |
g |
|
|
|
|
|
|
|
|
5.47 |
|
|
|
27455 |
|
|
G |
Gelofusine |
sol inf 10x500 ml (PE fľa.-Ecoflac Plus) |
BME |
DE |
7.27 |
39.67 |
39.67 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05AA07 |
|
|
|
Hydroxyetylškrob |
parent. 6 % |
50 |
g |
|
|
|
|
|
|
|
|
12.18 |
|
|
|
37061 |
|
|
G |
Tetraspan 6% |
sol inf 20x500 ml (vak) |
BME |
DE |
12 |
146.11000000000001 |
146.11000000000001 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05AA07 |
|
|
|
Hydroxyetylškrob |
parent. 10 % |
50 |
g |
|
|
|
|
|
|
|
|
10.220000000000001 |
|
|
|
37067 |
|
|
G |
Tetraspan 10% |
sol inf 20x500 ml (vak) |
BME |
DE |
20 |
204.16 |
204.16 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05BA03 |
|
|
|
Cukry |
parent. glukóza 5% (100 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.9 |
|
|
|
97728 |
|
|
G |
GLUCOSE 5%W/V I.V.B.P. BIEFFE |
sol inf 1x100 ml (sklo) |
BFF |
IT |
1 |
0.89 |
0.89 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05BA03 |
|
|
|
Cukry |
parent. glukóza 5% (250 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.40100000000000002 |
|
|
|
34406 |
|
|
O |
Glukóza 5% Baxter-Viaflo |
sol inf 30x250 ml (vak POF/PA) |
BAX-CZ-1 |
CZ |
75 |
29.76 |
29.76 |
A |
0 |
0 |
0 |
|
|
|
|
|
34253 |
|
|
G |
Glukóza 5 Braun inf. |
sol inf 10x250 ml (PE fľa.) |
BME |
DE |
25 |
10.01 |
10.01 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05BA03 |
|
|
|
Cukry |
parent. glukóza 5% (400-500 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
34254 |
|
|
G |
Glukóza 5 Braun inf. |
sol inf 10x500 ml (PE fľa.) |
BME |
DE |
50 |
10.49 |
10.49 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05BA03 |
|
|
|
Cukry |
parent. glukóza 10% (400-500 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.26100000000000001 |
|
|
|
34261 |
|
|
G |
Glukóza 10 Braun inf. |
sol inf 10x500 ml (PE fľa.) |
BME |
DE |
50 |
12.93 |
12.93 |
A |
0 |
0 |
0 |
|
|
|
|
|
97736 |
|
|
G |
GLUCOSE 10%W/V I.V.B.P.BIEFFE |
sol inf 1x500 ml (sklo) |
BFF |
IT |
5 |
1.31 |
1.31 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05BA03 |
|
|
|
Cukry |
parent. glukóza 20% (400-500 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.32300000000000001 |
|
|
|
97738 |
|
|
G |
GLUCOSE 20%W/V I.V.B.P.BIEFFE |
sol inf 1x500 ml (sklo) |
BFF |
IT |
5 |
1.62 |
1.62 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05BA03 |
|
|
|
Cukry |
parent. glukóza 40% (400-500 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.42 |
|
|
|
34273 |
|
|
G |
Glukóza 40 Braun inf. |
sol inf 10x500 ml (PE fľa.) |
BME |
DE |
50 |
20.53 |
20.53 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05BB01 |
|
|
|
Elektrolyty |
parent. chlorid sodný 0,9% (5- 10 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
2.2200000000000002 |
|
|
|
27789 |
|
|
G |
Chlorid sodný 0,9% Braun Injekčný roztok |
sol inj 20x10 ml (PE amp.) |
BME |
DE |
2 |
4.4400000000000004 |
4.4400000000000004 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05BB01 |
|
|
|
Elektrolyty |
parent. chlorid sodný 0,9% (100 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.89 |
|
|
|
97748 |
|
|
G |
SODIUM CHLORIDE 0,9%W/V I.V. INF |
sol inf 1x100 ml (sklo) |
BFF |
IT |
1 |
0.89 |
0.89 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05BB01 |
|
|
|
Elektrolyty |
parent. chlorid sodný 0,9% (200- 250 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.38 |
|
|
|
97749 |
|
|
G |
SODIUM CHLORIDE 0,9%W/V I.V. INF |
sol inf 1x250 ml (sklo) |
BFF |
IT |
2.5 |
0.95 |
0.95 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05BB01 |
|
|
|
Elektrolyty |
parent. chlorid sodný 0,9% (400-500 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.23 |
|
|
|
97750 |
|
|
G |
SODIUM CHLORIDE 0,9%W/V I.V. INF B |
sol inf 1x500 ml (sklo) |
BFF |
IT |
5 |
1.1299999999999999 |
1.1299999999999999 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05BB01 |
|
|
|
Elektrolyty |
parent. chlorid sodný 0,9% (1000 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.21 |
|
|
|
13907 |
|
|
G |
Chlorid sodný 0,9 % Braun Infúzny Intravenózny roztok |
sol inf 10x1000 ml (PE obal) |
BME |
DE |
100 |
14.92 |
14.92 |
A |
0 |
0 |
0 |
|
|
|
|
|
33596 |
|
|
O |
0,9% SODIUM ChL.IN W.F.I.FRESENIUS |
sol inf 1x1000 ml (PE) |
FRK |
DE |
10 |
1.96 |
1.96 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05BB01 |
|
|
|
Elektrolyty |
parent. chlorid sodný 0,9% a kalcium (400-500 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.3 |
|
|
|
33636 |
|
|
G |
Compound Sodium Lactate Ringer-Lactat (PE) |
sol inf 10x500 ml |
BME |
DE |
50 |
14.55 |
14.55 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05BB01 |
|
|
|
Elektrolyty |
parent. Ringer (400-500 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.23 |
|
|
|
33976 |
|
|
G |
Ringer´s Braun Injection (PL.) |
sol inf 10x500ml |
BME |
DE |
50 |
10.77 |
10.77 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05BC01 |
|
|
|
Manitol |
parent. (200-250 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
0.79 |
|
|
|
90530 |
|
|
O |
INFUSIO MANNITOLI IMUNA 10% |
sol inf 1x250 ml-skl.f. |
IMA |
SK |
2.5 |
1.97 |
1.97 |
A |
0 |
0 |
0 |
|
|
|
|
|
B05XA01 |
|
|
|
Chlorid draselný |
parent. 7,45 % (100 ml) |
100 |
ml |
|
|
|
|
|
|
|
|
1.46 |
|
|
|
18346 |
|
|
G |
INFUSIO KALII CHLORATI CONC. |
sol inf 1x100 ml |
IMA |
SK |
1 |
1.46 |
1.46 |
A |
0 |
0 |
0 |
|
|
|
|
|
B06AC04 |
|
|
|
Konestat alfa |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
883.69 |
|
|
|
03531 |
|
|
O |
Ruconest |
plv ino 1x2100 U (liek.inj.skl.) |
PNV |
NL |
1 |
878.38 |
878.38 |
I |
0 |
0 |
0 |
ALG |
ind.obm., ZP |
|
|
|
C01AA05 |
|
|
|
Digoxín |
p.o. 0,25 mg (30 ks) |
0.25 |
mg |
|
|
|
|
|
|
|
|
6.4500000000000002E-2 |
|
|
|
03542 |
|
|
G |
DIGOXIN LÉČIVA |
tbl 30x0,25 mg |
ZNT |
CZ |
30 |
1.91 |
1.91 |
I |
0 |
0 |
0 |
|
|
|
|
|
C01BA08 |
|
|
|
Prajmalín |
p.o. 20 mg (50 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.44 |
|
|
|
26531 |
|
|
O |
NEO-GILURYTMAL |
tbl obd 50x20 mg |
SYF |
DE |
33.335000000000001 |
14.54 |
14.54 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF |
|
|
|
|
C01BC03 |
|
|
|
Propafenón |
p.o. 150 mg (50 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.24299999999999999 |
|
|
|
91276 |
|
|
G |
PROLEKOFEN |
tbl flm 50x150 mg |
LEK |
SI |
25 |
6.08 |
6.08 |
I |
0 |
0 |
0 |
|
|
|
|
|
C01BC03 |
|
|
|
Propafenón |
p.o. 300 mg (50 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.27300000000000002 |
|
|
|
91277 |
|
|
G |
PROLEKOFEN |
tbl flm 50x300 mg |
LEK |
SI |
50 |
9.91 |
9.91 |
I |
0 |
0 |
0 |
|
|
|
|
|
58838 |
|
|
G |
PROPANORM 300 mg |
tbl flm 50x300 mg |
PMP |
CZ |
50 |
11.09 |
11.09 |
I |
0 |
0 |
0 |
|
|
|
|
|
91004 |
|
|
O |
RYTMONORM 300 |
tbl obd 50x300 mg |
KNO |
DE |
50 |
11.65 |
11.65 |
I |
0 |
0 |
0 |
|
|
|
|
|
C01BC03 |
|
|
|
Propafenón |
p.o. predĺžené uvoľňovanie 325 mg (60 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.33 |
|
|
|
93535 |
|
|
O |
Rytmonorm SR 325 mg |
cps pld 60x325 mg |
TPH |
SK |
65 |
21.41 |
21.41 |
I |
0 |
0 |
0 |
|
|
|
|
|
C01BC03 |
|
|
|
Propafenón |
parent. |
0.3 |
g |
|
|
|
|
|
|
|
|
4.6319999999999997 |
|
|
|
08151 |
|
|
G |
Propanorm 35 mg/10 ml |
sol inj 10x10 ml (amp.skl.) |
PMP |
CZ |
1.167 |
5.41 |
5.41 |
A |
0 |
0 |
0 |
|
|
|
|
|
C01BC04 |
|
|
|
Flekainid |
p.o. 100 mg (30 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
0.3 |
|
|
|
36590 |
|
|
G |
Flekainid Sandoz 100 mg tablety |
tbl 30x100 mg |
SAN |
SI |
30 |
8.6 |
8.6 |
I |
0 |
0 |
0 |
KAR |
|
|
|
|
C01BD01 |
|
|
|
Amiodarón |
parent. 50 mg/ml |
0.2 |
g |
|
|
|
|
|
|
|
|
0.65 |
|
|
|
80155 |
|
|
O |
CORDARONE |
sol inj 6x3 ml/150 mg |
SWA |
FR |
4.5 |
2.89 |
2.89 |
A |
0 |
0 |
0 |
|
|
|
|
|
C01BG11 |
|
|
|
Vernakalant |
parent. 20 mg/ml |
1 |
DF |
|
|
|
|
|
|
|
|
449.62 |
|
|
|
23386 |
|
|
O |
BRINAVESS 20 mg/ml |
con inf 1x25 ml/500 mg |
MSD |
GB |
1 |
449.61 |
449.61 |
A |
0 |
0 |
0 |
KAR |
ind.obm. |
|
|
|
C01CA04 |
|
|
|
Dopamín |
parent. 40 mg/ml |
0.5 |
g |
|
|
|
|
|
|
|
|
5.82 |
|
|
|
04380 |
|
|
G |
TENSAMIN |
sol inj 10x5 ml |
ZNT |
CZ |
4 |
23.25 |
23.25 |
A |
0 |
0 |
0 |
|
|
|
|
|
C01CA24 |
|
|
|
Epinefrín |
parent. 1 mg/ml |
0.5 |
mg |
|
|
|
|
|
|
|
|
0.47099999999999997 |
|
|
|
00362 |
|
|
G |
ADRENALIN LÉČIVA |
sol inj 5x1 ml/1 mg |
ZNT |
CZ |
10 |
4.6399999999999997 |
4.6399999999999997 |
A |
0 |
0 |
0 |
|
|
|
|
|
C01DA02 |
|
|
|
Glycerol trinitrát |
sublng. 0,5 mg (20 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
0.33300000000000002 |
|
|
|
00231 |
|
|
G |
NITROGLYCERIN SLOVAKOFARMA |
tbl slg 20x0,5 mg |
ZNT |
SK |
4 |
1.33 |
1.33 |
I |
0 |
0 |
0 |
|
|
|
|
|
C01DX12 |
|
|
|
Molsidomín |
p.o. predĺžené uvoľňovanie 8 mg (30 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
5.2999999999999999E-2 |
|
|
|
15116 |
X |
|
O |
CORVATON RETARD |
tbl plg 30x8 mg |
HBS |
SK |
40 |
2.1 |
2.1 |
I |
0 |
0 |
0 |
|
|
|
|
|
C01EA01 |
|
|
|
Alprostadil |
parent. |
20 |
µg |
|
|
|
|
|
|
|
|
4.24 |
|
|
|
92305 |
|
|
G |
ALPROSTAN |
con inf 10x0,2 ml |
ZNT |
CZ |
50 |
211.96 |
211.96 |
A |
0 |
0 |
0 |
ANG, CCH, CHI, KAR |
ind.obm. |
|
|
|
C02AC05 |
|
|
|
Moxonidín |
p.o. 0,2 mg (28-30 ks) |
0.3 |
mg |
|
|
|
|
|
|
|
|
0.17299999999999999 |
|
|
|
37735 |
X |
|
G |
Moxonidin Actavis 0,2mg |
tbl flm 30x0,2 mg |
ACT |
IS |
20 |
3.44 |
3.44 |
I |
0 |
0 |
0 |
|
|
|
|
|
37695 |
X |
|
G |
Moxonidin ratiopharm 0,2mg |
tbl flm 30x0,2 mg |
RAT |
DE |
20 |
3.44 |
3.44 |
I |
0 |
0 |
0 |
|
|
|
|
|
42231 |
X |
|
G |
MOXOSTAD 0,2 mg |
tbl flm 30x0,2 mg |
STD |
DE |
20 |
3.44 |
3.44 |
I |
0 |
0 |
0 |
|
|
|
|
|
C02AC05 |
|
|
|
Moxonidín |
p.o. 0,2 mg (100 ks) |
0.3 |
mg |
|
|
|
|
|
|
|
|
0.17299999999999999 |
|
|
|
42235 |
X |
|
G |
MOXOSTAD 0,2 mg |
tbl flm 100x0,2 mg |
STD |
DE |
66.667000000000002 |
11.47 |
11.47 |
I |
0 |
0 |
0 |
|
|
|
|
|
C02AC05 |
|
|
|
Moxonidín |
p.o. 0,3 mg (28-30 ks) |
0.3 |
mg |
|
|
|
|
|
|
|
|
0.13500000000000001 |
|
|
|
37749 |
X |
|
G |
Moxonidin Actavis 0,3mg |
tbl flm 30x0,3 mg |
ACT |
IS |
30 |
4.04 |
4.04 |
I |
0 |
0 |
0 |
|
|
|
|
|
37700 |
X |
|
G |
Moxonidin ratiopharm 0,3mg |
tbl flm 30x0,3 mg |
RAT |
DE |
30 |
4.04 |
4.04 |
I |
0 |
0 |
0 |
|
|
|
|
|
C02AC05 |
|
|
|
Moxonidín |
p.o. 0,3 mg (98-100 ks) |
0.3 |
mg |
|
|
|
|
|
|
|
|
0.13500000000000001 |
|
|
|
37755 |
X |
|
G |
Moxonidin Actavis 0,3 mg filmom obalená tableta |
tbl flm 100x0,3 mg |
ACT-3 |
IS |
100 |
13.47 |
13.47 |
I |
0 |
0 |
0 |
|
|
|
|
|
42246 |
X |
|
G |
MOXOSTAD 0,3 mg |
tbl flm 100x0,3 mg |
STD |
DE |
100 |
13.47 |
13.47 |
I |
0 |
0 |
0 |
|
|
|
|
|
C02AC05 |
|
|
|
Moxonidín |
p.o. 0,4 mg (28-30 ks) |
0.3 |
mg |
|
|
|
|
|
|
|
|
0.14499999999999999 |
|
|
|
37763 |
X |
|
G |
Moxonidin Actavis 0,4mg |
tbl flm 30x0,4 mg |
ACT |
IS |
40 |
5.41 |
5.41 |
I |
0 |
0 |
0 |
|
|
|
|
|
37705 |
X |
|
G |
Moxonidin ratiopharm 0,4mg |
tbl flm 30x0,4 mg |
RAT |
DE |
40 |
5.41 |
5.41 |
I |
0 |
0 |
0 |
|
|
|
|
|
42252 |
X |
|
G |
MOXOSTAD 0,4 mg |
tbl flm 30x0,4 mg |
STD |
DE |
40 |
5.41 |
5.41 |
I |
0 |
0 |
0 |
|
|
|
|
|
42658 |
X |
|
G |
Moxogamma 0,4 mg |
tbl flm 30x0,4 mg |
WGP |
DE |
40 |
5.57 |
5.57 |
I |
0 |
0 |
0 |
|
|
|
|
|
C02AC05 |
|
|
|
Moxonidín |
p.o. 0,4 mg (98-100 ks) |
0.3 |
mg |
|
|
|
|
|
|
|
|
0.14499999999999999 |
|
|
|
37777 |
X |
|
G |
Moxonidin Actavis 0,4 mg filmom obalená tableta |
tbl flm 100x0,4 mg |
ACT-3 |
IS |
133.333 |
18 |
18 |
I |
0 |
0 |
0 |
|
|
|
|
|
42256 |
X |
|
G |
MOXOSTAD 0,4 mg |
tbl flm 100x0,4 mg |
STD |
DE |
133.333 |
18 |
18 |
I |
0 |
0 |
0 |
|
|
|
|
|
C02CA06 |
|
|
|
Urapidil |
p.o. predĺžené uvoľňovanie 30 mg (50 ks) |
0.12 |
g |
|
|
|
|
|
|
|
|
0.77010000000000001 |
|
|
|
90760 |
X |
|
O |
EBRANTIL RETARD |
cps 50x30 mg |
BGL |
DE |
12.5 |
9.58 |
9.58 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C02CA06 |
|
|
|
Urapidil |
p.o. predĺžené uvoľňovanie 60 mg (50 ks) |
0.12 |
g |
|
|
|
|
|
|
|
|
0.65 |
|
|
|
89771 |
X |
|
O |
EBRANTIL RETARD |
cps 50x60 mg |
BGL |
DE |
25 |
15.89 |
15.89 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C02KX01 |
|
|
|
Bosentan |
p.o. 62,5 mg (56 ks) |
250 |
mg |
|
|
|
|
|
|
|
|
150.37 |
|
|
|
41413 |
|
|
O |
Tracleer 62,5 mg filmom obalené tablety |
tbl flm 56x62,5 mg (blis.PVC/PE/PVDC/Al) |
ACB |
GB |
14 |
2105 |
2105 |
I |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
C02KX01 |
|
|
|
Bosentan |
p.o. 125 mg (56 ks) |
250 |
mg |
|
|
|
|
|
|
|
|
76.105000000000004 |
|
|
|
41415 |
|
|
O |
Tracleer 125 mg filmom obalené tablety |
tbl flm 56x125 mg (blis.PVC/PE/PVDC/Al) |
ACB |
GB |
28 |
2130.92 |
2130.92 |
I |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
C02KX02 |
|
|
|
Ambrisentan |
p.o. 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
74.352000000000004 |
|
|
|
50467 |
|
|
O |
Volibris |
tbl flm 30x5 mg |
GLA |
GB |
30 |
2230.54 |
2230.54 |
I |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
C02KX02 |
|
|
|
Ambrisentan |
p.o. 10 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
37.950000000000003 |
|
|
|
50469 |
|
|
O |
Volibris |
tbl flm 30x10 mg |
GLA |
GB |
60 |
2276.56 |
2276.56 |
I |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
C03AA03 |
|
|
|
Hydrochlórotiazid |
p.o. 25 mg (20 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
0.10299999999999999 |
|
|
|
00168 |
X |
|
G |
HYDROCHLOROTHIAZID LÉČIVA |
tbl 20x25 mg |
ZNT |
CZ |
20 |
2.0099999999999998 |
2.0099999999999998 |
I |
0 |
0 |
0 |
|
|
|
|
|
C03BA11 |
|
|
|
Indapamid |
p.o. 2,5 mg (30 ks) |
1.5 |
mg |
|
|
|
|
|
|
|
|
3.9800000000000002E-2 |
|
|
|
96696 |
X |
|
G |
INDAP |
cps 30x2,5 mg |
PMP |
CZ |
50 |
1.91 |
1.91 |
I |
0 |
0 |
0 |
|
|
|
|
|
C03BA11 |
|
|
|
Indapamid |
p.o. predĺžené uvoľňovanie 1,5 mg (30 ks) |
1.5 |
mg |
|
|
|
|
|
|
|
|
0.08 |
|
|
|
52163 |
X |
|
G |
Actapam 1,5 mg |
tbl plg 30x1,5 mg |
ACT |
IS |
30 |
2.2999999999999998 |
2.2999999999999998 |
I |
0 |
0 |
0 |
|
|
|
|
|
49965 |
X |
|
G |
Indapamid STADA 1,5 mg |
tbl plg 30x1,5 mg |
STD |
NO |
30 |
2.2999999999999998 |
2.2999999999999998 |
I |
0 |
0 |
0 |
|
|
|
|
|
53477 |
X |
|
G |
Indapamide Orion 1,5 mg |
tbl plg 30x1,5 mg |
ORN |
FI |
30 |
2.2999999999999998 |
2.2999999999999998 |
I |
0 |
0 |
0 |
|
|
|
|
|
69884 |
X |
|
G |
Indapamid ratiopharm 1,5mg |
tbl plg 30x1,5 mg |
RAT |
DE |
30 |
2.39 |
2.39 |
I |
0 |
0 |
0 |
|
|
|
|
|
C03CA01 |
|
|
|
Furosemid |
p.o. 40 mg (50 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
3.9800000000000002E-2 |
|
|
|
98219 |
X |
|
G |
FURON |
tbl 50x40 mg |
MCK |
DE |
50 |
1.94 |
1.94 |
I |
0 |
0 |
0 |
|
|
|
|
|
C03CA01 |
|
|
|
Furosemid |
p.o. 250 mg (50 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
56811 |
X |
|
G |
FURORESE 250 |
tbl 50x250 mg |
SFS |
DE |
312.5 |
10.31 |
10.31 |
I |
0 |
0 |
0 |
|
|
|
|
|
90108 |
X |
|
G |
Furosemid-Slovakofarma forte |
tbl 50x250 mg (blis.PVC/Al) |
ZNT |
SK |
312.5 |
10.31 |
10.31 |
I |
0 |
0 |
0 |
|
|
|
|
|
C03CA01 |
|
|
|
Furosemid |
p.o. 250 mg (100 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
56812 |
X |
|
G |
FURORESE 250 |
tbl 100x250 mg |
SFS |
DE |
625 |
19.559999999999999 |
19.559999999999999 |
I |
0 |
0 |
0 |
|
|
|
|
|
C03CA01 |
|
|
|
Furosemid |
parent. 12,5 mg/ml |
40 |
mg |
|
|
|
|
|
|
|
|
0.33 |
|
|
|
99333 |
|
|
G |
FUROSEMID BIOTIKA FORTE |
sol inj 10x10 ml/125 mg |
HBS |
SK |
31.25 |
10.25 |
10.25 |
A |
0 |
0 |
0 |
|
|
|
|
|
C03DA04 |
|
|
|
Eplerenón |
p.o. 25 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.78400000000000003 |
|
|
|
0678A |
X |
|
G |
Eleveon 25 mg |
tbl flm 30x25 mg (blis.PVC/Al nepriehľ.) |
ZNT |
CZ |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
7039A |
X |
|
G |
Eplerenon Mylan 25 mg filmom obalené rablety |
tbl flm 30 x 25 mg (fľ. HDPE) |
GNS |
UK |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
08245 |
X |
|
G |
Eplerenon STADA 25 mg filmom obalené tablety |
tbl flm 30x25 mg (blis.PVC/Al) |
STD |
DE |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
3378B |
X |
|
G |
Eplerenone Actavis 25 mg |
tbl flm 30x25 mg (blis.PVC/Al) |
ACT-5 |
IS |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
3399A |
X |
|
G |
Eplerenone Teva 25 mg |
tbl flm 30x1x25 mg (blis.PVC/PVDC/Al perf.) |
TEV-SK |
SK |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
C03DA04 |
|
|
|
Eplerenón |
p.o. 25 mg (90-100 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.78400000000000003 |
|
|
|
0680A |
X |
|
G |
Eleveon 25 mg |
tbl flm 90x25 mg (blis.PVC/Al nepriehľ.) |
ZNT |
CZ |
90 |
70.53 |
70.53 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
3401A |
X |
|
G |
Eplerenone Teva 25 mg |
tbl flm 90x1x25 mg (blis.PVC/PVDC/Al perf.) |
TEV-SK |
SK |
90 |
70.53 |
70.53 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
9253A |
X |
|
G |
Eplerenon STADA 25 mg filmom obalené tablety |
tbl flm 100x25 mg (blis.PVC/Al) |
STD |
DE |
100 |
78.38 |
78.38 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
C03DA04 |
|
|
|
Eplerenón |
p.o. 50 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.78400000000000003 |
|
|
|
0625A |
X |
|
G |
Eleveon 50 mg |
tbl flm 30x50 mg (blis.PVC/Al nepriehľ.) |
ZNT |
CZ |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
7043A |
X |
|
G |
Eplerenon Mylan 50 mg filmom obalené tablety |
tbl flm 30 x 50 mg (fľ.HDPE) |
GNS |
UK |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
08247 |
X |
|
G |
Eplerenon STADA 50 mg filmom obalené tablety |
tbl flm 30x50 mg (blis.PVC/Al) |
STD |
DE |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
3390B |
X |
|
G |
Eplerenone Actavis 50 mg |
tbl flm 30x50 mg (blis.PVC/Al) |
ACT-5 |
IS |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
3381A |
X |
|
G |
Eplerenone Teva 50 mg |
tbl flm 30x1x50 mg (blis.PVC/PVDC/Al perf.) |
TEV-SK |
SK |
30 |
23.51 |
23.51 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
C03DA04 |
|
|
|
Eplerenón |
p.o. 50 mg (90-100 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.78400000000000003 |
|
|
|
0627A |
X |
|
G |
Eleveon 50 mg |
tbl flm 90x50 mg (blis.PVC/Al nepriehľ.) |
ZNT |
CZ |
90 |
70.53 |
70.53 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
3383A |
X |
|
G |
Eplerenone Teva 50 mg |
tbl flm 90x1x50 mg (blis.PVC/PVDC/Al perf.) |
TEV-SK |
SK |
90 |
70.53 |
70.53 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
9257A |
X |
|
G |
Eplerenon STADA 50 mg filmom obalené tablety |
tbl flm 100x50 mg (blis.PVC/Al) |
STD |
DE |
100 |
78.38 |
78.38 |
I |
0 |
0 |
0 |
INT, KAR |
ind.obm. |
|
|
U76 |
C03EA01 |
|
|
|
Hydrochlórotiazid a liečivá šetriace draslík |
p.o. (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
7.1999999999999995E-2 |
|
|
|
70425 |
|
|
G |
RHEFLUIN |
tbl 30 |
ZNT-1 |
CZ |
30 |
2.0699999999999998 |
2.0699999999999998 |
I |
0 |
0 |
0 |
|
|
|
|
|
68965 |
|
|
O |
MODURETIC |
tbl 30 |
MSD |
NL |
30 |
2.09 |
2.09 |
I |
0 |
0 |
0 |
|
|
|
|
|
C03EA06 |
|
|
|
Chlórtalidon a draslík šetriace diuretikum |
p.o. (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
7.4999999999999997E-2 |
|
|
|
88518 |
|
|
G |
AMICLOTON |
tbl 30 |
ZNT |
SK |
30 |
1.99 |
1.99 |
I |
0 |
0 |
0 |
|
|
|
|
|
C07AB02 |
|
|
|
Metoprolol |
p.o. 50 mg (50-60 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.122 |
|
|
|
25634 |
X |
|
G |
VASOCARDIN 50(BLIST.5X10 TAB) |
tbl 50x50 mg |
ZNT |
SK |
16.657 |
2.02 |
2.02 |
I |
0 |
0 |
0 |
|
|
|
|
U77 |
C07AB02 |
|
|
|
Metoprolol |
p.o. 100 mg (50-60 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.122 |
|
|
|
27978 |
X |
|
G |
EGILOK 100 mg |
tbl 60x100 mg |
EGI |
HU |
40 |
4.8 |
4.8 |
I |
0 |
0 |
0 |
|
|
|
|
U77 |
26610 |
X |
|
G |
VASOCARDIN 100 (blis.5x10 tbl.) |
tbl 50x100 mg |
ZNT |
SK |
33.343000000000004 |
4.04 |
4.04 |
I |
0 |
0 |
0 |
|
|
|
|
U77 |
C07AB02 |
|
|
|
Metoprolol |
p.o. predĺžené uvoľňovanie 25 mg (28-30 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.41 |
|
|
|
81678 |
X |
|
G |
Metoprolol Mylan 23,75mg |
tbl plg 30x23,75 mg |
GNC |
GB |
5 |
2.0499999999999998 |
2.0499999999999998 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
69814 |
X |
|
G |
Metoprolol ratiopharm 25 mg |
tbl plg 30x25 mg |
RAT |
DE |
5 |
2.0499999999999998 |
2.0499999999999998 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C07AB02 |
|
|
|
Metoprolol |
p.o. predĺžené uvoľňovanie 50 mg (28-30 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.17399999999999999 |
|
|
|
69827 |
X |
|
G |
Metoprolol ratiopharm 50 mg |
tbl plg 30x50mg |
RAT |
DE |
10 |
1.67 |
1.67 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C07AB02 |
|
|
|
Metoprolol |
p.o. predĺžené uvoľňovanie 100 mg (28-30 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.17 |
|
|
|
81715 |
X |
|
G |
Metoprolol Mylan 95mg |
tbl plg 30x95 mg |
GNC |
GB |
20 |
3.17 |
3.17 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
69840 |
X |
|
G |
Metoprolol ratiopharm 100 mg |
tbl plg 30x100 mg |
RAT |
DE |
20 |
3.17 |
3.17 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C07AB03 |
|
|
|
Atenolol |
p.o. 100 mg (50 ks) |
75 |
mg |
|
|
|
|
|
|
|
|
5.5E-2 |
|
|
|
24950 |
X |
|
G |
ATENOBENE |
tbl obd 50x100 mg |
MCK |
DE |
66.667000000000002 |
3.62 |
3.62 |
I |
0 |
0 |
0 |
|
|
|
|
U78 |
C07AB05 |
|
|
|
Betaxolol |
p.o. 20 mg (28-30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
0.15 |
|
|
|
96475 |
X |
|
O |
LOKREN 20 mg |
tbl flm 28x20 mg |
XSB |
FR |
28 |
4.03 |
4.03 |
I |
0 |
0 |
0 |
|
|
|
|
|
59188 |
X |
|
G |
BETAC |
tbl flm 30x20mg |
MOE |
CY |
30 |
4.5 |
4.5 |
I |
0 |
0 |
0 |
|
|
|
|
|
C07AB12 |
|
|
|
Nebivolol |
p.o. 5 mg (28-30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.13400000000000001 |
|
|
|
76073 |
X |
|
G |
Nebitrix 5 mg |
tbl 30x5 mg (blis. PVC/PVDC/Al) |
GLM |
CZ |
30 |
4.01 |
4.01 |
I |
0 |
0 |
0 |
|
|
|
|
|
C07AG02 |
|
|
|
Carvedilol |
p.o. 12,5 mg (28-30 ks) |
37.5 |
mg |
|
|
|
|
|
|
|
|
0.19919999999999999 |
|
|
|
38523 |
X |
|
G |
CARVEDILOL ORION 12,5 mg |
tbl flm 30x12,5 mg |
ORN |
FI |
10 |
1.99 |
1.99 |
I |
0 |
0 |
0 |
|
|
|
|
|
1583A |
X |
|
G |
OCAROX 12,5 mg filmom obalené tablety |
tbl flm 30x12,5 mg (blis.PVC/PE/PVDC/Al) |
ORN |
FI |
10 |
1.99 |
1.99 |
I |
0 |
0 |
0 |
|
|
|
|
|
C07AG02 |
|
|
|
Carvedilol |
p.o. 12,5 mg (100 ks) |
37.5 |
mg |
|
|
|
|
|
|
|
|
0.19919999999999999 |
|
|
|
38527 |
X |
|
G |
CARVEDILOL ORION 12,5 mg |
tbl flm 100x12,5 mg |
ORN |
FI |
33.332999999999998 |
6.64 |
6.64 |
I |
0 |
0 |
0 |
|
|
|
|
|
1590A |
X |
|
G |
OCAROX 12,5 mg filmom obalené tablety |
tbl flm 100x12,5 mg (blis.PVC/PE/PVDC/Al) |
ORN |
FI |
33.332999999999998 |
6.64 |
6.64 |
I |
0 |
0 |
0 |
|
|
|
|
|
C07AG02 |
|
|
|
Carvedilol |
p.o. 25 mg (90-100 ks) |
37.5 |
mg |
|
|
|
|
|
|
|
|
0.14000000000000001 |
|
|
|
38543 |
X |
|
G |
CARVEDILOL ORION 25 mg |
tbl flm 100x25 mg |
ORN |
FI |
66.667000000000002 |
9.09 |
9.09 |
I |
0 |
0 |
0 |
|
|
|
|
|
1620A |
X |
|
G |
OCAROX 25 mg filmom obalené tablety |
tbl flm 100x25 mg (blis.PVC/PE/PVDC/Al) |
ORN |
FI |
66.667000000000002 |
9.09 |
9.09 |
I |
0 |
0 |
0 |
|
|
|
|
|
C08CA01 |
|
|
|
Amlodipín |
p.o. 10 mg (28-30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
1.4999999999999999E-2 |
|
|
|
34889 |
X |
|
G |
Amlodipin-ratiopharm 10 mg |
tbl 30x10 mg |
RAT |
DE |
60 |
0.87 |
0.87 |
I |
0 |
0 |
0 |
|
|
|
|
|
C08CA05 |
|
|
|
Nifedipín |
p.o. predĺžené uvoľňovanie 20 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
8.3000000000000004E-2 |
|
|
|
93460 |
X |
|
G |
CORDIPIN RETARD |
tbl plg 30x20 mg |
KRK |
SI |
20 |
1.63 |
1.63 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09AA02 |
|
|
|
Enalapril |
p.o. 20 mg (100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.03 |
|
|
|
68737 |
X |
|
G |
Enalapril Vitabalans 20 mg tablety |
tbl 100x20 mg (blister) |
VTB |
FI |
200 |
5.31 |
5.31 |
I |
0 |
0 |
0 |
|
|
|
|
U7 |
C09AA03 |
|
|
|
Lizinopril |
p.o. 20 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
33472 |
X |
|
G |
Lisinopril-ratiopharm 20 mg |
tbl 30x20 mg |
MCK |
DE |
60 |
2.67 |
2.67 |
I |
0 |
0 |
0 |
|
|
|
|
U8 |
C09AA04 |
|
|
|
Perindopril terc-butylamin |
p.o. 4 mg (30 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
8.4000000000000005E-2 |
|
|
|
0877A |
X |
|
G |
Perindopril Mylan 4 mg |
tbl 30x4 mg (blis.Al/OPA/PVC/Al) |
GNS |
UK |
30 |
2.52 |
2.52 |
I |
0 |
0 |
0 |
|
|
|
|
U9 |
C09AA04 |
|
|
|
Perindopril terc-butylamin |
p.o. 8 mg (30 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
5.3999999999999999E-2 |
|
|
|
0869A |
X |
|
G |
Perindopril Mylan 8 mg |
tbl 30x8 mg (blis.Al/OPA/PVC/Al) |
GNS |
UK |
60 |
3.2 |
3.2 |
I |
0 |
0 |
0 |
|
|
|
|
U10 |
C09BA02 |
|
|
|
Enalapril a diuretiká |
p.o. 10/12,5 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
8.2000000000000003E-2 |
|
|
|
55429 |
|
|
G |
ENAP HL |
tbl 30x10/12,5 mg |
KRK |
SI |
30 |
2.4300000000000002 |
2.4300000000000002 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09BA04 |
|
|
|
Perindopril a diuretiká |
p.o. 4/1,25 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.161 |
|
|
|
58825 |
|
|
G |
Perindopril/Indapamid Actavis 4 mg/1,25 mg |
tbl 30x4 mg/1,25 mg (blis.Al/Al) |
ACT-5 |
IS |
30 |
4.83 |
4.83 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09BA04 |
|
|
|
Perindopril a diuretiká |
p.o. 4/1,25 mg (90-100 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.161 |
|
|
|
58829 |
|
|
G |
Perindopril/Indapamid Actavis 4 mg/1,25 mg |
tbl 90x4 mg/1,25 mg (blis.Al/Al) |
ACT-5 |
IS |
90 |
14.48 |
14.48 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09BA04 |
|
|
|
Perindopril a diuretiká |
p.o. 8/2,5 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.253 |
|
|
|
89441 |
|
|
G |
Co-Prenessa 8 mg/2,5 mg |
tbl 30x8 mg/2,5 mg |
KRK |
SI |
30 |
6.73 |
6.73 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09BA05 |
|
|
|
Ramipril a diuretiká |
p.o. 5/25 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.19270000000000001 |
|
|
|
09530 |
|
|
G |
Ramipril H 5mg/25 mg Actavis |
tbl 30x5 mg/25 mg (blis.Al/Al) |
ACT-DK-1 |
DK |
30 |
4.4400000000000004 |
4.4400000000000004 |
I |
0 |
0 |
0 |
|
|
|
|
|
94827 |
|
|
G |
AMPRIL HD |
tbl 28x5 mg/25 mg |
KRK |
SI |
28 |
4.17 |
4.17 |
I |
0 |
0 |
0 |
|
|
|
|
|
56661 |
|
|
O |
TRITAZIDE 5 mg/25 mg |
tbl 28x5 mg/25 mg |
HOE |
DE |
28 |
4.53 |
4.53 |
I |
0 |
0 |
0 |
|
|
|
|
|
46311 |
|
|
G |
RAMIMED HCT 5/25 |
tbl 30x5 mg / 25 mg |
MOE |
CY |
30 |
5.19 |
5.19 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09CA01 |
|
|
|
Losartan |
p.o. 50 mg (28-30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
6.4000000000000001E-2 |
|
|
|
77878 |
X |
|
G |
Losartan Orion 50 mg |
tbl flm 28x50 mg (blis. PVC/LDPE/PVDC/Al) |
ORN |
FI |
28 |
1.78 |
1.78 |
I |
0 |
0 |
0 |
|
|
|
|
U11 |
49527 |
X |
|
G |
Losartan Zentiva 50 mg filmom obalené tablety |
tbl flm 30x50 mg (bli. PVC/PVDC/Al) |
ZNT |
SK |
30 |
1.91 |
1.91 |
I |
0 |
0 |
0 |
|
|
|
|
U11 |
C09CA01 |
|
|
|
Losartan |
p.o. 50 mg (90-100 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
6.4000000000000001E-2 |
|
|
|
49530 |
X |
|
G |
Losartan Zentiva 50 mg filmom obalené tablety |
tbl flm 90x50 mg (bli. PVC/PVDC/Al) |
ZNT |
SK |
90 |
5.75 |
5.75 |
I |
0 |
0 |
0 |
|
|
|
|
U11 |
C09CA01 |
|
|
|
Losartan |
p.o. 100 mg (28-30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
6.4000000000000001E-2 |
|
|
|
49505 |
X |
|
G |
Losartan Zentiva 100 mg filmom obalené tablety |
tbl flm 30x100 mg (bli. PVC/PVDC/Al) |
ZNT |
SK |
60 |
3.54 |
3.54 |
I |
0 |
0 |
0 |
|
|
|
|
U11 |
77882 |
X |
|
G |
Losartan Orion 100 mg |
tbl flm 28x100 mg (blis. PVC/LDPE/PVDC/Al) |
ORN |
FI |
56 |
3.31 |
3.31 |
I |
0 |
0 |
0 |
|
|
|
|
U11 |
C09CA01 |
|
|
|
Losartan |
p.o. 100 mg (84 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
6.4000000000000001E-2 |
|
|
|
37293 |
X |
|
G |
Lorista 100 |
tbl flm 84x100 mg |
KRK |
SI |
168 |
9.8000000000000007 |
9.8000000000000007 |
I |
0 |
0 |
0 |
|
|
|
|
U11 |
C09CA01 |
|
|
|
Losartan |
p.o. 100 mg (90-100 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
6.4000000000000001E-2 |
|
|
|
49507 |
X |
|
G |
Losartan Zentiva 100 mg filmom obalené tablety |
tbl flm 90x100 mg (bli. PVC/PVDC/Al) |
ZNT |
SK |
180 |
11.52 |
11.52 |
I |
0 |
0 |
0 |
|
|
|
|
U11 |
C09CA03 |
|
|
|
Valsartan |
p.o. 160 mg (28-30 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
81775 |
X |
|
G |
Valzap 160 mg |
tbl flm 28x160 mg (blis.PVC/PE/PVDC/Al) |
ZNT |
CZ |
56 |
5.44 |
5.44 |
I |
0 |
0 |
0 |
|
|
|
|
U12 |
82997 |
X |
|
G |
Vasopentol 160 mg |
tbl flm 30x160 mg (blis.PVC/PE/PVDC-Al) |
EGI |
HU |
60 |
5.92 |
5.92 |
I |
0 |
0 |
0 |
|
|
|
|
U12 |
39980 |
X |
|
G |
VALSACOR 160 mg |
tbl flm 28x160 mg |
KRK |
SI |
56 |
5.59 |
5.59 |
I |
0 |
0 |
0 |
|
|
|
|
U12 |
51645 |
X |
|
G |
Valsartan Actavis 160 mg |
tbl flm 28x160 mg (blis.PVC/PE/PVDC/Al) |
ACT-5 |
IS |
56 |
5.6 |
5.6 |
I |
0 |
0 |
0 |
|
|
|
|
U12 |
C09CA03 |
|
|
|
Valsartan |
p.o. 160 mg (84-98 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
81777 |
X |
|
G |
Valzap 160 mg |
tbl flm 84x160 mg (blis.PVC/PE/PVDC/Al) |
ZNT |
CZ |
168 |
16.670000000000002 |
16.670000000000002 |
I |
0 |
0 |
0 |
|
|
|
|
U12 |
53680 |
X |
|
G |
Vasopentol 160 mg |
tbl flm 98x160 mg (blister) |
EGI |
HU |
196 |
19.45 |
19.45 |
I |
0 |
0 |
0 |
|
|
|
|
U12 |
39982 |
X |
|
G |
Valsacor 160 |
tbl flm 98x160 mg |
KRK |
SI |
196 |
19.59 |
19.59 |
I |
0 |
0 |
0 |
|
|
|
|
U12 |
51647 |
X |
|
G |
Valsartan Actavis 160 mg |
tbl flm 98x160 mg (blis.PVC/PE/PVDC/Al) |
ACT-5 |
IS |
196 |
19.600000000000001 |
19.600000000000001 |
I |
0 |
0 |
0 |
|
|
|
|
U12 |
C09CA03 |
|
|
|
Valsartan |
p.o. 320 mg (28 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
84984 |
X |
|
G |
Valsacor 320 mg |
tbl flm 28x320 mg |
KRK |
SI |
112 |
12.19 |
12.19 |
I |
0 |
0 |
0 |
|
|
|
|
U13 |
C09CA04 |
|
|
|
Irbesartan |
p.o. 300 mg (28-30 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
11253 |
X |
|
G |
Irbesartan Mylan 300 mg |
tbl 28x300 mg (blis.Aclar/PVC/Al) |
GNC |
UK |
56 |
5.92 |
5.92 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
59453 |
X |
|
O |
Ifirmasta |
tbl flm 28x300mg |
KRK |
SI |
56 |
6.32 |
6.32 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
80013 |
X |
|
G |
Irbesartan Actavis 300 mg |
tbl flm 28x300 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
56 |
6.32 |
6.32 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
76167 |
X |
|
G |
Irbesartan Sandoz 300 mg filmom obalené tablety |
tbl flm 28x300 mg (blis. PVC/PVDC/Al) |
SAN |
SI |
56 |
6.32 |
6.32 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
38270 |
X |
|
G |
Irbesartan Zentiva 300 mg filmom obalené tablety |
tbl flm 28x300 mg (blis.PVC/PVDC/Al) |
SAV-FR |
FR |
56 |
6.32 |
6.32 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
C09CA04 |
|
|
|
Irbesartan |
p.o. 300 mg (60 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
80020 |
X |
|
G |
Irbesartan Actavis 300 mg |
tbl flm 60x300 mg (fl. HDPE)) |
ACT |
IS |
120 |
13.56 |
13.56 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, NEF |
ind.obm. |
|
|
U13 |
C09CA04 |
|
|
|
Irbesartan |
p.o. 300 mg (84-98 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
80016 |
X |
|
G |
Irbesartan Actavis 300 mg |
tbl flm 84x300 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
168 |
18.98 |
18.98 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
38273 |
X |
|
G |
Irbesartan Zentiva 300 mg filmom obalené tablety |
tbl flm 84x300 mg (blis.PVC/PVDC/Al) |
SAV-FR |
FR |
168 |
18.98 |
18.98 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
C09CA06 |
|
|
|
Candesartan |
p.o. 16 mg (90-98 ks) |
8 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
86119 |
X |
|
G |
Karbis 16mg |
tbl 98x16 mg |
KRK |
SI |
196 |
21.3 |
21.3 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
10517 |
X |
|
G |
Stadacand 16 mg |
tbl 98x16 mg (blis.PVC/PVDC/Al) |
STD |
DE |
196 |
21.3 |
21.3 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
81118 |
X |
|
G |
Candesartan Sandoz 16 mg tablety |
tbl 90x16 mg (blis. Al/Al) |
SAN |
SI |
180 |
20.34 |
20.34 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
10419 |
X |
|
G |
Carzap 16 mg |
tbl 90x16 mg (blis.PVC/PVDC/Al) |
ZNT |
CZ |
180 |
20.34 |
20.34 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
C09CA06 |
|
|
|
Candesartan |
p.o. 32 mg (90-98 ks) |
8 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
10538 |
X |
|
G |
Stadacand 32 mg |
tbl 98x32 mg (blis.PVC/PVDC/Al) |
STD |
DE |
392 |
41.32 |
41.32 |
I |
0 |
0 |
0 |
GER, INT, KAR, KLF |
ind.obm. |
|
|
U13 |
C09CA07 |
|
|
|
Telmisartan |
p.o. 80 mg (28-30 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
01096 |
X |
|
G |
Telmisartan Sandoz 80 mg tablety |
tbl 28x80 mg |
SAN |
SI |
56 |
4.6500000000000004 |
4.6500000000000004 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
08879 |
X |
|
G |
Telmizek 80 mg |
tbl 28x80 mg (blis. Al/Al) |
ADD |
PL |
56 |
5.81 |
5.81 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
07040 |
X |
|
G |
Telmark 80 mg |
tbl flm 28x80 mg (blis.Al/Al) |
GLM |
CZ |
56 |
5.95 |
5.95 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
01604 |
X |
|
G |
Telmisartan Actavis 80 mg tablety |
tbl 28(4x7)x80 mg (blis.Al/Al) |
ACT |
IS |
56 |
5.95 |
5.95 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
87161 |
X |
|
G |
Tezeo 80 mg |
tbl 30x80 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
60 |
6.38 |
6.38 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
21205 |
X |
|
G |
Telmisartan ratiopharm 80 mg |
tbl 28x80 mg (blis.Al/Al) |
RAT |
DE |
56 |
6.29 |
6.29 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
20495 |
X |
|
G |
Tolura 80mg |
tbl 28x80mg |
KRK |
SI |
56 |
6.29 |
6.29 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
C09CA07 |
|
|
|
Telmisartan |
p.o. 80 mg (84-100 ks) |
40 |
mg |
|
|
|
|
|
|
|
|
0.113 |
|
|
|
07045 |
X |
|
G |
Telmark 80 mg |
tbl flm 98x80 mg (blis.Al/Al) |
GLM |
CZ |
196 |
20.34 |
20.34 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
2354A |
X |
|
G |
Telmisartan EGIS 80mg |
tbl flm 98x80mg |
EGI |
HU |
196 |
20.34 |
20.34 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
01609 |
X |
|
G |
Telmisartan Actavis 80 mg |
tbl 90(9x10)x80 mg (blis.Al/Al) |
ACT-5 |
IS |
180 |
19.13 |
19.13 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
01108 |
X |
|
G |
Telmisartan Sandoz 80 mg tablety |
tbl 90x80 mg (blis.Al/Al) |
SAN |
SI |
180 |
19.13 |
19.13 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
87162 |
X |
|
G |
Tezeo 80 mg |
tbl 90x80 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
180 |
19.13 |
19.13 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
20498 |
X |
|
G |
Tolura 80mg |
tbl 84x80mg |
KRK |
SI |
168 |
17.88 |
17.88 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
U13 |
C09DA01 |
|
|
|
Losartan a diuretiká |
p.o. 50/12,5 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.11550000000000001 |
|
|
|
51955 |
|
|
G |
Losartan/Hydrochlorothiazid STADA 50 mg/12,5 mg |
tbl flm 30x50 mg/12,5 mg |
STD |
DE |
30 |
3.25 |
3.25 |
I |
0 |
0 |
0 |
|
|
|
|
|
80847 |
|
|
G |
Loscomb 50 mg/12,5 mg |
tbl flm 28x50 mg/12,5 mg (blis. PVC/LDPE/PVDC/Al) |
ORN |
FI |
28 |
3.23 |
3.23 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09DA01 |
|
|
|
Losartan a diuretiká |
p.o. 100/25 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
50047 |
|
|
G |
Lorista H 100mg/25mg |
tbl flm 28x100mg/25mg |
KRK |
SI |
28 |
4.4000000000000004 |
4.4000000000000004 |
I |
0 |
0 |
0 |
|
|
|
|
|
51948 |
|
|
G |
Losartan/Hydrochlorothiazid STADA 100 mg/25 mg |
tbl flm 30x100 mg/25 mg |
STD |
DE |
30 |
6.43 |
6.43 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09DA01 |
|
|
|
Losartan a diuretiká |
p.o. 100/25 mg (84 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
50050 |
|
|
G |
Lorista H 100mg/25mg |
tbl flm 84x100mg/25mg |
KRK |
SI |
84 |
13.67 |
13.67 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09DA01 |
|
|
|
Losartan a diuretiká |
p.o. 100/25 mg (90-100 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
51951 |
|
|
G |
Losartan/Hydrochlorothiazid STADA 100 mg/25 mg |
tbl flm 98x100 mg/25 mg |
STD |
DE |
98 |
16.34 |
16.34 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09DA03 |
|
|
|
Valsartan a diuretiká |
p.o.160/12,5 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.252 |
|
|
|
64632 |
|
|
G |
Vasopentol HCT 160/12,5 mg |
tbl flm 30x160/12,5 mg (blis.) |
EGI |
HU |
30 |
6.85 |
6.85 |
I |
0 |
0 |
0 |
|
|
|
|
|
76751 |
|
|
G |
Co-Valsacor 160mg/12,5mg |
tbl flm 28x160mg/12,5mg |
KRK |
SI |
28 |
6.4 |
6.4 |
I |
0 |
0 |
0 |
|
|
|
|
|
66194 |
|
|
G |
Valsartan HCT Actavis 160/12,5 mg |
tbl flm 28x160 mg/12,5 mg (blis.PVC/PE/PVDC/Al) |
ACT-5 |
IS |
28 |
6.4 |
6.4 |
I |
0 |
0 |
0 |
|
|
|
|
|
81830 |
|
|
G |
Valzap HCT 160 mg/12,5 mg |
tbl flm 28x160 mg/12,5 mg (blis.PVC/PE/PVDC/Al) |
ZNT |
CZ |
28 |
6.4 |
6.4 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09DA03 |
|
|
|
Valsartan a diuretiká |
p.o.160/12,5 mg (84-98 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.252 |
|
|
|
81833 |
|
|
G |
Valzap HCT 160 mg/12,5 mg |
tbl flm 84x160 mg/12,5 mg (blis.PVC/PE/PVDC/Al) |
ZNT |
CZ |
84 |
19.170000000000002 |
19.170000000000002 |
I |
0 |
0 |
0 |
|
|
|
|
|
64634 |
|
|
G |
Vasopentol HCT 160/12,5 mg |
tbl flm 98x160/12,5 mg (blis. ) |
EGI |
HU |
98 |
22.37 |
22.37 |
I |
0 |
0 |
0 |
|
|
|
|
|
66199 |
|
|
G |
Valsartan HCT Actavis 160/12,5 mg |
tbl flm 98x160 mg/12,5 mg (blis.PVC/PE/PVDC/Al) |
ACT-5 |
IS |
98 |
22.39 |
22.39 |
I |
0 |
0 |
0 |
|
|
|
|
|
76757 |
|
|
G |
Co-Valsacor 160mg/12,5mg filmom obalené tablety |
tbl flm 98x160 mg/12,5 mg (blis. PVC/PE/PVDC/Al) |
KRK |
SL |
98 |
22.87 |
22.87 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09DA03 |
|
|
|
Valsartan a diuretiká |
p.o.160/25 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.30299999999999999 |
|
|
|
64656 |
|
|
G |
Vasopentol HCT 160/25 mg |
tbl flm 30x160/25 mg (blis.) |
EGI |
HU |
30 |
6.94 |
6.94 |
I |
0 |
0 |
0 |
|
|
|
|
|
76772 |
|
|
G |
Co-Valsacor 160mg/25mg |
tbl flm 28x160mg/25mg |
KRK |
SI |
28 |
6.48 |
6.48 |
I |
0 |
0 |
0 |
|
|
|
|
|
66180 |
|
|
G |
Valsartan HCT Actavis 160/25 mg |
tbl flm 28x160 mg/25 mg (blis.PVC/PE/PVDC/Al) |
ACT-5 |
IS |
28 |
6.48 |
6.48 |
I |
0 |
0 |
0 |
|
|
|
|
|
81835 |
|
|
G |
Valzap HCT 160 mg/25 mg |
tbl flm 28x160 mg/25 mg (blis.PVC/PE/PVDC/Al) |
ZNT |
CZ |
28 |
6.48 |
6.48 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09DA03 |
|
|
|
Valsartan a diuretiká |
p.o.160/25 mg (98 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.30299999999999999 |
|
|
|
64658 |
|
|
G |
Vasopentol HCT 160/25 mg |
tbl flm 98x160/25 mg (blis. ) |
EGI |
HU |
98 |
22.68 |
22.68 |
I |
0 |
0 |
0 |
|
|
|
|
|
C09DA07 |
|
|
|
Telmisartan a diuretiká |
p.o. 80/12,5 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.2525 |
|
|
|
4634A |
|
|
G |
Actelsar HCT 80 mg/12,5 mg tablety |
tbl 28x80 mg/12,5 mg (blis.Al/Al) |
ACT-5 |
IS |
28 |
7.03 |
7.03 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
4928A |
|
|
G |
Telmisartan/Hydrochlorotiazid EGIS 80mg/12,5mg |
tbl 28x80mg/12,5mg (blis. Al/Al) |
EGI |
HU |
28 |
7.03 |
7.03 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
6418A |
|
|
G |
Telmizek Combi 80 mg/12,5 mg tablety |
tbl 28x80 mg/12,5 mg (blis. Al/Al) |
ADD |
PL |
28 |
7.03 |
7.03 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
6444A |
|
|
G |
TEZEO HCT 80 mg/12,5 mg |
tbl 28x80 mg/12,5 mg (blis. OPA/Al/PVC/Al) |
ZNT |
CZ |
28 |
7.03 |
7.03 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
7049A |
|
|
G |
Telmark Plus 80 mg/12,5 mg |
tbl 30x80 mg/12,5 mg (blis.Al/Al) |
GLM-CZ |
CZ |
30 |
7.56 |
7.56 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
5431A |
|
|
G |
Telmisartan/Hydrochlorotiazid Sandoz 80 mg/12,5 mg |
tbl obd 28x80 mg/12,5 mg (blis. Al/Al) |
SAN |
SI |
28 |
7.06 |
7.06 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
4760A |
|
|
G |
Tolucombi 80mg/12,5mg tablety |
tbl 28x80mg/12,5mg |
KRK |
SL |
28 |
7.06 |
7.06 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09DA07 |
|
|
|
Telmisartan a diuretiká |
p.o. 80/12,5 mg (56 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.2525 |
|
|
|
4929A |
|
|
G |
Telmisartan/Hydrochlorotiazid EGIS 80mg/12,5mg |
tbl 56x80mg/12,5mg (blis. Al/Al) |
EGI |
HU |
56 |
14.06 |
14.06 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09DA07 |
|
|
|
Telmisartan a diuretiká |
p.o. 80/12,5 mg (84-90 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.2525 |
|
|
|
4637A |
|
|
G |
Actelsar HCT 80 mg/12,5 mg tablety |
tbl 90x80 mg/12,5 mg (blis.Al/Al) |
ACT-5 |
IS |
90 |
22.6 |
22.6 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
4764A |
|
|
G |
Tolucombi 80mg/12,5mg tablety |
tbl 84x80mg/12,5mg |
KRK |
SL |
84 |
21.16 |
21.16 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
7052A |
|
|
G |
Telmark Plus 80 mg/12,5 mg |
tbl 90x80 mg/12,5 mg (blis.Al/Al) |
GLM-CZ |
CZ |
90 |
22.68 |
22.68 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
5437A |
|
|
G |
Telmisartan/Hydrochlorotiazid Sandoz 80 mg/12,5 mg |
tbl obd 90x80 mg/12,5 mg (blis. Al/Al) |
SAN |
SI |
90 |
22.68 |
22.68 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
6448A |
|
|
G |
TEZEO HCT 80 mg/12,5 mg |
tbl 90x80 mg/12,5 mg (blis. OPA/Al/PVC/Al) |
ZNT |
CZ |
90 |
22.68 |
22.68 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09DA07 |
|
|
|
Telmisartan a diuretiká |
p.o. 80/25 mg (28-30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.309 |
|
|
|
4648A |
|
|
G |
Actelsar HCT 80 mg/25 mg tablety |
tbl 28x80 mg/25 mg (blis.Al/Al) |
ACT-5 |
IS |
28 |
8.64 |
8.64 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
4934A |
|
|
G |
Telmisartan/Hydrochlorotiazid EGIS 80mg/25mg |
tbl 28x80mg/25mg (blis. Al/Al) |
EGI |
HU |
28 |
8.64 |
8.64 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
5442A |
|
|
G |
Telmisartan/Hydrochlorotiazid Sandoz 80 mg/25 mg |
tbl obd 28x80 mg/25 mg (blis. Al/Al) |
SAN |
SI |
28 |
8.64 |
8.64 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
6451A |
|
|
G |
TEZEO HCT 80 mg/25 mg |
tbl 28x80 mg/25 mg (blis. OPA/Al/PVC/Al) |
ZNT |
CZ |
28 |
8.64 |
8.64 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
4772A |
|
|
G |
Tolucombi 80mg/25mg tablety |
tbl 28x80mg/25mg |
KRK |
SL |
28 |
8.64 |
8.64 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
7056A |
|
|
G |
Telmark Plus 80 mg/25 mg |
tbl 30x80 mg/25 mg (blis.Al/Al) |
GLM-CZ |
CZ |
30 |
9.27 |
9.27 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C09DA07 |
|
|
|
Telmisartan a diuretiká |
p.o. 80/25 mg (56 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.309 |
|
|
|
4935A |
|
|
G |
Telmisartan/Hydrochlorotiazid EGIS 80mg/25mg |
tbl 56x80mg/25mg (blis. Al/Al) |
EGI |
HU |
56 |
17.28 |
17.28 |
I |
0 |
0 |
0 |
DIA, GER, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
C10AA05 |
|
|
|
Atorvastatín |
p.o. 20 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
21270 |
X |
|
G |
Atorvastatin Teva Pharma 20 mg |
tbl flm 30x20 mg (blis.Al/Al) |
TEV |
SK |
60 |
1.55 |
1.55 |
I |
0 |
0 |
0 |
|
|
|
|
U14 |
38841 |
X |
|
G |
Atorvastatin Actavis 20mg |
tbl flm 30x20 mg |
ACT |
IS |
60 |
1.76 |
1.76 |
I |
0 |
0 |
0 |
|
|
|
|
U14 |
4283A |
X |
|
G |
Atorvastatin Billev 20 mg filmom obalené tablety |
tbl flm 30x20mg(blis.OPA/Al/PVC/Al) |
BIP |
DK |
60 |
1.76 |
1.76 |
I |
0 |
0 |
0 |
|
|
|
|
U14 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 20 mg (84-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
3.3000000000000002E-2 |
|
|
|
82560 |
X |
|
G |
Gletor 20 mg |
tbl flm 100x20 mg |
GLM |
CZ |
200 |
6.6 |
6.6 |
I |
0 |
0 |
0 |
|
|
|
|
U14 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 40 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
32736 |
X |
|
G |
Atorvastatin Mylan 40 mg |
tbl flm 30x 40 mg (fľ.HDPE) |
GNS |
UK |
120 |
4.49 |
4.49 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
21287 |
X |
|
G |
Atorvastatin Teva Pharma 40 mg |
tbl flm 30x40 mg (blis.Al/Al) |
TEV |
SK |
120 |
4.49 |
4.49 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
82589 |
X |
|
G |
Gletor 40 mg |
tbl flm 30x40 mg |
GLM |
CZ |
120 |
4.49 |
4.49 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
57072 |
X |
|
G |
Pharmastatin 40 mg |
tbl flm 30x40 mg (blister) |
STD |
DE |
120 |
4.49 |
4.49 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
92749 |
X |
|
G |
ATORIS 40 |
tbl flm 30x40 mg |
KRK |
SI |
120 |
4.58 |
4.58 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
38861 |
X |
|
G |
Atorvastatin Actavis 40 mg |
tbl flm 30x40 mg (blis.) |
ACT |
IS |
120 |
4.58 |
4.58 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 40 mg (84-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
00991 |
X |
|
G |
Atorvastatin Mylan 40mg |
tbl flm 90x40mg |
GNC |
GB |
360 |
13.47 |
13.47 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
21293 |
X |
|
G |
Atorvastatin Teva Pharma 40 mg |
tbl flm 90x40 mg (blis.Al/Al) |
TEV |
SK |
360 |
13.47 |
13.47 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
6937A |
X |
|
G |
Atorvastatin Farmax 40 mg |
tbl flm 100x40 mg (blis.Al/Al) |
SVS |
CZ |
400 |
14.97 |
14.97 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
92751 |
X |
|
G |
ATORIS 40 |
tbl flm 90x40 mg |
KRK |
SI |
360 |
13.74 |
13.74 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
38866 |
X |
|
G |
Atorvastatin Actavis 40 mg |
tbl flm 100x40 mg (blis.) |
ACT-3 |
IS |
400 |
15.27 |
15.27 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
57077 |
X |
|
G |
Pharmastatin 40 mg |
tbl flm 100x40 mg (blister) |
STD |
DE |
400 |
15.27 |
15.27 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
82594 |
X |
|
G |
Gletor 40 mg |
tbl flm 100x40 mg (blis.OPA-Al-PVC/Al) |
GLM |
CZ |
400 |
16 |
16 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 60 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
04622 |
X |
|
G |
Atoris 60 |
tbl flm 30x60mg |
KRK |
SI |
180 |
7.2 |
7.2 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF |
ind.obm. |
|
|
U15 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 80 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
4.2000000000000003E-2 |
|
|
|
04625 |
X |
|
G |
Atoris 80 |
tbl flm 30x80 mg |
KRK |
SI |
240 |
9.26 |
9.26 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
3436A |
X |
|
G |
Tulip 80 mg filmom obalené tablety |
tbl flm 30x80 mg (blis.Al/Al) |
SAN |
SI |
240 |
9.26 |
9.26 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
34351 |
X |
|
O |
SORTIS 80 mg |
tbl flm 30x80 mg (blis. PA/Al/PVC) |
PFI-GB-3 |
GB |
240 |
9.89 |
9.89 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
0366A |
X |
|
G |
Atorvastatin Actavis 80 mg |
tbl flm 30x80 mg (blis.Al/Al) |
ACT-3 |
IS |
240 |
9.94 |
9.94 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
12486 |
X |
|
G |
TORVACARD 80 mg |
tbl flm 30x80 mg (blis.OPA/Al/PVC/Al) |
ZNT-SK-2 |
SK |
240 |
9.94 |
9.94 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
3073B |
X |
|
G |
Torvacard Novum 80 mg |
tbl flm 30x80 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
240 |
9.94 |
9.94 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
21302 |
X |
|
G |
Atorvastatin Teva Pharma 80 mg |
tbl flm 28x80 mg (blis.Al/Al) |
TEV |
IL |
224 |
9.2899999999999991 |
9.2899999999999991 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
C10AA05 |
|
|
|
Atorvastatín |
p.o. 80 mg (90-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
4.2000000000000003E-2 |
|
|
|
04627 |
X |
|
G |
Atoris 80 |
tbl flm 90x80 mg |
KRK |
SI |
720 |
27.78 |
27.78 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
3446A |
X |
|
G |
Tulip 80 mg filmom obalené tablety |
tbl flm 90x80 mg (blis.Al/Al) |
SAN |
SI |
720 |
27.78 |
27.78 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
0371A |
X |
|
G |
Atorvastatin Actavis 80 mg |
tbl flm 100x80 mg (blis.Al/Al) |
ACT-3 |
IS |
800 |
30.87 |
30.87 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
34353 |
X |
|
O |
SORTIS 80 mg |
tbl flm 100x80 mg (blis.PA/Al/PVC) |
PFI-GB-3 |
GB |
800 |
31.2 |
31.2 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
21309 |
X |
|
G |
Atorvastatin Teva Pharma 80 mg |
tbl flm 90x80 mg (blis.Al/Al) |
TEV |
SK |
720 |
29.82 |
29.82 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
12487 |
X |
|
G |
TORVACARD 80 mg |
tbl flm 90x80 mg (blis.OPA/Al/PVC/Al) |
ZNT-SK-2 |
SK |
720 |
29.82 |
29.82 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
3077B |
X |
|
G |
Torvacard Novum 80 mg |
tbl flm 90x80 mg (blis.OPA/Al/PVC/Al) |
ZNT |
|
720 |
29.82 |
29.82 |
I |
0 |
0 |
0 |
DIA, END, GER, INT, KAR, KLF, NEU |
ind.obm. |
|
|
U16 |
C10AB05 |
|
|
|
Fenofibrát |
p.o. 200 mg (90 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.19719999999999999 |
|
|
|
85488 |
X |
|
G |
Fenofix 200 |
cps dur 90x200 mg (blis.PVC/PVDC/Al) |
TEV-SK |
SK |
90 |
17.75 |
17.75 |
I |
0 |
0 |
0 |
|
|
|
|
|
D01BA02 |
|
|
|
Terbinafín |
p.o. 250 mg (28-30 ks) |
0.25 |
g |
|
|
|
|
|
|
|
|
0.34639999999999999 |
|
|
|
90378 |
X |
|
G |
Terbinafin Mylan 250 mg |
tbl 28x250 mg |
GNS |
GB |
28 |
6.94 |
6.94 |
I |
0 |
0 |
0 |
DER |
ind.obm. |
|
|
|
D01BA02 |
|
|
|
Terbinafín |
p.o. 250 mg (56 ks) |
0.25 |
g |
|
|
|
|
|
|
|
|
0.34639999999999999 |
|
|
|
35837 |
X |
|
G |
Terbinafin Actavis 250 mg |
tbl 56x250 mg (bli.) |
ACT-3 |
IS |
56 |
13.88 |
13.88 |
I |
0 |
0 |
0 |
DER |
ind.obm. |
|
|
|
D02AC |
|
|
|
Mäkký parafín a tuky |
loc. liq (500 ml) |
1 |
ml |
|
|
|
|
|
|
|
|
1.7000000000000001E-2 |
|
|
|
44359 |
|
|
O |
OILATUM EMOLLIENT |
add bal 1x500 ml |
STI |
IE |
500 |
8.4499999999999993 |
8.4499999999999993 |
I |
0 |
0 |
0 |
DER, PED, PLM |
|
|
|
|
D05BB02 |
|
|
|
Acitretín |
p.o. 10 mg (30 ks) |
35 |
mg |
|
|
|
|
|
|
|
|
1.32 |
|
|
|
76660 |
|
|
O |
NEOTIGASON |
cps 30x10 mg |
ACT-5 |
IS |
8.57 |
11.27 |
11.27 |
I |
0 |
0 |
0 |
DER, REU |
|
|
|
|
D05BB02 |
|
|
|
Acitretín |
p.o. 25 mg (30 ks) |
35 |
mg |
|
|
|
|
|
|
|
|
1.05 |
|
|
|
76661 |
|
|
O |
NEOTIGASON |
cps 30x25 mg |
ACT-5 |
IS |
21.43 |
22.47 |
22.47 |
I |
0 |
0 |
0 |
DER, REU |
|
|
|
|
D06BB10 |
|
|
|
Imikvimod |
loc. crm 5% |
250 |
mg |
|
|
|
|
|
|
|
|
4.62 |
|
|
|
01796 |
|
|
O |
Aldara |
crm 12x250 mg (vrecko PE/Al) |
MPH-S |
SE |
12 |
55.42 |
55.42 |
I |
0 |
0 |
0 |
DER, GYN, ONK |
ind.obm. |
|
|
|
D06BB12 |
|
|
|
Epigalokatechíngalát |
loc. ung. 10% |
750 |
mg |
|
|
|
|
|
|
|
|
2.41 |
|
|
|
2050A |
|
|
O |
Veregen 100 mg/g masť |
ung 1x15 g (tuba Al) |
NRC-CZ |
CZ |
20 |
48.14 |
48.14 |
I |
0 |
0 |
0 |
DER, GYN, URO |
ind.obm. |
|
|
|
D07AD01 |
|
|
|
Klobetazol propionát |
loc.0,05% |
1 |
ml |
|
|
|
|
|
|
|
|
0.105 |
|
|
|
30137 |
|
|
O |
CLARELUX 500 mikrogramov/g dermálna pena |
spm der 1x100 g (fľ. Al) |
PFD |
FR |
100 |
10.45 |
10.45 |
I |
0 |
0 |
0 |
DER |
|
|
|
|
D10BA01 |
|
|
|
Izotretinoín |
p.o. 10 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.9 |
|
|
|
7558A |
|
|
G |
Isotretinoin Actavis 10 mg |
cps mol 30x10 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
10 |
8.85 |
8.85 |
I |
0 |
0 |
0 |
DER |
ind.obm. |
|
|
|
D10BA01 |
|
|
|
Izotretinoín |
p.o. 20 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.7 |
|
|
|
7563A |
|
|
G |
Isotretinoin Actavis 20 mg |
cps mol 30x20 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
20 |
13.8 |
13.8 |
I |
0 |
0 |
0 |
DER |
ind.obm. |
|
|
|
D10BA01 |
|
|
|
Izotretinoín |
p.o. 40 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.91 |
|
|
|
49915 |
|
|
G |
CURACNÉ 40 mg |
cps mol 30x40 mg |
PAH |
FR |
40 |
36.15 |
36.15 |
I |
0 |
0 |
0 |
DER |
ind.obm. |
|
|
|
D11A |
|
|
|
Iné dermatologiká |
loc. 95% ( 150 g ) |
1 |
g |
|
|
|
|
|
|
|
|
1.2999999999999999E-2 |
|
|
|
24432 |
|
|
O |
SPIRITUS CUM BENZINO DENAT. |
sol der 1x150 g |
VUL |
SK |
150 |
1.83 |
1.83 |
I |
0 |
0 |
0 |
|
|
|
|
U80 |
G02CB01 |
|
|
|
Bromkriptín |
p.o. 2,5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.33 |
|
|
|
03747 |
X |
|
O |
PARLODEL |
tbl 30x2,5 mg |
MPH-CZ |
CZ |
15 |
4.91 |
4.91 |
I |
0 |
0 |
0 |
END, GYN, ENP |
|
|
|
|
G02CB04 |
|
|
|
Quinagolid |
p.o. 75 µg |
75 |
mcg |
|
|
|
|
|
|
|
|
0.78 |
|
|
|
95582 |
X |
|
O |
Norprolac 75µg tablety |
tbl 30x75µg |
FEI-CZ |
CZ |
30 |
23.35 |
23.35 |
I |
0 |
0 |
0 |
END, GYN |
ind.obm. |
|
|
U85 |
G03BA03 |
|
|
|
Testosterón |
parent. |
18 |
mg |
|
|
|
|
|
|
|
|
0.34 |
|
|
|
00373 |
|
|
G |
AGOVIRIN DEPOT |
sus inj 5x2 ml/50 mg |
BTA |
SK |
13.888999999999999 |
4.7 |
4.7 |
I |
0 |
0 |
0 |
END, ENP, SEX, URO |
ind.obm. |
|
|
|
G03BA03 |
|
|
|
Testosterón |
parent. undekanoát |
10.199999999999999 |
mg |
|
|
|
|
|
|
|
|
0.96299999999999997 |
|
|
|
90439 |
|
|
O |
NEBIDO 1000 mg/4 ml injekčný roztok |
sol inj 1x4 ml |
BAS |
DE |
98 |
94.32 |
94.32 |
I |
0 |
0 |
0 |
END, SEX, URO |
ind.obm. |
|
|
|
G03CA03 |
|
|
|
Estradiol |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.2 |
|
|
|
00365 |
|
|
G |
AGOFOLLIN-DEPOT |
sus inj 1x2 ml/10 mg |
BTA |
SK |
10 |
1.89 |
1.89 |
I |
0 |
0 |
0 |
END, GYN |
|
|
|
|
G03DB04 |
|
|
|
Nomegestrol acetát |
p.o. 5 mg (10 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.54 |
|
|
|
47059 |
X |
|
O |
LUTENYL |
tbl 10x5 mg |
THL |
MC |
10 |
5.25 |
5.25 |
I |
0 |
0 |
0 |
END, GYN |
|
|
|
|
G03DC02 |
|
|
|
Noretisterón |
p.o. 5 mg (45 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.26 |
|
|
|
2015B |
X |
|
G |
Norethisteron Zentiva |
tbl 45x5 mg (blis.Al/PVC) |
ZNT |
SK |
45 |
11.7 |
11.7 |
I |
0 |
0 |
0 |
END, GYN |
|
|
|
|
G03FA01 |
|
|
|
Noretisterón a estrogén |
p.o. 1/0,5 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.23100000000000001 |
|
|
|
47651 |
|
|
O |
Gynovel 1 mg/ 0,5 mg tablety |
tbl 28x1mg/0,5 mg |
DRK |
DE |
28 |
6.46 |
6.46 |
I |
0 |
0 |
0 |
END, GYN |
|
|
|
|
G03FA01 |
|
|
|
Noretisterón a estrogén |
p.o. 1/0,5 mg (84 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
0.23100000000000001 |
|
|
|
47653 |
|
|
O |
Gynovel 1 mg/ 0,5 mg tablety |
tbl 84x1mg/0,5 mg |
DRK |
DE |
84 |
19.38 |
19.38 |
I |
0 |
0 |
0 |
END, GYN |
|
|
|
|
G03FA15 |
|
|
|
Dienogest a estradiol |
p.o. 2/1mg (84 ks) kontinuálne prípravky |
1 |
DF |
|
|
|
|
|
|
|
|
1.5149999999999999 |
|
|
|
2051B |
|
|
G |
VELBIENNE 2 mg/1 mg filmom obalené tablety |
tbl flm 3x28 (blis.PVC/PVDC/Al) |
LDP-SK |
SK |
84 |
127.24 |
127.24 |
I |
0 |
0 |
0 |
END, GYN |
|
|
|
|
G03HA01 |
|
|
|
Cyproterón |
p.o. 50 mg (50 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.84 |
|
|
|
32095 |
X |
|
G |
Cyproplex |
tbl 50x50mg |
PHM |
NL |
25 |
20.98 |
20.98 |
I |
0 |
0 |
0 |
END, GYN, ONK, PSY, SEX, URO, ENP |
|
|
|
|
G04BD04 |
|
|
|
Oxybutynín |
p.o. 5 mg (60 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
0.254 |
|
|
|
33013 |
X |
|
G |
Eurin 5mg |
tbl 60x5 mg |
GNS |
GB |
20 |
5.03 |
5.03 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
|
|
|
|
G04BD04 |
|
|
|
Oxybutynín |
p.o. 5 mg (90 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
0.254 |
|
|
|
33014 |
X |
|
G |
Eurin 5mg |
tbl 90x5 mg |
GNS |
GB |
30 |
7.55 |
7.55 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
|
|
|
|
G04BD04 |
|
|
|
Oxybutynín |
transd. |
15 |
mg |
|
|
|
|
|
|
|
|
1.2130000000000001 |
|
|
|
40835 |
|
|
O |
KENTERA |
emp tdm 8 (3,9 mg/24 hod) |
NCB |
GB |
28 |
33.82 |
33.82 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
40836 |
|
|
O |
KENTERA |
emp tdm 24 (3,9 mg/24 hod) |
NCB |
GB |
84 |
101.88 |
101.88 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
G04BD08 |
|
|
|
Solifenacín |
p.o. 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.66 |
|
|
|
23015 |
X |
|
G |
Asolfena 5mg |
tbl flm 30x5 mg |
KRK |
SI |
30 |
19.559999999999999 |
19.559999999999999 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30311 |
X |
|
G |
Karesol 5 mg filmom obalené tablety |
tbl flm 30x5 mg (blis.PVC/PVDC/Al) |
STD |
DE |
30 |
19.559999999999999 |
19.559999999999999 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
9836A |
X |
|
G |
Sentacurin 5mg |
tbl flm 30x5mg (blis.PVC/Al) |
EGI |
HU |
30 |
19.559999999999999 |
19.559999999999999 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30207 |
X |
|
G |
Solifenacin Teva 5 mg |
tbl flm 30x5 mg (blis.PVC/PVDC/Al) |
TEV |
SK |
30 |
19.559999999999999 |
19.559999999999999 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30232 |
X |
|
G |
Soliflow 5 mg filmom obalené tablety |
tbl flm 30x5 mg (blis.PVC/PVDC/Al) |
ADD |
PL |
30 |
19.559999999999999 |
19.559999999999999 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30184 |
X |
|
G |
Zabcare 5 mg |
tbl flm 30x5 mg |
HTN-3 |
CZ |
30 |
19.559999999999999 |
19.559999999999999 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
04865 |
X |
|
G |
Zevesin 5 mg |
tbl flm 30x5 mg (blis.OPA/Al/PVC/Al) |
ZNT-SK-2 |
SK |
30 |
19.559999999999999 |
19.559999999999999 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
G04BD08 |
|
|
|
Solifenacín |
p.o. 5 mg (100 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.66 |
|
|
|
23019 |
X |
|
G |
Asolfena 5mg |
tbl flm 100x5 mg |
KRK |
SI |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30312 |
X |
|
G |
Karesol 5 mg filmom obalené tablety |
tbl flm 100x5 mg (blis.PVC/PVDC/Al) |
STD |
DE |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
9840A |
X |
|
G |
Sentacurin 5mg |
tbl flm 100x5mg (blis.PVC/Al) |
EGI |
HU |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
9381A |
X |
|
G |
Solifenacin PMCS 5 mg |
tbl flm 100x5 mg (blis. OPA/Al/PVC/Al) |
PMP |
CZ |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30738 |
X |
|
G |
Solifenacin Sandoz 5 mg filmom obalené tablety |
tbl flm 100x5mg (blis.PVC/PVDC/Al) |
SAN |
SI |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30208 |
X |
|
G |
Solifenacin Teva 5 mg |
tbl flm 100x5 mg (blis.PVC/PVDC/Al) |
TEV |
SK |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30233 |
X |
|
G |
Soliflow 5 mg filmom obalené tablety |
tbl flm 100x5 mg (blis.PVC/PVDC/Al) |
ADD |
PL |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
0395B |
X |
|
G |
SOLIMED 5 mg |
tbl flm, 100x5 mg (blis.PVC/AI) |
CRR |
SK |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
9273A |
X |
|
G |
Urokur 5 mg filmom obalené tablety |
tbl flm 100x5 mg (blis.OPA/Al/PVC/Al) |
GLH-2 |
AT |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
30185 |
X |
|
G |
Zabcare 5 mg |
tbl flm 100 x 5 mg |
HTN-3 |
CZ |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
04866 |
X |
|
G |
Zevesin 5 mg |
tbl flm 100x5 mg (blis.OPA/Al/PVC/Al) |
ZNT-SK-2 |
SK |
100 |
65.19 |
65.19 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind. obm. |
|
|
|
G04BD08 |
|
|
|
Solifenacín |
p.o. 10 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.54100000000000004 |
|
|
|
04868 |
X |
|
G |
Zevesin 10 mg |
tbl flm 30x10 mg (blis.OPA/Al/PVC/Al) |
ZNT |
SK |
60 |
32.11 |
32.11 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
1558B |
X |
|
G |
Solifenacin Actavis 10 mg |
tbl flm 30x10 mg (blis PVC/Al) |
ACT-5 |
IS |
60 |
32.130000000000003 |
32.130000000000003 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
G04BD08 |
|
|
|
Solifenacín |
p.o. 10 mg (100 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.54100000000000004 |
|
|
|
30323 |
X |
|
G |
Karesol 10 mg filmom obalené tablety |
tbl flm 100x10 mg (blis.PVC/PVDC/Al) |
STD |
DE |
200 |
107.03 |
107.03 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
9850A |
X |
|
G |
Sentacurin 10mg |
tbl flm 100x10mg (blis.PVC/Al) |
EGI |
HU |
200 |
107.03 |
107.03 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
30748 |
X |
|
G |
Solifenacin Sandoz 10 mg filmom obalené tablety |
tbl flm 100x10 mg (blis.PVC/PVDC/Al) |
SAN |
SI |
200 |
107.03 |
107.03 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
0401B |
X |
|
G |
SOLIMED 10 mg |
tbl flm 100x10 mg (blis.PVC/AI) |
CRR |
SK |
200 |
107.03 |
107.03 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
23026 |
X |
|
G |
Asolfena 10mg |
tbl flm 100x10 mg |
KRK |
SI |
200 |
107.08 |
107.08 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
1560B |
X |
|
G |
Solifenacin Actavis 10 mg |
tbl flm 100x10 mg (blis PVC/Al) |
ACT-5 |
IS |
200 |
107.08 |
107.08 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
30222 |
X |
|
G |
Solifenacin Teva 10 mg |
tbl flm 100x10 mg (blis.PVC/PVDC/Al) |
TEV |
SK |
200 |
107.08 |
107.08 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
30242 |
X |
|
G |
Soliflow 10 mg filmom obalené tablety |
tbl flm 100x10 mg (blis.PVC/PVDC/Al) |
ADD |
PL |
200 |
107.08 |
107.08 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
9284A |
X |
|
G |
Urokur 10 mg filmom obalené tablety |
tbl flm 100x10 mg (blis.OPA/Al/PVC/Al) |
GLH-2 |
AT |
200 |
107.08 |
107.08 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
04869 |
X |
|
G |
Zevesin 10 mg |
tbl flm 100x10 mg (blis.OPA/Al/PVC/Al) |
ZNT |
SK |
200 |
107.08 |
107.08 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
9388A |
X |
|
G |
Solifenacin PMCS 10 mg |
tbl flm 100x10 mg (blis. OPA/Al/PVC/Al) |
PMP |
CZ |
200 |
108.16 |
108.16 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
30196 |
X |
|
G |
Zabcare 10 mg |
flm tbl 100x10 mg |
HTN-3 |
CZ |
200 |
108.16 |
108.16 |
I |
0 |
0 |
0 |
GYN, GYU, URO |
ind.obm. |
|
|
|
G04BE03 |
|
|
|
Sildenafil |
p.o. 20 mg (90 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
16.22 |
|
|
|
95558 |
|
|
O |
Revatio 20 mg filmom obalené tablety |
tbl flm 90x20 mg (blis.PVC/Al) |
PFI-GB-1 |
GB |
30 |
486.33 |
486.33 |
I |
0 |
0 |
0 |
KAR |
ind.obm., ZP |
|
|
|
G04CA01 |
|
|
|
Alfuzosín |
p.o. predĺžené uvoľňovanie 10 mg (60 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.17100000000000001 |
|
|
|
35235 |
|
|
G |
Alfuzosin Mylan 10 mg |
tbl plg 60x10 mg |
GNS |
GB |
60 |
10.26 |
10.26 |
I |
0 |
0 |
0 |
URO |
|
|
|
U20 |
G04CA02 |
|
|
|
Tamsulosín |
p.o. predĺžené uvoľňovanie 0,4 mg (90-100 ks) |
0.4 |
mg |
|
|
|
|
|
|
|
|
0.1 |
|
|
|
23098 |
X |
|
G |
Solesmin 0,4 mg |
cps mdd 100x0,4 mg (blis.PVC/PVDC/Al) |
CIA-GB-1 |
GB |
100 |
9.86 |
9.86 |
I |
0 |
0 |
0 |
URO |
|
|
|
|
95320 |
X |
|
G |
Tamsulosin HCL Mylan 0,4mg |
cps mdd 100x0,4mg |
GNC |
GB |
100 |
9.86 |
9.86 |
I |
0 |
0 |
0 |
URO |
|
|
|
|
95374 |
X |
|
G |
Tamsulosin-Teva 0,4 mg |
cps mdd 100x0,4 mg |
SBV |
NL |
100 |
9.86 |
9.86 |
I |
0 |
0 |
0 |
URO |
|
|
|
|
G04CB01 |
|
|
|
Finasterid |
p.o. 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.245 |
|
|
|
04879 |
X |
|
G |
Finasteride Accord 5mg |
tbl flm 30x5 mg (blis.PVC/PVDC/AI) |
ACC |
GB |
30 |
7.35 |
7.35 |
I |
0 |
0 |
0 |
URO |
ind.obm. |
|
|
U86 |
G04CB01 |
|
|
|
Finasterid |
p.o. 5 mg (50 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.245 |
|
|
|
76417 |
X |
|
G |
Finanorm 5 mg |
tbl flm 50x5 mg (blis. PVC/PVDC/Al) |
PRW |
CZ |
50 |
12.25 |
12.25 |
I |
0 |
0 |
0 |
URO |
ind.obm. |
|
|
U86 |
G04CB01 |
|
|
|
Finasterid |
p.o. 5 mg (90-100 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.245 |
|
|
|
76418 |
X |
|
G |
Finanorm 5 mg |
tbl flm 100x5 mg (blis. PVC/PVDC/Al) |
PRW |
CZ |
100 |
24.5 |
24.5 |
I |
0 |
0 |
0 |
URO |
ind.obm. |
|
|
U86 |
04884 |
X |
|
G |
Finasteride Accord 5 mg filmom obalené tablety |
tbl flm 90x5 mg (blis.PVC/PVDC/Al) |
ACC |
GB |
90 |
22.05 |
22.05 |
I |
0 |
0 |
0 |
URO |
ind.obm. |
|
|
U86 |
37581 |
X |
|
O |
PENESTER |
tbl flm 90x5 mg |
ZNT |
CZ |
90 |
22.05 |
22.05 |
I |
0 |
0 |
0 |
URO |
ind.obm. |
|
|
U86 |
H01AB01 |
|
|
|
Tyrotropín |
parent. |
0.9 |
mg |
|
|
|
|
|
|
|
|
367.6 |
|
|
|
40768 |
|
|
O |
THYROGEN |
plv ino 2x0,9 mg (skl. liek.) |
GZE |
NL |
2 |
735.2 |
735.2 |
I |
0 |
0 |
0 |
END, ONK, RAT |
|
|
|
|
H01AC01 |
|
|
|
Somatotropín |
parent. |
2 |
UT |
|
|
|
|
|
|
|
|
14.34 |
|
|
|
05884 |
|
|
O |
GENOTROPIN 5,3 mg |
plv iol 1x5,3 mg (náplň inj.skl.dvojkom.+pero GoQuick) |
PFI-GB-3 |
GB |
8 |
105.76 |
105.76 |
A |
0 |
0 |
0 |
END, ENP |
ind.obm., ZP |
|
|
U21 |
24791 |
|
|
O |
HUMATROPE 36 UT (12 mg) |
plv iol 36 UT+sol. |
LIL |
FR |
18 |
246.85 |
246.85 |
A |
0 |
0 |
0 |
END, ENP |
ind.obm., ZP |
|
|
U21 |
05886 |
|
|
O |
GENOTROPIN 12 mg |
plv iol 1x12 mg (náplň inj.skl.dvojkom.+pero GoQuick) |
PFI-GB-3 |
GB |
18 |
254.54 |
254.54 |
A |
0 |
0 |
0 |
END, ENP |
ind.obm., ZP |
|
|
U21 |
24788 |
|
|
O |
HUMATROPE 18 UT (6 mg) |
plv iol 18 UT+sol. |
LIL |
FR |
9 |
127.93 |
127.93 |
A |
0 |
0 |
0 |
END, ENP |
ind.obm., ZP |
|
|
U21 |
H01AX01 |
|
|
|
Pegvisomant |
s.c. |
10 |
mg |
|
|
|
|
|
|
|
|
66.150000000000006 |
|
|
|
40901 |
|
|
O |
Somavert |
plv iol 30x15 mg |
PFI-GB-1 |
GB |
45 |
2976.5 |
2976.5 |
I |
0 |
0 |
0 |
ENP, END |
ind.obm., ZP |
|
|
|
40899 |
|
|
O |
Somavert |
plv iol 30x10 mg |
PFI-GB-1 |
GB |
30 |
1984.35 |
1984.35 |
I |
0 |
0 |
0 |
ENP, END |
ind.obm., ZP |
|
|
|
40902 |
|
|
O |
Somavert |
plv iol 30x20 mg |
PFI-GB-1 |
GB |
60 |
3968.7 |
3968.7 |
I |
0 |
0 |
0 |
ENP, END |
ind.obm., ZP |
|
|
|
H01BA02 |
|
|
|
Dezmopresín |
p.o. sublng. lyofilizát 60 mcg (30 ks) |
240 |
µg |
|
|
|
|
|
|
|
|
2.93 |
|
|
|
92644 |
X |
|
O |
MINIRIN Melt |
lyo por 30 x 60 µg |
FEI |
GB |
7.5 |
21.94 |
21.94 |
I |
0 |
0 |
0 |
|
|
|
|
|
H01BA02 |
|
|
|
Dezmopresín |
p.o. sublng. lyofilizát 120 mcg (30 ks) |
240 |
µg |
|
|
|
|
|
|
|
|
2.68 |
|
|
|
92650 |
X |
|
O |
MINIRIN Melt |
lyo por 30 x 120µg |
FEI |
GB |
15 |
40.18 |
40.18 |
I |
0 |
0 |
0 |
|
|
|
|
|
H01BA02 |
|
|
|
Dezmopresín |
p.o. sublng. lyofilizát 240 mcg (30 ks) |
240 |
µg |
|
|
|
|
|
|
|
|
2.6854 |
|
|
|
92647 |
|
|
O |
MINIRIN MELT 240 µg |
lyo por 30 x 240 µg |
FRL |
ČR |
30 |
80.56 |
80.56 |
I |
0 |
0 |
0 |
|
|
|
|
|
H01CB02 |
|
|
|
Oktreotid |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
72 |
|
|
|
93866 |
|
|
O |
SANDOSTATIN |
sol ijf 5x1 ml/0,5 mg |
NPA |
CH |
2.5 |
179.99 |
179.99 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
H01CB02 |
|
|
|
Oktreotid |
parent. inj. |
1 |
mg |
|
|
|
|
|
|
|
|
66.37 |
|
|
|
93865 |
|
|
O |
SANDOSTATIN |
sol ijf 5x1 ml/0,1 mg |
NPA |
CH |
0.5 |
10.59 |
10.59 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
93867 |
|
|
O |
SANDOSTATIN |
sol ijf 1x5 ml/1 mg-fľaš. |
NPA |
CH |
1 |
53.71 |
53.71 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
H01CB02 |
|
|
|
Oktreotid |
parent. depot. 10 mg |
1 |
mg |
|
|
|
|
|
|
|
|
61.579700000000003 |
|
|
|
0597A |
|
|
O |
Sandostatin LAR 10 mg |
plv iul 1x10 mg (liek.skl.)+1xstriek.inj.napl.+nástavec+1xbezp.ihla |
NAI |
CZ |
10 |
615.79999999999995 |
615.79999999999995 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
H01CB02 |
|
|
|
Oktreotid |
parent. depot. 20 mg |
1 |
mg |
|
|
|
|
|
|
|
|
38.953000000000003 |
|
|
|
0599A |
|
|
O |
Sandostatin LAR 20 mg |
plv iul 1x20 mg (liek.skl.)+1xstriek.inj.napl.+nástavec+1xbezp.ihla |
NAI |
CZ |
20 |
779.06 |
779.06 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
H01CB02 |
|
|
|
Oktreotid |
parent. depot. 30 mg |
1 |
mg |
|
|
|
|
|
|
|
|
35.82 |
|
|
|
0601A |
|
|
O |
Sandostatin LAR 30 mg |
plv iul 1x30 mg (liek.skl.)+1xstriek.inj.napl.+nástavec+1xbezp.ihla |
NAI |
CZ |
30 |
1074.5899999999999 |
1074.5899999999999 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
H01CB03 |
|
|
|
Lanreotid |
parent. 30 mg |
2.14 |
mg |
|
|
|
|
|
|
|
|
27.193000000000001 |
|
|
|
84701 |
|
|
O |
SOMATULINE P.R. |
plv iud 1x30 mg+solv. |
PBE |
FR |
14.019 |
381.22 |
381.22 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
H01CB03 |
|
|
|
Lanreotid |
parent. 60 mg |
2.14 |
mg |
|
|
|
|
|
|
|
|
24.99 |
|
|
|
46342 |
|
|
O |
Somatuline Autogel 60 mg |
sol inj 1x0,5 ml/60 mg (striek. naplnená PP) |
IAA-1 |
FR |
28.036999999999999 |
700.59 |
700.59 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
H01CB03 |
|
|
|
Lanreotid |
parent. 120 mg |
2.14 |
mg |
|
|
|
|
|
|
|
|
20.260000000000002 |
|
|
|
46343 |
|
|
O |
Somatuline Autogel 120 mg |
sol inj 1x0,5ml/120mg |
IAA-1 |
FR |
56.075000000000003 |
1135.47 |
1135.47 |
I |
0 |
0 |
0 |
END, ENP, GIT, ONK |
ind.obm., ZP |
|
|
|
H02AB02 |
|
|
|
Dexametazón |
parent. 4 mg/ml |
1.5 |
mg |
|
|
|
|
|
|
|
|
0.32 |
|
|
|
84090 |
|
|
G |
DEXAMED |
inj 10x2 ml/8 mg |
MOE |
CY |
53 |
4.7 |
4.7 |
A |
0 |
0 |
0 |
|
|
|
|
|
27534 |
|
|
G |
DEXA-RATIOPHARM 4 |
inj 3x1 ml/4 mg |
MCK |
DE |
8 |
2.36 |
2.36 |
A |
0 |
0 |
0 |
|
|
|
|
|
H02AB04 |
|
|
|
Metylprednizolón |
parent. 40 mg/ml |
20 |
mg |
|
|
|
|
|
|
|
|
0.89 |
|
|
|
40536 |
|
|
O |
DEPO-MEDROL 40 mg/ml |
sus inj 1x5 ml/200 mg (liek.inj.skl.) |
PFI-GB-3 |
GB |
10 |
8.8699999999999992 |
8.8699999999999992 |
I |
0 |
0 |
0 |
|
|
|
|
|
H02AB04 |
|
|
|
Metylprednizolón |
parent. 40 mg/ml |
20 |
mg |
|
|
|
|
|
|
|
|
0.65300000000000002 |
|
|
|
9117A |
|
|
G |
Metylprednizolón Hikma 40 mg |
plv ino 10x40 mg (liek.inj.skl.) |
HKP-P |
PT |
20 |
13.06 |
13.06 |
I |
0 |
0 |
0 |
|
|
|
|
|
H02AB04 |
|
|
|
Metylprednizolón |
parent. 125 mg |
20 |
mg |
|
|
|
|
|
|
|
|
0.38500000000000001 |
|
|
|
9119A |
|
|
G |
Metylprednizolón Hikma 125 mg |
plv ino 10x125 mg (liek.inj.skl.) |
HKP-P |
PT |
62.5 |
24.04 |
24.04 |
I |
0 |
0 |
0 |
|
|
|
|
|
H02AB07 |
|
|
|
Prednizón |
p.o. 5 mg (20 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.29799999999999999 |
|
|
|
00269 |
X |
|
G |
PREDNISON 5 LÉČIVA |
tbl 20x5 mg |
ZNT |
CZ |
10 |
2.98 |
2.98 |
I |
0 |
0 |
0 |
|
|
|
|
|
H02AB07 |
|
|
|
Prednizón |
p.o. 20 mg (20 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.16 |
|
|
|
02963 |
X |
|
G |
PREDNISON 20 LÉČIVA |
tbl 20x20 mg (blis.) |
ZNT |
CZ |
40 |
6.22 |
6.22 |
I |
0 |
0 |
0 |
|
|
|
|
|
H02AB09 |
|
|
|
Hydrokortizón |
parent. |
30 |
mg |
|
|
|
|
|
|
|
|
0.66610000000000003 |
|
|
|
12124 |
|
|
G |
Hydrocortison VUAB 100 mg |
plv ino 1x100 mg (liek.inj.skl.) |
VUA-1 |
CZ |
3.3330000000000002 |
1.97 |
1.97 |
I |
0 |
0 |
0 |
|
|
|
|
|
2410B |
|
|
G |
HYDROCORTISONE MEDOPHARM 100 mg |
plo ijf 1x100 mg (liek.inj.skl.) |
MPM |
CR |
3.3330000000000002 |
2.2200000000000002 |
2.2200000000000002 |
I |
0 |
0 |
0 |
|
|
|
|
|
H03AA01 |
|
|
|
Levotyroxín - sodná soľ |
p.o. 100 mcg (100 ks) |
0.15 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
97186 |
|
|
O |
EUTHYROX 100 ug |
tbl 100x100 ug |
MEC |
DE |
66.67 |
2.96 |
2.96 |
I |
0 |
0 |
0 |
END, ENP, GER, INT, KLF, PED |
|
|
|
U81 |
H03AA01 |
|
|
|
Levotyroxín - sodná soľ |
p.o. 150 mcg (100 ks) |
0.15 |
mg |
|
|
|
|
|
|
|
|
4.4999999999999998E-2 |
|
|
|
69191 |
|
|
O |
EUTHYROX 150 ug |
tbl 100x150 ug |
MEC |
DE |
100 |
4.3499999999999996 |
4.3499999999999996 |
I |
0 |
0 |
0 |
END, ENP, GER, INT, KLF, PED |
|
|
|
U81 |
H03BA02 |
|
|
|
Propyltiouracil |
p.o. 50 mg (100 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.23 |
|
|
|
26588 |
X |
|
O |
PROPYCIL 50 |
tbl 100x50 mg |
SYF |
DE |
50 |
10.95 |
10.95 |
I |
0 |
0 |
0 |
END, ENP |
|
|
|
|
H03BB02 |
|
|
|
Tiamazol |
p.o. 10 mg (50 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.112 |
|
|
|
2523A |
|
|
O |
Thyrozol 10 mg |
tbl flm 50 x 10 mg (blis.PVC/Al) |
MEC |
DE |
50 |
5.59 |
5.59 |
I |
0 |
0 |
0 |
END, INT, ENP |
|
|
|
|
H05BX01 |
|
|
|
Cinakalcet |
p.o. 30 mg (28 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
12.1 |
|
|
|
41634 |
X |
|
O |
MIMPARA |
tbl flm 28x30 mg (blis.) |
AMG |
NL |
14 |
169.19 |
169.19 |
I |
0 |
0 |
0 |
NEF, END |
ind.obm. |
|
|
|
H05BX01 |
|
|
|
Cinakalcet |
p.o. 60 mg (28 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
11.401999999999999 |
|
|
|
41638 |
X |
|
O |
MIMPARA |
tbl flm 28x60 mg (blis.) |
AMG |
NL |
28 |
319.24 |
319.24 |
I |
0 |
0 |
0 |
NEF, END |
ind.obm. |
|
|
|
H05BX01 |
|
|
|
Cinakalcet |
p.o. 90 mg (28 ks) |
60 |
mg |
|
|
|
|
|
|
|
|
11.233000000000001 |
|
|
|
41642 |
X |
|
O |
MIMPARA |
tbl flm 28x90 mg (blis.) |
AMG |
NL |
42 |
471.76 |
471.76 |
I |
0 |
0 |
0 |
NEF, END |
ind.obm. |
|
|
|
H05BX02 |
|
|
|
Parikalcitol |
p.o. 1 mcg (28 ks) |
2 |
mcg |
|
|
|
|
|
|
|
|
4.9400000000000004 |
|
|
|
46784 |
X |
|
O |
Zemplar 1 µg kapsuly |
cps mol 28x1 µg (blis.PVC/fluóropolymér/Al) |
ABV |
SK |
14 |
69.099999999999994 |
69.099999999999994 |
I |
0 |
0 |
0 |
END, NEF |
|
|
|
|
H05BX02 |
|
|
|
Parikalcitol |
p.o. 2 mcg (28 ks) |
2 |
mcg |
|
|
|
|
|
|
|
|
5.59 |
|
|
|
46788 |
X |
|
O |
Zemplar 2 µg kapsuly |
cps mol 28x2 µg (blis.PVC/fluóropolymér/Al) |
ABV |
SK |
28 |
156.38999999999999 |
156.38999999999999 |
I |
0 |
0 |
0 |
END, NEF |
|
|
|
|
H05BX02 |
|
|
|
Parikalcitol |
parent. |
1.7 |
mcg |
|
|
|
|
|
|
|
|
5.19 |
|
|
|
0310B |
|
|
O |
Zemplar 5 µg/ml |
sol inj 5x1 ml/5 µg (liek.inj.skl.), |
ABV |
SK |
14.706 |
76.2 |
76.2 |
A |
0 |
0 |
0 |
NEF |
|
|
|
|
J01CR04 |
|
|
|
Sultamicilín |
parent. |
1.5 |
g |
|
|
|
|
|
|
|
|
2.6 |
|
|
|
31791 |
|
|
G |
Ampisulcillin 1,5 g |
plo ijf 10x1,5 g Iliek.inj.) |
ACT-5 |
IS |
10 |
25.74 |
25.74 |
A |
0 |
0 |
0 |
|
|
|
|
|
J01CR05 |
|
|
|
Piperacilin/tazobactam |
parent. |
14 |
g |
|
|
|
|
|
|
|
|
60.09 |
|
|
|
80777 |
|
|
G |
Piperacilin/Tazobactam Mylan 4g/0,5g |
plo jof 1x4g/0,5g |
MLB |
FR |
0.32100000000000001 |
9.26 |
9.26 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
J01DD01 |
|
|
|
Cefotaxim |
parent. 1 g |
4 |
g |
|
|
|
|
|
|
|
|
12.2531 |
|
|
|
31787 |
|
|
G |
ABRICEF |
plo ijf 10x1 g |
ACT-5 |
IS |
2.5 |
26.16 |
26.16 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01DE01 |
|
|
|
Cefepim |
parent. inj. 1 g |
2 |
g |
|
|
|
|
|
|
|
|
16.14 |
|
|
|
87199 |
|
|
O |
MAXIPIME 1 g |
plv ino 1x1 g |
BMS |
IT |
0.5 |
8.07 |
8.07 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01DH02 |
|
|
|
Meropeném |
parent. |
2 |
g |
|
|
|
|
|
|
|
|
17.559999999999999 |
|
|
|
02112 |
|
|
G |
Meropenem Hospira 500 mg |
plo jof 10x500 mg (liek.inj.skl.) |
HSP |
GB |
2.5 |
43.9 |
43.9 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01EE01 |
|
|
|
Sulfametoxazol a trimetoprim |
parent. |
4 |
DF |
|
|
|
|
|
|
|
|
17.920000000000002 |
|
|
|
11706 |
|
|
G |
BISEPTOL 480 |
con inf 10x5 ml |
WZF |
PL |
1 |
17.91 |
17.91 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01FF01 |
|
|
|
Klindamycín |
parent. |
1.8 |
g |
|
|
|
|
|
|
|
|
17.46 |
|
|
|
27029 |
|
|
G |
KLIMICIN I.V. A I.M. |
sol ijf 10x4 ml/600 mg |
LEK |
SI |
3.3330000000000002 |
58.17 |
58.17 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
97878 |
|
|
G |
KLIMICIN I.V. A I.M. |
sol ijf 10x2 ml/300 mg |
LEK |
SI |
1.667 |
29.11 |
29.11 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01GB01 |
|
|
|
Tobramycín |
inhal. |
600 |
mg |
|
|
|
|
|
|
|
|
53.185000000000002 |
|
|
|
37450 |
|
|
O |
BRAMITOB |
sol neb 56x4 ml/300 mg (obal PE) |
CHS-AT |
AT |
28 |
1489.17 |
1489.17 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm., ZP |
|
|
|
J01GB03 |
|
|
|
Gentamicín |
parent. |
0.24 |
g |
|
|
|
|
|
|
|
|
0.93 |
|
|
|
96414 |
|
|
G |
GENTAMICIN 80MG LEK |
sol inj 10x2 ml/80 mg |
LEK |
SI |
3.3330000000000002 |
3.09 |
3.09 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01MA12 |
|
|
|
Levofloxacín |
p.o. 500 mg (10 ks) |
0.25 |
g |
|
|
|
|
|
|
|
|
0.59499999999999997 |
|
|
|
3980B |
X |
|
G |
Levalox 500 mg filmom obalené tablety |
tbl flm 10x500mg (blis.PVC/PE/PVDC/Al) |
KRK |
SL |
20 |
10.19 |
10.19 |
I |
0 |
0 |
0 |
URO, NEF, TRN, ORL, INF |
ind.obm. |
|
|
S35 |
J01XA01 |
|
|
|
Vankomycín |
parent. 500 mg (1 ks) |
2 |
g |
|
|
|
|
|
|
|
|
22.17 |
|
|
|
08255 |
|
|
G |
Vancomycin Mylan 500mg |
plv ifo 1 x 500 mg |
MRK |
FR |
0.25 |
5.54 |
5.54 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01XA01 |
|
|
|
Vankomycín |
parent. 500 mg (10 ks) |
2 |
g |
|
|
|
|
|
|
|
|
22.17 |
|
|
|
01836 |
|
|
G |
Vancomycin PharmaSwiss 500 mg |
plv ifo 10x500 mg (liek. Inj.skl.) |
PRW |
CZ |
2.5 |
55.41 |
55.41 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01XA01 |
|
|
|
Vankomycín |
parent. 1000 mg (1 ks) |
2 |
g |
|
|
|
|
|
|
|
|
25.15 |
|
|
|
08259 |
|
|
G |
Vancomycin Mylan 1g |
plv ifo 1 x 1 g |
MRK |
FR |
0.5 |
12.57 |
12.57 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01XA01 |
|
|
|
Vankomycín |
parent. 1000 mg (10 ks) |
2 |
g |
|
|
|
|
|
|
|
|
25.15 |
|
|
|
01840 |
|
|
G |
Vancomycin PharmaSwiss 1000 mg |
plv ifo 10x1000 mg (liek. Inj.skl.) |
PRW |
CZ |
5 |
125.72 |
125.72 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01XB01 |
|
|
|
Kolistín |
parent. |
3 |
MU |
|
|
|
|
|
|
|
|
7.8460000000000001 |
|
|
|
61178 |
|
|
O |
COLIMYCINE |
plv ino 50x1 MU |
RDG |
GB |
16.667000000000002 |
130.77000000000001 |
130.77000000000001 |
I |
0 |
0 |
0 |
TRN, ALG |
ind.obm. |
|
|
|
J01XX08 |
|
|
|
Linezolid |
p.o. 600 mg (10 ks) |
1200 |
mg |
|
|
|
|
|
|
|
|
56.99 |
|
|
|
0872B |
X |
|
G |
Linezolid Sandoz 600 mg filmom obalené tablety |
tbl flm 10x600 mg (blis.OPA/Al/PVC/Al) |
SAN |
SI |
5 |
284.93 |
284.93 |
I |
0 |
0 |
0 |
HEM, CHI, INF, INT, NEF, TRN, CCH, KLF |
ind.obm. |
|
|
U56 |
J02AC03 |
|
|
|
Vorikonazol |
p.o. 40 mg/ml |
0.4 |
g |
|
|
|
|
|
|
|
|
79.650000000000006 |
|
|
|
40906 |
X |
|
O |
VFEND 40 mg/ml prášok na perorálnu suspenziu |
plu por 1x45 g (40 mg/ml) (fľ.HDPE) |
PFI-GB-1 |
GB |
7 |
556.38 |
556.38 |
I |
0 |
0 |
0 |
INF, ONK, HEM, TRN |
ind.obm., ZP |
|
|
U57tek |
J02AC03 |
|
|
|
Vorikonazol |
p.o. 200 mg (14 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
80.971000000000004 |
|
|
|
33741 |
X |
|
O |
VFEND 200 mg filmom obalené tablety |
tbl flm 14x200 mg (blis.PVC/Alu) |
PFI-GB-1 |
GB |
7 |
566.79999999999995 |
566.79999999999995 |
I |
0 |
0 |
0 |
INF, ONK, HEM, TRN |
ind.obm., ZP |
|
|
U57pev |
J02AC04 |
|
|
|
Posakonazol |
p.o. 40 mg/ml |
800 |
mg |
|
|
|
|
|
|
|
|
123.13 |
|
|
|
95513 |
X |
|
O |
Noxafil 40 mg/ml perorálna suspenzia |
sus por 1x105 ml (fľa.jant.skl.) |
MSD-GB-1 |
GB |
5.25 |
645.01 |
645.01 |
I |
0 |
0 |
0 |
HEM, INF, ONK, TRN |
ind.obm., ZP |
|
|
U58tek |
J04AB02 |
|
|
|
Rifampicín |
p.o. 150 mg (100 ks) |
0.6 |
g |
|
|
|
|
|
|
|
|
0.52939999999999998 |
|
|
|
93921 |
X |
|
G |
BENEMICIN 150 mg |
cps 100x150 mg |
POL |
PL |
25 |
13.22 |
13.22 |
I |
0 |
0 |
0 |
INF, TRN |
ind.obm. |
|
|
|
J04AB02 |
|
|
|
Rifampicín |
p.o. 300 mg (100 ks) |
0.6 |
g |
|
|
|
|
|
|
|
|
0.41 |
|
|
|
93922 |
X |
|
G |
BENEMICIN 300 mg |
cps 100x300 mg |
POL |
PL |
50 |
20.03 |
20.03 |
I |
0 |
0 |
0 |
INF, TRN |
ind.obm. |
|
|
|
J04AC01 |
|
|
|
Izoniazid |
p.o. 100 mg (250 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.104 |
|
|
|
03303 |
X |
|
G |
NIDRAZID |
tbl 250x100 mg |
ZNT |
CZ |
83.332999999999998 |
8.6199999999999992 |
8.6199999999999992 |
I |
0 |
0 |
0 |
TRN |
ind.obm. |
|
|
|
J04AK02 |
|
|
|
Etambutol |
p.o. 400 mg (100 ks) |
1.2 |
g |
|
|
|
|
|
|
|
|
0.38200000000000001 |
|
|
|
03023 |
X |
|
O |
SURAL 400MG |
tbl 100x400 mg |
CHN |
HU |
33.332999999999998 |
12.59 |
12.59 |
I |
0 |
0 |
0 |
TRN |
ind.obm. |
|
|
|
J04BA02 |
|
|
|
Dapson |
p.o. 100 mg (100 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
5.7099999999999998E-2 |
|
|
|
93821 |
X |
|
O |
DISULONE 100 AU PROTOX.DE FER |
tbl 100x100 mg |
SPC |
FR |
200 |
11.26 |
11.26 |
I |
0 |
0 |
0 |
DER, INF,TRN |
|
|
|
|
J05AB04 |
|
|
|
Ribavirín |
p.o. 200 mg (168 ks) |
1 |
g |
|
|
|
|
|
|
|
|
6.38 |
|
|
|
5025A |
|
|
G |
Ribavirin Mylan 200 mg filmom obalené tablety |
tbl flm 168x200mg(fľ.HDPE) |
GNS |
UK |
33.6 |
214.21 |
214.21 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
J05AB14 |
|
|
|
Valganciklovir |
p.o. 450 mg (60 ks) |
0.9 |
g |
|
|
|
|
|
|
|
|
40.619999999999997 |
|
|
|
2711B |
|
|
G |
Valdamin 450mg |
tbl flm 60x450mg (blis.OPA/Al/PVC/Al) |
EGI |
HU |
30 |
790.66 |
790.66 |
I |
0 |
0 |
0 |
HEM, INF, KAR, NEF, ONK |
ind.obm. |
|
|
|
97249 |
|
|
O |
VALCYTE 450 mg |
tbl flm 60x450 mg |
HLR |
CH |
30 |
1218.52 |
1218.52 |
I |
0 |
0 |
0 |
HEM, INF, KAR, NEF, ONK |
ind.obm. |
|
|
|
J05AE |
|
|
|
Boceprevir |
p.o. 200 mg (336 ks) |
2400 |
mg |
|
|
|
|
|
|
|
|
91.653000000000006 |
|
|
|
10913 |
X |
|
O |
VICTRELIS |
cps dur 336(4x84)x200 mg |
MSD |
GB |
28 |
2566.2800000000002 |
2566.2800000000002 |
I |
0 |
0 |
0 |
INF, HEP |
ind.obm., ZP |
|
|
|
J05AE02 |
|
|
|
Indinavír |
p.o. 400 mg (180 ks) |
2.4 |
g |
|
|
|
|
|
|
|
|
7.83 |
|
|
|
26796 |
X |
|
O |
CRIXIVAN 400MG |
cps 180x400 mg |
MSD |
NL |
30 |
234.55 |
234.55 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AE06 |
|
|
|
Lopinavir |
p.o. 200/50 mg (120 ks) |
0.8 |
g |
|
|
|
|
|
|
|
|
12.503 |
|
|
|
35543 |
X |
|
O |
Kaletra 200 mg/50 mg filmom obalené tablety |
tbl flm 120x200 mg/50 mg (fľ.HDPE) |
ABV-GB |
GB |
30 |
375.05 |
375.05 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AE07 |
|
|
|
Fosamprenavir |
p.o. 700 mg (60 ks) |
1.4 |
g |
|
|
|
|
|
|
|
|
10.702999999999999 |
|
|
|
41929 |
X |
|
O |
TELZIR |
tbl flm 60x700 mg (fľ. HDPE) |
GLA |
GB |
30 |
321 |
321 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AE10 |
|
|
|
Darunavir |
p.o. 400 mg (30 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
13.93 |
|
|
|
4226A |
X |
|
O |
PREZISTA 800 mg filmom obalené tablety |
tbl flm 30x800 mg (fľ.HDPE) |
JNS |
BE |
30 |
417.82 |
417.82 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AE10 |
|
|
|
Darunavir |
p.o. 600 mg (60 ks) |
1.2 |
g |
|
|
|
|
|
|
|
|
20.8 |
|
|
|
65045 |
X |
|
O |
Prezista |
tbl flm 60x600 mg |
JNS |
BE |
30 |
623.89 |
623.89 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AE14 |
|
|
|
Simeprevir |
p.o. 150 mg (28 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
330.93099999999998 |
|
|
|
0252B |
|
|
O |
OLYSIO 150 mg tvrdé kapsuly |
cps dur 28x150 mg (blis.PVC/PE/PVDC/Al) |
JNS |
BE |
28 |
9266.0499999999993 |
9266.0499999999993 |
I |
0 |
0 |
0 |
HEP, INF |
ind.obm., ZP |
|
|
|
J05AF01 |
|
|
|
Zidovudin |
p.o. 250 mg (40 ks) |
600 |
mg |
|
|
|
|
|
|
|
|
4.1929999999999996 |
|
|
|
14102 |
|
|
O |
RETROVIR |
cps 40x250 mg |
GWL |
GB |
16.667000000000002 |
69.77 |
69.77 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AF05 |
|
|
|
Lamivudin |
p.o. 100 mg (28 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
3.33 |
|
|
|
02085 |
X |
|
O |
ZEFFIX 100MG |
tbl flm 28x100 mg |
GOW |
GB |
9.3330000000000002 |
31.08 |
31.08 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
J05AF05 |
|
|
|
Lamivudin |
p.o. 100 mg (84 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
3.33 |
|
|
|
02087 |
X |
|
O |
ZEFFIX 100MG |
tbl flm 84x100 mg |
GOW |
GB |
28 |
93.24 |
93.24 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
J05AF05 |
|
|
|
Lamivudin |
p.o. 150 mg (60 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
2.65 |
|
|
|
56452 |
X |
|
O |
EPIVIR |
tbl flm 60x150 mg |
XGO |
GB |
30 |
79.17 |
79.17 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AF06 |
|
|
|
Abakavir |
p.o. 300 mg (60 ks) |
600 |
mg |
|
|
|
|
|
|
|
|
7.29 |
|
|
|
58396 |
X |
|
O |
ZIAGEN 300 mg |
tbl flm 60x300 mg |
GLA |
GB |
30 |
218.57 |
218.57 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AF07 |
|
|
|
Tenofovir |
p.o. 145 mg (30 ks) |
245 |
mg |
|
|
|
|
|
|
|
|
9.6549999999999994 |
|
|
|
40908 |
X |
|
O |
VIREAD |
tbl flm 30x245 mg |
GSA |
GB |
30 |
289.63 |
289.63 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
J05AF08 |
|
|
|
Adefovir |
p.o. 10 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
9.9529999999999994 |
|
|
|
40907 |
X |
|
O |
HEPSERA |
tbl 30x10 mg |
GSA |
GB |
30 |
298.58 |
298.58 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
J05AF10 |
|
|
|
Entekavir |
p.o. 0,5 mg (30 ks) |
0.5 |
mg |
|
|
|
|
|
|
|
|
13.693 |
|
|
|
35555 |
X |
|
O |
BARACLUDE |
tbl flm 30x0,5 mg |
BMS |
GB |
30 |
410.78 |
410.78 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
J05AF10 |
|
|
|
Entekavir |
p.o. 1 mg (30 ks) |
0.5 |
mg |
|
|
|
|
|
|
|
|
7.36 |
|
|
|
35556 |
X |
|
O |
BARACLUDE |
tbl flm 30x1 mg |
BMS |
GB |
60 |
441.42 |
441.42 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
J05AG01 |
|
|
|
Nevirapin |
p.o. 200 mg (60 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
4.32 |
|
|
|
64988 |
X |
|
O |
VIRAMUNE 200 mg |
tbl flm 60x200 mg |
BOE |
DE |
30 |
129.46 |
129.46 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AG04 |
|
|
|
Etravirin |
p.o. 200 mg (60 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
14.37 |
|
|
|
30687 |
X |
|
O |
Intelence 200 mg tablety |
tbl 60x 200 mg (fl. HDPE) |
JNS |
BE |
30 |
431.08 |
431.08 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AG05 |
|
|
|
Rilpivirín |
p.o. 25 mg (30 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
8.69 |
|
|
|
30688 |
|
|
O |
EDURANT 25 mg filmom obalené tablety |
tbl flm 30x25 mg (fl. HDPE) |
JNS |
BE |
30 |
260.55 |
260.55 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AR01 |
|
|
|
Lamivudin, zidovudin |
p.o. 150/300 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
4.1900000000000004 |
|
|
|
57852 |
|
|
O |
COMBIVIR |
tbl flm 60 blist. |
GWE |
GB |
30 |
125.63 |
125.63 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AR02 |
|
|
|
Lamivudin, abakavir |
p.o. 300/600 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
12.77 |
|
|
|
42714 |
|
|
O |
KIVEXA |
tbl flm 30 (blis.) |
GLA |
GB |
30 |
382.7 |
382.7 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AR03 |
|
|
|
Tenofovir disoproxil a emtricitabin |
p.o. 245/200 mg |
1 |
DF |
|
|
|
|
|
|
|
|
16.510999999999999 |
|
|
|
98584 |
|
|
O |
Truvada |
tbl flm 30 |
GSA |
GB |
30 |
495.31 |
495.31 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AR08 |
|
|
|
Emtricitabín, tenofovir dizoproxyl a rilpivirín |
p.o. 200/245/25 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
26.03 |
|
|
|
31086 |
|
|
O |
Eviplera 200 mg/25 mg/245 mg filmom obalené tablety |
tbl flm 30x200 mg/25 mg/245 mg (fľ.HDPE) |
GSA |
UK |
30 |
780.81 |
780.81 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AR09 |
|
|
|
Emtricitabín, tenofovir dizoproxil, elvitegravir a kobicistát |
p.o. 150/150/200/245 mg (30 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
34.892000000000003 |
|
|
|
6113A |
|
|
O |
Stribild 150 mg/150 mg/200 mg/245 mg filmom obalené tablety |
tbl flm 30x150 mg/150 mg/200 mg/245 mg (fľ.HDPE) |
GSA |
UK |
30 |
1046.75 |
1046.75 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AR13 |
|
|
|
Lamivudin, abakavir, dolutegravir |
p.o. 50/600/300 mg (30ks) |
1 |
DF |
|
|
|
|
|
|
|
|
34.834000000000003 |
|
|
|
1459B |
|
|
O |
Triumeq 50mg/600mg/300mg filmom obalené tablety |
tbl flm 30x50mg/600mg/300mg (fľ.HDPE) |
VVH |
GB |
30 |
1045 |
1045 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AX08 |
|
|
|
Raltegravír |
p.o. 400 mg (60 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
21.062000000000001 |
|
|
|
47025 |
|
|
O |
ISENTRESS 400mg |
tbl flm 60x400 mg |
MSD |
GB |
30 |
631.85 |
631.85 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AX12 |
|
|
|
Dolutegravir |
p.o. 50 mg (30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
21.800999999999998 |
|
|
|
8746A |
|
|
O |
Tivicay 50 mg filmom obalené tablety |
tbl flm 30x50 mg (fľ.HDPE) |
VVH |
GB |
30 |
654.03 |
654.03 |
I |
0 |
0 |
0 |
INF |
ind.obm., ZP |
|
|
|
J05AX15 |
|
|
|
Sofosbuvir |
p.o. 400 mg (28 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
562.93499999999995 |
|
|
|
8996A |
|
|
O |
Sovaldi 400 mg filmom obalené tablety |
tbl flm 28x400 mg (fľ.HDPE) |
GSA |
UK |
28 |
15762.17 |
15762.17 |
I |
0 |
0 |
0 |
HEP, INF |
ind.obm., ZP |
2015-01-01T00:00:00.000 |
|
|
J05AX16 |
|
|
|
Dasabuvir |
p.o. 250 mg (56 ks) |
500 |
mg |
|
|
|
|
|
|
|
|
46.96 |
|
|
|
2708B |
|
|
O |
Exviera 250 mg filmom obalené tablety |
tbl flm 56(4x14)x250 mg (blis.PVC/PE/PCTFE/AI-multibal.) |
ABV-GB |
GB |
28 |
1314.86 |
1314.86 |
I |
0 |
0 |
0 |
HEP, INF |
ind.obm., ZP |
|
|
|
J05AX65 |
|
|
|
Sofosbuvir a ledipasvir |
p.o. 90mg/400mg ( 28 ks ) |
1 |
DF |
|
|
|
|
|
|
|
|
638.89499999999998 |
|
|
|
2394B |
|
|
O |
Harvoni 90 mg/400 mg filmom obalené tablety |
tbl flm 28x90 mg/400 mg (fľ.HDPE) |
GSA |
UK |
28 |
17889.04 |
17889.04 |
I |
0 |
0 |
0 |
HEP, INF |
ind.obm., ZP |
|
|
|
J05AX67 |
|
|
|
Ombitasvir, paritaprevir, ritonavir |
p. o. 12,5/75/50 mg (56 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
540.03399999999999 |
|
|
|
2709B |
|
|
O |
Viekirax 12,5 mg/75 mg/50 mg filmom obalené tablety |
tbl flm 56(4x14)x12,5 mg/75 mg/50 mg (blis.PVC/PE/PCTFE/AI) |
ABV-GB |
GB |
28 |
15120.93 |
15120.93 |
I |
0 |
0 |
0 |
HEP, INF |
ind.obm., ZP |
|
|
|
J06AA06 |
|
|
|
Sérum proti besnote |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
85.73 |
|
|
|
42843 |
|
|
O |
FAVIRAB |
sol inj 1x5 ml |
XAL |
FR |
1 |
85.72 |
85.72 |
A |
0 |
0 |
0 |
INF |
ind.obm. |
|
|
|
J06BA01 |
|
|
|
Imunoglobulín, normálny ľudský pre extravazálnu a. |
parent. 1000 mg |
1 |
g |
|
|
|
|
|
|
|
|
50.1 |
|
|
|
07750 |
|
|
O |
Hizentra 200 mg/ml roztok na subkutánnu injekciu |
sol inj 1x5 ml/1 g (liek.inj.skl.) |
CSL |
DE |
1 |
50.1 |
50.1 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
|
|
|
|
J06BA01 |
|
|
|
Imunoglobulín, normálny ľudský pre extravazálnu a. |
parent. 2000 mg |
1 |
g |
|
|
|
|
|
|
|
|
45.65 |
|
|
|
07753 |
|
|
O |
Hizentra 200 mg/ml roztok na subkutánnu injekciu |
sol inj 1x10 ml/2 g (liek.inj.skl.) |
CSL |
DE |
2 |
91.3 |
91.3 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
|
|
|
|
J06BA01 |
|
|
|
Imunoglobulín, normálny ľudský pre extravazálnu a. |
parent. 4000 mg |
1 |
g |
|
|
|
|
|
|
|
|
44.892000000000003 |
|
|
|
07759 |
|
|
O |
Hizentra 200 mg/ml roztok na subkutánnu injekciu |
sol inj 1x20 ml/4 g (liek.inj.skl.) |
CSL |
DE |
4 |
179.57 |
179.57 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
|
|
|
|
J06BA01 |
|
|
|
Imunoglobulín, normálny ľudský pre extravazálnu a. |
parent. 800 mg |
1 |
g |
|
|
|
|
|
|
|
|
49.25 |
|
|
|
91622 |
|
|
O |
SUBCUVIA, 160 g/l |
sol inj 20x5ml/800 mg |
BAX |
AT |
16 |
787.88 |
787.88 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
57670 |
|
|
O |
Igamplia 160 mg/ml |
sol inj 1x5 ml/800 mg |
GFO |
ES |
0.8 |
39.4 |
39.4 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J06BA01 |
|
|
|
Imunoglobulín, normálny ľudský pre extravazálnu a. |
parent. 1600 mg |
1 |
g |
|
|
|
|
|
|
|
|
49.83 |
|
|
|
91623 |
|
|
O |
SUBCUVIA, 160 g/l |
sol inj 20x10ml/1600 mg |
BAX |
AT |
32 |
1594.33 |
1594.33 |
I |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J06BA01 |
|
|
|
Imunoglobulín, normálny ľudský pre extravazálnu a. |
parent. 1650 mg |
1 |
DF |
|
|
|
|
|
|
|
|
76.06 |
|
|
|
45894 |
|
|
O |
Gammanorm 165 mg/ ml |
sol inj 1x10ml |
OCP |
GB |
1 |
76.05 |
76.05 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
ind.obm. |
|
|
|
J06BA01 |
|
|
|
Normálny ludský imunoglobulín (10% IG) |
s.c. 2,5g |
1 |
g |
|
|
|
|
|
|
|
|
61.5 |
|
|
|
5730A |
|
|
O |
HyQvia 100 mg/ml infúzny roztok na subkutánne použitie |
sol inf 1x25 ml (10 % IG)+1x1,25 ml (rHuPH20) (liek.inj.skl.) |
BXI |
AT |
2.5 |
153.75 |
153.75 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
ind.obm. |
|
|
|
J06BA01 |
|
|
|
Normálny ludský imunoglobulín (10% IG) |
s.c. 5 g |
1 |
g |
|
|
|
|
|
|
|
|
61.5 |
|
|
|
5731A |
|
|
O |
HyQvia 100 mg/ml infúzny roztok na subkutánne použitie |
sol inf 1x50 ml (10 % IG)+1x2,5 ml (rHuPH20) (liek.inj.skl.) |
BXI |
AT |
5 |
307.5 |
307.5 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
ind.obm. |
|
|
|
J06BA01 |
|
|
|
Normálny ludský imunoglobulín (10% IG) |
s.c. 10 g |
1 |
g |
|
|
|
|
|
|
|
|
61.5 |
|
|
|
5732A |
|
|
O |
HyQvia 100 mg/ml infúzny roztok na subkutánne použitie |
sol inf 1x100 ml (10 % IG)+1x5 ml (rHuPH20) (liek.inj.skl.) |
BXI |
AT |
10 |
615 |
615 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
ind.obm. |
|
|
|
J06BA01 |
|
|
|
Normálny ludský imunoglobulín (10% IG) |
s.c. 20 g |
1 |
g |
|
|
|
|
|
|
|
|
61.5 |
|
|
|
5733A |
|
|
O |
HyQvia 100 mg/ml infúzny roztok na subkutánne použitie |
sol inf 1x200 ml (10 % IG)+1x10 ml (rHuPH20) (liek.inj.skl.) |
BXI |
AT |
20 |
1229.99 |
1229.99 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
ind.obm. |
|
|
|
J06BA01 |
|
|
|
Normálny ludský imunoglobulín (10% IG) |
s.c. 30 g |
1 |
g |
|
|
|
|
|
|
|
|
61.5 |
|
|
|
5734A |
|
|
O |
HyQvia 100 mg/ml infúzny roztok na subkutánne použitie |
sol inf 1x300 ml (10 % IG)+1x15 ml (rHuPH20) (liek.inj.skl.) |
BXI |
AT |
30 |
1845 |
1845 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
ind.obm. |
|
|
|
J06BA02 |
|
|
|
Imunoglobulín, normálny ľudský pre i. v. a. |
parent. 0,5 g |
1 |
g |
|
|
|
|
|
|
|
|
68.760000000000005 |
|
|
|
45080 |
|
|
O |
Flebogamma DIF 50 mg/ml infúzny roztok |
sol inf 1x10 ml/0,5 g (liek.skl.) |
GFO |
ES |
0.5 |
34.380000000000003 |
34.380000000000003 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
|
|
|
|
J06BA02 |
|
|
|
Imunoglobulín, normálny ľudský pre i. v. a. |
parent. 2 g |
1 |
g |
|
|
|
|
|
|
|
|
51.28 |
|
|
|
83310 |
|
|
O |
Octagam 10% |
sol inf 1x20 ml (liek.inj.skl.) |
OCP-GB-1 |
GB |
2 |
100.87 |
100.87 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
|
|
|
|
J06BA02 |
|
|
|
Imunoglobulín, normálny ľudský pre i. v. a. |
parent. 2,5 g |
1 |
g |
|
|
|
|
|
|
|
|
48.62 |
|
|
|
45081 |
|
|
O |
Flebogamma DIF 50 mg/ml infúzny roztok |
sol inf 1x50 ml/2,5 g (liek.skl.) |
GFO |
ES |
2.5 |
121.55 |
121.55 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
|
|
|
|
12691 |
|
|
O |
OCTAGAM |
sol inf 1x50 ml |
OCP |
AT |
2.5 |
121.55 |
121.55 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
|
|
|
|
80027 |
|
|
O |
Privigen 100 mg/ml infúzny intravenózny roztok |
sol inf 1 x 25 ml (liek.inj.skl.) |
CSL |
DE |
2.5 |
121.55 |
121.55 |
I |
0 |
0 |
0 |
ALG, HEM, INF |
|
|
|
|
J06BA02 |
|
|
|
Imunoglobulín, normálny ľudský pre i. v. a. |
parent. 5 g |
1 |
g |
|
|
|
|
|
|
|
|
46.67 |
|
|
|
06837 |
|
|
O |
Flebogamma DIF 100 mg/ml infúzny roztok |
sol inf 1x50 ml/5 g (liek.skl.) |
GFO |
ES |
5 |
233.35 |
233.35 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
45082 |
|
|
O |
Flebogamma DIF 50 mg/ml infúzny roztok |
sol inf 1x100 ml/5 g (liek.skl.) |
GFO |
ES |
5 |
233.35 |
233.35 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
12692 |
|
|
O |
OCTAGAM |
sol inf 1x100 ml |
OCP |
AT |
5 |
233.35 |
233.35 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
83311 |
|
|
O |
Octagam 10% |
sol inf 1x50 ml (liek.inj.skl.) |
OCP-GB-1 |
GB |
5 |
233.35 |
233.35 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
50934 |
|
|
O |
PRIVIGEN |
sol inf 50 ml/5 g |
CSL |
DE |
5 |
233.35 |
233.35 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
J06BA02 |
|
|
|
Imunoglobulín, normálny ľudský pre i. v. a. |
parent. 10 g |
1 |
g |
|
|
|
|
|
|
|
|
46.191000000000003 |
|
|
|
06838 |
|
|
O |
Flebogamma DIF 100 mg/ml infúzny roztok |
sol inf 1x100 ml/10 g (liek.skl.) |
GFO |
ES |
10 |
461.91 |
461.91 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
45083 |
|
|
O |
Flebogamma DIF 50 mg/ml infúzny roztok |
sol inf 1x200 ml/10 g (liek.skl.) |
GFO |
ES |
10 |
461.91 |
461.91 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
12693 |
|
|
O |
OCTAGAM |
sol inf 1x200 ml |
OCP |
AT |
10 |
461.91 |
461.91 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
83312 |
|
|
O |
Octagam 10% |
sol inf 1x100 ml (liek.inj.skl.) |
OCP-GB-1 |
GB |
10 |
461.91 |
461.91 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
50935 |
|
|
O |
PRIVIGEN |
sol inf 100 ml/10 g |
CSL |
DE |
10 |
461.91 |
461.91 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
J06BA02 |
|
|
|
Imunoglobulín, normálny ľudský pre i. v. a. |
parent. 20 g |
1 |
g |
|
|
|
|
|
|
|
|
55.11 |
|
|
|
83313 |
|
|
O |
Octagam 10% |
sol inf 1x200 ml (liek.inj.skl.) |
OCP-GB-1 |
GB |
20 |
943.05 |
943.05 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
06839 |
|
|
O |
Flebogamma DIF 100 mg/ml infúzny roztok |
sol inf 1x200 ml/20 g (liek.skl.) |
GFO |
ES |
20 |
961.22 |
961.22 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
45084 |
|
|
O |
Flebogamma DIF 50 mg/ml infúzny roztok |
sol inf 1x400 ml/20 g (liek.skl.) |
GFO |
ES |
20 |
961.22 |
961.22 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
50936 |
|
|
O |
PRIVIGEN |
sol inf 200 ml/20 g |
CSL |
DE |
20 |
961.22 |
961.22 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
97250 |
|
|
O |
Kiovig |
sol inf 1x200 ml/20 g (liek.inj.skl.) |
BAX-A |
AT |
20 |
1022.2 |
1022.2 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
J06BA02 |
|
|
|
Imunoglobulín, normálny ľudský pre i. v. a. |
parent. 30 g |
1 |
g |
|
|
|
|
|
|
|
|
53.715000000000003 |
|
|
|
20049 |
|
|
O |
Kiovig |
sol inf 1x300 ml/30 g ( liek.inj.skl.) |
BAX-A |
AT |
30 |
1611.44 |
1611.44 |
I |
0 |
0 |
0 |
ALG, DER, HEM, INF, NEU |
|
|
|
|
J06BB01 |
|
|
|
Anti-d (rh) imunoglobulín |
parent. |
250 |
mcg |
|
|
|
|
|
|
|
|
42.4 |
|
|
|
50053 |
|
|
O |
Rhesonativ |
sol inj 1x2 ml/1250 |
OCP |
SE |
1 |
39.07 |
39.07 |
A |
0 |
0 |
0 |
|
|
|
|
|
46594 |
|
|
O |
Rhophylac 300 mikrogramov/2 ml |
sol inj 1 x 2 ml/300 ug + ihla |
CSL |
DE |
1.2 |
46.93 |
46.93 |
A |
0 |
0 |
0 |
|
|
|
|
|
91630 |
|
|
O |
IGAMAD 1500 I.U. |
sol inj 1500 I.U./2 ml |
GFO |
ES |
1.2 |
50.87 |
50.87 |
A |
0 |
0 |
0 |
|
|
|
|
|
J06BB02 |
|
|
|
Imonoglobulín proti tetanu |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
13.36 |
|
|
|
57804 |
|
|
O |
Pasteurised Hum.Antitet.Ig.Grifols |
sol inj 250 IU/2 ml+str. |
GFO |
ES |
1 |
12.04 |
12.04 |
A |
0 |
0 |
0 |
|
|
|
|
|
J06BB16 |
|
|
|
Palivizumab |
parent. 50 mg |
50 |
mg |
|
|
|
|
|
|
|
|
484.01 |
|
|
|
02106 |
|
|
O |
Synagis 50 mg prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x50 mg (liek.inj.skl.)+1 ml solv. (amp.skl.) |
ABV-GB |
GB |
1 |
484.01 |
484.01 |
A |
0 |
0 |
0 |
KAR, LRN, TRN |
ind.obm., ZP |
|
|
|
J06BB16 |
|
|
|
Palivizumab |
parent. 100 mg |
50 |
mg |
|
|
|
|
|
|
|
|
409.67 |
|
|
|
02143 |
|
|
O |
Synagis 100 mg prášok a rozpúšťadlo na injekčný roztok |
plv iol 1x100 mg (liek.inj.skl.)+1 ml solv. (amp.skl.) |
ABV-GB |
GB |
2 |
819.33 |
819.33 |
A |
0 |
0 |
0 |
KAR, LRN, TRN |
ind.obm., ZP |
|
|
|
J07AH03 |
|
|
|
Vakcína proti meningokokom, bivalentný purifikovaný polysacharidový antigén |
parent. 1 dávka |
0.5 |
ml |
|
|
|
|
|
|
|
|
1 |
|
|
|
76063 |
|
|
O |
MENINGOCOCCAL POLYS.VACCINE A+C |
plv iul 1x1dávka+str. |
PMX |
FR |
1 |
11.19 |
11.19 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J07AH07 |
|
|
|
Vakcína proti Meningococcus C, purifikovaný polysacharidový konjugovaný antigén |
parent. 1 dávka |
0.5 |
ml |
|
|
|
|
|
|
|
|
1 |
|
|
|
32685 |
|
|
O |
NEISVAC-C |
sus inj 1x0,5 ml (striek. inj. skl. naplnená) |
PFI-GB-7 |
GB |
1 |
29.75 |
29.75 |
V |
0 |
0 |
0 |
INF, PED |
ind.obm. |
|
|
|
J07AL01 |
|
|
|
Vakcína proti pneumokokom, purifikovaný polysacharidový antigén |
parent. |
0.5 |
ml |
|
|
|
|
|
|
|
|
1 |
|
|
|
85534 |
|
|
O |
PNEUMO 23 |
sol inj 1x0,5 ml+striek. |
XAL |
FR |
1 |
12.54 |
12.54 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J07AL52 |
|
|
|
Vakcína proti pneumokokom, purifikovaný polysacharidový konjugovaný antigén |
parent. 10-valentná |
0.5 |
ml |
|
|
|
|
|
|
|
|
38.154000000000003 |
|
|
|
69867 |
|
|
O |
Synflorix |
sus inj 10x0,5ml +10 ihiel |
GAG |
BE |
10 |
381.54 |
381.54 |
V |
0 |
0 |
0 |
PED |
ind.obm. |
|
|
U22 |
J07AM01 |
|
|
|
Tetanový toxoid |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
5.5 |
|
|
|
7207A |
|
|
O |
ALTEANA |
sus inj 1x0,5 ml/40 IU (striek.inj.napl.) |
IMA |
SK |
1 |
5.5 |
5.5 |
A |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J07AM51 |
|
|
|
Tetanický toxoid, kombinácie s difterickým toxoidom |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
1 |
|
|
|
33919 |
|
|
O |
IMOVAX D.T. ADULT |
sus inj 1x0,5ml inj.striek. |
XAL |
FR |
1 |
5.86 |
5.86 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J07AN01 |
|
|
|
Vakcíny proti tuberkulóze, živé atenuované |
parent. |
0.1 |
ml |
|
|
|
|
|
|
|
|
1.29 |
|
|
|
91324 |
|
|
O |
BCG VACCINE SSI |
plv iul 10+10 solv. |
SST |
DE |
100 |
60.59 |
60.59 |
A |
0 |
0 |
0 |
TRN |
|
|
|
|
91323 |
|
|
O |
BCG VACCINE SSI |
plv iul 5+5 solv. |
SST |
DE |
50 |
64.3 |
64.3 |
A |
0 |
0 |
0 |
TRN |
|
|
|
|
J07BB02 |
|
|
|
Vakcíny proti chrípke, purifikovaný antigén |
parent. |
0.5 |
ml |
|
|
|
|
|
|
|
|
5.72 |
|
|
|
56079 |
|
|
O |
INFLUVAC (INJ.STRIEK.) |
sus inj 1x0,5 ml |
SDU |
NL |
1 |
5.72 |
5.72 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J07BC01 |
|
|
|
Vakcína proti hepatitíde B, purifikovaný antigén |
parent. adjuvans adsorbovaná |
0.5 |
ml |
|
|
|
|
|
|
|
|
54.9 |
|
|
|
42652 |
|
|
O |
FENDRIX |
sus inj 1x0,5 ml |
GAG |
BE |
1 |
54.89 |
54.89 |
A |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
J07BC01 |
|
|
|
Vakcíny proti hepatitíde B, purifikovaný antigén |
parent. do 10 ug povinné očkovanie |
1 |
DF |
|
|
|
|
|
|
|
|
1 |
|
|
|
28452 |
|
|
O |
EUVAX B 10 mG |
sus inj 1x0,5 ml |
XLG |
PL |
1 |
6.76 |
6.76 |
V |
0 |
0 |
0 |
PED |
ind.obm. |
|
|
|
J07BC01 |
|
|
|
Vakcíny proti hepatitíde B, purifikovaný antigén |
parent. 20 ug povinné očkovanie |
1 |
ml |
|
|
|
|
|
|
|
|
1 |
|
|
|
28454 |
|
|
O |
EUVAX B 20 mG |
sus inj 1x1 ml |
XLG |
PL |
1 |
12.01 |
12.01 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
25092 |
|
|
O |
ENGERIX-B 20RG(DOS.ADUL) |
sus inj 1x1 ml (v nap.s.) |
SKX |
BE |
1 |
13.57 |
13.57 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J07BC02 |
|
|
|
Vakcíny proti hepatitíde A, inaktivovaný celobunkový vírus |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
1 |
|
|
|
25982 |
|
|
O |
HAVRIX 720 Jun.monodose (inj.s.) |
sus inj 1x0,5 ml/720 eu |
SKX |
BE |
1 |
16.36 |
16.36 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
14675 |
|
|
O |
VAQTA 25 U (striek.inj.napl.) |
sus inj 1x0,5 ml/25 U |
MSD |
NL |
1 |
20.91 |
20.91 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
25980 |
|
|
O |
HAVRIX 1440 Dos.adulta (inj.s.) |
sus inj 1x1 ml/1440 eu |
SKX |
BE |
1 |
24.07 |
24.07 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
14677 |
|
|
O |
VAQTA 50 U (striek.inj.napl.) |
sus inj 1x1 ml/50 U |
MSD |
NL |
1 |
27.35 |
27.35 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
92296 |
|
|
O |
AVAXIM 160 |
sus inj 1x0,5 ml |
PMX |
FR |
1 |
29.5 |
29.5 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J07BD52 |
|
|
|
Vakcíny proti osýpkam, v kombinácii proti príušniciam, ružienke, živá atenuovaná |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
9.4499999999999993 |
|
|
|
36424 |
|
|
O |
M-M-RVAXPRO |
plv iul 10x liek.+10x solv. |
SNP |
FR |
10 |
94.46 |
94.46 |
V |
0 |
0 |
0 |
PED |
ind.obm. |
|
|
|
28654 |
|
|
O |
PRIORIX (inj.str.) |
plv iol 10x0,5 ml+sol |
GAG |
BE |
10 |
94.46 |
94.46 |
V |
0 |
0 |
0 |
PED |
ind.obm. |
|
|
|
J07BG01 |
|
|
|
Vakcíny proti besnote, inaktivovaná, celobunková |
parent. |
2.5 |
UT |
|
|
|
|
|
|
|
|
1 |
|
|
|
93706 |
|
|
O |
IMOVAX RABIES VERO (=VERORAB) |
plv iul 2,5 ut+0,5 ml |
PMX |
FR |
1 |
14.45 |
14.45 |
V |
0 |
0 |
0 |
|
ind.obm. |
|
|
|
J07CA02 |
|
|
|
Vakcína proti diftérii, tetanu, pertussis, detskej obrne |
parent. povinné očkovanie |
0.5 |
ml |
|
|
|
|
|
|
|
|
21.792999999999999 |
|
|
|
45411 |
|
|
G |
Boostrix polio |
sus.inj 10x0,5ml+10 ihiel |
GLA-SK |
SK |
10 |
217.93 |
217.93 |
V |
0 |
0 |
0 |
PED |
ind.obm. |
|
|
|
J07CA02 |
|
|
|
Vakcína proti diftérii, tetanu, pertussis, detskej obrne |
parent. povinné očkovanie |
1 |
DF |
|
|
|
|
|
|
|
|
1 |
|
|
|
52280 |
|
|
O |
Infanrix Polio |
sus inj 1x0,5ml |
GAG |
BE |
1 |
24.01 |
24.01 |
V |
0 |
0 |
0 |
PED |
ind.obm. |
|
|
|
J07CA06 |
|
|
|
Vakcíny proti diftérii, tetanu, pertussis, Haemophilus influenzae b, detskej obrne |
parent. povinné očkovanie |
1 |
DF |
|
|
|
|
|
|
|
|
25.61 |
|
|
|
43006 |
|
|
O |
INFANRIX-IPV+Hib (inj. liek.+ napln.inj.str. s ihlou) |
plu inu 1x0,5 ml |
GLA |
GB |
1 |
25.61 |
25.61 |
V |
0 |
0 |
0 |
PED |
ind.obm. |
|
|
|
J07CA09 |
|
|
|
Vakcína proti diftérii, tetanu, pertussis, Haemophilus influenzae b, detskej obrne, hepatitíde B |
parent. povinné očkovanie sus. inj. |
1 |
DF |
|
|
|
|
|
|
|
|
42.9 |
|
|
|
34905 |
|
|
O |
Infanrix hexa |
plv iul 10x0,5 ml, str.+2i. |
GAG |
BE |
10 |
428.99 |
428.99 |
V |
0 |
0 |
0 |
PED |
ind.obm. |
|
|
|
L01AA01 |
|
|
|
Cyklofosfamid |
parent. |
10 |
mg |
|
|
|
|
|
|
|
|
0.23499999999999999 |
|
|
|
0384B |
|
|
O |
Endoxan 200 mg prášok na infúzny roztok |
plv ino 50x200 mg (liek.inj.skl) |
XBT-1 |
DE |
1000 |
234.09 |
234.09 |
A |
0 |
0 |
0 |
|
|
|
|
|
0385B |
|
|
O |
Endoxan 500 mg prášok na infúzny roztok |
plv ino 6x500 mg (liek.inj.skl) |
XBT-1 |
DE |
300 |
70.23 |
70.23 |
A |
0 |
0 |
0 |
|
|
|
|
|
0387B |
|
|
O |
Endoxan 1000 mg prášok na infúzny roztok |
plv ino 5x1g (liek.inj.skl) |
XBT-1 |
DE |
500 |
117.06 |
117.06 |
A |
0 |
0 |
0 |
|
|
|
|
|
L01AA06 |
|
|
|
Ifosfamid |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.06 |
|
|
|
0389B |
|
|
O |
Holoxan 1000mg prášok na infúzny roztok |
plv ifo 5x1g (liek.inj.) |
XBT-1 |
DE |
5000 |
299.08999999999997 |
299.08999999999997 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
0391B |
|
|
O |
Holoxan 2000mg prášok na infúzny roztok |
plv ifo 5x2g (liek.inj.) |
XBT-1 |
DE |
10000 |
598.17999999999995 |
598.17999999999995 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01AA09 |
|
|
|
Bendamustín |
parent. 25 mg |
58.3 |
mg |
|
|
|
|
|
|
|
|
179.52 |
|
|
|
2723B |
|
|
G |
Bendamustine Accord 2,5 mg/ml prášok na infúzny koncentrát |
plc ifo 20x25 mg (liek.skl.jantárová) |
ACC |
GB |
8.5760000000000005 |
1522.24 |
1522.24 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
2721B |
|
|
G |
Bendamustine Accord 2,5 mg/ml prášok na infúzny koncentrát |
plc ifo 5x25 mg (liek.skl.jantárová) |
ACC |
GB |
2.1440000000000001 |
380.56 |
380.56 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
4324B |
|
|
G |
Bendamustine Actavis 2,5 mg/ml |
plc ifo 20x25 mg (liek.skl.inj.jantárová) |
ACT-5 |
IS |
8.5760000000000005 |
1522.24 |
1522.24 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
4322B |
|
|
G |
Bendamustine Actavis 2,5 mg/ml |
plc ifo 5x25 mg (liek.skl.inj.jantárová) |
ACT-5 |
IS |
2.1440000000000001 |
380.56 |
380.56 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
9763A |
|
|
G |
Lynetoril 2,5 mg/ml |
plc ifo 5x25 mg (liek.inj.skl.) |
CHS-AT |
AT |
2.1440000000000001 |
384.6 |
384.6 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
08143 |
|
|
G |
Levact 2,5 mg/ml |
plc ifo 20x25 mg (liek.inj.skl.hnedá) |
ASL-D |
DE |
8.5760000000000005 |
1539.53 |
1539.53 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01AA09 |
|
|
|
Bendamustín |
parent. 100 mg |
58.3 |
mg |
|
|
|
|
|
|
|
|
162.25 |
|
|
|
2725B |
|
|
G |
Bendamustine Accord 2,5 mg/ml prášok na infúzny koncentrát |
plc ifo 5x100 mg (liek.skl.jantárová) |
ACC |
GB |
8.5760000000000005 |
1391.43 |
1391.43 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
4326B |
|
|
G |
Bendamustine Actavis 2,5 mg/ml |
plc ifo 5x100 mg (liek.skl.inj.jantárová) |
ACT-5 |
IS |
8.5760000000000005 |
1391.43 |
1391.43 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
9767A |
|
|
G |
Lynetoril 2,5 mg/ml |
plc ifo 5x100 mg (liek.inj.skl.) |
CHS-AT |
AT |
8.5760000000000005 |
1391.43 |
1391.43 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01AD02 |
|
|
|
Lomustín |
p.o. 40 mg (20 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
0.185 |
|
|
|
60271 |
|
|
O |
CEENU LOMUSTINE (CCNU) |
cps 20x40 mg |
BMS |
IT |
800 |
145.44 |
145.44 |
I |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01AD05 |
|
|
|
Fotemustín |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
1.3 |
|
|
|
55407 |
|
|
O |
MUSTOPHORAN |
plv fol 1x208 mg+4 ml |
THN |
BE |
208 |
268.67 |
268.67 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
L01AX03 |
|
|
|
Temozolomid |
p.o. 20 mg (5 ks) |
350 |
mg |
|
|
|
|
|
|
|
|
60.8 |
|
|
|
6893A |
X |
|
G |
Nogron 20mg |
cps dur 5x20mg |
EGI |
HU |
0.28599999999999998 |
17.39 |
17.39 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
65579 |
X |
|
O |
TEMODAL 20 mg |
cps dur 5x20 mg (jedn.vrecko) |
MSD-GB-1 |
GB |
0.28599999999999998 |
17.39 |
17.39 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
88980 |
X |
|
G |
TEMOSTAD 20 mg |
cps dur 5x20 mg (fľ.sklo, jantár) |
STD |
DE |
0.28599999999999998 |
17.39 |
17.39 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
L01AX03 |
|
|
|
Temozolomid |
p.o. 100 mg (5 ks) |
350 |
mg |
|
|
|
|
|
|
|
|
51.5 |
|
|
|
6896A |
|
|
G |
Nogron 100mg |
cps dur 5x100mg (liek.PE) |
EGI |
HU |
1.429 |
73.59 |
73.59 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
65581 |
|
|
O |
TEMODAL 100 mg |
cps dur 5x100 mg (jedn.vrecko) |
MSD-GB-1 |
GB |
1.429 |
73.59 |
73.59 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
88982 |
|
|
G |
TEMOSTAD 100 mg |
cps dur 5x100 mg (fľ.sklo, jantár) |
STD |
DE |
1.429 |
73.59 |
73.59 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
86562 |
|
|
G |
Temozolomide Teva |
cps dur 5x100 mg (fľa.skl.) |
TEV |
FR |
1.429 |
73.59 |
73.59 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
L01AX03 |
|
|
|
Temozolomid |
p.o. 140 mg (5 ks) |
350 |
mg |
|
|
|
|
|
|
|
|
74.680000000000007 |
|
|
|
6899A |
|
|
G |
Nogron 140mg |
cps dur 5x140mg (liek.PE) |
EGI |
HU |
2 |
149.35 |
149.35 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
65583 |
|
|
O |
TEMODAL 140 mg |
cps dur 5x140 mg (jedn.vrecko) |
MSD-GB-1 |
GB |
2 |
149.35 |
149.35 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
88984 |
|
|
G |
TEMOSTAD 140 mg |
cps dur 5x140 mg (fľ.sklo, jantár) |
STD |
DE |
2 |
149.35 |
149.35 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
86564 |
|
|
G |
Temozolomide Teva |
cps dur 5x140 mg (fľa.skl.) |
TEV |
FR |
2 |
149.35 |
149.35 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
L01AX03 |
|
|
|
Temozolomid |
p.o. 180 mg (5 ks) |
350 |
mg |
|
|
|
|
|
|
|
|
75 |
|
|
|
6902A |
|
|
G |
Nogron 180mg |
cps dur 5x180mg (liek.PE) |
EGI |
HU |
2.5710000000000002 |
192.83 |
192.83 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
65585 |
|
|
O |
TEMODAL 180 mg |
cps dur 5x180 mg (jedn.vrecko) |
MSD-GB-1 |
GB |
2.5710000000000002 |
192.83 |
192.83 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
L01AX03 |
|
|
|
Temozolomid |
p.o. 250 mg (5 ks) |
350 |
mg |
|
|
|
|
|
|
|
|
122.41 |
|
|
|
65587 |
|
|
O |
TEMODAL 250 mg |
cps dur 5x250 mg (jedn.vrecko) |
SCH-B-2 |
BE |
3.5710000000000002 |
437.11 |
437.11 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
88988 |
|
|
G |
TEMOSTAD 250 mg |
cps dur 5x250 mg (fľ.sklo, jantár) |
STD |
DE |
3.5710000000000002 |
437.11 |
437.11 |
I |
0 |
0 |
0 |
NEU, ONK |
ind.obm., ZP |
|
|
|
L01BA01 |
|
|
|
Metotrexát |
parent. |
10 |
mg |
|
|
|
|
|
|
|
|
0.19 |
|
|
|
69166 |
|
|
G |
METHOTREXAT-EBEWE 5000MG |
sol inj 1x50 ml/5000 mg |
EBW |
AT |
500 |
85.11 |
85.11 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01BA01 |
|
|
|
Metotrexát |
parent. napl. striekačka s ihlou |
15 |
mg |
|
|
|
|
|
|
|
|
20.8 |
|
|
|
82673 |
|
|
G |
Methotrexat Ebewe 20 mg/ml |
sol inj 1x1 ml/20 mg (striek.skl.napl.) |
EBW |
AT |
1.333 |
23.84 |
23.84 |
I |
0 |
0 |
0 |
DER, REU |
ind.obm. |
|
|
|
60935 |
|
|
G |
Metoject 50 mg/ml injekčný roztok |
sol inj 1x0,50 ml/ 25 mg (vsadená ihla) |
MED |
DE |
1.67 |
30.25 |
30.25 |
I |
0 |
0 |
0 |
DER, REU |
ind.obm. |
|
|
|
60769 |
|
|
G |
Metoject 50 mg/ml injekčný roztok |
sol inj 1x0,40 ml/ 20 mg (vsadená ihla) |
MED |
DE |
1.33 |
27.65 |
27.65 |
I |
0 |
0 |
0 |
DER, REU |
ind.obm. |
|
|
|
8928A |
|
|
G |
Metoject PEN 20 mg injekčný roztok naplnený v injekčnom pere |
sol ira 1x0,40 ml/20 mg (pero napl.) |
MED |
DE |
1.33 |
27.65 |
27.65 |
I |
0 |
0 |
0 |
DER, REU |
ind.obm. |
|
|
|
8950A |
|
|
G |
Metoject PEN 25 mg injekčný roztok naplnený v injekčnom pere |
sol ira 1x0,5 ml/25 mg (pero napl.) |
MED |
DE |
1.67 |
34.729999999999997 |
34.729999999999997 |
I |
0 |
0 |
0 |
DER, REU |
ind.obm. |
|
|
|
5573A |
|
|
G |
Methotrexat Ebewe 20 mg/ml |
sol inj 1x0,75 ml/15 mg (striek.skl.napl.) |
EBW |
AT |
1 |
20.8 |
20.8 |
I |
0 |
0 |
0 |
DER, REU |
ind.obm. |
|
|
|
L01BA04 |
|
|
|
Pemetrexed |
parent. 100 mg |
500 |
mg |
|
|
|
|
|
|
|
|
1103.96 |
|
|
|
46538 |
|
|
O |
ALIMTA 100 mg prášok na infúzny koncentrát |
pls ifo 1 x 100 mg |
LIL |
NL |
0.2 |
220.79 |
220.79 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01BA04 |
|
|
|
Pemetrexed |
parent. 500 mg |
500 |
mg/m2 |
|
|
|
|
|
|
|
|
1050.1300000000001 |
|
|
|
41437 |
|
|
O |
ALIMTA |
plc ifo 1x500 mg |
LIL |
NL |
1 |
1050.1300000000001 |
1050.1300000000001 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01BB04 |
|
|
|
Kladribin |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
32.71 |
|
|
|
31741 |
|
|
O |
LITAK 10 Solution |
sol inj 5x5 ml |
LMG-D |
DE |
50 |
1635.06 |
1635.06 |
A |
0 |
0 |
0 |
|
|
|
|
|
L01BB05 |
|
|
|
Fludarabín |
p.o. 10 mg (15 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
196.72 |
|
|
|
58897 |
|
|
O |
FLUDARA ORAL |
tbl flm 15x10 mg |
GZE |
NL |
1.875 |
368.84 |
368.84 |
I |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01BB05 |
|
|
|
Fludarabín |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
2.87 |
|
|
|
52466 |
|
|
G |
Fludarabin Ebewe 25 mg/ ml |
con ijf 1x2 ml/50 mg |
EBW |
AT |
50 |
98.7 |
98.7 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01BC02 |
|
|
|
Fluorouracil |
loc. ung. |
1 |
g |
|
|
|
|
|
|
|
|
1.0149999999999999 |
|
|
|
03739 |
|
|
G |
EFUDIX |
ung 20 g 5% |
MPH |
SK |
20 |
20.29 |
20.29 |
I |
0 |
0 |
0 |
DER, ONK |
|
|
|
|
L01BC02 |
|
|
|
Fluorouracil |
parent. |
10 |
mg |
|
|
|
|
|
|
|
|
4.3999999999999997E-2 |
|
|
|
05194 |
|
|
G |
Fluorouracil Accord 50 mg/ml injekčný a infúzny roztok |
sol ijf 1x100 ml/5 g (liek.inj.skl.) |
ACC |
GB |
500 |
16.12 |
16.12 |
A |
0 |
0 |
0 |
DER, GER, INT, KLF, ONK, OPH |
|
|
|
|
05193 |
|
|
G |
Fluorouracil Accord 50 mg/ml injekčný a infúzny roztok |
sol ijf 1x20 ml/1000 mg (liek.inj.skl.) |
ACC |
GB |
100 |
4.4000000000000004 |
4.4000000000000004 |
A |
0 |
0 |
0 |
DER, GER, INT, KLF, ONK, OPH |
|
|
|
|
L01BC05 |
|
|
|
Gemcitabín |
parent. 200 mg |
1 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
51255 |
|
|
G |
CITEGIN |
plv ifo 1x200mg |
EGI |
HU |
200 |
7.36 |
7.36 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
2494A |
|
|
G |
Gemcitabine Accord 100 mg/ml infúzny koncentrát |
con inf 1x200 mg/2 ml (liek.inj.skl.) |
ACC |
GB |
200 |
7.36 |
7.36 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
82623 |
|
|
G |
GEMSTAD |
con inf 1x5,26 ml/200 mg |
STD |
DE |
200 |
7.36 |
7.36 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
79324 |
|
|
G |
Gemcirena 38 mg/ml |
plv ifo 1x200 mg |
FRK |
DE |
200 |
8 |
8 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
76528 |
|
|
G |
Gemcitabin Actavis 38 mg/ml |
plv ifo 1x200 mg (liek.inj.skl.) |
ACT-5 |
IS |
200 |
8 |
8 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
85883 |
|
|
G |
Gemliquid 10 mg/ml |
con inf x20 ml/200 mg (liek.inj.skl.) |
EBW |
AT |
200 |
8 |
8 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
02113 |
|
|
G |
Gemliquid 40 mg/ml con inf |
con inf 1x5 ml/200 mg (liek.inj.skl.) |
EBW |
AT |
200 |
8 |
8 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
L01BC05 |
|
|
|
Gemcitabín |
parent. 1000 mg |
1 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
51256 |
|
|
G |
CITEGIN 1 g |
plv ifo 1x1 g |
EGI |
HU |
1000 |
36.799999999999997 |
36.799999999999997 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
89447 |
|
|
G |
Gemcitabin Actavis 38 mg/ml |
plv ifo 1x1 g (liek.inj.skl.) |
ACT |
IS |
1000 |
36.799999999999997 |
36.799999999999997 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
00538 |
|
|
G |
Gemcitabin Mylan 40 mg/ml infúzny koncentrát |
con inf 1x25 ml/1 g (liek.inj.skl.) |
MLB-F |
FR |
1000 |
36.799999999999997 |
36.799999999999997 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
2495A |
|
|
G |
Gemcitabine Accord 100 mg/ml infúzny koncentrát |
con inf 1x1000 mg/10 ml (liek.inj.skl.) |
ACC |
GB |
1000 |
36.799999999999997 |
36.799999999999997 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
82624 |
|
|
G |
GEMSTAD |
con inf 1x26,3 ml/1000 mg |
STD |
DE |
1000 |
36.799999999999997 |
36.799999999999997 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
79325 |
|
|
G |
Gemcirena 38 mg/ml |
plv ifo 1 x 1000 mg |
FRK |
DE |
1000 |
37.76 |
37.76 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
85896 |
|
|
G |
Gemliquid 10 mg/ml |
con inf 1x100 ml/1000 mg (liek.inj.skl.) |
EBW |
AT |
1000 |
40 |
40 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
02131 |
|
|
G |
Gemliquid 40 mg/ml con inf |
con inf 1x25 ml/1000 mg (liek.inj.skl.+ochr.viečko Onco-Safe) |
EBW |
AT |
1000 |
40 |
40 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
L01BC05 |
|
|
|
Gemcitabín |
parent. 2000 mg |
1 |
mg |
|
|
|
|
|
|
|
|
0.04 |
|
|
|
03852 |
|
|
G |
Gemcirena 38 mg/ml prášok na infúzny roztok |
plv ifo 1x2000 mg (liek. inj. skl.) |
FRK |
CZ |
2000 |
79.61 |
79.61 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
U24 |
L01BC06 |
|
|
|
Kapecitabin |
p.o. 500 mg (120 ks) |
4 |
g |
|
|
|
|
|
|
|
|
6.625 |
|
|
|
8077A |
|
|
G |
Capecitabin Sandoz 500 mg filmom obalené tablety |
tbl flm 120x500 mg (blis.Al/Al) |
SAN |
SI |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
1211A |
|
|
G |
Capecitabine Accord 500 mg filmom obalené tablety |
tbl flm 120x500 mg (blis.PVC/PVDC/Al) |
ACC |
GB |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
2003A |
|
|
G |
Capecitabine Actavis 500 mg |
tbl flm 120x500 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
4156A |
|
|
G |
Capecitabine CANDE 500 mg |
tbl flm 120x500 mg (blis.PVC/PE/PVDC/Al) |
CRR-SK |
SK |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
4138A |
|
|
G |
Capecitabine Fresenius Kabi 500 mg filmom obalené tablety |
tbl flm(12x10) x500 mg (blis.PVC/PVDC/AL) |
FSN |
UK |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
2854A |
|
|
G |
Capecitabine Glenmark 500 mg filmom obalené tablety |
tbl flm 120x500 mg (blis.PVC/PVDC/Al) |
GLM-CZ |
CZ |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
4199A |
|
|
G |
Capecitabine Pharmacenter 500 mg filmom obalené tablety |
tbl flm 120x500 mg (blis. PVC/PVDC/Al) |
PMT-SK |
SK |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
2398A |
|
|
G |
Capecitabine STADA |
tbl flm 120x500 mg (blis.PVC/PVDC/Al) |
STD |
DE |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
1228A |
|
|
G |
Capecitabine Teva 500 mg filmom obalené tablety |
tbl flm 120x500 mg (blis.PVC/PE/PVDC/Al) |
TVP-2 |
NL |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
4823A |
|
|
G |
Capecitalox 500 mg |
tbl flm 120 x 500 mg (blis Al/PVC/PE/PVDC) |
GNS |
UK |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
3464A |
|
|
G |
Coloxet 500mg |
tbl flm 120x500mg (blis. PVC/PVDC/AL |
EGI |
HU |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
1184A |
|
|
G |
Ecansya 500mg filmom obalené tablety |
tbl flm120x500mg(blis.PVC/PVDC/Al) |
KRK |
SL |
15 |
99.37 |
99.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01BC07 |
|
|
|
Azacitidín |
parent. |
33.75 |
mg |
|
|
|
|
|
|
|
|
128.41999999999999 |
|
|
|
64369 |
|
|
O |
Vidaza |
plv inu 1x100 mg |
CLG-1 |
GB |
2.96 |
380.11 |
380.11 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01BC53 |
|
|
|
Tegafur. kombinácie |
p.o. 15/4,35/11,8 mg (126 ks) |
90 |
mg |
|
|
|
|
|
|
|
|
18.010000000000002 |
|
|
|
07499 |
|
|
O |
TEYSUNO 15 mg/4,35 mg/11,8 mg tvrdé kapsuly |
cps dur 126x15 mg/4,35 mg/11,8 mg (blis.PCTFE/PVC/Al) |
NRC-1 |
NL |
21 |
378.17 |
378.17 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01BC53 |
|
|
|
Tegafur. kombinácie |
p.o. 20/5,8/15,8 mg (84 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
15.644 |
|
|
|
07501 |
|
|
O |
Teysuno 20 mg/5,8 mg/15,8 mg tvrdé kapsuly |
cps dur 84x20 mg/5,8 mg/15,8 mg (blis.PCTFE/PVC/Al) |
NRC-1 |
NL |
21 |
328.51 |
328.51 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01CA01 |
|
|
|
Vinblastin |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
1.153 |
|
|
|
31134 |
|
|
G |
VINBLASTIN RICHTER 5 mg |
plv iol 10x5 mg+5 ml sol. |
GDN |
HU |
50 |
57.6 |
57.6 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01CA04 |
|
|
|
Vinorelbin |
p.o. 20 mg (1 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
2.5409999999999999 |
|
|
|
05924 |
|
|
O |
Navelbine Oral |
cps1x20mg |
PFB |
FR |
20 |
50.81 |
50.81 |
I |
0 |
0 |
0 |
ONK |
|
|
|
|
L01CA04 |
|
|
|
Vinorelbin |
p.o. 30 mg (1 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
2.46 |
|
|
|
05925 |
|
|
O |
Navelbine Oral |
cps1x30mg |
PFB |
FR |
30 |
73.58 |
73.58 |
I |
0 |
0 |
0 |
ONK |
|
|
|
|
L01CA04 |
|
|
|
Vinorelbin |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
1.1100000000000001 |
|
|
|
36467 |
|
|
G |
Vinorelbin "EBEWE" 10 mg/ml |
con inf 1x5 ml/50 mg |
EBW |
AT |
50 |
54.85 |
54.85 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
50573 |
|
|
G |
Visera 10 mg/ml |
con inf 1x5 ml/50 mg (liek.inj.skl.) |
ACT |
IS |
50 |
55.49 |
55.49 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
36466 |
|
|
G |
Vinorelbin "EBEWE" 10 mg/ml |
con inf 1x1 ml/10 mg |
EBW |
AT |
10 |
11.1 |
11.1 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
50570 |
|
|
G |
Visera 10 mg/ml |
con inf 1x1 ml/10 mg (liek.inj.skl.) |
ACT-5 |
IS |
10 |
11.1 |
11.1 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01CB01 |
|
|
|
Etopozid |
parent. sol. |
1 |
mg |
|
|
|
|
|
|
|
|
0.11 |
|
|
|
12670 |
|
|
G |
Etoposid "Ebewe" 200 mg |
sol inf 1x200 mg/10 ml |
EBW |
AT |
200 |
19.04 |
19.04 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
12669 |
|
|
G |
Etoposid "Ebewe" 100 mg |
sol inf 1x100 mg/5 ml |
EBW |
AT |
100 |
10.11 |
10.11 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
12668 |
|
|
G |
Etoposid "Ebewe" 50 mg |
sol inf 1x50 mg/2,5 ml |
EBW |
AT |
50 |
5.0599999999999996 |
5.0599999999999996 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01CD01 |
|
|
|
Paklitaxel |
parent. nanočastice viazané na albumín |
1 |
mg |
|
|
|
|
|
|
|
|
2.9039999999999999 |
|
|
|
47858 |
|
|
O |
Abraxane 5 mg/ml prášok na infúznu suspenziu |
plv ins 1x100 mg (liek.inj.skl.) |
CLG |
GB |
100 |
290.31 |
290.31 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01CD01 |
|
|
|
Paklitaxel |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.32 |
|
|
|
32938 |
|
|
G |
PACLITAXEL "Ebewe" 6 mg/ ml |
con inf 1x5 ml/30 mg |
EBW |
AT |
30 |
9.59 |
9.59 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
20362 |
|
|
G |
Paclitaxel Accord 6mg/ml |
con inf 1x5ml/30mg |
ACC |
GB |
30 |
9.59 |
9.59 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
92125 |
|
|
G |
Paclitaxel Hospira 6 mg/ml |
con inf 1x5 ml/30 mg (inj.liek.) |
HSP |
GB |
30 |
9.59 |
9.59 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
38518 |
|
|
G |
Paclitaxel Mylan 6mg/ml |
con inf 1x5ml/30mg |
MRK |
FR |
30 |
9.59 |
9.59 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
20363 |
|
|
G |
Paclitaxel Accord 6mg/ml |
con inf 1x16,7ml/100mg |
ACC |
GB |
100 |
31.98 |
31.98 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
92126 |
|
|
G |
Paclitaxel Hospira 6 mg/ml |
con inf 1x16,7 ml/100mg (inj.liek.) |
HSP |
GB |
100 |
31.98 |
31.98 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
38519 |
|
|
G |
Paclitaxel Mylan 6mg/ml |
con inf 1x16,7ml/100mg |
MRK |
FR |
100 |
31.98 |
31.98 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
32939 |
|
|
G |
PACLITAXEL "Ebewe" 6 mg/ ml |
con inf 1x16,6 ml/100 mg |
EBW |
AT |
100 |
31.99 |
31.99 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
32941 |
|
|
G |
PACLITAXEL "Ebewe" 6 mg/ ml |
con inf 1x50 ml/300 mg |
EBW |
AT |
300 |
96 |
96 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
L01CD02 |
|
|
|
Docetaxel |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.75 |
|
|
|
1564A |
|
|
G |
Docetaxel Kabi 160 mg/8 ml infúzny koncentrát |
con inf 1x8 ml/160 mg (liek.inj.skl.) |
FSN |
GB |
160 |
119.87 |
119.87 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
1559A |
|
|
G |
Docetaxel Accord 20 mg/1 ml infúzny koncentrát |
con inf 1x1 ml/20 mg (liek.inj.skl.) |
ACC |
GB |
20 |
15 |
15 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
1560A |
|
|
G |
Docetaxel Accord 80 mg/4 ml infúzny koncentrát |
con inf 1x4 ml/80 mg (liek.inj.skl.) |
ACC |
GB |
80 |
60 |
60 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
83294 |
|
|
G |
Docetaxel Hospira 10 mg/ ml |
con inf 1x2 ml/20 mg (liek.inj.skl.) |
HSP |
GB |
20 |
15 |
15 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01DB01 |
|
|
|
Doxorubicín |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.27 |
|
|
|
12663 |
|
|
G |
DOXORUBICIN |
sol ijf 1x5ml/10 mg |
EBW |
AT |
10 |
2.65 |
2.65 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
12664 |
|
|
G |
DOXORUBICIN |
sol ijf 1x25ml/50 mg |
EBW |
AT |
50 |
13.26 |
13.26 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01DB01 |
|
|
|
Doxorubicín |
parent. lipozomálny, nepegylovaný |
1 |
mg |
|
|
|
|
|
|
|
|
10.79 |
|
|
|
42120 |
|
|
O |
Myocet 50 mg prášok, disperzia a rozpúšťadlo na koncentrát pre infúznu disperziu |
plv dct 2xset (50 mg prášok+1,9 ml lip.+3 ml tlm.roztoku) (liek.inj.skl.) |
TVP-2 |
NL |
100 |
1078.17 |
1078.17 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01DB01 |
|
|
|
Doxorubicín |
parent. pegylovaný, lipozomálny |
1 |
mg |
|
|
|
|
|
|
|
|
19 |
|
|
|
53712 |
|
|
O |
CAELYX 2 mg/ml infúzny koncentrát |
con inf 1x10 ml (liek.inj.skl.) |
JNS |
BE |
20 |
379.92 |
379.92 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
L01DB02 |
|
|
|
Daunorubicín |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.66 |
|
|
|
96122 |
|
|
O |
DAUNOBLASTINA |
plv iol 1x20 mg + 1x10 ml solv. |
PFI-GB-3 |
GB |
20 |
13.06 |
13.06 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01DB03 |
|
|
|
Epirubicín |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.69 |
|
|
|
20076 |
|
|
G |
Epirubicin Accord 2 mg/ml |
sol ijf 1x25ml/50mg (liek.skl.) |
ACC |
GB |
50 |
34.49 |
34.49 |
A |
0 |
0 |
0 |
HEM, ONK, URO |
|
|
|
|
52549 |
|
|
G |
Epirubicin Mylan 2mg/ml |
sol inj 1 x 25 ml / 50mg |
MLB-F |
FR |
50 |
34.49 |
34.49 |
A |
0 |
0 |
0 |
HEM, ONK, URO |
|
|
|
|
20074 |
|
|
G |
Epirubicin Accord 2 mg/ml |
sol ijf 1x5 ml/10 mg (liek.skl.) |
ACC |
GB |
10 |
6.9 |
6.9 |
A |
0 |
0 |
0 |
HEM, ONK, URO |
|
|
|
|
52547 |
|
|
G |
Epirubicin Mylan 2mg/ml |
sol inj 1 x 5 ml /10 mg |
MLB-F |
FR |
10 |
6.9 |
6.9 |
A |
0 |
0 |
0 |
HEM, ONK, URO |
|
|
|
|
L01DB06 |
|
|
|
Idarubicín |
parent. 10 mg |
1 |
mg |
|
|
|
|
|
|
|
|
11.1 |
|
|
|
01181 |
|
|
O |
ZAVEDOS 10 mg |
plv ino 1x10 mg (liek.inj.skl.) |
PFI-GB-3 |
GB |
10 |
110.91 |
110.91 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01DB07 |
|
|
|
Mitoxantrón |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
7.4930000000000003 |
|
|
|
56073 |
|
|
O |
ONKOTRONE |
inj 1x10,0 ml/20 mg |
XBT-1 |
DE |
20 |
149.85 |
149.85 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
L01DC03 |
|
|
|
Mitomycín C |
parent. |
20 |
mg |
|
|
|
|
|
|
|
|
30.710999999999999 |
|
|
|
44076 |
|
|
O |
Mitomycin C Kyowa |
plv iio 5x20 mg |
KWH |
JP |
5 |
153.56 |
153.56 |
A |
0 |
0 |
0 |
ONK, URO |
|
|
|
|
L01XA01 |
|
|
|
Cisplatina |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.27 |
|
|
|
2042B |
|
|
G |
Cisplatin Kabi 1 mg/1 ml |
con inf 1x50 ml/50 mg ( liek. inj. jantárová) |
FSN |
UK |
50 |
13.25 |
13.25 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
95273 |
|
|
G |
Cisplatina Hospira 1 mg/ml |
con inf 1x10 ml/10 mg (liek.inj.skl.) |
HSP-GB |
GB |
10 |
2.65 |
2.65 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
95274 |
|
|
G |
Cisplatina Hospira 1 mg/ml |
con inf 1x50 ml/50 mg (liek.inj.skl.) |
HSP-GB |
GB |
50 |
13.25 |
13.25 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
2043B |
|
|
G |
Cisplatin Kabi 1 mg/ml |
con inf 1x100 ml/100 mg( liek. inj.jantárová) |
FSN |
UK |
100 |
26.51 |
26.51 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
95275 |
|
|
G |
Cisplatina Hospira 1 mg/ml |
con inf 1x100 ml/100 mg (liek.inj.skl.) |
HSP-GB |
GB |
100 |
26.51 |
26.51 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
L01XA02 |
|
|
|
Karboplatina |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
9.2999999999999999E-2 |
|
|
|
0071A |
|
|
G |
Carboplatin Kabi 10 mg/ml |
con inf 1x45 ml/450 mg (liek.inj.skl.) |
FSN |
UK |
450 |
41.51 |
41.51 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
22426 |
|
|
G |
Carboplatin Accord 10mg/ml infúzny koncentrát |
con inf 1x15ml/150mg (liek.skl.hnedá) |
ACC |
GB |
150 |
13.94 |
13.94 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
0070A |
|
|
G |
Carboplatin Kabi 10 mg/ml |
con inf 1x15 ml/150 mg (liek.inj.skl.) |
FSN |
UK |
150 |
13.94 |
13.94 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
22427 |
|
|
G |
Carboplatin Accord 10mg/ml infúzny koncentrát |
con inf 1x45ml/450mg (liek.skl.hnedá) |
ACC |
GB |
450 |
41.85 |
41.85 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
0072A |
|
|
G |
Carboplatin Kabi 10 mg/ml |
con inf 1x60 ml/600 mg (liek.inj.skl.) |
FSN |
UK |
600 |
55.8 |
55.8 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
L01XA03 |
|
|
|
Oxaliplatina |
parent. |
80 |
mg/m2 |
|
|
|
|
|
|
|
|
2.2530000000000001 |
|
|
|
80761 |
|
|
G |
Oxaliplatin Kabi 5 mg/ml |
con inf 1x20 ml/100 mg (liek.inj.skl.) |
FSN |
GB |
9.3000000000000007 |
20.95 |
20.95 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
44922 |
|
|
G |
Oxaliplatina Mylan 5mg/ml |
plv ifo 1 x 100 mg + 20 ml solv. |
MRK |
FR |
9.41 |
21.2 |
21.2 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
80760 |
|
|
G |
Oxaliplatin Kabi 5 mg/ml |
con inf 1x10 ml/50 mg (liek.inj.skl.) |
FSN |
GB |
4.7 |
10.59 |
10.59 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
44916 |
|
|
G |
Oxaliplatina Mylan 5mg/ml |
plv ifo 1x50mg + 10ml solv. |
MRK |
FR |
4.7 |
10.59 |
10.59 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01XC02 |
|
|
|
Rituximab |
s.c.1400 mg |
1 |
DF |
|
|
|
|
|
|
|
|
1739.78 |
|
|
|
9687A |
|
|
O |
Mabthera 1400 mg roztok na subkutánnu injekciu |
sol icu 1x11,7 ml/1400 mg (liek.inj.skl.) |
HLR-GB |
GB |
1 |
1739.78 |
1739.78 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XC02 |
|
|
|
Rituximab |
parent. 100 mg |
86 |
mg |
|
|
|
|
|
|
|
|
213.08 |
|
|
|
59839 |
|
|
O |
MABTHERA 100MG |
con inf 2x100 mg |
HLR |
DE |
2.3260000000000001 |
495.6 |
495.6 |
A |
0 |
0 |
0 |
HEM, ONK, REU |
ind.obm., ZP |
|
|
|
L01XC02 |
|
|
|
Rituximab |
parent. 500 mg |
86 |
mg |
|
|
|
|
|
|
|
|
210.91 |
|
|
|
46130 |
|
|
O |
MABTHERA 500MG |
con inf 1x500 mg |
HLR |
DE |
5.8140000000000001 |
1226.1600000000001 |
1226.1600000000001 |
A |
0 |
0 |
0 |
HEM, ONK, REU |
ind.obm., ZP |
|
|
|
L01XC03 |
|
|
|
Trastuzumab |
parent. 150 mg |
1 |
DF |
|
|
|
|
|
|
|
|
576.05999999999995 |
|
|
|
05959 |
|
|
O |
HERCEPTIN 150 mg |
plc ifo 1x150 mg |
HLR |
DE |
1 |
576.05999999999995 |
576.05999999999995 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XC03 |
|
|
|
Trastuzumab |
s.c. 600 mg |
28.571999999999999 |
mg |
|
|
|
|
|
|
|
|
81.34 |
|
|
|
6957A |
|
|
O |
Herceptin 600 mg/5 ml injekčný roztok |
sol inj 1x5 ml (liek.inj.skl.) |
HLR-GB |
GB |
21 |
1708.12 |
1708.12 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XC06 |
|
|
|
Cetuximab |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
206.33 |
|
|
|
40890 |
|
|
O |
ERBITUX |
sol inf 1x20 ml (5 mg/ml) (skl. liek.) |
MEC |
DE |
1 |
206.33 |
206.33 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XC07 |
|
|
|
Bevacizumab |
parent. 100 mg |
5 |
mg/kg |
|
|
|
|
|
|
|
|
15.801 |
|
|
|
42389 |
|
|
O |
Avastin 25 mg/ml |
con inf 1x4ml/100 mg |
HLR |
DE |
20 |
316.01 |
316.01 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XC07 |
|
|
|
Bevacizumab |
parent. 400 mg |
5 |
mg/kg |
|
|
|
|
|
|
|
|
14.49 |
|
|
|
42415 |
|
|
O |
Avastin 25 mg/ml |
con inf 1x16ml/400 mg |
HLR |
DE |
80 |
1159.0999999999999 |
1159.0999999999999 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XC08 |
|
|
|
Panitumumab |
parent. |
400 |
mg |
|
|
|
|
|
|
|
|
1675.68 |
|
|
|
47011 |
|
|
O |
VECTIBIX |
con inf 1x5 ml (20 mg/ ml) |
AMG |
NL |
0.25 |
418.92 |
418.92 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XC15 |
|
|
|
Obinutuzumab |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
4400.3599999999997 |
|
|
|
1191B |
|
|
O |
Gazyvaro 1 000 mg infúzny koncentrát |
con inf 1x40 ml (liek inj.skl.) |
HLR-GB |
GB |
1 |
4400.3599999999997 |
4400.3599999999997 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XD03 |
|
|
|
Metylaminolevulonát |
loc. |
2 |
g |
|
|
|
|
|
|
|
|
204.81 |
|
|
|
41469 |
|
|
O |
METVIX |
crm 1x2 g |
GAD |
FR |
1 |
204.81 |
204.81 |
A |
0 |
0 |
0 |
DER, ONK |
ind.obm. |
|
|
|
L01XE01 |
|
|
|
Imatinib |
p.o. 100 mg (60 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
12.8 |
|
|
|
4391A |
|
|
G |
Imatinib Fresenius Kabi 100 mg |
tbl flm,p.o. 60x100 mg |
FRK-1 |
D |
60 |
671.53 |
671.53 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
4026A |
|
|
G |
Meaxin 100mg filmom obalené tablety |
tbl flm 60x100mg(blis.PVC/PE/PVDC/Al) |
KRK |
SL |
60 |
671.53 |
671.53 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XE01 |
|
|
|
Imatinib |
p.o. 400 mg (30 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
12.71 |
|
|
|
4397A |
|
|
G |
Imatinib Fresenius Kabi 400 mg |
tbl flm,p.o. 30x400 mg |
FRK-1 |
D |
120 |
1389.83 |
1389.83 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
4035A |
|
|
G |
Meaxin 400mg filmom obalené tablety |
tbl flm 30x400mg(blis.PVC/PE/PVDC/Al) |
KRK |
SL |
120 |
1389.83 |
1389.83 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XE02 |
|
|
|
Gefitinib |
p.o. 250 mg (30 ks) |
250 |
mg |
|
|
|
|
|
|
|
|
72.52 |
|
|
|
87371 |
|
|
O |
IRESSA |
tbl flm 30(3x10) x 250 mg (blis.PVC/Al neperfor.) |
AZC |
SE |
30 |
2175.5300000000002 |
2175.5300000000002 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
78264 |
|
|
O |
IRESSA |
tbl flm 30x250 mg |
AZC |
SE |
30 |
2175.5300000000002 |
2175.5300000000002 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE03 |
|
|
|
Erlotinib |
p.o. 100 mg (30 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
77.373000000000005 |
|
|
|
94488 |
|
|
O |
Tarceva 100 mg |
tbl flm 30x100 mg |
HLR |
DE |
20 |
1547.39 |
1547.39 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE03 |
|
|
|
Erlotinib |
p.o. 150 mg (30 ks) |
150 |
mg |
|
|
|
|
|
|
|
|
65.23 |
|
|
|
94490 |
|
|
O |
Tarceva 150 mg |
tbl flm 30x150 mg |
HLR |
DE |
30 |
1956.8 |
1956.8 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE04 |
|
|
|
Sunitinib |
p.o. 12,5 mg (30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
161.56399999999999 |
|
|
|
35915 |
|
|
O |
SUTENT |
cps dur 30x12,5 mg (fľaša HDPE) |
PFI-GB-1 |
GB |
7.5 |
1211.73 |
1211.73 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE04 |
|
|
|
Sunitinib |
p.o. 25 mg (30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
160.785 |
|
|
|
35916 |
|
|
O |
SUTENT |
cps dur 30x25 mg (fľaša HDPE) |
PFI-GB-1 |
GB |
15 |
2411.77 |
2411.77 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE04 |
|
|
|
Sunitinib |
p.o. 50 mg (30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
160.065 |
|
|
|
35917 |
|
|
O |
SUTENT |
cps dur 30x50 mg (fľaša HDPE) |
PFI-GB-1 |
GB |
30 |
4801.9399999999996 |
4801.9399999999996 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE05 |
|
|
|
Sorafenib |
p.o. 200 mg (112 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
123.605 |
|
|
|
36227 |
|
|
O |
NEXAVAR |
tbl flm 112 x 200 mg |
BAS |
DE |
28 |
3460.93 |
3460.93 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE06 |
|
|
|
Dasatinib |
p.o. 70 mg (60 ks) |
140 |
mg |
|
|
|
|
|
|
|
|
119.42 |
|
|
|
37369 |
|
|
O |
SPRYCEL 70 mg |
tbl flm 60x70 mg |
BMS |
GB |
30 |
3582.57 |
3582.57 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XE07 |
|
|
|
Lapatinib |
p.o. 250 mg (70 ks) |
1250 |
mg |
|
|
|
|
|
|
|
|
79.180000000000007 |
|
|
|
07339 |
|
|
O |
Tyverb |
tbl flm 70x250 mg (fľaša HDPE) |
GLA |
GB |
14 |
1108.43 |
1108.43 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE08 |
|
|
|
Nilotinib |
p.o. 150 mg (112-120 ks) |
600 |
mg |
|
|
|
|
|
|
|
|
103.3552 |
|
|
|
11645 |
|
|
O |
TASIGNA 150 mg |
cps dur 120 (3x40)x 150 mg (blis. PVC/PVDC/Al) |
NEH |
GB |
30 |
3100.65 |
3100.65 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XE08 |
|
|
|
Nilotinib |
p.o. 200 mg (112-120 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
127.36 |
|
|
|
11647 |
|
|
O |
TASIGNA 200 mg |
cps dur 120 (3x40)x 200 mg (lis. PVC/PVDC/Al) |
NEH |
GB |
30 |
3820.39 |
3820.39 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XE09 |
|
|
|
Temsirolimus |
parent. |
25 |
mg |
|
|
|
|
|
|
|
|
834.16 |
|
|
|
46872 |
|
|
O |
TORISEL 30 mg koncentrát a rozpúšťadlo na infúzny roztok |
cif fol 1x1,2 ml/30 mg + 1x2,2 ml solv. (liek.inj.skl.) |
PFI-GB-1 |
GB |
1 |
834.16 |
834.16 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE10 |
|
|
|
Everolimus |
p.o. 5 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
164.83 |
|
|
|
79395 |
|
|
O |
AFINITOR 5 mg |
tbl 30x5 mg |
NEH |
GB |
15 |
2472.34 |
2472.34 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE10 |
|
|
|
Everolimus |
p.o. 10 mg (30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
116.66 |
|
|
|
79398 |
|
|
O |
AFINITOR 10 mg |
tbl 30x10 mg |
NEH |
GB |
30 |
3499.66 |
3499.66 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE11 |
|
|
|
Pazopanib |
p.o. 200 mg (90 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
98.123999999999995 |
|
|
|
20582 |
|
|
O |
Votrient |
tbl flm 90x200 mg |
NEH-1 |
GB |
22.5 |
2207.7800000000002 |
2207.7800000000002 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE11 |
|
|
|
Pazopanib |
p.o. 400 mg (30 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
101.8 |
|
|
|
20584 |
|
|
O |
Votrient |
tbl flm 30x400 mg |
NEH-1 |
GB |
15 |
1527 |
1527 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE13 |
|
|
|
Afatinib |
p.o. 20 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
75.099999999999994 |
|
|
|
7594A |
|
|
O |
GIOTRIF 20 mg filmom obalené tablety |
tbl flm 28x1x20 mg (blis.PVC/PVDC-perf.) |
BOE |
DE |
28 |
2102.7800000000002 |
2102.7800000000002 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE13 |
|
|
|
Afatinib |
p.o. 30 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
75.099999999999994 |
|
|
|
7597A |
|
|
O |
GIOTRIF 30 mg filmom obalené tablety |
tbl flm 28x1x30 mg (blis.PVC/PVDC-perf.) |
BOE |
DE |
28 |
2102.7800000000002 |
2102.7800000000002 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE13 |
|
|
|
Afatinib |
p.o. 40 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
75.099999999999994 |
|
|
|
7600A |
|
|
O |
GIOTRIF 40 mg filmom obalené tablety |
tbl flm 28x1x40 mg (blis.PVC/PVDC-perf.) |
BOE |
DE |
28 |
2102.7800000000002 |
2102.7800000000002 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XE13 |
|
|
|
Afatinib |
p.o. 50 mg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
75.099999999999994 |
|
|
|
7603A |
|
|
O |
GIOTRIF 50 mg filmom obalené tablety |
tbl flm 28x1x50 mg (blis.PVC/PVDC-perf.) |
BOE |
DE |
28 |
2102.7800000000002 |
2102.7800000000002 |
I |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XX02 |
|
|
|
Asparagináza |
parent. 5000 U |
1 |
mg |
|
|
|
|
|
|
|
|
384.47 |
|
|
|
40588 |
|
|
O |
Asparaginase medac 5000 |
plv iol 5x5000 U |
MED |
DE |
1 |
384.46 |
384.46 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
L01XX02 |
|
|
|
Asparagináza |
parent. 10000 U |
2 |
mg |
|
|
|
|
|
|
|
|
537.51 |
|
|
|
40589 |
|
|
O |
Asparaginase medac 10000 |
plv iol 5x10000 U |
MED |
DE |
1 |
537.5 |
537.5 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
L01XX11 |
|
|
|
Estramustin |
p.o. 140 mg (100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
7.0999999999999994E-2 |
|
|
|
58742 |
X |
|
O |
ESTRACYT 140 mg |
cps dur 100x140 mg |
PFI-GB-3 |
GB |
1400 |
92.37 |
92.37 |
I |
0 |
0 |
0 |
HEM, ONK, URO |
|
|
|
|
L01XX17 |
|
|
|
Topotekan |
p.o. 0,25 mg (10 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
31.73 |
|
|
|
49736 |
X |
|
O |
Hycamtin |
cps dur 10x0,25 mg |
NEH-1 |
GB |
2.5 |
79.33 |
79.33 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01XX17 |
|
|
|
Topotekan |
p.o. 1 mg (10 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
30.51 |
|
|
|
49737 |
X |
|
O |
Hycamtin |
cps dur 10x1,0 mg |
SKB |
GB |
10 |
305.08 |
305.08 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01XX17 |
|
|
|
Topotekan |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
24.22 |
|
|
|
03463 |
|
|
G |
Topotecan Kabi 4 mg |
plc ifo 1x4 mg (liek.inj.skl.) |
FSN |
GB |
4 |
59.39 |
59.39 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
20666 |
|
|
G |
Topotecan Hospira |
con inf 5x4 ml/4 mg (liek.inj.skl.) |
HSP |
GB |
20 |
369 |
369 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
2773A |
|
|
G |
Topotecan Accord 1 mg/ml infúzny koncentrát |
con inf 1x1 ml/1 mg (liek.inj.skl.jantárová) |
ACC |
UK |
1 |
19.27 |
19.27 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
2774A |
|
|
G |
Topotecan Accord 1 mg/ml infúzny koncentrát |
con inf 1x4 ml/4 mg (liek.inj.skl.jantárová) |
ACC |
GB |
4 |
77.08 |
77.08 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01XX19 |
|
|
|
Irinotekan |
parent. |
1 |
mg |
|
|
|
|
|
|
|
|
0.17199999999999999 |
|
|
|
86627 |
|
|
G |
Irinotecan Fresenius 20 mg/ml infúzny koncentrát |
con inf 1x5 ml/100 mg (liek.skl.hnedá) |
FSN |
GB |
100 |
17.2 |
17.2 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
58653 |
|
|
G |
Irinotecan Mylan 20mg/ml |
con inf 1 x 2 ml / 40mg |
MLB-F |
FR |
40 |
6.88 |
6.88 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
58658 |
|
|
G |
Irinotecan Mylan 20mg/ml |
con inf 1 x 5 ml / 100mg |
MLB-F |
FR |
100 |
17.2 |
17.2 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
82012 |
|
|
G |
Irinotecan STADA 20 mg/ml |
con inf 1x2 ml/40 mg |
STD |
DE |
40 |
6.88 |
6.88 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
82013 |
|
|
G |
Irinotecan STADA 20 mg/ml |
con inf 1x5 ml/100 mg |
STD |
DE |
100 |
17.2 |
17.2 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01XX23 |
|
|
|
Mitotan |
p.o. 500 mg (100 ks) |
3 |
g |
|
|
|
|
|
|
|
|
36.71 |
|
|
|
40828 |
X |
|
O |
LYSODREN |
tbl 100x500 mg |
BMS |
IT |
16.5 |
605.64 |
605.64 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L01XX25 |
|
|
|
Bexaroten |
p.o. 75 mg (100 ks) |
300 |
mg/m2 |
|
|
|
|
|
|
|
|
39.170999999999999 |
|
|
|
98994 |
X |
|
O |
TARGRETIN |
cps mol 100x75 mg |
LGD |
GB |
25 |
979.26 |
979.26 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XX32 |
|
|
|
Bortezomib |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
199.55 |
|
|
|
5046B |
|
|
G |
Bortega 3,5 mg |
plv ino 1x3,5 mg (liek.inj.skl.) |
HTN |
CZ |
5.25 |
684.32 |
684.32 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
4562B |
|
|
G |
Bortezomib Glenmark 3,5 mg |
plv ino 1x3,5 mg (liek.inj.skl.) |
GLM-CZ |
CZ |
5.25 |
684.32 |
684.32 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
4973B |
|
|
G |
Bortezomib Pharmevid 3,5 mg prašok na injekčný roztok |
plv ino 1x3,5 mg (liek.inj.skl.) |
PEV |
SK |
5.25 |
684.32 |
684.32 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
4443B |
|
|
G |
Zegomib 3,5mg |
plv ino 1x3,5mg (liek.inj.skl.) |
EGI |
HU |
5.25 |
684.32 |
684.32 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
40531 |
|
|
O |
VELCADE |
plv ino 1x3,5 mg |
JNS |
BE |
5.25 |
1047.6199999999999 |
1047.6199999999999 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L01XX35 |
|
|
|
Anagrelid |
p.o. 0,5 mg (100 ks) |
2 |
mg |
|
|
|
|
|
|
|
|
14.54 |
|
|
|
47614 |
|
|
O |
THROMBOREDUCTIN 0,5 mg |
cps 100x0,5 mg |
ORV |
AT |
25 |
363.35 |
363.35 |
I |
0 |
0 |
0 |
HEM |
ind.obm., ZP |
|
|
|
L01XX44 |
|
|
|
Aflibercept |
parent. 100 mg |
4 |
mg/kg |
|
|
|
|
|
|
|
|
14.752000000000001 |
|
|
|
4323A |
|
|
O |
ZALTRAP 25 mg/ml infúzny koncentrát |
con inf 1x4 ml/100 mg (liek.inj.skl.) |
SOI |
FR |
25 |
368.8 |
368.8 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L01XX44 |
|
|
|
Aflibercept |
parent. 200 mg |
4 |
mg/kg |
|
|
|
|
|
|
|
|
14.624000000000001 |
|
|
|
4325A |
|
|
O |
ZALTRAP 25 mg/ml infúzny koncentrát |
con inf 1x8 ml/200 mg (liek.inj.skl.) |
SOI |
FR |
50 |
731.12 |
731.12 |
A |
0 |
0 |
0 |
ONK |
ind.obm., ZP |
|
|
|
L02AB01 |
|
|
|
Megestrol |
p.o. 160 mg (100 ks) |
0.16 |
g |
|
|
|
|
|
|
|
|
0.73470000000000002 |
|
|
|
34950 |
X |
|
G |
MEGESIN 160mg |
tbl 100x160 mg |
ACT-5 |
IS |
100 |
71.69 |
71.69 |
I |
0 |
0 |
0 |
GYN, HEM, ONK, TRN, URO, INF |
|
|
|
|
L02AE02 |
|
|
|
Leuprorelin |
parent. 3,75 mg inj. |
0.13 |
mg |
|
|
|
|
|
|
|
|
2.0699999999999998 |
|
|
|
L02AE02 |
|
|
|
Leuprorelin |
parent. 5 mg imp. |
0.13 |
mg |
|
|
|
|
|
|
|
|
2.2029999999999998 |
|
|
|
80448 |
|
|
G |
Leuprorelin Sandoz 5 mg implantát |
imp 1x5 mg ( striek. inj. napl. plast. ) |
SAN |
SI |
84 |
184.86 |
184.86 |
I |
0 |
0 |
0 |
ONK, URO |
|
|
|
|
L02AE02 |
|
|
|
Leuprorelin |
parent. 7,5 mg plv. iol. |
0.25 |
mg |
|
|
|
|
|
|
|
|
2.5009999999999999 |
|
|
|
42281 |
|
|
O |
ELIGARD 7,5 mg |
plv iol 1x 7,5mg + 1x sol. |
YEU |
NL |
30 |
75.03 |
75.03 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
L02AE02 |
|
|
|
Leuprorelin |
parent. 22,5 mg plv. iol. |
0.25 |
mg |
|
|
|
|
|
|
|
|
2.29 |
|
|
|
42283 |
|
|
O |
ELIGARD 22,5 mg |
plv iol 1x 22,5mg + 1x sol. |
YEU |
NL |
90 |
204.8 |
204.8 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
L02AE02 |
|
|
|
Leuprorelin |
parent. 45 mg plv. iol. |
0.25 |
mg |
|
|
|
|
|
|
|
|
2.34 |
|
|
|
46793 |
|
|
O |
Eligard 45 mg |
plv iol 1x 45 mg + 1 solv. (vanička) |
ASL-CZ |
CZ |
180 |
420.6 |
420.6 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
U25 |
L02AE03 |
|
|
|
Goserelin |
parent. depot. 3,6 mg |
0.13 |
mg |
|
|
|
|
|
|
|
|
2.5649999999999999 |
|
|
|
99174 |
|
|
O |
ZOLADEX DEPOT 3,6 mg |
imp 1x3,6 mg |
AZC |
GB |
27.907 |
71.52 |
71.52 |
I |
0 |
0 |
0 |
GYN, ONK, RPM, URO |
ind.obm. |
|
|
|
L02AE03 |
|
|
|
Goserelin |
parent. depot. 10,8 mg |
0.13 |
mg |
|
|
|
|
|
|
|
|
2.72 |
|
|
|
12320 |
|
|
O |
ZOLADEX LA DEPOT 10,8MG |
imp 1x10,8 mg |
AZC |
GB |
83.721000000000004 |
227.32 |
227.32 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
L02AE04 |
|
|
|
Triptorelín |
parent. 0,1 mg |
0.13 |
mg |
|
|
|
|
|
|
|
|
4.8 |
|
|
|
L02AE04 |
|
|
|
Triptorelín |
parent. 3,75 mg |
0.13 |
mg |
|
|
|
|
|
|
|
|
3.0750000000000002 |
|
|
|
01656 |
|
|
O |
DIPHERELINE S.R. 3.75 mg |
plv iud 1x3,75 mg+ sol. |
IPE |
FR |
27.984999999999999 |
86.01 |
86.01 |
I |
0 |
0 |
0 |
END, ENP, GYN, ONK, RPM, URO |
ind.obm. |
|
|
|
L02AE04 |
|
|
|
Triptorelín |
parent. 11,25 mg |
0.13 |
mg |
|
|
|
|
|
|
|
|
2.83 |
|
|
|
06215 |
|
|
O |
DIPHERELINE S.R. 11.25 mg |
plv iud 1x11,25 mg+ sol. |
IPE |
FR |
83.954999999999998 |
236.97 |
236.97 |
I |
0 |
0 |
0 |
END, ENP, GYN, ONK, URO |
ind.obm. |
|
|
|
L02AE04 |
|
|
|
Triptorelín |
parent. depot. |
0.13 |
mg |
|
|
|
|
|
|
|
|
3.0049999999999999 |
|
|
|
96107 |
|
|
O |
DECAPEPTYL DEPOT |
plv iul 1x3,75 mg |
FEI |
DE |
27.984999999999999 |
84.03 |
84.03 |
I |
0 |
0 |
0 |
END, ENP, GYN, ONK, RPM, URO |
ind.obm. |
|
|
|
L02BA03 |
|
|
|
Fulvestrant |
parent. |
16.600000000000001 |
mg |
|
|
|
|
|
|
|
|
21.01 |
|
|
|
40812 |
|
|
O |
FASLODEX |
sol inj 1x5 ml (250 mg/5 ml) |
AZC |
GB |
15.06 |
316.33 |
316.33 |
A |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L02BB01 |
|
|
|
Flutamid |
p.o. 250 mg (90-100 ks) |
0.75 |
g |
|
|
|
|
|
|
|
|
1 |
|
|
|
40460 |
X |
|
G |
FLUTASIN250mg |
tbl 90x250 mg |
ACT-5 |
IS |
30 |
29.99 |
29.99 |
I |
0 |
0 |
0 |
ONK, URO |
|
|
|
|
L02BB03 |
|
|
|
Bikalutamid |
p.o. 150 mg (28-30 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
0.5 |
|
|
|
58679 |
X |
|
G |
Binabic 150 mg |
tbl flm 28x150 mg (blis. PVC/PVDC/Al) |
VIH |
PL |
84 |
41.6 |
41.6 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
22291 |
X |
|
G |
Bicacel 150 mg |
tbl flm 30x150 mg (blis.PVC/PE/PVDC/Al) |
GLM-CZ |
CZ |
90 |
44.58 |
44.58 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
54433 |
X |
|
G |
Bicusan 150 mg |
tbl flm 30x150 mg |
ACT |
IS |
90 |
44.58 |
44.58 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
2473B |
X |
|
G |
Brectasa 150 mg |
tbl flm 30x150 mg (blis.PVC/Al) |
ACT-5 |
IS |
90 |
44.58 |
44.58 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
L02BB03 |
|
|
|
Bikalutamid |
p.o. 150 mg (90-98 ks) |
50 |
mg |
|
|
|
|
|
|
|
|
0.5 |
|
|
|
0806B |
X |
|
G |
Binabic 150 mg |
tbl flm 98x150 mg (blis.PVC/PVDC/Al) |
VIH |
PL |
294 |
145.61000000000001 |
145.61000000000001 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
46903 |
X |
|
G |
Bicalutamid - Teva 150 mg |
tbl flm 90x150 mg |
TEV |
SK |
270 |
133.72999999999999 |
133.72999999999999 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
22315 |
X |
|
G |
Bicalutamide Pharmevid 150 mg |
tbl flm 90x150 mg (blis. PVC/PE/PVDC/Al) |
PMT-SK |
SK |
270 |
133.72999999999999 |
133.72999999999999 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
54439 |
X |
|
G |
Bicusan 150 mg |
tbl flm 90x150 mg |
ACT-5 |
IS |
270 |
133.72999999999999 |
133.72999999999999 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
2478B |
X |
|
G |
Brectasa 150 mg |
tbl flm 90x150 mg (blis.PVC/Al) |
ACT-5 |
IS |
270 |
133.72999999999999 |
133.72999999999999 |
I |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
L02BB04 |
|
|
|
Enzalutamid |
p.o. 40 mg (112 cps.) |
0.16 |
g |
|
|
|
|
|
|
|
|
127.26300000000001 |
|
|
|
6336A |
|
|
O |
Xtandi 40 mg mäkké kapsuly |
cps mol 112x40 mg (blis.PVC/PCTFE/Al) |
ASL-2 |
NL |
28 |
3563.36 |
3563.36 |
I |
0 |
0 |
0 |
ONK, URK |
ind.obm., ZP |
|
|
|
L02BG03 |
|
|
|
Anastrozol |
p.o. 1 mg (28-30 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
0.27 |
|
|
|
64313 |
X |
|
G |
Anastrozole Pharmacenter |
tbl flm 30x1 mg (blister PVC/PE/PVDC/Al) |
PMT-SK |
SK |
30 |
7.82 |
7.82 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
52361 |
X |
|
G |
Anaprex 1mg |
tbl flm 28x1 mg |
NVN |
CZ |
28 |
7.3 |
7.3 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
39818 |
X |
|
G |
Anastrozol Sandoz 1mg filmom obalené tablety |
tbl flm 28x1 mg |
SAN |
SI |
28 |
7.3 |
7.3 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
39799 |
X |
|
G |
Anastrozol-ratiopharm 1mg |
tbl flm 28x1mg |
RAT |
DE |
28 |
7.3 |
7.3 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
78626 |
X |
|
G |
Ozolan 1 mg filmom obalené tablety |
tbl flm 28x1 mg (blis.PVC/Al) |
GLM |
CZ |
28 |
7.3 |
7.3 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L02BG03 |
|
|
|
Anastrozol |
p.o. 1 mg (90-100 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
0.27 |
|
|
|
39805 |
X |
|
G |
Anastrozol ratiopharm 1mg |
tbl flm 90x1mg |
RAT |
DE |
90 |
23.46 |
23.46 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
64318 |
X |
|
G |
Anastrozole Pharmacenter |
tbl flm 90x1 mg (blister PVC/PE/PVDC/Al) |
PMT-SK |
SK |
90 |
23.46 |
23.46 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L02BG04 |
|
|
|
Letrozol |
p.o. 2,5 mg (28-30 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
0.65 |
|
|
|
88592 |
X |
|
G |
Clarzole |
tbl flm 30x2,5 mg |
ACT |
IS |
30 |
19.37 |
19.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
07338 |
X |
|
G |
Letrovena 2,5 mg filmom obalené tablety |
tbl flm 30x2,5 mg (blis.PVC/Al) |
ONC |
PL |
30 |
19.37 |
19.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
51831 |
X |
|
G |
Letrozol STADA 2,5 mg filmom obalené tablety |
tbl flm 30x2,5 mg (blis. PVC/Al) |
STD |
DE |
30 |
19.37 |
19.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
75535 |
X |
|
G |
Letrozole Pharmacenter 2,5 mg |
tbl flm 30x2,5 mg |
PMT-SK |
SK |
30 |
19.37 |
19.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
4008A |
X |
|
G |
Lortanda 2,5mg filmom obalené tablety |
tbl flm 30x2,5mg |
KRK |
SL |
30 |
19.37 |
19.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
83880 |
X |
|
G |
Trozel 2,5 mg |
tbl flm 30x2,5 mg (blis.PVC/PVdC/Al) |
GLM-CZ |
CZ |
30 |
19.37 |
19.37 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L02BG04 |
|
|
|
Letrozol |
p.o. 2,5 mg (90-100 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
0.65 |
|
|
|
75539 |
X |
|
G |
Letrozole Pharmacenter 2,5 mg |
tbl flm 90x2,5 mg |
PMT-SK |
SK |
90 |
58.1 |
58.1 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
54673 |
X |
|
G |
ETRUZIL |
tbl flm 90x2,5 mg |
EGI |
HU |
90 |
58.11 |
58.11 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
07348 |
X |
|
G |
Letrovena 2,5 mg filmom obalené tablety |
tbl flm 100x2,5 mg (blis.PVC/Al) |
ONC |
PL |
100 |
64.569999999999993 |
64.569999999999993 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
54211 |
X |
|
G |
Letrozol Sandoz 2,5mg filmom obalené tablety |
tbl flm 100x2,5 mg |
SAN |
SI |
100 |
64.569999999999993 |
64.569999999999993 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
51832 |
X |
|
G |
Letrozol STADA 2,5 mg filmom obalené tablety |
tbl flm 100 (10x10)x2,5 mg (blis. PVC/Al) |
STD |
DE |
100 |
64.569999999999993 |
64.569999999999993 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
88596 |
X |
|
G |
Clarzole |
tbl flm 100x2,5 mg (blis.Al/PVC) |
ACT-5 |
IS |
100 |
65 |
65 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L02BG06 |
|
|
|
Exemestan |
p.o. 25 mg (30 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
0.66 |
|
|
|
04235 |
X |
|
G |
Cotamox 25 mg |
tbl flm 30x25 mg (blis. Al/PVC) |
ACT |
IS |
30 |
19.77 |
19.77 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
89864 |
X |
|
G |
Escepran 25mg filmom obalené tablety |
tbl flm 30x25mg |
KRK |
SL |
30 |
19.77 |
19.77 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
05310 |
X |
|
G |
Exemestan Mylan 25 mg |
tbl flm 30 x 25 mg |
GNC |
GB |
30 |
19.77 |
19.77 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
20635 |
X |
|
G |
Exemestane Accord 25mg |
tbl flm 30x25 mg |
ACC |
GB |
30 |
19.77 |
19.77 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
20333 |
X |
|
G |
Exemestane Pharmacenter 25 mg filmom obalené tablety |
tbl flm 30x25 mg (blis. PVC/PVDC/Al) |
PMT-SK |
SK |
30 |
19.77 |
19.77 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L02BG06 |
|
|
|
Exemestan |
p.o. 25 mg (90-100 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
0.66 |
|
|
|
20334 |
X |
|
G |
Exemestane Pharmacenter 25 mg filmom obalené tablety |
tbl flm 90x25 mg (blis. PVC/PVDC/Al) |
PMT-SK |
SK |
90 |
59.31 |
59.31 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
22724 |
X |
|
G |
Astexana 25 mg |
tbl flm 100x25 mg |
VIH |
PL |
100 |
66 |
66 |
I |
0 |
0 |
0 |
ONK |
ind.obm. |
|
|
|
L02BX02 |
|
|
|
Degarelix |
parent. 80 mg |
2.7 |
mg |
|
|
|
|
|
|
|
|
4.66 |
|
|
|
03856 |
|
|
O |
FIRMAGON |
plv iol 3x80 mg + 3x6 ml solv. |
FEI |
DK |
90 |
419.4 |
419.4 |
I |
0 |
0 |
0 |
ONK, URK, URO |
ind.obm. |
|
|
|
L02BX02 |
|
|
|
Degarelix |
parent. 120 mg |
2.7 |
mg |
|
|
|
|
|
|
|
|
2.84 |
|
|
|
65736 |
|
|
O |
FIRMAGON |
plv iol 2x120 mg + 2x6 ml solv |
FEI |
DK |
88 |
249.75 |
249.75 |
I |
0 |
0 |
0 |
ONK, URK, URO |
ind.obm. |
|
|
|
L02BX03 |
|
|
|
Abiraterón |
p.o. 250 mg (120 ks) |
1 |
g |
|
|
|
|
|
|
|
|
119.85 |
|
|
|
10799 |
|
|
O |
Zytiga 250 mg tablety |
tbl 120x250 mg (fľ.HDPE) |
JNS |
BE |
30 |
3595.38 |
3595.38 |
I |
0 |
0 |
0 |
ONK, URK |
ind.obm., ZP |
2014-10-01T00:00:00.000 |
|
|
L03AA02 |
|
|
|
Filgrastim |
parent. 300 mcg |
0.35 |
mg |
|
|
|
|
|
|
|
|
31.122 |
|
|
|
65482 |
|
|
O |
Zarzio |
sol ijf 1x0,5 ml/30 MU |
SAN |
AT |
0.85699999999999998 |
26.67 |
26.67 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
2231B |
|
|
B |
Accofil 30 MU/0,5 ml injekčný alebo infúzny roztok v naplnenej injekčnej striekačke |
sol ijf 5x0,5 ml (striek.inj.napl.skl.) |
ACC |
GB |
4.2859999999999996 |
133.38999999999999 |
133.38999999999999 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
7809A |
|
|
B |
Grastofil 30 MU/0,5 ml |
sol ijf 5x0,5 ml/30 MU (striek.inj.napl.skl.) |
AEL |
NL |
4.2859999999999996 |
133.38999999999999 |
133.38999999999999 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
20505 |
|
|
B |
Nivestim |
sol ijf 5x0,5 ml/300 µg (striek.inj.napl.skl.+ochr.kryt ihly) |
HSP |
GB |
4.2859999999999996 |
133.38999999999999 |
133.38999999999999 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
85145 |
|
|
G |
Ratiograstim 30 MIU/0,5ml injekčný alebo infúzny roztok |
sol ijf 5x0,5 ml/300 ug(30 MIU) (striek.skl.napln. s bezp. zar.) |
RAT |
DE |
4.2859999999999996 |
133.38999999999999 |
133.38999999999999 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
L03AA02 |
|
|
|
Filgrastim |
parent. 480 mcg |
0.35 |
mg |
|
|
|
|
|
|
|
|
29.93 |
|
|
|
65487 |
|
|
O |
Zarzio |
sol ijf 1x0,5 ml/48 MU |
SAN |
AT |
1.371 |
41.03 |
41.03 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
2233B |
|
|
B |
Accofil 48 MU/0,5 ml injekčný alebo infúzny roztok v naplnenej injekčnej striekačke |
sol ijf 5x0,5 ml (striek.inj.napl.skl.) |
ACC |
GB |
6.8570000000000002 |
205.22 |
205.22 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
7811A |
|
|
B |
Grastofil 48 MU/0,5 ml |
sol ijf 5x0,5 ml/48 MU (striek.inj.napl.skl.) |
AEL |
NL |
6.8570000000000002 |
205.22 |
205.22 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
20508 |
|
|
B |
Nivestim |
sol ijf 5x0,5 ml/480 µg (striek.inj.napl.skl.+ochr.kryt ihly) |
HSP |
GB |
6.8570000000000002 |
205.22 |
205.22 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
85147 |
|
|
G |
Ratiograstim 48 MIU/0,8 ml injekčný alebo infúzny roztok |
sol ijf 5x0,8 ml/480 ug(48 MIU) (striek.skl.napln. s bezp. zar.) |
RAT |
DE |
6.8570000000000002 |
205.22 |
205.22 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
65489 |
|
|
O |
Zarzio |
sol ijf 5x0,5 ml/48 MU |
SAN |
AT |
6.8570000000000002 |
205.22 |
205.22 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
L03AA13 |
|
|
|
Pegfilgrastím |
parent. |
0.3 |
mg |
|
|
|
|
|
|
|
|
42.57 |
|
|
|
76081 |
|
|
O |
Neulasta |
sol inj 1x0,6 ml/6 mg (napln.skl.inj.striek.- blistr.bal.+ chránič ihly) |
AMG |
NL |
20 |
851.36 |
851.36 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
L03AA14 |
|
|
|
Lipegfilgrastim |
s.c. 6 mg |
0.3 |
mg |
|
|
|
|
|
|
|
|
41.911999999999999 |
|
|
|
6781A |
|
|
O |
Lonquex 6 mg injekčný roztok |
sol inj 1x0,6 ml/6 mg (striek.inj.skl.napl. s bezp.zar.) |
UAS |
LT |
20 |
838.23 |
838.23 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
L03AB01 |
|
|
|
Interferón-alfa z ľudských leukocytov |
parent. |
2 |
MU |
|
|
|
|
|
|
|
|
33.53 |
|
|
|
78288 |
|
|
O |
Multiferon |
sol iru 6x0,5 ml |
SWO |
SE |
15 |
502.91 |
502.91 |
I |
0 |
0 |
0 |
HEP, INF, ONK |
ind.obm., ZP |
|
|
|
L03AB05 |
|
|
|
Interferón alfa-2b |
parent. REDIPEN |
2 |
MU |
|
|
|
|
|
|
|
|
10.5 |
|
|
|
28929 |
|
|
O |
IntronA 18 miliónov IU injekčný roztok vo viacdávkovom pere |
sol inj 1x1,2 ml/18 MU (1x náplň vo viacdávk.pere+ 12x inj.set) |
MSD-GB-1 |
GB |
9 |
94.48 |
94.48 |
I |
0 |
0 |
0 |
GIT, HEM, HEP, INF, ONK, URO |
ind.obm., ZP |
|
|
|
28930 |
|
|
O |
IntronA 30 miliónov IU injekčný roztok vo viacdávkovom pere |
sol inj 1x1,2 ml/30 MU (1x náplň vo viacdávk.pere+ 12x inj.set) |
MSD-GB-1 |
GB |
15 |
157.47 |
157.47 |
I |
0 |
0 |
0 |
GIT, HEM, HEP, INF, ONK, URO |
ind.obm., ZP |
|
|
|
28931 |
|
|
O |
IntronA 60 miliónov IU injekčný roztok vo viacdávkovom pere |
sol inj 1x1,2 ml/60 MU (1x náplň vo viacdávk.pere+ 12x inj.set) |
MSD-GB-1 |
GB |
30 |
314.94 |
314.94 |
I |
0 |
0 |
0 |
GIT, HEM, HEP, INF, ONK, URO |
ind.obm., ZP |
|
|
|
L03AB07 |
|
|
|
Interferón beta-1a |
parent. sol. inj. |
4.3 |
µg |
|
|
|
|
|
|
|
|
19.91 |
|
|
|
08662 |
|
|
O |
Avonex |
sol inj 4x0,5 ml/30 µg (napln. inj. striek. v inj. pere) |
BGI-GB |
GB |
40 |
796.39 |
796.39 |
A |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
L03AB08 |
|
|
|
Interferón beta-1b |
parent. 300 mcg |
4 |
MU |
|
|
|
|
|
|
|
|
20.45 |
|
|
|
5283A |
|
|
O |
EXTAVIA 250 µg/ml |
plv iol (15x skl.liek.-prášok + 15x napl.inj.striek.-solvent) |
NEH |
GB |
30 |
613.33000000000004 |
613.33000000000004 |
A |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
L03AB10 |
|
|
|
Peginterferón alfa-2b |
parent. PERO |
7.5 |
µg |
|
|
|
|
|
|
|
|
13.032 |
|
|
|
95710 |
|
|
O |
PegIntron 120 mikrogramov, prášok a rozp. na inj. roztok naplnené v injekčnom pere |
plv ipl 4x120 ug (4x napl.skl.pero+ 4x ihla+ 8x čist.tampon) |
MSD-GB-1 |
GB |
64 |
833.97 |
833.97 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
95706 |
|
|
O |
PegIntron 100 mikrogramov, prášok a rozp. na inj. roztok naplnené v injekčnom pere |
plv ipl 4x 100 ug (4x napl.skl.pero+ 4x ihla+ 8x čist.tampon) |
MSD-GB-1 |
GB |
53.332999999999998 |
694.98 |
694.98 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
95708 |
|
|
O |
PegIntron 150 mikrogramov, prášok a rozp. na inj. roztok naplnené v injekčnom pere |
plv ipl 4x150 ug (4x napl.skl.pero+ 4x ihla+ 8x čist.tampon) |
MSD-GB-1 |
GB |
80 |
1042.48 |
1042.48 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
L03AB11 |
|
|
|
Peginterferón alfa-2a |
parent. sol. inj. |
26 |
µg |
|
|
|
|
|
|
|
|
24.92 |
|
|
|
09725 |
|
|
O |
Pegasys 180 mcg/0,5 ml |
sol inj 1x0,5 ml (pero napln.) |
HLR |
GB |
6.923 |
172.49 |
172.49 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
20237 |
|
|
O |
Pegasys 180 mcg/0,5 ml |
sol inj 1x180 mcg/0,5 ml |
HLR |
DE |
6.923 |
172.49 |
172.49 |
I |
0 |
0 |
0 |
GIT, HEP, INF |
ind.obm., ZP |
|
|
|
L03AB13 |
|
|
|
Peginterferón beta-1a |
s.c. 63 mcg a 94 mcg |
1 |
DF |
|
|
|
|
|
|
|
|
429.61 |
|
|
|
1538B |
|
|
O |
Plegridy 63 mikrogramov injekčný roztok naplnený v injekčnom pere, Plegridy 94 mikrogramov injekčný roztok naplnený v injekčnom pere |
sol inj 1x0,5 ml/63 µg + 1x0,5 ml/94 µg (pero.inj.napl. Plegridy Pen) |
BGI |
GB |
2 |
859.22 |
859.22 |
A |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
L03AB13 |
|
|
|
Peginterferón beta-1a |
s.c. 125 mcg |
1 |
DF |
|
|
|
|
|
|
|
|
429.61 |
|
|
|
1541B |
|
|
O |
Plegridy 125 mikrogramov injekčný roztok naplnený v injekčnom pere |
sol inj 2x125 µg/0,5 ml (pero inj.napl. Plegridy Pen) |
BGI |
GB |
2 |
859.22 |
859.22 |
A |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
L03AX03 |
|
|
|
BCG vakcína |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
92.67 |
|
|
|
40197 |
|
|
O |
BCG-medac |
plv iul 1x1 set (1 inj. liek.+ 50 ml disp. prostr.+ adapt. Luer-Lock) |
MED |
DE |
1 |
92.67 |
92.67 |
A |
0 |
0 |
0 |
ONK, URO |
ind.obm. |
|
|
|
L04AA06 |
|
|
|
Mofetyl mykofenolát |
p.o. 250 mg (100 ks) |
2 |
g |
|
|
|
|
|
|
|
|
3.62 |
|
|
|
47859 |
|
|
G |
Myfenax 250 mg tvrdé kapsuly |
cps dur 100x250 mg (blis.PVC/PVDC/Al) |
TEV-NL-4 |
NL |
12.5 |
45.21 |
45.21 |
I |
0 |
0 |
0 |
HEM, HEP, INT, KAR, KLF, NEF |
|
|
|
|
3572A |
|
|
G |
Mygref 250 mg |
cps dur 100x250 mg (blis.PVC/PVDC/Al) |
MDS |
CZ |
12.5 |
45.21 |
45.21 |
I |
0 |
0 |
0 |
HEM, HEP, INT, KAR, KLF, NEF |
|
|
|
|
25560 |
|
|
O |
CELLCEPT 250 |
cps dur 100x250 mg |
HLR |
DE |
12.5 |
45.22 |
45.22 |
I |
0 |
0 |
0 |
HEM, HEP, INT, KAR, KLF, NEF |
|
|
|
|
L04AA06 |
|
|
|
Mofetyl mykofenolát |
p.o. 500 mg (50 ks) |
2 |
g |
|
|
|
|
|
|
|
|
3.4359999999999999 |
|
|
|
47861 |
|
|
G |
Myfenax 500 mg filmom obalené tablety |
tbl flm 50x500 mg (blis.PVC/PVDC/Al) |
TEV-NL-4 |
NL |
12.5 |
42.93 |
42.93 |
I |
0 |
0 |
0 |
HEM, HEP, INT, KAR, KLF, NEF |
|
|
|
|
3574A |
|
|
G |
Mygref 500 mg |
tbl flm 50x500 mg (blis.PVC/PVDC/Al) |
MDS |
CZ |
12.5 |
42.93 |
42.93 |
I |
0 |
0 |
0 |
HEM, HEP, INT, KAR, KLF, NEF |
|
|
|
|
52089 |
|
|
G |
Mykofenolát mofetil Sandoz 500mg filmom obalené tablety |
tbl flm 50x500 mg |
SAN |
SI |
12.5 |
42.93 |
42.93 |
I |
0 |
0 |
0 |
HEM, HEP, INT, KAR, KLF, NEF |
|
|
|
|
44077 |
|
|
O |
CELLCEPT 500 |
tbl flm 50x500 mg |
HLR |
DE |
12.5 |
42.94 |
42.94 |
I |
0 |
0 |
0 |
HEM, HEP, INT, KAR, KLF, NEF |
|
|
|
|
L04AA06 |
|
|
|
Mofetyl mykofenolát |
parent. |
2 |
g |
|
|
|
|
|
|
|
|
48 |
|
|
|
55295 |
|
|
O |
CELLCEPT 500 |
plc ifo 4x500 mg |
HLR |
DE |
1 |
48 |
48 |
A |
0 |
0 |
0 |
HEM, HEP, INT, KAR, KLF, NEF |
|
|
|
|
L04AA06 |
|
|
|
Mofetyl mykofenolát, sodná soľ |
p.o. 180 mg (120 ks) |
1440 |
mg |
|
|
|
|
|
|
|
|
6.66 |
|
|
|
43041 |
|
|
O |
Myfortic 180 mg |
tbl fle 120x180 mg |
NAI |
CZ |
15 |
99.83 |
99.83 |
I |
0 |
0 |
0 |
INT, KLF, NEF |
ind.obm. |
|
|
|
L04AA06 |
|
|
|
Mofetyl mykofenolát, sodná soľ |
p.o. 360 mg (120 ks) |
1440 |
mg |
|
|
|
|
|
|
|
|
6.6550000000000002 |
|
|
|
43036 |
|
|
O |
Myfortic 360 mg |
tbl fle 120x360 mg |
NAI |
CZ |
30 |
199.64 |
199.64 |
I |
0 |
0 |
0 |
INT, KLF, NEF |
ind.obm. |
|
|
|
L04AA10 |
|
|
|
Sirolimus |
p.o. 1 mg (100 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
18.3 |
|
|
|
34341 |
|
|
O |
Rapamune 1 mg obalené tablety |
tbl obd 100x1 mg (blis.PVC/PE/Aclar/Al) |
PFI-GB-1 |
GB |
20 |
365.91 |
365.91 |
I |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
L04AA13 |
|
|
|
Leflunomid |
p.o. 10 mg (30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
1.28 |
|
|
|
21708 |
X |
|
G |
Leflunomide medac 10 mg filmom obalené tablety |
tbl flm 30x10 mg (fľaša HDPE) |
MED |
DE |
20 |
25.59 |
25.59 |
I |
0 |
0 |
0 |
REU |
ind.obm. |
|
|
|
L04AA13 |
|
|
|
Leflunomid |
p.o. 20 mg (30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
0.64 |
|
|
|
86931 |
X |
|
G |
Leflunomide Winthrop |
tbl flm 30x20 mg (fľaša HDPE) |
SAV-D |
DE |
40 |
25.29 |
25.29 |
I |
0 |
0 |
0 |
REU |
ind.obm. |
|
|
|
L04AA13 |
|
|
|
Leflunomid |
p.o. 20 mg (50 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
0.64 |
|
|
|
86932 |
X |
|
G |
Leflunomide Winthrop |
tbl flm 50x20 mg (fľaša HDPE) |
SAV-D |
DE |
66.665999999999997 |
42.15 |
42.15 |
I |
0 |
0 |
0 |
REU |
ind.obm. |
|
|
|
L04AA18 |
|
|
|
Everolimus |
p.o. 0,25 mg (60 ks) |
1.5 |
mg |
|
|
|
|
|
|
|
|
11.07 |
|
|
|
42169 |
|
|
O |
Certican 0,25mg tablety |
tbl 60x0,25 mg |
NAI |
CZ |
10 |
110.65 |
110.65 |
I |
0 |
0 |
0 |
ALG, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
L04AA18 |
|
|
|
Everolimus |
p.o. 0,75 mg (60 ks) |
1.5 |
mg |
|
|
|
|
|
|
|
|
10.993 |
|
|
|
42178 |
|
|
O |
Certican 0,75mg tablety |
tbl 60x0,75 mg |
NAI |
CZ |
30 |
329.78 |
329.78 |
I |
0 |
0 |
0 |
ALG, INT, KAR, KLF, NEF |
ind.obm. |
|
|
|
L04AA23 |
|
|
|
Natalizumab |
parent. |
10.71 |
mg |
|
|
|
|
|
|
|
|
53.01 |
|
|
|
35677 |
|
|
O |
Tysabri 300 mg |
con inf 1x15 ml/300mg |
Bio |
NL |
28 |
1484.15 |
1484.15 |
A |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
L04AA24 |
|
|
|
Abatacept |
parent. |
27 |
mg |
|
|
|
|
|
|
|
|
36.590000000000003 |
|
|
|
43230 |
|
|
O |
ORENCIA 250 mg |
plc ifo 1x250 mg(1xliek+1xstriek.) |
BMS |
GB |
9.25 |
338.42 |
338.42 |
A |
0 |
0 |
0 |
REU |
ind.obm., ZP |
|
|
|
L04AA26 |
|
|
|
Belimumab |
parent. 120 mg |
25.64 |
mg |
|
|
|
|
|
|
|
|
33.75 |
|
|
|
09504 |
|
|
O |
Benlysta 120 mg prášok na infúzny koncentrát |
plc ifo 1x120 mg (liek.inj.skl.) |
GLA |
GB |
4.68 |
157.93 |
157.93 |
A |
0 |
0 |
0 |
REU |
ind.obm., ZP |
|
|
|
L04AA26 |
|
|
|
Belimumab |
parent. 400 mg |
25.64 |
mg |
|
|
|
|
|
|
|
|
33.03 |
|
|
|
09505 |
|
|
O |
Benlysta 400 mg prášok na infúzny koncentrát |
plc ifo 1x400 mg (liek.inj.skl.) |
GLA |
GB |
15.601000000000001 |
515.16 |
515.16 |
A |
0 |
0 |
0 |
REU |
ind.obm., ZP |
|
|
|
L04AA27 |
|
|
|
Fingolimod |
p.o. 0,5 mg |
0.5 |
mg |
|
|
|
|
|
|
|
|
60.99 |
|
|
|
08294 |
|
|
O |
GILENYA 0,5 mg |
cps dur 28x0,5 mg |
NEH |
GB |
28 |
1707.54 |
1707.54 |
I |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
L04AA31 |
|
|
|
Teriflunomid |
p.o. 14 mg (28 ks) |
14 |
mg |
|
|
|
|
|
|
|
|
30.792000000000002 |
|
|
|
7010A |
|
|
O |
Aubagio 14 mg filmom obalené tablety |
tbl flm 28x14 mg (blisAI/AI) |
SOI |
FR |
28 |
862.16 |
862.16 |
I |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
L04AA34 |
|
|
|
Alemtuzumab |
parent. |
1 |
DF |
|
|
|
|
|
|
|
|
8152.55 |
|
|
|
7211A |
|
|
O |
LEMTRADA 12 mg infúzny koncentrát |
con inf 1x1,2 ml/12 mg (liek.inj.skl.) |
GZE |
GB |
1 |
8152.55 |
8152.55 |
A |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
L04AB01 |
|
|
|
Etanercept |
parent. |
7 |
mg |
|
|
|
|
|
|
|
|
32.83 |
|
|
|
36757 |
|
|
O |
Enbrel 50 mg injekčný roztok naplnený v injekčnej striekačke |
sol iru 4x1 ml/50 mg (4x striek.skl.napln.+8x tamp.) |
PFI-GB-1 |
GB |
28.57 |
937.85 |
937.85 |
I |
0 |
0 |
0 |
REU, DER |
ind.obm., ZP |
|
|
|
78432 |
|
|
O |
Enbrel 50 mg injekčný roztok v naplnenom pere |
sol ira 4x1 ml/50 mg (4x napl. pero+ 8x tamp.) |
PFI-GB-1 |
GB |
28.57 |
937.85 |
937.85 |
I |
0 |
0 |
0 |
REU, DER |
ind.obm., ZP |
|
|
|
36753 |
|
|
O |
Enbrel 25 mg injekčný roztok naplnený v injekčnej striekačke |
sol iru 4x0,5 ml/25 mg (4x striek.skl.napln.+8x tamp.) |
PFI-GB-1 |
GB |
14.29 |
469.14 |
469.14 |
I |
0 |
0 |
0 |
REU, DER |
ind.obm., ZP |
|
|
|
L04AB02 |
|
|
|
Infliximab |
parent. |
3.75 |
mg |
|
|
|
|
|
|
|
|
14.57 |
|
|
|
7169A |
|
|
B |
Inflectra 100 mg prášok na prípravu infúzneho koncentrátu |
plc ifo, 1x100 mg (liek.inj.skl.) |
HSP |
GB |
26.667000000000002 |
388.48 |
388.48 |
A |
0 |
0 |
0 |
DER, GIT, REU |
ind.obm., ZP |
|
|
|
7044A |
|
|
B |
Remsima 100mg prášok na prípravu infúzneho koncentrátu |
plc.ifo.1x100mg (liek.inj.skl.) |
CLO |
HU |
26.667000000000002 |
388.48 |
388.48 |
A |
0 |
0 |
0 |
DER, GIT, REU |
ind.obm., ZP |
|
|
|
L04AB04 |
|
|
|
Adalimumab |
parent. |
2.85 |
mg |
|
|
|
|
|
|
|
|
34.942 |
|
|
|
40795 |
|
|
O |
Humira 40 mg injekčný roztok naplnený v striekačke |
sol inj 2x0,8 ml/40 mg (striek.skl.napln.) |
ABV-GB |
GB |
28 |
978.37 |
978.37 |
I |
0 |
0 |
0 |
DER, GIT, REU |
ind.obm., ZP |
|
|
|
37218 |
|
|
O |
Humira 40 mg injekčný roztok v naplnenom pere |
sol inj 2x0,8 ml/40 mg (napl.skl.pero) |
ABV-GB |
GB |
28 |
978.37 |
978.37 |
I |
0 |
0 |
0 |
DER, GIT, REU |
ind.obm., ZP |
|
|
|
L04AB05 |
|
|
|
Certolizumab |
parent. |
14 |
mg |
|
|
|
|
|
|
|
|
31.343 |
|
|
|
81325 |
|
|
O |
Cimzia |
sol inj 2x200 mg/1 ml (striek.inj.napl. + lieh.tamp.) |
UCP |
BE |
28.571000000000002 |
895.49 |
895.49 |
I |
0 |
0 |
0 |
REU |
ind.obm., ZP |
|
|
|
L04AB06 |
|
|
|
Golimumab |
parent. |
1.64 |
mg |
|
|
|
|
|
|
|
|
31.95 |
|
|
|
83300 |
|
|
O |
Simponi |
sol inj 1x0,5 ml/50 mg (pero napl.sklo) |
CEO |
NL |
30.488 |
974.02 |
974.02 |
I |
0 |
0 |
0 |
REU |
ind.obm., ZP |
|
|
|
83302 |
|
|
O |
SIMPONI |
sol inj 1x0,5 ml/50 mg (striek.napl.skl.) |
JAN |
NL |
30.488 |
974.02 |
974.02 |
I |
0 |
0 |
0 |
REU |
ind.obm., ZP |
|
|
|
L04AC05 |
|
|
|
Ustekinumab |
parent. |
0.53420000000000001 |
mg |
|
|
|
|
|
|
|
|
36.362000000000002 |
|
|
|
87597 |
|
|
O |
Stelara |
sol iru 1x0,5 ml/45 mg (striek.skl.napln.) |
JNS |
BE |
84.238 |
3063.05 |
3063.05 |
I |
0 |
0 |
0 |
DER, REU |
ind.obm., ZP |
|
|
|
L04AC07 |
|
|
|
Tocilizumab |
s.c. 162 mg |
20 |
mg |
|
|
|
|
|
|
|
|
32.604999999999997 |
|
|
|
9954A |
|
|
O |
RoActemra 162 mg injekčný roztok v naplnenej injekčnej striekačke |
sol inj 4x0,9 ml/162 mg (striek.inj.napl.skl.) |
HLR-GB |
GB |
32.4 |
1056.3800000000001 |
1056.3800000000001 |
I |
0 |
0 |
0 |
REU |
ind.obm., ZP |
|
|
|
L04AC07 |
|
|
|
Tocilizumab |
parent. |
20 |
mg |
|
|
|
|
|
|
|
|
35.042000000000002 |
|
|
|
64991 |
|
|
O |
RoActemra |
con inf 1x20 ml/400 mg |
HLR |
GB |
20 |
700.83 |
700.83 |
A |
0 |
0 |
0 |
REU |
ind.obm., ZP |
|
|
|
L04AC10 |
|
|
|
Sekukinumab |
s.c. 150 mg |
9.8629999999999995 |
mg |
|
|
|
|
|
|
|
|
40.204999999999998 |
|
|
|
2817B |
|
|
O |
Cosentyx 150 mg injekčný roztok v naplnenom pere |
sol ira 2x1 ml/150 mg (striek.inj.skl. v pere SensoReady) |
NEH-1 |
GB |
30.417000000000002 |
1222.9000000000001 |
1222.9000000000001 |
I |
0 |
0 |
0 |
DER |
ind.obm., ZP |
|
|
|
L04AD01 |
|
|
|
Cyklosporín |
p.o. mikroemulgované 25 mg (50 ks) |
0.25 |
g |
|
|
|
|
|
|
|
|
3.36 |
|
|
|
50490 |
|
|
G |
Ciclosporin Mylan 25 mg |
cps mol 50x25 mg (blis. Al/Al) |
GNC |
GB |
5 |
16.8 |
16.8 |
I |
0 |
0 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
10183 |
|
|
G |
EQUORAL 25 mg |
cps 50x25 mg |
IVX |
CZ |
5 |
16.8 |
16.8 |
I |
0 |
0 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
L04AD01 |
|
|
|
Cyklosporín |
p.o. mikroemulgované 50 mg (50 ks) |
0.25 |
g |
|
|
|
|
|
|
|
|
3.181 |
|
|
|
50495 |
|
|
G |
Ciclosporin Mylan 50 mg |
cps mol 50x50 mg (blis. Al/Al) |
GNC |
GB |
10 |
31.81 |
31.81 |
I |
0 |
0 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
10184 |
|
|
G |
EQUORAL 50 mg |
cps 50x50 mg |
IVX |
CZ |
10 |
31.81 |
31.81 |
I |
0 |
0 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
L04AD01 |
|
|
|
Cyklosporín |
p.o. mikroemulgované 100 mg (50 ks) |
0.25 |
g |
|
|
|
|
|
|
|
|
2.72 |
|
|
|
50500 |
|
|
G |
Ciclosporin Mylan 100 mg |
cps mol 50x100 mg (blis. Al/Al) |
GNC |
GB |
20 |
54.26 |
54.26 |
I |
0 |
0 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
10185 |
|
|
G |
EQUORAL 100 mg |
cps 50x100 mg |
IVX |
CZ |
20 |
54.26 |
54.26 |
I |
0 |
0 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
L04AD01 |
|
|
|
Cyklosporín |
p.o. 100 mg/ml tekuté |
0.25 |
g |
|
|
|
|
|
|
|
|
2.83 |
|
|
|
06408 |
|
|
G |
EQUORAL |
sol por 1x50 ml |
IVX |
CZ |
20 |
56.49 |
56.49 |
I |
0 |
0 |
0 |
ALG, DER, HEM, HEP, INT, KAR, KLF, NEF, OPH, REU, TRN |
ind.obm. |
|
|
|
L04AD02 |
|
|
|
Takrolimus |
p.o. 1 mg (60 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
5.76 |
|
|
|
01914 |
|
|
G |
GECROL 1 mg |
cps dur 60x1 mg (blis. PVC/PVDC/Al) |
HTN |
CZ |
12 |
69.05 |
69.05 |
I |
0 |
0 |
0 |
HEP, KAR, NEF |
ind.obm. |
|
|
|
57628 |
|
|
O |
PROGRAF 1MG |
cps dur 60x1 mg |
FUJ |
IE |
12 |
69.05 |
69.05 |
I |
0 |
0 |
0 |
HEP, KAR, NEF |
ind.obm. |
|
|
|
L04AD02 |
|
|
|
Takrolimus |
p.o. 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
4.68 |
|
|
|
01922 |
|
|
G |
GECROL 5 mg |
cps dur 30x5 mg (blis. PVC/PVDC/Al) |
HTN |
CZ |
30 |
139.94999999999999 |
139.94999999999999 |
I |
0 |
0 |
0 |
HEP, KAR, NEF |
ind.obm. |
|
|
|
L04AD02 |
|
|
|
Takrolimus |
p.o. predĺžené uvoľňovanie 0,5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.7100000000000009 |
|
|
|
39629 |
|
|
O |
Advagraf |
cps pld 30x0,5 mg |
ASL |
IE |
3 |
26.11 |
26.11 |
I |
0 |
0 |
0 |
HEP, NEF |
ind.obm. |
|
|
|
L04AD02 |
|
|
|
Takrolimus |
p.o. predĺžené uvoľňovanie 1 mg (60 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
9.1199999999999992 |
|
|
|
39633 |
|
|
O |
Advagraf |
cps pld 60x1 mg |
ASL |
IE |
12 |
109.38 |
109.38 |
I |
0 |
0 |
0 |
HEP, NEF |
ind.obm. |
|
|
|
L04AD02 |
|
|
|
Takrolimus |
p.o. predĺžené uvoľňovanie 3 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
6.7119999999999997 |
|
|
|
76887 |
|
|
O |
Advagraf |
cps pld 30x3 mg |
ASL |
NL |
18 |
120.8 |
120.8 |
I |
0 |
0 |
0 |
HEP, NEF |
ind.obm. |
|
|
|
L04AD02 |
|
|
|
Takrolimus |
p.o. predĺžené uvoľňovanie 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
7.1219999999999999 |
|
|
|
39635 |
|
|
O |
Advagraf |
cps pld 30x5 mg |
ASL |
IE |
30 |
213.65 |
213.65 |
I |
0 |
0 |
0 |
HEP, NEF |
ind.obm. |
|
|
|
L04AX01 |
|
|
|
Azatioprin |
p.o. 50 mg (100 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.47 |
|
|
|
02418 |
|
|
O |
IMURAN |
tbl obd 100x50 mg |
GWE |
GB |
33.332999999999998 |
15.54 |
15.54 |
I |
0 |
0 |
0 |
|
|
|
|
|
98732 |
|
|
G |
Immunoprin 50 mg |
tbl flm 100x50 mg |
EBW |
AT |
33.33 |
15.67 |
15.67 |
I |
0 |
0 |
0 |
|
|
|
|
|
L04AX01 |
|
|
|
Azatioprin |
p.o. 100 mg (100 ks) |
0.15 |
g |
|
|
|
|
|
|
|
|
0.70809999999999995 |
|
|
|
23376 |
|
|
G |
Immunoprin 100mg |
tbl flm 100x100 mg |
EBW |
AT |
66.667000000000002 |
38.49 |
38.49 |
I |
0 |
0 |
0 |
|
|
|
|
|
L04AX03 |
|
|
|
Metotrexát |
p.o. 2,5 mg (100 ks) |
1 |
mg |
|
|
|
|
|
|
|
|
4.8500000000000001E-2 |
|
|
|
43180 |
X |
|
O |
Methotrexate-Teva 2,5 mg |
tbl 100x2,5 mg |
PHM |
NL |
250 |
7.03 |
7.03 |
I |
0 |
0 |
0 |
DER, HEM, ONK, PED, REU |
|
|
|
|
64424 |
X |
|
G |
Trexan 2,5 mg |
tbl 100x2,5 mg |
ORN |
FI |
250 |
7.03 |
7.03 |
I |
0 |
0 |
0 |
DER, HEM, ONK, PED, REU |
|
|
|
|
L04AX04 |
|
|
|
Lenalidomid |
p.o. 10 mg (21 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
596.08000000000004 |
|
|
|
43534 |
|
|
O |
Revlimid 10 mg tvrdé kapsuly |
cps dur 21x10 mg |
CLG |
GB |
8.4 |
5007.05 |
5007.05 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L04AX04 |
|
|
|
Lenalidomid |
p.o. 15 mg (21 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
418.50200000000001 |
|
|
|
43535 |
|
|
O |
Revlimid 15 mg tvrdé kapsuly |
cps dur 21x15 mg |
CLG |
GB |
12.6 |
5273.12 |
5273.12 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
L04AX04 |
|
|
|
Lenalidomid |
p.o. 25 mg (21 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
269.17 |
|
|
|
43536 |
|
|
O |
Revlimid 25 mg tvrdé kapsuly |
cps dur 21x25 mg |
CLG |
GB |
21 |
5652.56 |
5652.56 |
I |
0 |
0 |
0 |
HEM, ONK |
ind.obm., ZP |
|
|
|
M01AB05 |
|
|
|
Diklofenak |
p.o. 150 mg (50 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
14135 |
X |
|
G |
DICLOBENE 150 MG RETARD |
tbl mod 50x150 mg |
MCK |
DE |
75 |
5 |
5 |
I |
0 |
0 |
0 |
|
|
|
|
U26 |
M01AB05 |
|
|
|
Diklofenak |
parent. 25 mg/ml (5 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.30499999999999999 |
|
|
|
27910 |
|
|
G |
VERAL 75 |
inj 5x3 ml |
HEO |
CZ |
3.7519999999999998 |
1.1299999999999999 |
1.1299999999999999 |
I |
0 |
0 |
0 |
|
|
|
|
|
M01CC01 |
|
|
|
Penicilamín |
p.o. 150 mg (50 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
1.01 |
|
|
|
66755 |
X |
|
G |
METALCAPTASE 150 |
tbl flm 50x150 mg |
KNO |
DE |
15 |
15.06 |
15.06 |
I |
0 |
0 |
0 |
DER, DIA, GER, GIT, INT, KLF, REU |
|
|
|
|
M01CC01 |
|
|
|
Penicilamín |
p.o. 300 mg (50 ks) |
0.5 |
g |
|
|
|
|
|
|
|
|
0.79 |
|
|
|
66753 |
X |
|
G |
METALCAPTASE 300 |
tbl flm 50x300 mg |
KNO |
DE |
30 |
23.31 |
23.31 |
I |
0 |
0 |
0 |
DER, DIA, GER, GIT, INT, KLF, REU |
|
|
|
|
M03AX01 |
|
|
|
Botulotoxín |
parent. 100 UT |
100 |
UT |
|
|
|
|
|
|
|
|
160.9 |
|
|
|
75241 |
|
|
O |
BOTOX |
plv ino 1x100 U |
ALL |
IE |
1 |
160.9 |
160.9 |
A |
0 |
0 |
0 |
NEU, OPH, URO |
ind.obm. |
|
|
|
M03AX01 |
|
|
|
Botulotoxín typu B |
parent. 5000 IU/ml (2 ml) |
10000 |
U |
|
|
|
|
|
|
|
|
247.09 |
|
|
|
42394 |
|
|
O |
NEUROBLOC |
sol inj 1x2 ml (5000 IU/ml) (skl. liek.) |
XEI-GB |
GB |
1 |
247.09 |
247.09 |
A |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
M04AA01 |
|
|
|
Allopurinol |
p.o. 300 mg (30 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.15 |
|
|
|
01710 |
X |
|
G |
MILURIT |
tbl 30x300 mg |
EGI |
HU |
22.5 |
3.3 |
3.3 |
I |
0 |
0 |
0 |
|
|
|
|
|
M05BA02 |
|
|
|
Kyselina klodrónová |
p.o. 400 mg (120 ks) |
1.6 |
g |
|
|
|
|
|
|
|
|
2.91 |
|
|
|
34954 |
X |
|
G |
SINDRONAT 400 mg |
cps 120x400 mg |
ACT-5 |
IS |
30 |
87.2 |
87.2 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
M05BA02 |
|
|
|
Kyselina klodrónová |
p.o. 800 mg (60 ks) |
1.6 |
g |
|
|
|
|
|
|
|
|
4.6399999999999997 |
|
|
|
56638 |
X |
|
O |
BONEFOS 800 MG |
tbl flm 60x800 mg |
BAY |
FI |
30 |
139.05000000000001 |
139.05000000000001 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
M05BA03 |
|
|
|
Kyselina pamidronová |
parent. 3mg/ml (časová dávka) (10 ml) |
60 |
mg |
|
|
|
|
|
|
|
|
86.68 |
|
|
|
99827 |
|
|
O |
Pamifos |
con inf 1x10 ml/30 mg |
MCW |
DE |
0.5 |
43.34 |
43.34 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, URK |
ind.obm. |
|
|
|
M05BA03 |
|
|
|
Kyselina pamidronová |
parent. 3 mg/ml (časová dávka) (20 ml) |
60 |
mg |
|
|
|
|
|
|
|
|
86.64 |
|
|
|
99838 |
|
|
O |
Pamifos |
con inf 1x20 ml/60 mg |
MCW |
DE |
1 |
86.64 |
86.64 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, URK |
ind.obm. |
|
|
|
M05BA03 |
|
|
|
Kyselina pamidronová |
parent. 3 mg/ml (časová dávka) (30 ml) |
60 |
mg |
|
|
|
|
|
|
|
|
86.653300000000002 |
|
|
|
99845 |
|
|
O |
Pamifos |
con inf 1x30 ml/90 mg |
MCW |
DE |
1.5 |
129.97999999999999 |
129.97999999999999 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, URK |
ind.obm. |
|
|
|
M05BA03 |
|
|
|
Kyselina pamidronová |
parent. 15mg/ml (časová dávka) (2 ml) |
60 |
mg |
|
|
|
|
|
|
|
|
80.98 |
|
|
|
91528 |
|
|
O |
PAMITOR 15 mg/ml |
con inf 1x2 ml/30 mg (PE) |
CHS-AT |
AT |
0.5 |
40.49 |
40.49 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, URK |
ind.obm. |
|
|
|
M05BA03 |
|
|
|
Kyselina pamidronová |
parent. 15 mg/ml (časová dávka) (6 ml) |
60 |
mg |
|
|
|
|
|
|
|
|
70.05 |
|
|
|
91533 |
|
|
O |
PAMITOR 15 mg/ml |
con inf 1x6 ml/90 mg (PE) |
CHS-AT |
AT |
1.5 |
105.08 |
105.08 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, URK |
ind.obm. |
|
|
|
M05BA06 |
|
|
|
Kyselina ibandrónová |
p.o. 50 mg (28-30 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
0.315 |
|
|
|
04857 |
X |
|
G |
Phacebonate 50 mg filmom obalené tablety |
tbl flm 30x50 mg (blis. PVC/PVDC/Al) |
PMT-SK |
SK |
375 |
118 |
118 |
I |
0 |
0 |
0 |
ONK, PLM |
ind.obm. |
|
|
|
41491 |
X |
|
O |
BONDRONAT 50 mg |
tbl flm 28x50 mg (blis. PVC/Alu) |
HLR |
GB |
350 |
110.14 |
110.14 |
I |
0 |
0 |
0 |
ONK, PLM |
ind.obm. |
|
|
|
M05BA06 |
|
|
|
Kyselina ibandrónová |
p.o. 50 mg (90 ks) |
4 |
mg |
|
|
|
|
|
|
|
|
0.315 |
|
|
|
04859 |
X |
|
G |
Phacebonate 50 mg filmom obalené tablety |
tbl flm 90x50 mg (blis. PVC/PVDC/Al) |
PMT-SK |
SK |
1125 |
354 |
354 |
I |
0 |
0 |
0 |
ONK, PLM |
ind.obm. |
|
|
|
M05BA06 |
|
|
|
Kyselina ibandrónová |
p.o. 150 mg (1 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.27400000000000002 |
|
|
|
23998 |
X |
|
G |
Flastin 150mg |
tbl flm 1x150mg (blis.Al/Al) |
EGI |
HU |
30 |
8.19 |
8.19 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
80851 |
X |
|
G |
Ibandronic Acid Mylan 150mg |
tbl flm 1x150mg |
GNC |
GB |
30 |
8.19 |
8.19 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
21935 |
X |
|
G |
Kyselina ibandrónová Sandoz 150mg filmom obalené tablety |
tbl flm 1x150mg (blis.PA/Al/PVC/Al) |
SAN |
SI |
30 |
8.19 |
8.19 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
23383 |
X |
|
G |
Kyselina ibandronová Teva |
tbl flm 1x150 mg (blister PVC/Aclar/PVC-Al) |
TVP-2 |
NL |
30 |
8.19 |
8.19 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
M05BA06 |
|
|
|
Kyselina ibandrónová |
p.o. 150 mg (3 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.27400000000000002 |
|
|
|
80852 |
X |
|
G |
Ibandronic Acid Mylan 150mg |
tbl flm 3x150mg |
GNC |
GB |
90 |
24.57 |
24.57 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
21936 |
X |
|
G |
Kyselina ibandrónová Sandoz 150mg filmom obalené tablety |
tbl flm 3x150mg (blis.PA/Al/PVC/Al) |
SAN |
SI |
90 |
24.57 |
24.57 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
23999 |
X |
|
G |
Flastin 150mg |
tbl flm 3x150mg (blis.Al/Al) |
EGI |
HU |
90 |
24.59 |
24.59 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
04917 |
X |
|
G |
Ibandronat Actavis 150 mg |
tbl flm 3x150 mg (blis. PVC/PVDC/Al) |
ACT-5 |
IS |
90 |
24.59 |
24.59 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
04652 |
X |
|
G |
Ibandronic acid STADA |
tbl flm 3x150 mg (blis.PVC/PVDC/Al) |
STD |
DE |
90 |
24.59 |
24.59 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
04587 |
X |
|
G |
Ikametin 150 mg |
tbl flm 3x150 mg (blis. PVC/PVDC/Al) |
GLM-CZ |
CZ |
90 |
24.59 |
24.59 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
23384 |
X |
|
G |
Kyselina ibandrónová Teva |
tbl flm 3x150 mg (blister PVC/Aclar/PVC-Al) |
TVP |
NL |
90 |
24.59 |
24.59 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
12439 |
X |
|
G |
Osagrand 150 mg filmom obalené tablety |
tbl flm 3x150 mg (blis.PVC/PVDC/Al) |
ZNT-1 |
CZ |
90 |
24.59 |
24.59 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
86922 |
X |
|
G |
OSSICA 150 mg |
tbl flm 3x150 mg |
GDN |
HU |
90 |
24.59 |
24.59 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
M05BA06 |
|
|
|
Kyselina ibandrónová |
parent. sol inj 3 mg |
4 |
mg |
|
|
|
|
|
|
|
|
46.89 |
|
|
|
35459 |
|
|
O |
Bonviva 3 mg/3 ml |
sol inj 1x3 ml |
HLR |
DE |
0.75 |
35.17 |
35.17 |
I |
0 |
0 |
0 |
END, ORT, REU |
ind.obm. |
|
|
|
0498A |
|
|
G |
Ibandronic acid Actavis 3 mg |
sol inj 1x3 ml/3 mg (striek.inj.napl.+1x inj.ihla) |
ACT-5 |
IS |
0.75 |
35.17 |
35.17 |
I |
0 |
0 |
0 |
END, ORT, REU |
ind.obm. |
|
|
|
2198A |
|
|
G |
Ibandronic acid STADA 3 mg |
sol inj 1x3 ml/3 mg (striek.inj.napl.skl.+1x inj.ihla) |
STD |
DE |
0.75 |
35.17 |
35.17 |
I |
0 |
0 |
0 |
END, ORT, REU |
ind.obm. |
|
|
|
2195A |
|
|
G |
Kyselina ibandrónová Sandoz 3 mg/3 ml |
sol inj 1x3 ml/3 mg (striek.inj.napl.skl.+1x inj. ihla) |
SAN |
SI |
0.75 |
35.17 |
35.17 |
I |
0 |
0 |
0 |
END, ORT, REU |
ind.obm. |
|
|
|
12444 |
|
|
G |
Osagrand 3 mg/3 ml injekčný roztok |
sol inj 1x3 ml (liek.skl.) |
ZNT-1 |
CZ |
0.75 |
35.17 |
35.17 |
I |
0 |
0 |
0 |
END, ORT, REU |
ind.obm. |
|
|
|
31552 |
|
|
G |
Ossica 3 mg injekčný roztok naplnený v injekčnej striekačke |
sol iru 1x3 ml/3 mg (striek.inj.napln.)+1x inj.ihla |
GDN |
HU |
0.75 |
35.17 |
35.17 |
I |
0 |
0 |
0 |
END, ORT, REU |
ind.obm. |
|
|
|
M05BA06 |
|
|
|
Kyselina ibandrónová |
parent. con inf 1mg/ml |
4 |
mg |
|
|
|
|
|
|
|
|
73.05 |
|
|
|
41493 |
|
|
O |
BONDRONAT 6 mg/6 ml |
con inf 1x6 ml (liek.skl.) |
HLR |
GB |
1.5 |
109.58 |
109.58 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, URK |
ind.obm. |
|
|
|
M05BA07 |
|
|
|
Kyselina risedrónová |
p.o. 35 mg (4 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
64147 |
X |
|
G |
Norifaz 35 mg |
tbl flm 4x35 mg |
ADD |
PL |
28 |
1.96 |
1.96 |
I |
0 |
0 |
0 |
END, GYN, INT, ORT, REU, KLF |
ind.obm. |
|
|
|
M05BA07 |
|
|
|
Kyselina risedrónová |
p.o. 35 mg (12 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
7.0000000000000007E-2 |
|
|
|
64148 |
X |
|
G |
Norifaz 35 mg |
tbl flm 12(3x4)x35 mg |
ADD |
PL |
84 |
5 |
5 |
I |
0 |
0 |
0 |
END, GYN, INT, ORT, REU, KLF |
ind.obm. |
|
|
|
M05BA08 |
|
|
|
Kyselina zoledrónová |
parent. 0,05 mg/ml |
5 |
mg |
|
|
|
|
|
|
|
|
236.31 |
|
|
|
90197 |
|
|
O |
Aclasta 5 mg |
sol inf 1x 100 ml/5mg |
NEH |
GB |
1 |
236.31 |
236.31 |
I |
0 |
0 |
0 |
END, INT, KLF, ORT, REU |
ind.obm. |
|
|
|
M05BA08 |
|
|
|
Kyselina zoledrónová |
parent. |
4 |
mg |
|
|
|
|
|
|
|
|
68.62 |
|
|
|
6835A |
|
|
G |
Fayton 4 mg/100 ml infúzny roztok |
sol inf 1x100 ml/4 mg (liek.inj.plast.) |
GLM-CZ |
CZ |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
1837A |
|
|
G |
FAYTON 4 mg/5 ml |
con inf 1x5 ml/4 mg (liek.inj.plast.) |
GLM |
CR |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
1488A |
|
|
G |
Kyselina zoledrónová Sandoz 4 mg/100 ml infúzny roztok |
sol inf 1x4 mg/100 ml (fľ.inf.plast.) |
SAN |
SI |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
1485A |
|
|
G |
Kyselina zoledrónová Sandoz 4 mg/5 ml infúzny koncentrát |
con inf 1x4 mg/5 ml (liek.inj.plast.) |
SAN |
SI |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
2363A |
|
|
G |
Osporil 4mg/5ml infúzny koncentrát |
con inf 1x5ml/4mg (liek.inj.skl.) |
EGI |
HU |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
2361A |
|
|
G |
Zoledronat STADA |
con inf 1x5 ml/4 mg (liek.inj.plast.) |
STD |
DE |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
1224A |
|
|
G |
Zoledronic acid Actavis 4 mg/5 ml infúzny koncentrát |
con inf 1x5 ml/4 mg (liek.inj.plast) |
ACT-5 |
IS |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
3723A |
|
|
G |
Zoledronic acid Hospira 4 mg/100 ml infúzny roztok |
sol inf 1x100 ml/4 mg (vak PP/PP) |
HSP |
GB |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
7005A |
|
|
G |
Zoledronic acid Mylan 4 mg/100ml infúzny roztok |
sol inf 1 x 100ml/4mg(liek.inj.skl.), parent |
MYL |
FR |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
2540A |
|
|
G |
Zoledronic acid Mylan 4mg/5ml infúzny koncentrát |
con inf 1 x 5 ml/4 mg (liek.inj.skl.) |
MLB-F |
FR |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
3583A |
|
|
G |
Zoledronic acid Pharmacenter 4 mg/5 ml infúzny koncentrát |
con inf 1x5 ml/4 mg (liek.inj.plast.) |
PMT-SK |
SK |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
6034A |
|
|
G |
ZOLEMED 4 mg/5 ml |
con. Inf. 1 x 5 ml/4 mg (liek.inj.polymér) |
CRR |
SK |
1 |
68.62 |
68.62 |
I |
0 |
0 |
0 |
HEM, ONK, ORT, PLM, TRN, URK |
ind.obm. |
|
|
|
N01AB08 |
|
|
|
Sevofluran |
inhal. 100% |
100 |
ml |
|
|
|
|
|
|
|
|
44.05 |
|
|
|
13024 |
|
|
O |
SEVORANE |
vap inl 1x250 ml (PEN fľa.) |
ABV |
SK |
2.5 |
110.13 |
110.13 |
A |
0 |
0 |
0 |
ANS |
ind.obm. |
|
|
|
N01AX03 |
|
|
|
Ketamin |
parent. 50 mg/ml |
100 |
mg |
|
|
|
|
|
|
|
|
0.97 |
|
|
|
87814 |
|
|
G |
CALYPSOL |
inj 5x10 ml/500 mg |
GDN |
HU |
25 |
24.15 |
24.15 |
A |
0 |
0 |
0 |
ANS |
ind.obm. |
|
|
|
N01BB |
|
|
|
Amidy a anilidy |
parent. trimekain 10 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.125 |
|
|
|
00502 |
|
|
G |
MESOCAIN |
inj 10x10 ml 1% |
ZNT |
CZ |
100 |
11.76 |
11.76 |
A |
0 |
0 |
0 |
|
|
|
|
U33 |
N01BB01 |
|
|
|
Bupivakaín |
parent. 5 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.125 |
|
|
|
25043 |
|
|
O |
MARCAINE 0,5% |
inj 5x20 ml 0,5% |
AZC |
SE |
100 |
12.08 |
12.08 |
A |
0 |
0 |
0 |
|
|
|
|
U33 |
N01BX04 |
|
|
|
Kapsaicín 8% |
transd. 179 mg (1 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
244.95 |
|
|
|
76786 |
|
|
O |
Qutenza |
emp der 1x179 mg |
ASL |
NL |
1 |
244.95 |
244.95 |
A |
0 |
0 |
0 |
AGG, NEU |
ind.obm. |
|
|
|
N02AA01 |
|
§ |
|
Morfín |
p.o. 10 mg (60 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
2.66 |
|
|
|
92282 |
|
|
O |
Sevredol 10 mg |
tbl flm 60x10 mg |
MUP |
DE |
6 |
15.9 |
15.9 |
I |
0 |
0 |
0 |
|
|
|
|
U90 |
N02AA01 |
|
§ |
|
Morfín |
p.o. 100 mg (60 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.81200000000000006 |
|
|
|
94312 |
|
|
O |
MST CONTINUS 100 MG |
tbl mod 60x100 mg |
MUP |
AT |
60 |
48.67 |
48.67 |
I |
0 |
0 |
0 |
|
|
|
|
U34 |
N02AA01 |
|
§ |
|
Morfín |
parent. 10 mg/ml (1 ml) |
30 |
mg |
|
|
|
|
|
|
|
|
1.0788 |
|
|
|
01125 |
|
|
G |
MORPHIN BIOTIKA 1% |
inj 10x1 ml/10 mg |
HBS |
SK |
3.3330000000000002 |
3.59 |
3.59 |
I |
0 |
0 |
0 |
|
|
|
|
|
N02AA01 |
|
§ |
|
Morfín |
parent. 10 mg/ml (2 ml) |
30 |
mg |
|
|
|
|
|
|
|
|
0.624 |
|
|
|
01127 |
|
|
G |
MORPHIN BIOTIKA 1% |
inj 10x2 ml/20 mg |
HBS |
SK |
6.6669999999999998 |
4.16 |
4.16 |
I |
0 |
0 |
0 |
|
|
|
|
|
N02AA03 |
|
§ |
|
Hydromorfón |
p.o. 4 mg (60 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.74 |
|
|
|
92283 |
|
|
O |
Palladone-SR capsules 4 mg |
cps pld 60x4 mg |
MUP |
DE |
12 |
44.85 |
44.85 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AA03 |
|
§ |
|
Hydromorfón |
p.o. 8 mg (60 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.8 |
|
|
|
92284 |
|
|
O |
Palladone-SR capsules 8 mg |
cps pld 60x8 mg |
MUP |
DE |
24 |
91.16 |
91.16 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AA03 |
|
§ |
|
Hydromorfón |
p.o. 16 mg (60 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.2250000000000001 |
|
|
|
92285 |
|
|
O |
Palladone-SR capsules 16 mg |
cps pld 60x16 mg |
MUP |
DE |
48 |
154.74 |
154.74 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AA05 |
|
§ |
|
Oxykodón |
p.o. 10 mg (56-60 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
51288 |
|
|
G |
Contiroxil 10 mg tablety s predĺženým uvoľňovaním |
tbl plg 56x10 mg (blister) |
SAN |
SI |
18.666 |
15.81 |
15.81 |
I |
0 |
0 |
0 |
|
|
|
|
U35 |
89756 |
|
|
G |
Oxypro 10 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x10 mg (blis.PVC/PVDC/Al) |
GLH |
AT |
20 |
16.940000000000001 |
16.940000000000001 |
I |
0 |
0 |
0 |
|
|
|
|
U35 |
N02AA05 |
|
§ |
|
Oxykodón |
p.o. 20 mg (56-60 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
51317 |
|
|
G |
Contiroxil 20mg tablety s predĺženým uvoľňovaním |
tbl plg 56x20mg (blister) |
SAN |
SI |
37.332999999999998 |
31.63 |
31.63 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
U35 |
89786 |
|
|
G |
Oxypro 20 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x20 mg (blis.PVC/PVDC/Al) |
GLH |
AT |
40 |
33.89 |
33.89 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
U35 |
N02AA05 |
|
§ |
|
Oxykodón |
p.o. 40 mg (56-60 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
2422A |
|
|
G |
Contiroxil 40mg tablety s predĺženým uvoľňovaním |
tbl plg 56x40mg (blisPVC/PE/PVDC) |
SAN |
SI |
74.665999999999997 |
63.25 |
63.25 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
U35 |
89839 |
|
|
G |
Oxypro 40 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x40 mg (blis.PVC/PVDC/Al) |
GLH |
AT |
80 |
67.77 |
67.77 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
U35 |
N02AA05 |
|
§ |
|
Oxykodón |
p.o. 80 mg (56-60 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
2440A |
|
|
G |
Contiroxil 80mg tablety s predĺženým uvoľňovaním |
tbl plg 56x80mg (blisPVC/PE/PVDC) |
SAN |
SI |
149.333 |
126.5 |
126.5 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
U35 |
89806 |
|
|
G |
Oxypro 80 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x80 mg (blis. PVC/PVDC/Al) |
GLH |
AT |
160 |
135.54 |
135.54 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
U35 |
N02AB02 |
|
§ |
|
Petidín |
parent. 50mg/ ml (1 ml) |
0.4 |
g |
|
|
|
|
|
|
|
|
2.8879000000000001 |
|
|
|
02715 |
|
|
G |
DOLSIN |
inj 10x1 ml 5% |
HBS |
SK |
1.25 |
3.61 |
3.61 |
I |
0 |
0 |
0 |
|
|
|
|
|
N02AB02 |
|
§ |
|
Petidín |
parent. 50 mg/ ml (2 ml) |
0.4 |
g |
|
|
|
|
|
|
|
|
1.8355999999999999 |
|
|
|
02716 |
|
|
G |
DOLSIN |
inj 10x2 ml 5% |
HBS |
SK |
2.5 |
4.58 |
4.58 |
I |
0 |
0 |
0 |
|
|
|
|
|
N02AB03 |
|
§ |
|
Fentanyl |
p.o. flm. buc. 200 mcg (10 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
02492 |
|
|
G |
Breakyl 200 mikrogramov |
flm buc 10x200 µg (vrecko PAN/Al/PA/lamin.pap.) |
MDM |
DE |
10 |
55.38 |
55.38 |
I |
0 |
0 |
0 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 100 mcg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
50478 |
|
|
O |
Effentora 100 mikrogramov bukálne tablety |
tbl buc 28x100 µg (blis.PVC/Al/PA/PVC) |
TVP-2 |
NL |
28 |
155.06 |
155.06 |
I |
0 |
0 |
0 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 200 mcg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 400 mcg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 600 mcg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 800 mcg (28 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
N02AB03 |
|
§ |
|
Fentanyl |
p.o. 100 mcg (4 ks) |
1 |
DF |
|
|
|
|
|
|
|
|
5.54 |
|
|
|
71895 |
|
|
O |
LUNALDIN 100 mikrogramov |
tbl slg 30 x 100 ug |
GDN |
HU |
30 |
166.14 |
166.14 |
I |
0 |
0 |
0 |
AGG, NEU, ONK |
ind.obm. |
|
|
U36 |
N02AB03 |
|
§ |
|
Fentanyl |
transd. 12 mcg/h |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.9 |
|
|
|
44195 |
|
|
G |
Fentanyl-ratiopharm 12µg/h, |
emp tdm 5x12µg/h, |
RAT |
DE |
7.5 |
6.72 |
6.72 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU, URK |
ind.obm. |
|
|
|
N02AB03 |
|
§ |
|
Fentanyl |
transd. 25 mcg/h (5 ks) |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.89 |
|
|
|
36318 |
|
|
G |
Fentanyl Actavis 25 µg/h transdermálna náplasť |
emp tdm 5x25 µg/h |
ACT-5 |
IS |
15 |
13.24 |
13.24 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
38291 |
|
|
G |
Fentanyl Sandoz 25 µg/h matrix transdermálna náplasť |
emp tdm 5x25 µg/ 1h |
SAN |
SI |
15 |
13.24 |
13.24 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
36302 |
|
|
G |
Fentanyl-ratiopharm 25 mcg/h |
emp tdm 5x25 mcg/h |
RAT |
DE |
15 |
13.24 |
13.24 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
N02AB03 |
|
§ |
|
Fentanyl |
transd. 50 mcg/h (5 ks) |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.621 |
|
|
|
36322 |
|
|
G |
Fentanyl Actavis 50 µg/h transdermálna náplasť |
emp tdm 5x50 µg/h |
ACT-5 |
IS |
30 |
18.63 |
18.63 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
38295 |
|
|
G |
Fentanyl Sandoz 50 µg/h matrix transdermálna náplasť |
emp tdm 5 x 50 µg/ 1h |
SAN |
SI |
30 |
18.63 |
18.63 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
36306 |
|
|
G |
Fentanyl-ratiopharm 50 mcg/h |
emp tdm 5x50 mcg/h |
RAT |
DE |
30 |
18.63 |
18.63 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
N02AB03 |
|
§ |
|
Fentanyl |
transd. 75 mcg/h (5 ks) |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.755 |
|
|
|
36310 |
|
|
G |
Fentanyl ratiopharm 75 ug/h |
emp tdm 5x75 ug/1h |
RAT |
DE |
45 |
33.97 |
33.97 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU, URK |
ind.obm. |
|
|
|
38299 |
|
|
G |
Fentanyl Sandoz 75 µg/h matrix transdermálna náplasť |
emp tdm 5x75 µg/ 1h |
SAN |
SI |
45 |
33.97 |
33.97 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU, URK |
ind.obm. |
|
|
|
N02AB03 |
|
§ |
|
Fentanyl |
transd. 100 mcg/h (5 ks) |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.63 |
|
|
|
36330 |
|
|
G |
Fentanyl Actavis 100 µg/h transdermálna náplasť |
emp tdm 5x100 µg/h |
ACT-5 |
IS |
60 |
37.39 |
37.39 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
38303 |
|
|
G |
Fentanyl Sandoz 100 µg/h matrix transdermálna náplasť |
emp tdm 5x100 µg/ 1h |
SAN |
SI |
60 |
37.409999999999997 |
37.409999999999997 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
36314 |
|
|
G |
Fentanyl-ratiopharm 100 mcg/h |
emp tdm 5x100 mcg/h |
RAT |
DE |
60 |
37.409999999999997 |
37.409999999999997 |
I |
0 |
0 |
0 |
AGG, NEU, ONK,REU,ORT, URK |
ind.obm. |
|
|
|
N02AE01 |
|
§ |
|
Buprenorfín |
transd. nápl.35 mcg |
1 |
DF |
|
|
|
|
|
|
|
|
5.3810000000000002 |
|
|
|
42755 |
|
|
O |
TRANSTEC 35MCG/H |
emp tdm 5X20MG |
GNG |
DE |
5 |
26.91 |
26.91 |
I |
0 |
0 |
0 |
AGG,NEU,ONK,REU,ORT |
ind.obm. |
|
|
|
N02AE01 |
|
§ |
|
Buprenorfín |
transd. nápl. 52,5 mcg |
1 |
DF |
|
|
|
|
|
|
|
|
7.56 |
|
|
|
42758 |
|
|
O |
TRANSTEC 52.5MCG/H |
emp tdm 5X30MG |
GNG |
DE |
5 |
37.76 |
37.76 |
I |
0 |
0 |
0 |
AGG,NEU,ONK,REU,ORT |
ind.obm. |
|
|
|
N02AE01 |
|
§ |
|
Buprenorfín |
transd. nápl. 70 mcg |
1 |
DF |
|
|
|
|
|
|
|
|
9.69 |
|
|
|
42761 |
|
|
O |
TRANSTEC 70MCG/H |
emp tdm 5X40MG |
GNG |
DE |
5 |
48.41 |
48.41 |
I |
0 |
0 |
0 |
AGG,NEU,ONK,REU,ORT |
ind.obm. |
|
|
|
N02AX02 |
|
|
|
Tramadol |
p.o. predĺžené uvoľňovanie 100 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.48299999999999998 |
|
|
|
93330 |
X |
|
G |
Mabron Retard 100 |
tbl plg 30x100 mg |
MOE |
CY |
10 |
4.83 |
4.83 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
3606A |
X |
|
G |
Tramadol Mylan 100 mg |
tbl plg 30x100 mg blis(Al/PVC/PE/PVDC) |
GNS |
GB |
10 |
4.83 |
4.83 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
43087 |
X |
|
G |
Tramadol Retard Actavis 100 mg |
tbl plg 30 x 100 mg |
ACT |
IS |
10 |
4.83 |
4.83 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
26883 |
X |
|
O |
TRAMAL RETARD 100 |
tbl plg 30x100 mg |
GRU |
DE |
10 |
4.83 |
4.83 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
N02AX02 |
|
|
|
Tramadol |
p.o. predĺžené uvoľňovanie 150 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.48299999999999998 |
|
|
|
93335 |
X |
|
G |
Mabron Retard 150 |
tbl plg 30x150 mg |
MOE |
CY |
15 |
7.24 |
7.24 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
3627A |
X |
|
G |
Tramadol Mylan 150 mg |
tbl plg 30x150 mg(blis. Al/PVC/PE/PVDC) |
GNS |
GB |
15 |
7.24 |
7.24 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
43119 |
X |
|
G |
Tramadol Retard Actavis 150 mg |
tbl plg 30 x 150 mg |
ACT |
IS |
15 |
7.24 |
7.24 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
56844 |
X |
|
O |
TRAMAL RETARD 150 |
tbl plg 30x150 mg |
GRU |
DE |
15 |
7.24 |
7.24 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
N02AX02 |
|
|
|
Tramadol |
p.o. predĺžené uvoľňovanie 200 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.48299999999999998 |
|
|
|
43149 |
X |
|
G |
Tramadol Retard Actavis 200mg |
tbl plg 30 x 200 mg |
ACT |
IS |
20 |
9.65 |
9.65 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
93336 |
X |
|
G |
Mabron Retard 200 |
tbl plg 30x200 mg |
MOE |
CY |
20 |
9.66 |
9.66 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
3648A |
X |
|
G |
Tramadol Mylan 200mg |
tbl plg 30x200 mg (blis.Al/PVC/PE/PVDC) |
GNS |
GB |
20 |
9.66 |
9.66 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
56847 |
X |
|
O |
TRAMAL RETARD 200 |
tbl plg 30x200 mg |
GRU |
DE |
20 |
9.66 |
9.66 |
I |
0 |
0 |
0 |
|
|
|
|
U37 |
N02AX06 |
|
§ |
|
Tapentadol |
p.o. predĺžené uvoľňovanie 250 mg (60 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
5.49 |
|
|
|
23752 |
|
|
O |
PALEXIA retard 250 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x250 mg (blis.PVC/PVDC/Al/papier/PET) |
GRU |
DE |
30 |
164.46 |
164.46 |
I |
0 |
0 |
0 |
AGG, NEU, ONK, ORT, REU |
ind.obm. |
|
|
|
N02AX52 |
|
|
|
Tramadol, kombinácie |
p.o. 37,5/325 mg (30 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
0.191 |
|
|
|
2239B |
|
|
G |
Doletam 37,5 mg/325 mg |
tbl flm 30x37,5 mg/325 mg (blis.PVC/PVDC/Al) |
GLM-CZ |
CZ |
15 |
2.86 |
2.86 |
I |
0 |
0 |
0 |
|
|
|
|
U38 |
31960 |
|
|
G |
Tramcet 37,5 mg/325 mg tablety |
tbl 30x37,5 mg/325 mg (blis.PVC/PVDC/Al) |
ICN-PL |
PL |
15 |
2.86 |
2.86 |
I |
0 |
0 |
0 |
|
|
|
|
U38 |
31872 |
|
|
G |
Tramylpa 37,5 mg/325 mg |
tbl flm 30x37,5 mg/325 mg (blis.PVC/PVDC/Al) |
GNS |
UK |
15 |
2.86 |
2.86 |
I |
0 |
0 |
0 |
|
|
|
|
U38 |
00112 |
|
|
G |
Zaracet |
tbl flm 30x37,5 mg/325 mg |
BLU |
SR |
15 |
2.86 |
2.86 |
I |
0 |
0 |
0 |
|
|
|
|
U38 |
N02BB02 |
|
|
|
Metamizol, sodná soľ |
parent. 500 mg/ml (5 ml) |
3 |
g |
|
|
|
|
|
|
|
|
0.72499999999999998 |
|
|
|
24530 |
|
|
O |
NOVALGIN |
inj 5x5 ml 500 mg/ ml |
HBS |
SK |
4.1689999999999996 |
2.99 |
2.99 |
I |
0 |
0 |
0 |
|
|
|
|
|
N02CC01 |
|
|
|
Sumatriptan |
parent. 12 mg/ml |
6 |
mg |
|
|
|
|
|
|
|
|
14.55 |
|
|
|
96535 |
|
|
O |
IMIGRAN |
inj 2x0,5 ml |
GWE |
GB |
2 |
29.1 |
29.1 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N03AB02 |
|
|
|
Fenytoín |
p.o. 100 mg (100 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.11 |
|
|
|
62234 |
|
|
O |
EPILAN D GEROT |
tbl 100x100 mg |
GER |
AT |
33.347999999999999 |
3.19 |
3.19 |
I |
0 |
0 |
0 |
|
|
|
|
|
N03AE01 |
|
|
|
Klonazepam |
p.o. 2 mg (30 ks) |
8 |
mg |
|
|
|
|
|
|
|
|
0.32 |
|
|
|
03032 |
|
|
O |
Rivotril 2 mg |
tbl 30x2 mg |
HLR |
CH |
7.5 |
1.6 |
1.6 |
I |
0 |
0 |
0 |
NEU, PSY, AGG |
|
|
|
|
N03AF01 |
|
|
|
Karbamazepín |
p.o. predĺžené uvoľňovanie 150 mg (50 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.92610000000000003 |
|
|
|
71954 |
|
|
G |
TIMONIL RETARD |
tbl plg 50x150 mg |
DET |
DE |
7.5 |
3.61 |
3.61 |
I |
0 |
0 |
0 |
AGG, NEU, PSY |
|
|
|
|
N03AF01 |
|
|
|
Karbamazepín |
p.o. predĺžené uvoľňovanie 200 mg (50 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.45 |
|
|
|
92039 |
|
|
O |
TEGRETOL CR 200 |
tbl mod 50x200 mg |
XNT |
IT |
10 |
4.5 |
4.5 |
I |
0 |
0 |
0 |
DIA, NEU, PSY |
|
|
|
|
N03AF01 |
|
|
|
Karbamazepín |
p.o. predĺžené uvoľňovanie 400 mg (30 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.45 |
|
|
|
93619 |
|
|
O |
TEGRETOL CR 400 |
tbl mod 30x400 mg |
XNT |
IT |
12 |
5.39 |
5.39 |
I |
0 |
0 |
0 |
DIA, NEU, PSY |
|
|
|
|
N03AF01 |
|
|
|
Karbamazepín |
p.o. predĺžené uvoľňovanie 600 mg (50 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.31 |
|
|
|
60166 |
|
|
G |
TIMONIL RETARD |
tbl plg 50x600 mg |
DET |
DE |
30 |
8.6300000000000008 |
8.6300000000000008 |
I |
0 |
0 |
0 |
DIA, NEU, PSY |
|
|
|
|
N03AF03 |
|
|
|
Rufinamid |
p.o. 200 mg (50 ks) |
1600 |
mg |
|
|
|
|
|
|
|
|
8.7319999999999993 |
|
|
|
37873 |
|
|
O |
Inovelon 200 mg filmom obalené tablety |
tbl flm 50x200 mg |
XEI-GB |
GB |
6.25 |
54.58 |
54.58 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AF03 |
|
|
|
Rufinamid |
p.o. 400 mg (50 ks) |
1600 |
mg |
|
|
|
|
|
|
|
|
8.3450000000000006 |
|
|
|
37878 |
|
|
O |
Inovelon 400 mg filmom obalené tablety |
tbl flm 50x400 mg |
XEI-GB |
GB |
12.5 |
104.31 |
104.31 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AF04 |
|
|
|
Eslikarbazepín acetát |
p.o. 800 mg (30 ks) |
800 |
mg |
|
|
|
|
|
|
|
|
3.1749999999999998 |
|
|
|
75833 |
|
|
O |
Zebinix 800 mg |
tbl 30x800 mg (blister PVC/Al) |
BIAL |
PT |
30 |
95.24 |
95.24 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AG01 |
|
|
|
Kyselina valproová |
p.o. 300 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.39 |
|
|
|
08769 |
|
|
G |
Convulex 300 mg kapsuly |
cps 100x300 mg |
GER |
AT |
20 |
7.56 |
7.56 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
N03AG01 |
|
|
|
Kyselina valproová |
p.o. predĺžené uvoľňovanie 500 mg (30 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.39 |
|
|
|
11853 |
|
|
O |
DEPAKINE CHRONO 500MG |
tbl flp 30x500 mg |
SWA |
FR |
10 |
3.88 |
3.88 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
N03AG01 |
|
|
|
Kyselina valproová |
p.o. predĺžené uvoľňovanie 500 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.39 |
|
|
|
36737 |
|
|
G |
Valpro-ratiopharm Chrono 500 mg |
tbl plg 100x500mg |
RAT |
DE |
33.332999999999998 |
13 |
13 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
N03AG01 |
|
|
|
Kyselina valproová |
p.o.57,64 mg/ml |
1.5 |
g |
|
|
|
|
|
|
|
|
0.77 |
|
|
|
15412 |
|
|
O |
DEPAKINE |
sir 1x150 ml |
SNW |
FR |
5.76 |
4.37 |
4.37 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
N03AG01 |
|
|
|
Kyselina valproová |
p.o. 300 mg/ml |
1.5 |
g |
|
|
|
|
|
|
|
|
0.77010000000000001 |
|
|
|
08770 |
|
|
G |
Convulex 300 mg/ml kvapky |
gtt por 100 ml |
GER |
AT |
20 |
15.37 |
15.37 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
N03AX09 |
|
|
|
Lamotrigín |
p.o. 25 mg (28-30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.8 |
|
|
|
46235 |
|
|
G |
MEDOTRIGIN 25 mg |
tbl 30x25 mg |
MOE |
CY |
2.5 |
1.99 |
1.99 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N03AX09 |
|
|
|
Lamotrigín |
p.o. 50 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.73 |
|
|
|
46239 |
|
|
G |
MEDOTRIGIN 50 mg |
tbl 30x50 mg |
MOE |
CY |
5 |
3.62 |
3.62 |
I |
0 |
0 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
92684 |
|
|
G |
Lamotrigin Actavis 50mg |
tbl dsp 30 x 50mg |
ACT |
IS |
5 |
3.65 |
3.65 |
I |
0 |
0 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
N03AX09 |
|
|
|
Lamotrigín |
p.o. 50 mg (98 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.73 |
|
|
|
78350 |
|
|
G |
Lamictal 50 mg tablety |
tbl 98x50 mg (blis.PVC/Al) |
GAG |
SK |
16.332999999999998 |
10.68 |
10.68 |
I |
0 |
0 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
N03AX09 |
|
|
|
Lamotrigín |
p.o. 100 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.61499999999999999 |
|
|
|
92706 |
|
|
G |
Lamotrigin Actavis 100mg |
tbl dsp 30x100mg |
ACT |
DK |
10 |
6.14 |
6.14 |
I |
0 |
0 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
N03AX09 |
|
|
|
Lamotrigín |
p.o. 100 mg (98-100 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.61499999999999999 |
|
|
|
92713 |
|
|
G |
Lamotrigin Actavis 100mg |
tbl dsp 100 x 100mg |
ACT |
IS |
33.33 |
20.47 |
20.47 |
I |
0 |
0 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
46245 |
|
|
G |
MEDOTRIGIN 100 mg |
tbl 100x100 mg |
MOE |
CY |
33.332999999999998 |
20.49 |
20.49 |
I |
0 |
0 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
N03AX11 |
|
|
|
Topiramát |
p.o. 25 mg (60 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
1.288 |
|
|
|
53359 |
|
|
G |
Erravia 25 mg |
tbl flm 60X25 mg(blister) |
PRW |
CZ |
5 |
6.43 |
6.43 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
83244 |
|
|
G |
Talopam 25 mg |
tbl flm 60x25 mg (blis.Al/Al) |
ACT |
IS |
5 |
6.43 |
6.43 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
52033 |
|
|
G |
Topilex 25 mg |
tbl flm 60x 25 mg (bli.ppd) |
LAR |
AT |
5 |
6.43 |
6.43 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX11 |
|
|
|
Topiramát |
p.o. 50 mg (60 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.88400000000000001 |
|
|
|
53362 |
|
|
G |
Erravia 50 mg |
tbl flm 60X50 mg (blister) |
PRW |
CZ |
10 |
8.84 |
8.84 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
83256 |
|
|
G |
Talopam 50 mg |
tbl flm 60x50 mg (blis.Al/Al) |
ACT |
IS |
10 |
8.84 |
8.84 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
52014 |
|
|
G |
Topilex 50 mg |
tbl flm 60x 50 mg (bli.ppd) |
LAR |
AT |
10 |
8.84 |
8.84 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
50805 |
|
|
G |
Topimark 50 mg |
tbl flm 60x50 mg (blis.Al/Al) |
GLM-CZ |
CZ |
10 |
8.84 |
8.84 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX11 |
|
|
|
Topiramát |
p.o. 100 mg (60 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
1.05 |
|
|
|
53345 |
|
|
G |
Erravia 100 mg |
tbl flm 60X100 mg (blister) |
PRW |
CZ |
20 |
20.94 |
20.94 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
83271 |
|
|
G |
Talopam 100 mg |
tbl flm 60x100 mg (blis.Al/Al) |
ACT |
IS |
20 |
20.94 |
20.94 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
52027 |
|
|
G |
Topilex 100 mg |
tbl flm 60x 100 mg (bli.ppd) |
LAR |
AT |
20 |
20.94 |
20.94 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
50826 |
|
|
G |
Topimark 100 mg |
tbl flm 60x100 mg (blis.Al/Al) |
GLM-CZ |
CZ |
20 |
20.94 |
20.94 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX11 |
|
|
|
Topiramát |
p.o. 100 mg (120 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
1.05 |
|
|
|
50830 |
|
|
G |
Topimark 100 mg |
tbl flm 120x100 mg (blis.Al/Al) |
GLM-CZ |
CZ |
40 |
42 |
42 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX12 |
|
|
|
Gabapentín |
p.o. 100 mg (100 ks) |
1.8 |
g |
|
|
|
|
|
|
|
|
1.26 |
|
|
|
91364 |
|
|
G |
Gabapentin-Teva 100mg |
cps dur 100x100mg |
PHM |
NL |
5.556 |
6.93 |
6.93 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
N03AX12 |
|
|
|
Gabapentín |
p.o. 300 mg (50-60 ks) |
1.8 |
g |
|
|
|
|
|
|
|
|
0.82 |
|
|
|
68687 |
|
|
G |
Grimodin 300 mg tvrdé kapsuly |
cps dur 60x300 mg |
EGI |
HU |
10 |
8.18 |
8.18 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
91373 |
|
|
G |
Gabapentin-Teva 300mg |
cps dur 50x300mg |
PHM |
NL |
8.3330000000000002 |
6.82 |
6.82 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
N03AX12 |
|
|
|
Gabapentín |
p.o. 300 mg (100-120 ks) |
1.8 |
g |
|
|
|
|
|
|
|
|
0.82 |
|
|
|
76928 |
|
|
G |
Grimodin 300 mg tvrdé kapsuly |
cps dur 120x300 mg (blis.PVCI/PVDC/AI) |
EGI |
HU |
20 |
16.36 |
16.36 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
N03AX12 |
|
|
|
Gabapentín |
p.o. 400 mg (50-60 ks) |
1.8 |
g |
|
|
|
|
|
|
|
|
1.05 |
|
|
|
68686 |
|
|
G |
Grimodin 400 mg tvrdé kapsuly |
cps dur 60x400 mg |
EGI |
HU |
13.333 |
13.8 |
13.8 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
91383 |
|
|
G |
Gabapentin-Teva 400mg |
cps dur 50x400mg |
PHM |
NL |
11.111000000000001 |
11.51 |
11.51 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
84401 |
|
|
O |
NEURONTIN 400 mg tvrdé kapsuly |
cps dur 50x400 mg (blis.PVC/PVDC/Al) |
PFI-GB-1 |
GB |
11.111000000000001 |
11.67 |
11.67 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
N03AX12 |
|
|
|
Gabapentín |
p.o. 400 mg (200 ks) |
1.8 |
g |
|
|
|
|
|
|
|
|
1.05 |
|
|
|
47422 |
|
|
G |
Gabagamma 400 |
cps dur 200x400mg (blis.) |
WGP |
DE |
44.444000000000003 |
46.67 |
46.67 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
N03AX12 |
|
|
|
Gabapentín |
p.o. 600 mg (50-60 ks) |
1.8 |
g |
|
|
|
|
|
|
|
|
1.2410000000000001 |
|
|
|
91407 |
|
|
G |
Gabapentin-Teva 600mg |
tbl flm 50x600mg |
PHM |
NL |
16.667000000000002 |
20.67 |
20.67 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
N03AX12 |
|
|
|
Gabapentín |
p.o. 800 mg (50 ks) |
1.8 |
g |
|
|
|
|
|
|
|
|
1.2 |
|
|
|
65370 |
|
|
G |
Gabagamma 800 mg filmom obalené tablety |
tbl flm 50x800 mg |
WGP |
DE |
22.222000000000001 |
26.42 |
26.42 |
I |
0 |
0 |
0 |
AGG, DIA, NEU |
|
|
|
|
N03AX14 |
|
|
|
Levetiracetam |
p.o. 250 mg (30 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.79900000000000004 |
|
|
|
N03AX14 |
|
|
|
Levetiracetam |
p.o. 250 mg (50-60 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.79900000000000004 |
|
|
|
10908 |
|
|
G |
Epiletam 250 mg |
tbl flm 60x250 mg (blis.Al/PVC/PE/PVDC) |
EGI |
HU |
10 |
7.98 |
7.98 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
07343 |
|
|
G |
LEVEMED 250 mg |
tbl flm 50x250 mg (blis.PVC/PE/PVDC/Al) |
CRR |
SK |
8.3330000000000002 |
6.66 |
6.66 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
12357 |
|
|
G |
Levetiracetam Accord 250 mg filmom obalené tablety |
tbl flm 50x250 mg (blis.PVC/Al) |
ACC |
GB |
8.3330000000000002 |
6.66 |
6.66 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
32383 |
|
|
G |
Levetiracetam STADA 250 mg |
tbl flm 50x250 mg (blis.PVC/Al) |
STD |
DE |
8.3330000000000002 |
6.66 |
6.66 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
3769A |
|
|
G |
PTEROCYN 250 mg |
tbl flm 50x250 mg (blis.Al/PVC/PE/PVDC) |
SVS |
CZ |
8.3330000000000002 |
6.66 |
6.66 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX14 |
|
|
|
Levetiracetam |
p.o. 250 mg (100 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.79900000000000004 |
|
|
|
12085 |
|
|
G |
Levetiracetam Actavis 250 mg filmom obalené tablety |
tbl flm 100x250 mg (blis.Al/PVC) |
ACT-5 |
IS |
16.667000000000002 |
13.3 |
13.3 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX14 |
|
|
|
Levetiracetam |
p.o. 500 mg (50-60 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
3777A |
|
|
G |
PTEROCYN 500 mg |
tbl flm 50x500 mg (blis.Al/PVC/PE/PVDC) |
SVS |
CZ |
16.667000000000002 |
14.12 |
14.12 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX14 |
|
|
|
Levetiracetam |
p.o. 500 mg (100-120 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
07359 |
|
|
G |
LEVEMED 500 mg |
tbl flm 100x500 mg (blis.PVC/PE/PVDC/Al) |
CRR |
SK |
33.332999999999998 |
28.24 |
28.24 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
32396 |
|
|
G |
Levetiracetam STADA 500 mg |
tbl flm 100x500 mg (blis.PVC/Al) |
STD |
DE |
33.332999999999998 |
28.24 |
28.24 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
10925 |
|
|
G |
Epiletam 500 mg |
tbl flm 120x500 mg (blis.Al/PVC/PE/PVDC) |
EGI |
HU |
40 |
33.89 |
33.89 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
3780A |
|
|
G |
PTEROCYN 500 mg |
tbl flm 120x500 mg (blis.Al/PVC/PE/PVDC) |
SVS |
CZ |
40 |
33.89 |
33.89 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
12368 |
|
|
G |
Levetiracetam Accord 500 mg filmom obalené tablety |
tbl flm 100x500 mg (blis.PVC/Al) |
ACC |
GB |
33.332999999999998 |
28.26 |
28.26 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
12098 |
|
|
G |
Levetiracetam Actavis 500 mg filmom obalené tablety |
tbl flm 100x500 mg (blis.Al/PVC) |
ACT-5 |
IS |
33.332999999999998 |
28.26 |
28.26 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
3288A |
|
|
G |
Levetiracetam UCB 500 mg filmom obalené tablety |
tbl flm 100x500 mg (blis.PVC/Al) |
UCB |
CZ |
33.332999999999998 |
28.26 |
28.26 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
12303 |
|
|
G |
Matever 500 mg |
tbl flm 100x500 mg (PVC/PE/PVDC/Al) |
PMT |
GR |
33.332999999999998 |
28.26 |
28.26 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
11485 |
|
|
G |
TRUND 500 mg |
tbl flm 100x500 mg (blis.Al/PVC/PE/PVDC) |
GLM |
CZ |
33.332999999999998 |
28.26 |
28.26 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
13894 |
|
|
G |
Levetiracetam Sandoz 500 mg filmom obalené tablety |
tbl flm 100x500 mg (blis.OPA/Al/PVC/Al) |
SAN |
SI |
33.332999999999998 |
28.33 |
28.33 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX14 |
|
|
|
Levetiracetam |
p.o. 1000 mg (100-120 ks) |
1.5 |
g |
|
|
|
|
|
|
|
|
0.70699999999999996 |
|
|
|
10947 |
|
|
G |
Epiletam 1000 mg |
tbl flm 120x1000 mg (blis.Al/PVC/PE/PVDC) |
EGI |
HU |
80 |
56.54 |
56.54 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
3796A |
|
|
G |
PTEROCYN 1000 mg |
tbl flm 120x1000 mg (blis.Al/PVC/PE/PVDC) |
SVS |
CZ |
80 |
56.54 |
56.54 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
07353 |
|
|
G |
LEVEMED 1000 mg |
tbl flm 100x1000 mg (blis.PVC/PE/PVDC/Al) |
CRR |
SK |
66.667000000000002 |
47.12 |
47.12 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
12386 |
|
|
G |
Levetiracetam Accord 1000 mg filmom obalené tablety |
tbl flm 100x1000 mg (blis.PVC/Al) |
ACC |
GB |
66.667000000000002 |
47.12 |
47.12 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
12118 |
|
|
G |
Levetiracetam Actavis 1000 mg filmom obalené tablety |
tbl flm 100x1000 mg (blis.Al/PVC) |
ACT-5 |
IS |
66.667000000000002 |
47.12 |
47.12 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
13906 |
|
|
G |
Levetiracetam Sandoz 1000 mg filmom obalené tablety |
tbl flm 100x1000 mg (blis.OPA/Al/PVC/Al) |
SAN |
SI |
66.667000000000002 |
47.12 |
47.12 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
32406 |
|
|
G |
Levetiracetam STADA 1000 mg |
tbl flm 100x1000 mg (blis.PCV/Al) |
STD |
DE |
66.667000000000002 |
47.12 |
47.12 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
12322 |
|
|
G |
Matever 1000 mg |
tbl flm 100x1000 mg (PVC/PE/PVDC/Al) |
PMT |
GR |
66.667000000000002 |
47.12 |
47.12 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
11500 |
|
|
G |
TRUND 1000 mg |
tbl flm 100x1000 mg (blis.Al/PVC/PE/PVDC) |
GLM |
CZ |
66.667000000000002 |
47.12 |
47.12 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX15 |
|
|
|
Zonisamid |
p.o. 100 mg (98 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
3.81 |
|
|
|
92658 |
|
|
O |
Zonegran 100 mg tvrdé kapsuly |
cps dur 98x100 mg |
XEI-GB |
GB |
32.67 |
124.36 |
124.36 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX16 |
|
|
|
Pregabalín |
p.o. 75 mg (56 - 60 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
1.55 |
|
|
|
3858B |
|
|
G |
Pragiola 75mg tvrdé kapsuly |
cps dur 60x75mg(blis.PVC/PVDC/Al) |
KRK |
SL |
15 |
23.25 |
23.25 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4705B |
|
|
G |
Pregabalin Mylan Pharma 75 mg tvrdé kapsuly |
cps dur 56 x 75 mg (blis.PVC/PVDC/Al) |
GNS |
UK |
14 |
21.7 |
21.7 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4594B |
|
|
G |
Pregabalin Sandoz 75 mg tvrdé kapsuly |
cps dur 56x1x75 mg (blis.PVC/PVDC/Al-perf.) |
SAN |
AT |
14 |
21.7 |
21.7 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4910B |
|
|
G |
Pregabalin Teva 75 mg |
cps dur 56x75 mg (blis.PVC/Al) |
TEV |
SK |
14 |
21.7 |
21.7 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
5183B |
|
|
G |
Preglenix 75 mg tvrdé kapsuly |
cps dur 56x75 mg (blis.PVC/Al) |
GLM-CZ |
CZ |
14 |
21.7 |
21.7 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX16 |
|
|
|
Pregabalín |
p.o. 150 mg (56 - 60 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
1.0900000000000001 |
|
|
|
4717B |
|
|
G |
Pregabalin Mylan Pharma 150 mg tvrdé kapsuly |
cps dur 56 x150mg (blis.PVC/PVDC/Al) |
GNS |
UK |
28 |
30.51 |
30.51 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4625B |
|
|
G |
Pregabalin Sandoz 150 mg tvrdé kapsuly |
cps dur 56x1x150 mg (blis.PVC/PVDC/Al-perf.) |
SAN |
AT |
28 |
30.51 |
30.51 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4921B |
|
|
G |
Pregabalin Teva 150 mg |
cps dur 56x150 mg (blis.PVC/Al) |
TEV |
SK |
28 |
30.51 |
30.51 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
5191B |
|
|
G |
Preglenix 150 mg tvrdé kapsuly |
cps dur 56x150 mg (blis.PVC/Al) |
GLM-CZ |
CZ |
28 |
30.51 |
30.51 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4029B |
|
|
G |
Pragiola 150mg tvrdé kapsuly |
cps dur 60x150mg(blis.PVC/PVDC/Al) |
KRK |
SL |
30 |
32.700000000000003 |
32.700000000000003 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX16 |
|
|
|
Pregabalín |
p.o. 300 mg (56 - 60ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
3901B |
|
|
G |
Pragiola 300mg tvrdé kapsuly |
cps dur 60x300mg(blis.PVC/PVDC/Al) |
KRK |
SL |
60 |
51 |
51 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4734B |
|
|
G |
Pregabalin Mylan Pharma 300 mg tvrdé kapsuly |
cps dur 56 x 300 mg (blis.PVC/PVDC/Al) |
GNS |
UK |
56 |
47.6 |
47.6 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4652B |
|
|
G |
Pregabalin Sandoz 300 mg tvrdé kapsuly |
cps dur 56x1x300 mg (blis.PVC/PVDC/Al-perf.) |
SAN |
AT |
56 |
47.6 |
47.6 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
4934B |
|
|
G |
Pregabalin Teva 300 mg |
cps dur 56x300 mg (blis.PVC/Al) |
TEV |
SK |
56 |
47.6 |
47.6 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
5199B |
|
|
G |
Preglenix 300 mg tvrdé kapsuly |
cps dur 56x300 mg (blis.PVC/Al) |
GLM-CZ |
CZ |
56 |
47.6 |
47.6 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N03AX21 |
|
|
|
Retigabín |
p.o. 300 mg (84 ks) |
900 |
mg |
|
|
|
|
|
|
|
|
3.47 |
|
|
|
06138 |
|
|
O |
Trobalt 300mg filmom obalené tablety |
tbl flm 84x300 mg (blis. PVDC/PE/PVC/Al) |
GLA |
GB |
28 |
97.11 |
97.11 |
I |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
U42 |
N04AA02 |
|
|
|
Biperidén |
p.o. 2 mg (50 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.28000000000000003 |
|
|
|
20054 |
|
|
O |
AKINETON |
tbl 50x2 mg |
KNO |
DE |
10 |
2.77 |
2.77 |
I |
0 |
0 |
0 |
NEU,PSY |
|
|
|
|
N04BA02 |
|
|
|
Levodopa a inhibítory dekarboxylázy |
p.o. 100/25 mg (100 ks) |
0.6 |
g |
|
|
|
|
|
|
|
|
0.86 |
|
|
|
88498 |
|
|
G |
NAKOM MITE |
tbl 100x125 mg |
LEK |
SI |
16 |
13.76 |
13.76 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
N04BA03 |
|
|
|
Levodopa/karbidopa/entakapon |
p.o. levodopa 50 mg |
600 |
mg |
|
|
|
|
|
|
|
|
1.603 |
|
|
|
8250A |
|
|
G |
Corbilta 50 mg/12,5 mg/200 mg filmom obalené tablety |
tbl flm 100x50 mg/12,5 mg/200 mg (fľ.HDPE) |
ORN |
FI |
33.332999999999998 |
53.21 |
53.21 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1493B |
|
|
G |
Levodopa/Carbidopa/Entacapone Stada 50 mg/12,5 mg/200 mg |
tbl flm 100x50 mg/12,5 mg/200 mg (nád.HDPE) |
STD |
DE |
33.332999999999998 |
53.21 |
53.21 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1320B |
|
|
G |
Levodopa/Carbidopa/Entacapone Teva 50 mg/12,5 mg/200 mg |
tbl flm 100x50 mg/12,5 mg/200 mg (fľ.HDPE) |
TEV-SK |
SK |
33.332999999999998 |
53.21 |
53.21 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1210B |
|
|
G |
Sastravi 50 mg/12,5 mg/200 mg |
tbl flm 100x50 mg/12,5 mg/200 mg (obal HDPE) |
ACT-5 |
IS |
33.332999999999998 |
53.21 |
53.21 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1965B |
|
|
G |
STALEMED 50 mg/12,5 mg/200 mg |
tbl flm 100x50 mg/12,5 mg/200 mg (fľ. HDPE) |
CRR |
SK |
33.332999999999998 |
53.21 |
53.21 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3931B |
|
|
G |
Padovel 50 mg/12,5 mg/200 mg filmom obalené tablety |
tbl flm 100x50 mg/12,5 mg/200 mg (blis. Al/Al) |
SVS |
CZ |
33.332999999999998 |
53.42 |
53.42 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3907B |
|
|
G |
TADOGLEN 50 mg/12,5 mg/200 mg |
tbl flm 100x50 mg/12,5 mg/200 mg (fl. HDPE) |
GLM-CZ |
CZ |
33.332999999999998 |
53.42 |
53.42 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BA03 |
|
|
|
Levodopa/karbidopa/entakapon |
p.o. levodopa 100 mg |
600 |
mg |
|
|
|
|
|
|
|
|
1.603 |
|
|
|
8261A |
|
|
G |
Corbilta 100 mg/25 mg/200 mg filmom obalené tablety |
tbl flm 100x100 mg/25 mg/200 mg (fľ.HDPE) |
ORN |
FI |
33.332999999999998 |
53.18 |
53.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1501B |
|
|
G |
Levodopa/Carbidopa/Entacapone Stada 100 mg/25 mg/200 mg |
tbl flm 100x100 mg/25 mg/200 mg (nád.HDPE) |
STD |
DE |
33.332999999999998 |
53.18 |
53.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1346B |
|
|
G |
Levodopa/Carbidopa/Entacapone Teva 100 mg/25 mg/200 mg |
tbl flm 100x100 mg/25 mg/200 mg (fľ.HDPE) |
TEV-SK |
SK |
33.332999999999998 |
53.18 |
53.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3941B |
|
|
G |
Padovel 100 mg/25 mg/200 mg filmom obalené tablety |
tbl flm 100x100 mg/25 mg/200 mg (blis. Al/Al) |
SVS |
CZ |
33.332999999999998 |
53.18 |
53.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1215B |
|
|
G |
Sastravi 100 mg/25 mg/200 mg |
tbl flm 100x100 mg/25 mg/200 mg (obal HDPE) |
ACT-5 |
IS |
33.332999999999998 |
53.18 |
53.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1970B |
|
|
G |
STALEMED 100 mg/25 mg/200 mg |
tbl flm 100x100 mg/25 mg/200 mg (fľ. HDPE) |
CRR |
SK |
33.332999999999998 |
53.18 |
53.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3913B |
|
|
G |
TADOGLEN 100 mg/25 mg/200 mg |
tbl flm 100x100 mg/25 mg/200 mg (fl. HDPE) |
GLM-CZ |
CZ |
33.332999999999998 |
53.18 |
53.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BA03 |
|
|
|
Levodopa/karbidopa/entakapon |
p.o. levodopa 150 mg |
600 |
mg |
|
|
|
|
|
|
|
|
1.643 |
|
|
|
8272A |
|
|
G |
Corbilta 150 mg/37,5 mg/200 mg filmom obalené tablety |
tbl flm 100x150 mg/37,5 mg/200 mg (fľ.HDPE) |
ORN |
FI |
33.332999999999998 |
54.75 |
54.75 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1509B |
|
|
G |
Levodopa/Carbidopa/Entacapone Stada 150 mg/37,5 mg/200 mg |
tbl flm 100x150 mg/37,5 mg/200 mg (nád.HDPE) |
STD |
DE |
33.332999999999998 |
54.75 |
54.75 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1372B |
|
|
G |
Levodopa/Carbidopa/Entacapone Teva 150 mg/37,5 mg/200 mg |
tbl flm 100x150 mg/37,5 mg/200 mg (fľ.HDPE) |
TEV-SK |
SK |
33.332999999999998 |
54.75 |
54.75 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1220B |
|
|
G |
Sastravi 150 mg/37,5 mg/200 mg |
tbl flm 100x150 mg/37,5 mg/200 mg (obal HDPE) |
ACT-5 |
IS |
33.332999999999998 |
54.75 |
54.75 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1975B |
|
|
G |
STALEMED 150 mg/37,5 mg/200 mg |
tbl flm 100x150 mg/37,5 mg/200 mg (fľ. HDPE) |
CRR |
SK |
33.332999999999998 |
54.75 |
54.75 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BA03 |
|
|
|
Levodopa/karbidopa/entakapon |
p.o. levodopa 200 mg |
600 |
mg |
|
|
|
|
|
|
|
|
1.75 |
|
|
|
8283A |
|
|
G |
Corbilta 200 mg/50 mg/200 mg filmom obalené tablety |
tbl flm 100x200 mg/50 mg/200 mg (fľ.HDPE) |
ORN |
FI |
33.332999999999998 |
58.31 |
58.31 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1398B |
|
|
G |
Levodopa/Carbidopa/Entacapone Teva 200 mg/50 mg/200 mg |
tbl flm 100x200 mg/50 mg/200 mg (fľ.HDPE) |
TEV-SK |
SK |
33.332999999999998 |
58.31 |
58.31 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1225B |
|
|
G |
Sastravi 200 mg/50 mg/200 mg |
tbl flm 100x200 mg/50 mg/200 mg (obal HDPE) |
ACT-5 |
IS |
33.299999999999997 |
58.26 |
58.26 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
1525B |
|
|
G |
Levodopa/Carbidopa/Entacapone Stada 200 mg/50 mg/200 mg |
tbl flm 100x200 mg/50 mg/200 mg (nád.HDPE) |
STD |
DE |
33.332999999999998 |
58.32 |
58.32 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BB01 |
|
|
|
Amantadín |
p.o. 100 mg (50 ks) |
0.2 |
g |
|
|
|
|
|
|
|
|
0.183 |
|
|
|
02871 |
|
|
G |
VIREGYT-K |
cps 50x100 mg |
EGI |
HU |
25 |
4.5599999999999996 |
4.5599999999999996 |
I |
0 |
0 |
0 |
|
|
|
|
|
N04BB01 |
|
|
|
Amantadín |
parent. 0,5 mg/ml |
0.2 |
g |
|
|
|
|
|
|
|
|
17.22 |
|
|
|
76218 |
|
|
O |
PK-MERZ |
sol inf 2x500 ml |
MEZ |
DE |
2 |
34.44 |
34.44 |
A |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
N04BC04 |
|
|
|
Ropinirol |
p.o. 1 mg (84 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
0.93 |
|
|
|
47775 |
|
|
G |
Ropinirol Mylan 1mg |
tbl flm 84 x 1 mg |
GNS |
GB |
14 |
12.91 |
12.91 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC04 |
|
|
|
Ropinirol |
p.o. 2 mg (84 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
0.55000000000000004 |
|
|
|
47776 |
|
|
G |
Ropinirol Mylan 2 mg |
tbl flm 84 x 2 mg |
GNS |
GB |
28 |
15.33 |
15.33 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC04 |
|
|
|
Ropinirol |
p.o. predĺžené uvoľňovanie 2 mg (84 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
1.22 |
|
|
|
1250A |
|
|
G |
Raponer 2 mg |
tbl plg 84x2 mg (blis.Al/Al) |
ACT-5 |
IS |
28 |
34.07 |
34.07 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
02276 |
|
|
G |
Rolpryna SR 2mg |
tbl plg 84x2mg |
KRK |
SI |
28 |
34.07 |
34.07 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
4049A |
|
|
G |
ROPINSTAD retard 2 mg |
tbl plg 84x2 mg (blis.PVC/PCTFE/Al) |
STD |
DE |
28 |
34.07 |
34.07 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
31200 |
|
|
G |
Sindranol 2mg |
tbl plg 84x2mg |
EGI |
HU |
28 |
34.07 |
34.07 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC04 |
|
|
|
Ropinirol |
p.o. predĺžené uvoľňovanie 4 mg (84 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
0.92100000000000004 |
|
|
|
1236A |
|
|
G |
Raponer 4 mg |
tbl plg 84x4 mg (blis.Al/Al) |
ACT-5 |
IS |
56 |
51.55 |
51.55 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
36093 |
|
|
O |
REQUIP-MODUTAB 4 mg |
tbl plg 84x4 mg |
GAG |
SK |
56 |
51.55 |
51.55 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
02282 |
|
|
G |
Rolpryna SR 4mg |
tbl plg 84x4mg |
KRK |
SI |
56 |
51.55 |
51.55 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
4072A |
|
|
G |
ROPINSTAD retard 4 mg |
tbl plg 84x4 mg (blis.PVC/PCTFE/Al) |
STD |
DE |
56 |
51.55 |
51.55 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
31238 |
|
|
G |
Sindranol 4mg |
tbl plg 84x4mg |
EGI |
HU |
56 |
51.55 |
51.55 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC04 |
|
|
|
Ropinirol |
p.o. predĺžené uvoľňovanie 8 mg (84 ks) |
6 |
mg |
|
|
|
|
|
|
|
|
0.77100000000000002 |
|
|
|
1243A |
|
|
G |
Raponer 8 mg |
tbl plg 84x8 mg (blis.Al/Al) |
ACT-5 |
IS |
112 |
86.28 |
86.28 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
02288 |
|
|
G |
Rolpryna SR 8mg |
tbl plg 84x8mg |
KRK |
SI |
112 |
86.28 |
86.28 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
4094A |
|
|
G |
ROPINSTAD retard 8 mg |
tbl plg 84x8 mg (blis.PVC/PCTFE/Al) |
STD |
DE |
112 |
86.28 |
86.28 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
31259 |
|
|
G |
Sindranol 8mg |
tbl plg 84x8mg (blis.PVC/PCTFE/Al) |
EGI |
HU |
112 |
86.28 |
86.28 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
Pramipexol p.o. predĺžené uvoľňovanie 3,15 mg (30 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
1.367 |
|
|
|
3210B |
|
|
G |
Oprymea 3,15 mg tablety s predĺženým uvoľňovaním |
tbl plg 30x3,15 mg (blis.OPA/Al/vysušovadlo/PE/Al) |
KRK |
SL |
54 |
73.75 |
73.75 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. prepoč. na bázu 0,18 mg (30 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
53273 |
|
|
G |
Oprymea |
tbl 30x0,18 mg |
KRK |
SI |
3.0859999999999999 |
3.04 |
3.04 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
64435 |
|
|
G |
Pramipexol STADA 0,18 mg tablety |
tbl 3x10x0,18 mg (blis. OPA/Al/PVC/Al) |
STD |
DE |
3.0859999999999999 |
3.06 |
3.06 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. prepoč. na bázu 0,18 mg (100 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
66853 |
|
|
G |
Glepark 0,18 mg |
tbl 100x0,18 mg (blis.Al/Al) |
GLM-CZ |
CZ |
10.285 |
10.18 |
10.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
64437 |
|
|
G |
Pramipexol STADA 0,18 mg tablety |
tbl 10x10x0,18 mg |
STD |
DE |
10.285 |
10.18 |
10.18 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. prepoč. na bázu 0,7 mg (30 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
1.1399999999999999 |
|
|
|
53286 |
|
|
G |
Oprymea |
tbl 30x0,7 mg |
KRK |
SI |
12 |
13.62 |
13.62 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
64431 |
|
|
G |
Pramipexol STADA 0,7 mg tablety |
tbl 3x10x0,7 mg (blis. OPA/Al/PVC/Al) |
STD |
DE |
12 |
13.62 |
13.62 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
12456 |
|
|
G |
Pramipexole Accord 0,7 mg tablety |
tbl 30x0,7 mg (blis.Al/PVC/Al) |
ACC |
GB |
12 |
13.62 |
13.62 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. prepoč. na bázu 0,7 mg (100 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
1.1399999999999999 |
|
|
|
64433 |
|
|
G |
Pramipexol STADA 0,7 mg tablety |
tbl 10x10x0,7 mg |
STD |
DE |
40 |
45.4 |
45.4 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
12458 |
|
|
G |
Pramipexole Accord 0,7 mg tablety |
tbl 100x0,7 mg (blis.Al/PVC/Al) |
ACC |
GB |
40 |
45.4 |
45.4 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
66876 |
|
|
G |
Glepark 0,7 mg |
tbl 100x0,7 mg (blis.Al/Al) |
GLM-CZ |
CZ |
40 |
45.6 |
45.6 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. predĺžené uvoľňovanie 0,26 mg (30 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
1.75 |
|
|
|
8025A |
|
|
G |
Oprymea 0,26 tablety s predĺženým uvoľňovaním |
tbl plg 30x0,26mg (blis.OPA/Al/vysušovadlo/PE/Al |
KRK |
SL |
4.4569999999999999 |
7.76 |
7.76 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3267B |
|
|
G |
Pramipexol Teva Pharma 0,26 mg |
tbl plg 30x0,26 mg (blis.OPA/Al/PVC/Al) |
TEV |
SK |
4.4569999999999999 |
7.76 |
7.76 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. predĺžené uvoľňovanie 0,52 mg (30 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
1.62 |
|
|
|
81593 |
|
|
O |
Mirapexin 0,52 mg tablety s predĺženým uvoľňovaním |
tbl plg 30x(3x10)x0,52 mg |
BOE |
DE |
8.9139999999999997 |
14.36 |
14.36 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
8029A |
|
|
G |
Oprymea 0,52 tablety s predĺženým uvoľňovaním |
tbl plg 30x0,52mg (blis.OPA/Al/vysušovadlo/PE/Al) |
KRK |
SL |
8.9139999999999997 |
14.36 |
14.36 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3270B |
|
|
G |
Pramipexol Teva Pharma 0,52 mg |
tbl plg 30x0,52 mg (blis.OPA/Al/PVC/Al) |
TEV |
SK |
8.9139999999999997 |
14.36 |
14.36 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. predĺžené uvoľňovanie 1,05 mg (30 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
1.2 |
|
|
|
8032A |
|
|
G |
Oprymea 1,05 tablety s predĺženým uvoľňovaním |
tbl plg 30x1,05mg (blis.OPA/Al/vysušovadlo/PE/Al) |
KRK |
SL |
18 |
21.52 |
21.52 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3273B |
|
|
G |
Pramipexol Teva Pharma 1,05 mg |
tbl plg 30x1,05 mg (blis.OPA/Al/PVC/Al) |
TEV |
SK |
18 |
21.52 |
21.52 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. predĺžené uvoľňovanie 2,1 mg (30 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
1.1200000000000001 |
|
|
|
8041A |
|
|
G |
Oprymea 2,1 tablety s predĺženým uvoľňovaním |
tbl plg 30x2,1mg (blis.OPA/Al/vysušovadlo/PE/Al) |
KRK |
SL |
36 |
40.19 |
40.19 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3276B |
|
|
G |
Pramipexol Teva Pharma 2,1 mg |
tbl plg 30x2,1 mg (blis.OPA/Al/PVC/Al) |
TEV |
SK |
36 |
40.19 |
40.19 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC05 |
|
|
|
Pramipexol |
p.o. predĺžené uvoľňovanie 2,62 mg (30 ks) |
1.75 |
mg |
|
|
|
|
|
|
|
|
2.8639999999999999 |
|
|
|
3206B |
|
|
G |
Oprymea 2,62 tablety s predĺženým uvoľňovaním |
tbl plg 30x2,62mg (blis.OPA/Al/vysušovadlo/PE/Al |
KRK |
SL |
44.914000000000001 |
83.09 |
83.09 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
3279B |
|
|
G |
Pramipexol Teva Pharma 2,62 mg |
tbl plg 30x2,62 mg (blis.OPA/Al/PVC/Al) |
TEV |
SK |
44.914000000000001 |
83.09 |
83.09 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
21429 |
|
|
O |
Mirapexin 2,62 mg tablety s predĺženým uvoľňovaním |
tbl plg 30x(3x10)x2,62 mg |
BOE |
DE |
44.914000000000001 |
86.66 |
86.66 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N04BC07 |
|
|
|
Apomorfín |
parent. subkutánna infúzia, injekčný a infúzny roztok 10 mg/ml |
20 |
mg |
|
|
|
|
|
|
|
|
9.36 |
|
|
|
08468 |
|
|
G |
Dacepton 10 mg/ml injekčný a infúzny roztok |
sol ijf 2x(5x5 ml) (amp.skl.) |
HML |
DE |
25 |
233.99 |
233.99 |
A |
0 |
0 |
0 |
NEU |
ind.obm. |
|
|
|
N04BC09 |
|
|
|
Rotigotín |
transd. emp. 8 mg |
6 |
mg |
|
|
|
|
|
|
|
|
3.0150000000000001 |
|
|
|
98657 |
|
|
O |
Neupro 8 mg/24 h transdermálna náplasť |
emp tdm 28x8 mg/24 hodín |
SWP |
IE |
37.332999999999998 |
112.14 |
112.14 |
I |
0 |
0 |
0 |
NEU |
|
|
|
U43 |
N05AA01 |
|
|
|
Chlórpromazín |
parent. 5 mg/ml |
0.1 |
g |
|
|
|
|
|
|
|
|
2.0099999999999998 |
|
|
|
00560 |
|
|
G |
PLEGOMAZIN |
inj 10x5 ml 25 mg |
EGI |
HU |
2.5 |
5.03 |
5.03 |
A |
0 |
0 |
0 |
|
|
|
|
|
N05AA02 |
|
|
|
Levomepromazín |
p.o. 25 mg (50 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.65200000000000002 |
|
|
|
02429 |
X |
|
G |
TISERCIN |
tbl flm 50x25 mg |
EGI |
HU |
4.1660000000000004 |
2.72 |
2.72 |
I |
0 |
0 |
0 |
|
|
|
|
|
N05AB02 |
|
|
|
Flufenazín |
parent. 25 mg/ml |
1 |
mg |
|
|
|
|
|
|
|
|
0.13 |
|
|
|
03514 |
|
|
O |
AFLUDITEN 25 mg/ml |
sol inj 5x1 ml/25 mg |
BTA |
SK |
125 |
15.96 |
15.96 |
I |
0 |
0 |
0 |
|
|
|
|
|
N05AD01 |
|
|
|
Haloperidol |
p.o. 1,5 mg (50 ks) |
8 |
mg |
|
|
|
|
|
|
|
|
0.20499999999999999 |
|
|
|
02537 |
X |
|
O |
HALOPERIDOL-RICHTER 1,5 MG |
tbl 50x1,5 mg |
GDN |
HU |
9.375 |
1.92 |
1.92 |
I |
0 |
0 |
0 |
|
|
|
|
|
N05AD01 |
|
|
|
Haloperidol |
parent. depot. 50 mg/ml |
3.3 |
mg |
|
|
|
|
|
|
|
|
0.14000000000000001 |
|
|
|
12061 |
|
|
O |
HALOPERIDOL DECANOAT-RICHTER |
sol inj 5x1 ml/50 mg |
GDN |
HU |
75.757999999999996 |
10.26 |
10.26 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
N05AD01 |
|
|
|
Haloperidol |
parent. nedepot. 5 mg/ml |
8 |
mg |
|
|
|
|
|
|
|
|
0.9 |
|
|
|
02538 |
|
|
O |
HALOPERIDOL-RICHTER |
inj 5x1 ml/5 mg |
GDN |
HU |
3.125 |
2.8 |
2.8 |
A |
0 |
0 |
0 |
|
|
|
|
|
N05AE03 |
|
|
|
Sertindol |
p.o. 12 mg (28 ks) |
16 |
mg |
|
|
|
|
|
|
|
|
3.29 |
|
|
|
13052 |
X |
|
O |
SERDOLECT 12 mg |
tbl flm 28x12 mg |
LUN |
DK |
21 |
69.069999999999993 |
69.069999999999993 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AE04 |
|
|
|
Ziprasidón |
p.o. 40 mg (30 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
1.91 |
|
|
|
12406 |
X |
|
G |
Ziprasidon Mylan 40 mg |
cps 30 x 40 mg (blis.OPA/Al/PVC) |
GNS |
UK |
15 |
28.5 |
28.5 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
81935 |
X |
|
G |
Zipwell 40 mg |
cps dur 30x40 mg |
ACT |
IS |
15 |
28.5 |
28.5 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
52515 |
X |
|
G |
Zypsilan |
cps dur 30x40 mg |
KRK |
SI |
15 |
28.5 |
28.5 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AE04 |
|
|
|
Ziprasidón |
p.o. 40 mg (56-60 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
1.91 |
|
|
|
52518 |
X |
|
G |
Zypsilan 40mg |
cps dur 60x40mg |
KRK |
SI |
30 |
57 |
57 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
33898 |
X |
|
O |
ZELDOX 40 mg |
cps dur 56x40 mg (blis.) |
PFI-GB-3 |
GB |
28 |
53.21 |
53.21 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AE04 |
|
|
|
Ziprasidón |
p.o. 60 mg (30 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
1.69 |
|
|
|
12339 |
X |
|
G |
Ziprasidon Mylan 60 mg |
cps 30 x 60 mg (blis.OPA/Al/PVC) |
GNS |
UK |
22.5 |
38.020000000000003 |
38.020000000000003 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
82130 |
X |
|
G |
Zipwell 60 mg |
cps dur 30x60 mg |
ACT |
IS |
22.5 |
38.020000000000003 |
38.020000000000003 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
52524 |
X |
|
G |
Zypsilan |
cps dur 30x60 mg |
KRK |
SI |
22.5 |
38.020000000000003 |
38.020000000000003 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AE04 |
|
|
|
Ziprasidón |
p.o. 60 mg (56-60 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
1.69 |
|
|
|
33906 |
X |
|
O |
ZELDOX 60 mg |
cps dur 56x60 mg (blis.) |
PFI-GB-3 |
GB |
42 |
70.97 |
70.97 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AE04 |
|
|
|
Ziprasidón |
p.o. 80 mg (30 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
1.57 |
|
|
|
12392 |
X |
|
G |
Ziprasidon Mylan 80 mg |
cps 30 x 80 mg (blis.OPA/Al/PVC |
GNS |
UK |
30 |
47.05 |
47.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
82158 |
X |
|
G |
Zipwell 80 mg |
cps dur 30x80 mg |
ACT |
IS |
30 |
47.05 |
47.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
52533 |
X |
|
G |
Zypsilan |
cps dur 30x80 mg |
KRK |
SI |
30 |
47.05 |
47.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AE04 |
|
|
|
Ziprasidón |
p.o. 80 mg (56-60 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
1.57 |
|
|
|
33914 |
X |
|
O |
ZELDOX 80 mg |
cps dur 56x80 mg (blis.) |
PFI-GB-3 |
GB |
56 |
87.83 |
87.83 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AF01 |
|
|
|
Flupentixol |
parent. 20 mg/ml |
4 |
mg |
|
|
|
|
|
|
|
|
0.33 |
|
|
|
31298 |
|
|
O |
FLUANXOL DEPOT |
inj 10x1 ml |
LUN |
DK |
50 |
16.3 |
16.3 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
N05AF03 |
|
|
|
Chlórprotixén |
p.o. 15 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
1.17 |
|
|
|
75433 |
X |
|
G |
CHLORPROTHIXEN 15 LÉČIVA |
tbl obd 30x15 mg |
ZNT |
CZ |
1.5 |
1.75 |
1.75 |
I |
0 |
0 |
0 |
|
|
|
|
|
N05AF03 |
|
|
|
Chlórprotixén |
p.o. 50 mg (30 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.7 |
|
|
|
75428 |
X |
|
G |
CHLORPROTHIXEN 50 LÉČIVA |
tbl obd 30x50 mg |
ZNT |
CZ |
5 |
3.49 |
3.49 |
I |
0 |
0 |
0 |
|
|
|
|
|
N05AF05 |
|
|
|
Zuklopentixol |
p.o. 10 mg (50 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.3 |
|
|
|
88480 |
X |
|
O |
CISORDINOL 10 mg |
tbl flm 50x10 mg |
LUN |
DK |
16.667000000000002 |
4.9800000000000004 |
4.9800000000000004 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
N05AF05 |
|
|
|
Zuklopentixol |
parent. 200 mg/ml depot. |
15 |
mg |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
86901 |
|
|
O |
CISORDINOL DEPOT 200 mg |
sol inj 10x1 ml/200 mg |
LUN |
DK |
133.333 |
28.29 |
28.29 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
N05AH02 |
|
|
|
Klozapín |
p.o. 25 mg (50 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
1.5 |
|
|
|
03617 |
X |
|
O |
LEPONEX |
tbl 50x25 mg |
NHW |
GB |
4.1669999999999998 |
6.25 |
6.25 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH02 |
|
|
|
Klozapín |
p.o. 100 mg (50 ks) |
0.3 |
g |
|
|
|
|
|
|
|
|
0.99 |
|
|
|
02970 |
X |
|
O |
LEPONEX |
tbl 50x100 mg |
NHW |
GB |
16.667999999999999 |
16.440000000000001 |
16.440000000000001 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Monohydrát olanzapín pamoátu |
parent. 150 mg/ml (1,4ml) |
10 |
mg |
|
|
|
|
|
|
|
|
7.0149999999999997 |
|
|
|
64306 |
|
|
O |
ZYPADHERA 210 mg prášok a rozpúšťadlo na injekčnú suspenziu s predĺženým uvoľňovaním |
plu igf 1 x 210 mg (inj.liek.) +solv.(inj.liek.) |
LIL |
FR |
21 |
147.30000000000001 |
147.30000000000001 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Monohydrát olanzapín pamoátu |
parent. 150 mg/ml ( 2,0 ml) |
10 |
mg |
|
|
|
|
|
|
|
|
7.14 |
|
|
|
64307 |
|
|
O |
ZYPADHERA 300 mg prášok a rozpúšťadlo na injekčnú suspenziu s predĺženým uvoľňovaním |
plu igf 1 x 300 mg (inj.liek.) +solv.(inj.liek.) |
LIL |
FR |
30 |
214.05 |
214.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Monohydrát olanzapín pamoátu |
parent. 150 mg/ml (2,7 ml) |
10 |
mg |
|
|
|
|
|
|
|
|
7.05 |
|
|
|
64308 |
|
|
O |
ZYPADHERA 405 mg prášok a rozpúšťadlo na injekčnú suspenziu s predĺženým uvoľňovaním |
plu igf 1 x 405 mg (inj.liek.) +solv.(inj.liek.) |
LIL |
FR |
40.5 |
285.51 |
285.51 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. 5 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.18 |
|
|
|
05158 |
X |
|
G |
Olanzapin Actavis 5 mg filmom obalené tablety |
tbl flm 28x5 mg (blis.Al/Al) |
ACT-5 |
IS |
14 |
2.4700000000000002 |
2.4700000000000002 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
85084 |
X |
|
O |
Olazax |
tbl 28x5 mg (blis. Al/Al) |
GLM |
CZ |
14 |
2.4700000000000002 |
2.4700000000000002 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
0438A |
X |
|
G |
Olanzapine Accord 5 mg filmom obalené tablety |
tbl flm 28x5 mg (bli.Al/Al) |
ACC |
GB |
14 |
2.52 |
2.52 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. 5 mg (56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.18 |
|
|
|
88717 |
X |
|
G |
Nykob 5 mg filmom obalené tablety |
tbl flm 56x5 mg (blis. PA/Al/PVC/Al) |
SVS |
CZ |
28 |
4.9400000000000004 |
4.9400000000000004 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
05161 |
X |
|
G |
Olanzapin Actavis 5 mg filmom obalené tablety |
tbl flm 56x5 mg (blis.Al/Al) |
ACT-5 |
IS |
28 |
5.04 |
5.04 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. 10 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.13400000000000001 |
|
|
|
88682 |
X |
|
G |
Nykob 10 mg filmom obalené tablety |
tbl flm 28x10 mg (blis. PA/Al/PVC/Al) |
SVS |
CZ |
28 |
3.75 |
3.75 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
05172 |
X |
|
G |
Olanzapin Actavis 10 mg filmom obalené tablety |
tbl flm 28x10 mg (blis.Al/Al) |
ACT-5 |
IS |
28 |
3.75 |
3.75 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
0454A |
X |
|
O |
Olanzapine Accord 10 mg filmom obalené tablety |
tbl flm 28x10 mg (blis.Al/Al) |
ACC |
GB |
28 |
3.75 |
3.75 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
85086 |
X |
|
O |
Olazax |
tbl 28x10 mg (blis.Al/Al) |
GLM |
CZ |
28 |
3.75 |
3.75 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. 10 mg (56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.13400000000000001 |
|
|
|
88684 |
X |
|
G |
Nykob 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis. PA/Al/PVC/Al) |
SVS |
CZ |
56 |
7.5 |
7.5 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
05175 |
X |
|
G |
Olanzapin Actavis 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis.Al/Al) |
ACT-5 |
IS |
56 |
7.5 |
7.5 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. 15 mg (56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.96 |
|
|
|
05182 |
X |
|
G |
Olanzapin Actavis 15 mg filmom obalené tablety |
tbl flm 56x15 mg (blis.Al/Al) |
ACT-5 |
IS |
84 |
79.959999999999994 |
79.959999999999994 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 5 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
89247 |
X |
|
G |
Bloonis 5 mg |
tbl oro 28x5 mg (blis.OPA/Al/PVC/Al) |
SAV-SK |
SK |
14 |
3.07 |
3.07 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
53188 |
X |
|
G |
Olanzapin Actavis 5 mg |
tbl oro 28x5 mg(blister s odlep.fól) |
ACT |
IS |
14 |
3.07 |
3.07 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
0240A |
X |
|
G |
Olanzapin Mylan 5 mg orodispergovateľné tablety |
tbl oro 28 x 5 mg (blis. OPA/Al/PVC/Al) |
GNS |
GB |
14 |
3.07 |
3.07 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 5 mg (50-56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
89249 |
X |
|
G |
Bloonis 5 mg |
tbl oro 56x5 mg (blis.OPA/Al/PVC/Al) |
SAV-SK |
SK |
28 |
6.14 |
6.14 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
53193 |
X |
|
G |
Olanzapin Actavis 5 mg |
tbl oro 56x5 mg (blister s odlep.fól.) |
ACT-5 |
IS |
28 |
6.14 |
6.14 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 5 mg (70 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
45753 |
X |
|
G |
Zalasta 5 mg |
tbl oro 70x5 mg |
KRK |
SI |
35 |
7.68 |
7.68 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 10 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.13300000000000001 |
|
|
|
53216 |
X |
|
G |
Olanzapin Actavis 10 mg |
tbl oro 28x10 mg(blister s odlep.fól) |
ACT |
IS |
28 |
3.72 |
3.72 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
0276A |
X |
|
G |
Olanzapin Mylan 10 mg orodispergovateľné tablety |
tbl oro 28 x 10 mg (blis. OPA/Al/PVC/Al) |
GNS |
GB |
28 |
3.72 |
3.72 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 10 mg (50-56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.13300000000000001 |
|
|
|
89297 |
X |
|
G |
Bloonis 10 mg |
tbl oro 56x10 mg (blis.OPA/Al/PVC/Al) |
SAV-SK |
SK |
56 |
7.44 |
7.44 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
53219 |
X |
|
G |
Olanzapin Actavis 10 mg |
tbl oro 56x10 mg (blister s odlep.fól.) |
ACT-5 |
IS |
56 |
7.44 |
7.44 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 10 mg (70 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.13300000000000001 |
|
|
|
45763 |
X |
|
G |
Zalasta 10 mg |
tbl oro 70x10 mg |
KRK |
SI |
70 |
9.3000000000000007 |
9.3000000000000007 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 15 mg (70 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.32 |
|
|
|
45768 |
X |
|
G |
Zalasta 15 mg |
tbl oro 70x15 mg |
KRK |
SI |
105 |
29.01 |
29.01 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 20 mg (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.63200000000000001 |
|
|
|
89309 |
X |
|
G |
Bloonis 20 mg |
tbl oro 28x20 mg (blis.OPA/Al/PVC/Al) |
SAV-SK |
SK |
56 |
35.35 |
35.35 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 20 mg (56ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.63200000000000001 |
|
|
|
89311 |
X |
|
G |
Bloonis 20 mg |
tbl oro 56x20 mg (blis.OPA/Al/PVC/Al) |
SAV-SK |
SK |
112 |
70.7 |
70.7 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH03 |
|
|
|
Olanzapín |
p.o. oro 20 mg (70 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.63200000000000001 |
|
|
|
45773 |
X |
|
G |
Zalasta 20 mg |
tbl oro 70x20 mg |
KRK |
SI |
140 |
88.38 |
88.38 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. 25 mg (30 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
1.05 |
|
|
|
59968 |
X |
|
G |
Equeta 25 mg |
tbl flm 30X25 mg |
PRW |
CZ |
1.875 |
1.97 |
1.97 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
46013 |
X |
|
G |
Questax 25 mg |
tbl flm 30x25 mg |
SVS |
CZ |
1.875 |
1.97 |
1.97 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
03867 |
X |
|
G |
Quetiapin Saneca 25 mg |
tbl flm 30x25 mg (blis.PVC/PVDC/Al) |
SNC |
SK |
1.875 |
1.97 |
1.97 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
07813 |
X |
|
G |
Quetiapine Accord 25 mg filmom obalené tablety |
tbl flm 30x25 mg (blis.PVC/Al) |
ACC |
GB |
1.875 |
1.97 |
1.97 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. 100 mg (30 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.38100000000000001 |
|
|
|
46051 |
X |
|
G |
Questax 100 mg |
tbl flm 30x100 mg |
SVS |
CZ |
7.5 |
2.86 |
2.86 |
I |
0 |
0 |
0 |
|
|
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. 100 mg (60 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.38100000000000001 |
|
|
|
46053 |
X |
|
G |
Questax 100 mg |
tbl flm 60x100 mg (blis.) |
SVS |
CZ |
15 |
5.71 |
5.71 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
07859 |
X |
|
G |
Quetiapine Accord 100 mg filmom obalené tablety |
tbl flm 60x100 mg |
ACC |
GB |
15 |
5.71 |
5.71 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
69175 |
X |
|
G |
Setinin 100 mg |
tbl flm 60x100 mg (blister PVC/Alu) |
ACT |
IS |
15 |
5.71 |
5.71 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. 150 mg (60 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.53 |
|
|
|
59956 |
X |
|
G |
Equeta 150 mg |
tbl flm 60x150 mg |
PRW |
CZ |
22.5 |
11.88 |
11.88 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. 200 mg (30 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.37 |
|
|
|
46077 |
X |
|
G |
Questax 200 mg |
tbl flm 30x200 mg |
SVS |
CZ |
15 |
5.51 |
5.51 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. 200 mg (60 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.37 |
|
|
|
44012 |
X |
|
G |
KVENTIAX |
tbl flm 60x200 mg |
KRK |
SI |
30 |
11.05 |
11.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
46079 |
X |
|
G |
Questax 200 mg |
tbl flm 60x200 mg (blis.) |
SVS |
CZ |
30 |
11.05 |
11.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
54060 |
X |
|
G |
Quetiapin Teva 200 mg filmom obalené tablety |
tbl flm 60x200 mg |
TEV |
GB |
30 |
11.05 |
11.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
07962 |
X |
|
G |
Quetiapine Accord 200 mg filmom obalené tablety |
tbl flm 60x200 mg |
ACC |
GB |
30 |
11.05 |
11.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
69506 |
X |
|
G |
Setinin 200 mg |
tbl flm 60x200 mg (blister PVC/Alu) |
ACT |
IS |
30 |
11.05 |
11.05 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. 300 mg (60 ks) |
0.4 |
g |
|
|
|
|
|
|
|
|
0.46 |
|
|
|
66693 |
X |
|
G |
Derin 300 mg filmom obalené tablety |
tbl flm 60 (10x6)x300 mg |
VIH |
PL |
45 |
20.53 |
20.53 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
39955 |
X |
|
G |
Quetiapin Mylan 300 mg |
tbl flm 60x300mg |
GNS |
GB |
45 |
20.53 |
20.53 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
54019 |
X |
|
G |
Quetiapin Teva 300 mg filmom obalené tablety |
tbl flm 60x300 mg |
TEV |
GB |
45 |
20.53 |
20.53 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
07976 |
X |
|
G |
Quetiapine Accord 300 mg filmom obalené tablety |
tbl flm 60x300 mg |
ACC |
GB |
45 |
20.53 |
20.53 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
69514 |
X |
|
G |
Setinin 300 mg |
tbl flm 60x300 mg (blister PVC/Alu) |
ACT |
IS |
45 |
20.53 |
20.53 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
44043 |
X |
|
G |
KVENTIAX |
tbl flm 60x300 mg |
KRK |
SI |
45 |
20.6 |
20.6 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
03922 |
X |
|
G |
Quetiapin Saneca 300 mg |
tbl flm 60x300 mg (blis.PVC/PVDC/Al) |
SNC |
SK |
45 |
20.6 |
20.6 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. predĺžené uvoľňovanie 200 mg (60 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
1.734 |
|
|
|
3023B |
X |
|
G |
Kventiax SR 200 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x200mg(blis. OPA/Al/PVC/Al) |
KRK |
SL |
30 |
52 |
52 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
30411 |
X |
|
G |
Quetiapine Accord 200 mg filmom obalené tablety s predĺženým uvoľňovaním |
tbl plg 60x200 mg (blis.PVC/PVDC/Al) |
ACC |
GB |
30 |
52 |
52 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AH04 |
|
|
|
Kvetiapín |
p.o. predĺžené uvoľňovanie 300 mg (60 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
1.464 |
|
|
|
3029B |
X |
|
G |
Kventiax SR 300 mg tablety s predĺženým uvoľňovaním |
tbl plg 60x300mg(blis. OPA/Al/PVC/Al) |
KRK |
SL |
45 |
65.849999999999994 |
65.849999999999994 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
30416 |
X |
|
G |
Quetiapine Accord 300 mg filmom obalené tablety s predĺženým uvoľňovaním |
tbl plg 60x300 mg (blis.PVC/PVDC/Al) |
ACC |
GB |
45 |
65.849999999999994 |
65.849999999999994 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AL03 |
|
|
|
Tiaprid |
parent. 50 mg/ml |
0.4 |
g |
|
|
|
|
|
|
|
|
0.79 |
|
|
|
91117 |
|
|
O |
TIAPRIDAL |
inj 12x2 ml/100 mg |
LSY |
FR |
3 |
2.34 |
2.34 |
A |
0 |
0 |
0 |
GER, INT, KLF, NEU, PSY |
|
|
|
|
N05AL05 |
|
|
|
Amisulprid |
p.o. 100 mg (30 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
1.339 |
|
|
|
64875 |
X |
|
G |
SOLIAN 100MG |
tbl 30x100 mg |
SSJ |
RO |
7.5 |
10.039999999999999 |
10.039999999999999 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AL05 |
|
|
|
Amisulprid |
p.o. 200 mg (60 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
0.96 |
|
|
|
4778B |
X |
|
G |
AKTIPROL 200 mg |
tbl 60x200 mg |
MOE |
CY |
30 |
28.78 |
28.78 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
79388 |
X |
|
G |
Amisulprid Mylan 200 mg |
tbl 60 x 200 mg |
GNC |
GB |
30 |
28.78 |
28.78 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AL05 |
|
|
|
Amisulprid |
p.o. 400 mg (60 ks) |
400 |
mg |
|
|
|
|
|
|
|
|
1.1000000000000001 |
|
|
|
4784B |
X |
|
G |
AKTIPROL 400 mg |
tbl 60x400 mg |
MOE |
CY |
60 |
42.86 |
42.86 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
14657 |
X |
|
O |
SOLIAN 400MG |
tbl 60x400 mg |
SSJ |
FR |
60 |
65.95 |
65.95 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AN01 |
|
|
|
Lítium |
p.o. 300 mg (100 ks) |
1 |
g |
|
|
|
|
|
|
|
|
0.28560000000000002 |
|
|
|
02481 |
X |
|
G |
LITHIUM CARBONICUM SLOVAKOFARMA |
tbl 100x300 mg |
ZNT |
SK |
30 |
8.4499999999999993 |
8.4499999999999993 |
I |
0 |
0 |
0 |
END, PSY |
|
|
|
|
N05AX08 |
|
|
|
Risperidón |
p.o. 2 mg (50-60 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.24199999999999999 |
|
|
|
34745 |
X |
|
G |
RISPEN 2 |
tbl flm 50X2MG |
ZNT |
CZ |
20 |
4.83 |
4.83 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
44708 |
X |
|
G |
Risepro 2 mg |
tbl flm 60x2 mg |
PRW |
CZ |
24 |
5.8 |
5.8 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
81563 |
X |
|
G |
Risperidon Orion 2 mg |
tbl flm 60(6x10)x2 mg (blis.PVC/LDPE/PVDC/Al) |
ORN |
FI |
24 |
5.8 |
5.8 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
N05AX08 |
|
|
|
Risperidón |
p.o. 3 mg (50-60 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.26200000000000001 |
|
|
|
2716B |
X |
|
G |
Risperidon Farmax 3 mg filmom obalené tablety |
tbl flm 60x3 mg (blis.PVC/LDPE/PVDC/A) |
SVS |
CZ |
36 |
9.43 |
9.43 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
81564 |
X |
|
G |
Risperidon Orion 3 mg |
tbl flm 60(6x10)x3 mg (blis.PVC/LDPE/PVDC/Al) |
ORN |
FI |
36 |
9.43 |
9.43 |
I |
0 |
0 |
0 |
PSY |
|
|
|
|
N05AX08 |
|
|
|
Risperidón |
p.o.1 mg/ml (60 ml) |
5 |
mg |
|
|
|
|
|
|
|
|
3.1829999999999998 |
|
|
|
50853 |
X |
|
G |
RISPERIDON ORION 1 mg/ml perorálny roztok |
sol por 1x60 ml |
ORN |
FI |
12 |
38.19 |
38.19 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX08 |
|
|
|
Risperidón |
parent.12,5 mg/ml depot. |
2.7 |
mg |
|
|
|
|
|
|
|
|
9.0399999999999991 |
|
|
|
97605 |
|
|
O |
RISPERDAL CONSTA 25 mg |
plv iul 1x25 mg + solv.+ Alaris SmartSite systém |
JAN |
BE |
9.2590000000000003 |
83.67 |
83.67 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX08 |
|
|
|
Risperidón |
parent. 18,75 mg/ml depot. |
2.7 |
mg |
|
|
|
|
|
|
|
|
8.452 |
|
|
|
97606 |
|
|
O |
RISPERDAL CONSTA 37,5 mg |
plv iul 1x37,5 mg + solv.+ Alaris SmartSite systém |
JAN |
BE |
13.888999999999999 |
117.39 |
117.39 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX08 |
|
|
|
Risperidón |
parent. 25 mg/ml depot. |
2.7 |
mg |
|
|
|
|
|
|
|
|
7.8730000000000002 |
|
|
|
97607 |
|
|
O |
RISPERDAL CONSTA 50 mg |
plv iul 1x50 mg + solv.+ Alaris SmartSite systém |
JAN |
BE |
18.518999999999998 |
145.80000000000001 |
145.80000000000001 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX12 |
|
|
|
Aripiprazol |
p.o. 15 mg (28-30 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
2.0819999999999999 |
|
|
|
4535B |
X |
|
G |
Aripiprazol Glenmark 15 mg tablety |
tbl 28x1x15 mg (blis. OPA/Al/PVC/Al-perfor.) |
GLM-CZ |
CZ |
28 |
58.29 |
58.29 |
I |
0 |
0 |
0 |
PSY |
ind. obm. |
|
|
|
4863B |
X |
|
G |
Aripiprazole Zentiva 15 mg tablety |
tbl 28x15 mg (blis.OPA/Al/PVC/Al) |
ZNT |
CZ |
28 |
58.29 |
58.29 |
I |
0 |
0 |
0 |
PSY |
ind. obm. |
|
|
|
5156B |
X |
|
G |
Asduter 15 mg tablety |
tbl 28x15 mg (fľ.HDPE) |
VIH |
PL |
28 |
58.29 |
58.29 |
I |
0 |
0 |
0 |
PSY |
ind. obm. |
|
|
|
N05AX12 |
|
|
|
Aripiprazol |
p.o. oro 10 mg (28 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
4.5730000000000004 |
|
|
|
5059B |
X |
|
G |
Explemed Rapid 10mg |
tbl oro 28x10mg (blis. OPA/Al/PVC/PET/Al) |
EGI |
HU |
18.667000000000002 |
65.7 |
65.7 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX12 |
|
|
|
Aripiprazol |
p.o. oro 10 mg (56 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
4.5730000000000004 |
|
|
|
5060B |
X |
|
G |
Explemed Rapid 10mg |
tbl oro 56x10mg (blis. OPA/Al/PVC/PET/Al) |
EGI |
HU |
37.334000000000003 |
131.30000000000001 |
131.30000000000001 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX12 |
|
|
|
Aripiprazol |
p.o. oro 15 mg (28 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
3.0459999999999998 |
|
|
|
5062B |
X |
|
G |
Explemed Rapid 15mg |
tbl oro 28x15mg (blis. OPA/Al/PVC/PET/Al) |
EGI |
HU |
28 |
65.7 |
65.7 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX12 |
|
|
|
Aripiprazol |
p.o. oro 15 mg (56 ks) |
15 |
mg |
|
|
|
|
|
|
|
|
3.0459999999999998 |
|
|
|
5063B |
X |
|
G |
Explemed Rapid 15mg |
tbl oro 56x15mg (blis. OPA/Al/PVC/PET/Al) |
EGI |
HU |
56 |
131.30000000000001 |
131.30000000000001 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX12 |
|
|
|
Aripiprazol |
parent. predĺžené uvoľňovanie 400 mg |
15 |
mg |
|
|
|
|
|
|
|
|
12 |
|
|
|
8419A |
|
|
O |
Abilify Maintena 400 mg |
plu igf 1x400 mg+1x2 ml+samost.bal.(liek.inj.skl.) |
OTS-2 |
GB |
26.667000000000002 |
319.98 |
319.98 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX13 |
|
|
|
Paliperidón palmitát |
parent. predĺžené uvoľňovanie 50 mg (1 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
10.522 |
|
|
|
06231 |
|
|
O |
XEPLION 50 mg injekčná suspenzia s predĺženým uvoľňovaním |
sus ijp 1x50 mg (striek.napln.skl.+2 ihly) |
JNS |
BE |
20 |
210.43 |
210.43 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX13 |
|
|
|
Paliperidón palmitát |
parent. predĺžené uvoľňovanie 75 mg (1 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
9.07 |
|
|
|
06232 |
|
|
O |
XEPLION 75 mg injekčná suspenzia s predĺženým uvoľňovaním |
sus ijp 1x75 mg (striek.napln.skl.+2 ihly |
JNS |
BE |
30 |
272.06 |
272.06 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX13 |
|
|
|
Paliperidón palmitát |
parent. predĺžené uvoľňovanie 100 mg (1 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
8.3450000000000006 |
|
|
|
06233 |
|
|
O |
XEPLION 100 mg injekčná suspenzia s predĺženým uvoľňovaním |
sus ijp 1x100 mg (striek.napln.skl.+2 ihly |
JNS |
BE |
40 |
333.75 |
333.75 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05AX13 |
|
|
|
Paliperidón palmitát |
parent. predĺžené uvoľňovanie 150 mg (1 ks) |
2.5 |
mg |
|
|
|
|
|
|
|
|
8.1050000000000004 |
|
|
|
06234 |
|
|
O |
XEPLION 150 mg injekčná suspenzia s predĺženým uvoľňovaním |
sus ijp 1x150 mg (striek.napln.skl.+2 ihly |
JNS |
BE |
60 |
486.24 |
486.24 |
I |
0 |
0 |
0 |
PSY |
ind.obm. |
|
|
|
N05BA01 |
|
|
|
Diazepam |
parent. 5 mg/ml |
10 |
mg |
|
|
|
|
|
|
|
|
0.24399999999999999 |
|
|
|
96610 |
|
|
G |
APAURIN |
sol inj 10x2 ml/10 mg |
KRK |
SI |
10 |
2.44 |
2.44 |
I |
0 |
0 |
0 |
|
|
|
|
|
N06AA04 |
|
|
|
Klomipramín |
p.o. 25 mg (30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.45 |
|
|
|
08557 |
X |
|
O |
ANAFRANIL |
tbl obd 30x25 mg |
XNT |
IT |
7.5 |
3.28 |
3.28 |
I |
0 |
0 |
0 |
AGG, NEU, PSY |
|
|
|
|
N06AA04 |
|
|
|
Klomipramín |
p.o. predĺžené uvoľňovanie 75 mg (20 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.4 |
|
|
|
93828 |
X |
|
O |
ANAFRANIL SR 75 |
tbl flp 20x75 mg |
XNT |
IT |
15 |
5.98 |
5.98 |
I |
0 |
0 |
0 |
AGG, NEU, PSY |
|
|
|
|
N06AA21 |
|
|
|
Maprotilín |
p.o. 75 mg (20 ks) |
100 |
mg |
|
|
|
|
|
|
|
|
0.42099999999999999 |
|
|
|
04257 |
X |
|
O |
Ludiomil 75 |
tbl flm 20x75 mg (blis.PVC/PVDC) |
AMD |
IR |
15 |
6.32 |
6.32 |
I |
0 |
0 |
0 |
|
|
|
|
|
N06AB04 |
|
|
|
Citalopram |
p.o. 20 mg (98-100 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
3.4000000000000002E-2 |
|
|
|
98958 |
X |
|
G |
Citalopram - Teva 20 mg |
tbl flm 100x20 mg |
PHM |
NL |
100 |
3.3 |
3.3 |
I |
0 |
0 |
0 |
|
|
|
|
U46 |
N06AB10 |
|
|
|
Escitalopram |
p.o. 5 mg (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.183 |
|
|
|
6262A |
|
|
G |
Elicea Q-Tab 5 mg orodispergovateľné tablety |
tbl oro 28x5 mg(blis.OPA/Al/PVC s odlup. fóliou PET/Al) |
KRK |
SL |
14 |
2.5499999999999998 |
2.5499999999999998 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06AB10 |
|
|
|
Escitalopram |
p.o. 10 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.183 |
|
|
|
08705 |
X |
|
G |
Escitalopram FARMAX 10 mg |
tbl flm 30x10 mg (blis. PVC-PE-PVdC-PE-PVC/Al) |
SVS |
CZ |
30 |
5.45 |
5.45 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
80861 |
X |
|
G |
Escitalopram Mylan 10mg |
tbl flm 28x10 mg |
GNC |
GB |
28 |
5.09 |
5.09 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
68670 |
X |
|
G |
Escitalopram Teva 10 mg |
tbl flm 28x10 mg |
TEV |
NL |
28 |
5.09 |
5.09 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
89315 |
X |
|
G |
Isozyloram 10 mg |
tbl flm 28x10 mg (blis.PAD/PVC/Al) |
RNB |
GB |
28 |
5.09 |
5.09 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
23112 |
X |
|
G |
Despra 10 mg |
tbl flm 28x10 mg (blis.PVC/PE/PVDC/Al) |
GLM |
CZ |
28 |
5.0999999999999996 |
5.0999999999999996 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
21992 |
X |
|
G |
Solatcit 10 mg |
tbl flm 28x10 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
28 |
5.0999999999999996 |
5.0999999999999996 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
8404A |
X |
|
G |
Escitalopram Zentiva 10 mg orodispergovateľné tablety |
tbl oro 30x10 mg (blis.papier/PET/Al/PVC/Al/OPA) |
ZNT |
CZ |
30 |
5.47 |
5.47 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
76818 |
X |
|
G |
Esoprex 10 mg |
tbl flm 30x10 mg (blis. OPA/Al/PVC/Al) |
ZNT-SK-2 |
SK |
30 |
5.48 |
5.48 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
79133 |
X |
|
G |
Elicea 10mg |
tbl flm 28x10 mg |
KRK |
SI |
28 |
5.12 |
5.12 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
6286A |
X |
|
G |
Elicea Q-Tab 10 mg orodispergovateľné tablety |
tbl oro 28x10 mg (blis.OPA/Al/PVC s odlup.fóliou PET/Al) |
KRK |
SL |
28 |
5.12 |
5.12 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
N06AB10 |
|
|
|
Escitalopram |
p.o. 10 mg (56-60 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.183 |
|
|
|
08706 |
X |
|
G |
Escitalopram FARMAX 10 mg |
tbl flm 60x10 mg (blis. PVC-PE-PVdC-PE-PVC/Al) |
SVS |
CZ |
60 |
10.89 |
10.89 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
76979 |
X |
|
G |
Escitil 10 mg |
tbl flm 56x10 mg (blis. OPA/AI/PVC/AI) |
EGI |
HU |
56 |
10.17 |
10.17 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
22492 |
X |
|
G |
Miraklide 10 mg |
tbl flm 56x10 mg (blis.PVC/PE/PVDC/Al) |
VIH |
PL |
56 |
10.17 |
10.17 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
21995 |
X |
|
G |
Solatcit 10 mg |
tbl flm 56x10 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
56 |
10.17 |
10.17 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
68674 |
X |
|
G |
Escitalopram Teva 10 mg |
tbl flm 56x10 mg (blis. PVC/PVDC/Al) |
TEV |
NL |
56 |
10.18 |
10.18 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
79137 |
X |
|
G |
Elicea 10mg |
tbl flm 60x10 mg |
KRK |
SI |
60 |
10.98 |
10.98 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
8406A |
X |
|
G |
Escitalopram Zentiva 10 mg orodispergovateľné tablety |
tbl oro 60x10 mg (blis.papier/PET/Al/PVC/Al/OPA) |
ZNT |
CZ |
60 |
10.98 |
10.98 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
76819 |
X |
|
G |
Esoprex 10 mg |
tbl flm 60x10 mg (blis. OPA/Al/PVC/Al) |
ZNT-SK-2 |
SK |
60 |
10.98 |
10.98 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
N06AB10 |
|
|
|
Escitalopram |
p.o. 10 mg (90-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.183 |
|
|
|
79138 |
X |
|
G |
Elicea 10mg |
tbl flm 90x10mg (blis.OPA/Al/PVC/Al) |
KRK |
SL |
90 |
16.34 |
16.34 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
08711 |
X |
|
G |
Escitalopram FARMAX 10 mg |
tbl flm 90x10 mg (blis.PVC-PE-PVdC-PE-PVC/Al) |
SVS |
CZ |
90 |
16.34 |
16.34 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
21997 |
X |
|
G |
Solatcit 10 mg |
tbl flm 98x10 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
98 |
17.84 |
17.84 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
N06AB10 |
|
|
|
Escitalopram |
p.o. 15 mg (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.28000000000000003 |
|
|
|
6230A |
X |
|
G |
Elicea Q-Tab 15 mg orodispergovateľné tablety |
tbl oro 28x15 mg(blis.OPA/Al/PVC s odlup. fóliou PET/Al) |
KRK |
SL |
42 |
11.55 |
11.55 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
N06AB10 |
|
|
|
Escitalopram |
p.o. 15 mg (56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.28000000000000003 |
|
|
|
77012 |
X |
|
G |
Escitil 15mg |
tbl flm 56x15mg |
EGI |
HU |
84 |
23.1 |
23.1 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
N06AB10 |
|
|
|
Escitalopram |
p.o. 20 mg (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.19 |
|
|
|
6274A |
X |
|
G |
Elicea Q-Tab 20 mg orodispergovateľné tablety |
tbl oro 28x20 mg (blis.OPA/Al/PVC s odlup.fóliou PET/Al) |
KRK |
SL |
56 |
10.24 |
10.24 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
22015 |
X |
|
G |
Solatcit 20 mg |
tbl flm 28x20 mg (bli.PVC/PVDC/Al) |
ACT-5 |
IS |
56 |
10.24 |
10.24 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
23200 |
X |
|
G |
Despra 20 mg |
tbl flm 28x20 mg (blis.PVC/PE/PVDC/Al) |
GLM |
CZ |
56 |
10.25 |
10.25 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
77051 |
X |
|
G |
Escitil 20 mg |
tbl flm 28x20 mg (blis. OPA/AI/PVC/AI) |
EGI |
HU |
56 |
10.25 |
10.25 |
I |
0 |
0 |
0 |
PSY, NEU |
ind.obm. |
|
|
|
N06AX16 |
|
|
|
Venlafaxín |
p.o. predĺžené uvoľňovanie 75 mg (28-30 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.11 |
|
|
|
38629 |
X |
|
G |
ALVENTA 75mg |
cps pld 30x75mg |
KRK |
SI |
22.5 |
2.41 |
2.41 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
N06AX16 |
|
|
|
Venlafaxín |
p.o. predĺžené uvoľňovanie 75 mg (50-60 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.11 |
|
|
|
38631 |
X |
|
G |
Alventa 75mg |
cps pld 60x75 mg |
KRK |
SI |
45 |
4.7 |
4.7 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
N06AX16 |
|
|
|
Venlafaxín |
p.o. predĺžené uvoľňovanie 150 mg (50-60 ks) |
0.1 |
g |
|
|
|
|
|
|
|
|
0.09 |
|
|
|
38643 |
X |
|
G |
Alventa 150mg |
cps pld 60x150 mg |
KRK |
SI |
90 |
8.06 |
8.06 |
I |
0 |
0 |
0 |
NEU, PSY |
|
|
|
|
N06AX21 |
|
|
|
Duloxetín |
p.o. 20 mg (56 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
3.1720000000000002 |
|
|
|
4377B |
X |
|
G |
Loxentia 20 mg tvrdé gastrorezistentné kapsuly |
cps end 56x20 mg (blis.OPA/Al/(HDPE/PE+DES z CaO/HDPE)/Al/PE) |
KRK |
SL |
14 |
31.63 |
31.63 |
I |
0 |
0 |
0 |
URO, GYN |
ind.obm. |
|
|
|
N06AX21 |
|
|
|
Duloxetín |
p.o. 40 mg (56 ks) |
80 |
mg |
|
|
|
|
|
|
|
|
1.5649999999999999 |
|
|
|
4386B |
X |
|
G |
Loxentia 40 mg tvrdé gastrorezistentné kapsuly |
cps end 56x40 mg (blis.OPA/Al/(HDPE/PE+DES z CaO/HDPE)/Al/PE) |
KRK |
SL |
28 |
31.36 |
31.36 |
I |
0 |
0 |
0 |
URO, GYN |
ind.obm. |
|
|
|
N06BA04 |
|
§ |
|
Metylfenidát |
p.o. predĺžené uvoľňovanie 36 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
1 |
|
|
|
49924 |
|
|
O |
Concerta 36mg tablety s predĺženým uvoľňovaním |
tbl plg 30x36mg |
JAN |
BE |
36 |
35.869999999999997 |
35.869999999999997 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06BA04 |
|
§ |
|
Metylfenidát |
p.o. predĺžené uvoľňovanie 54 mg (30 ks) |
30 |
mg |
|
|
|
|
|
|
|
|
0.92 |
|
|
|
49926 |
|
|
O |
Concerta 54mg tablety s predĺženým uvoľňovaním |
tbl plg 30x54mg |
JAN |
BE |
54 |
49.31 |
49.31 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06BA07 |
|
|
|
Modafinil |
p.o. 100 mg (30 ks) |
300 |
mg |
|
|
|
|
|
|
|
|
6.19 |
|
|
|
01689 |
X |
|
G |
ASPENDOS 100 mg |
tbl 30x100 mg (blis.PVC/Al) |
MOE |
CY |
10 |
61.83 |
61.83 |
I |
0 |
0 |
0 |
NEU, PSY, TRN |
|
|
|
|
N06DA02 |
|
|
|
Donepezil |
p.o. 5 mg (28-30 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
0.28000000000000003 |
|
|
|
66855 |
X |
|
G |
Adonep 5 mg filmom obalené tablety |
tbl flm 28 (14x2)x5 mg (blis.PVC/PE/PVDC/Al) |
STD |
DE |
18.667000000000002 |
5.22 |
5.22 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
22767 |
X |
|
G |
Donepezil Accord 5 mg |
tbl flm 28x5 mg (blis. PVC/AI) |
ACC |
GB |
18.667000000000002 |
5.22 |
5.22 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
88925 |
X |
|
G |
Donepezil Mylan 5 mg orodispergovateľné tablety |
tbl oro 28 x 5mg(blis. OPA/Al/PVC/Al) |
GNC |
UK |
18.667000000000002 |
5.22 |
5.22 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA02 |
|
|
|
Donepezil |
p.o. 5 mg (84-100 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
0.28000000000000003 |
|
|
|
09329 |
X |
|
G |
Yasnal 5 mg |
tbl flm 84x5mg (blis.Al/OPA/Al/PVC) |
KRK |
SL |
56 |
15.68 |
15.68 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA02 |
|
|
|
Donepezil |
p.o. 10 mg (28-30 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
0.36499999999999999 |
|
|
|
66868 |
X |
|
G |
Adonep 10 mg filmom obalené tablety |
tbl flm 28 (14x2)x10 mg (blis.PVC/PE/PVDC/Al) |
STD |
DE |
37.332999999999998 |
13.29 |
13.29 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
47822 |
X |
|
G |
Cognezil 10 mg |
tbl flm 28x10 mg (blis. PVC/Alu) |
GLM |
CZ |
37.332999999999998 |
13.29 |
13.29 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
22757 |
X |
|
G |
Donepezil Accord 10 mg |
tbl flm 28x10 mg |
ACC |
GB |
37.332999999999998 |
13.29 |
13.29 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
88952 |
X |
|
G |
Donepezil Mylan 10 mg orodispergovateľné tablety |
tbl oro 28 x 10mg(blis. OPA/Al/PVC/Al) |
GNC |
UK |
37.332999999999998 |
13.29 |
13.29 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
09129 |
X |
|
G |
PROMEMORE 10 mg |
tbl flm 30x10 mg (blis. PVC/PVDC/Al) |
SVS |
CZ |
40 |
14.24 |
14.24 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
04986 |
X |
|
G |
Yasnal Q-Tab 10mg |
tbl oro 28x10mg |
KRK |
SI |
37.332999999999998 |
13.6 |
13.6 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
40543 |
X |
|
G |
YASNAL 10 |
tbl flm 28x10 mg |
KRK |
SI |
37.332999999999998 |
13.61 |
13.61 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA02 |
|
|
|
Donepezil |
p.o. 10 mg (84-100 ks) |
7.5 |
mg |
|
|
|
|
|
|
|
|
0.36499999999999999 |
|
|
|
09131 |
X |
|
G |
PROMEMORE 10 mg |
tbl flm 90x10 mg (blis. PVC/PVDC/Al) |
SVS |
CZ |
120 |
42.71 |
42.71 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
47803 |
X |
|
G |
Donesyn 10 mg |
tbl flm 98x10 mg |
VIH |
PL |
130.667 |
46.51 |
46.51 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
09317 |
X |
|
G |
Yasnal 10 mg |
tbl flm 84x10mg (blis.Al/OPA/Al/PVC) |
KRK |
SL |
112 |
39.869999999999997 |
39.869999999999997 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
p.o. 1,5 mg (28-30 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
3.93 |
|
|
|
76506 |
X |
|
O |
Nimvastid |
tbl oro 28x1,5 mg |
KRK |
SI |
4.6669999999999998 |
18.329999999999998 |
18.329999999999998 |
I |
0 |
0 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
p.o. 1,5 mg (56 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
3.93 |
|
|
|
85734 |
X |
|
G |
RISTIDIC 1,5 mg |
cps dur 56x1,5 mg (blis.PVC/Al) |
PRW |
CZ |
9.3330000000000002 |
7.86 |
7.86 |
I |
0 |
0 |
0 |
NEU,PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
p.o. 3 mg (28-30 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
0.92 |
|
|
|
76511 |
X |
|
O |
Nimvastid |
tbl oro 28x3 mg |
KRK |
SI |
9.3330000000000002 |
8.57 |
8.57 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
p.o. 3 mg (56 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
0.92 |
|
|
|
85737 |
X |
|
G |
RISTIDIC 3 mg |
cps dur 56x3 mg (blis.PVC/Al) |
PRW |
CZ |
18.667000000000002 |
17.059999999999999 |
17.059999999999999 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
p.o. 4,5 mg (28-30 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
0.87 |
|
|
|
76516 |
X |
|
O |
Nimvastid |
tbl oro 28x4,5 mg |
KRK |
SI |
14 |
12.17 |
12.17 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
p.o. 4,5 mg (56 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
0.87 |
|
|
|
85972 |
X |
|
G |
RISTIDIC 4,5 mg |
cps dur 56x4,5 mg (blis.PVC/Al) |
PRW |
CZ |
28 |
24.34 |
24.34 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
p.o. 6,0 mg (28-30 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
76521 |
X |
|
O |
Nimvastid |
tbl oro 28x6 mg |
KRK |
SI |
18.667000000000002 |
15.86 |
15.86 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
p.o. 6,0 mg (56 ks) |
9 |
mg |
|
|
|
|
|
|
|
|
0.85 |
|
|
|
85975 |
X |
|
G |
RISTIDIC 6 mg |
cps dur 56x6 mg (blis.PVC/Al) |
PRW |
CZ |
37.332999999999998 |
31.67 |
31.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
transd. emp. tdm. 4,6 mg |
9.5 |
mg |
|
|
|
|
|
|
|
|
3.32 |
|
|
|
45204 |
|
|
O |
EXELON 4,6 mg/24h |
emp tdm 30 x 4,6 mg/24h |
NEH |
GB |
14.526 |
48.16 |
48.16 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA03 |
|
|
|
Rivastigmín |
transd. emp. tdm. 9,5 mg |
9.5 |
mg |
|
|
|
|
|
|
|
|
1.9930000000000001 |
|
|
|
45208 |
|
|
O |
EXELON 9,5 mg/24h |
emp tdm 30 x 9,5 mg/24h |
NEH |
GB |
30 |
59.78 |
59.78 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA04 |
|
|
|
Galantamín |
p.o. predĺžené uvoľňovanie 8 mg (7 ks) |
16 |
mg |
|
|
|
|
|
|
|
|
2.89 |
|
|
|
31370 |
X |
|
G |
Galantamin Mylan 8 mg |
cps pld 7x8 mg (blis.Al/Al) |
GNS |
UK |
3.5 |
10.08 |
10.08 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA04 |
|
|
|
Galantamín |
p.o. predĺžené uvoľňovanie 8 mg (14 ks) |
16 |
mg |
|
|
|
|
|
|
|
|
2.89 |
|
|
|
06926 |
X |
|
G |
Galsya SR 8mg |
cps pld 14x8mg |
KRK |
SI |
7 |
20.16 |
20.16 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DA04 |
|
|
|
Galantamín |
p.o. predĺžené uvoľňovanie 16 mg (28 ks) |
16 |
mg |
|
|
|
|
|
|
|
|
0.84499999999999997 |
|
|
|
06945 |
X |
|
G |
Galsya SR 16 mg |
cps pld 28x16 mg |
KRK |
SI |
28 |
23.62 |
23.62 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DX01 |
|
|
|
Memantín |
p.o. 10 mg/ml (50 ml) |
20 |
mg |
|
|
|
|
|
|
|
|
1.72 |
|
|
|
7580A |
|
|
G |
Memantin Mylan 10 mg/ml perorálny roztok |
sol por 1x50 ml (fľ.skl.hnedá s pumpou) |
GNS |
UK |
25 |
43 |
43 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DX01 |
|
|
|
Memantín |
p.o. 5 mg (7 ks), 10 mg (7 ks), 15 mg (7 ks), 20 mg (7 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
1.1299999999999999 |
|
|
|
8023A |
|
|
G |
Zenmem 5 mg orodispergovateľné tablety, Zenmem 10 mg orodispergovateľné tablety, Zenmem 15 mg orodispergovateľné tablety, Zenmem 20 mg orodispergovateľné tablety |
tbl oro 28(7x5mg+7x10 mg+7x15 mg+7x20 mg) (blis.PET/Al/PVC/Al/OPA-initiation pack) |
ZNT |
CZ |
17.5 |
19.73 |
19.73 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DX01 |
|
|
|
Memantín |
p.o. 10 mg (28-30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
1.1000000000000001 |
|
|
|
5289A |
X |
|
G |
Marixino 10 mg filmom obalené tablety |
tbl flm 28x10 mg (blis.PVC/PVDC/Al) |
CNK-IE |
IE |
14 |
15.33 |
15.33 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
7853A |
X |
|
G |
Memolan 10 mg filmom obalené tablety |
tbl flm 30x10 mg (blis.PVC/PE/PVDC/Al) |
GLH-2 |
AT |
15 |
16.43 |
16.43 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
0992B |
X |
|
G |
MORYSA 10 mg filmom obalené tablety |
tbl flm 30x10 mg (fľ.HDPE) |
SVS |
CZ |
15 |
16.43 |
16.43 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8012A |
X |
|
G |
Zenmem 10 mg orodispergovateľné tablety |
tbl oro 30x10 mg (blis.PET/Al/PVC/Al/OPA) |
ZNT |
CZ |
15 |
16.43 |
16.43 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DX01 |
|
|
|
Memantín |
p.o. 10 mg (56-60 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
1.1000000000000001 |
|
|
|
2834B |
X |
|
G |
MANTOMED 10 mg |
tbl flm 56x10 mg (blis.PVC/PE/PVDC/Al) |
MOE |
CY |
28 |
30.66 |
30.66 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
6790A |
X |
|
G |
Memigmin 10mg |
tbl flm 56x10 mg (blis.PVC/PE/PVDC/AL) |
EGI |
HU |
28 |
30.66 |
30.66 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
5969A |
X |
|
G |
Xapimant 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis.PVC/PVDC/Al) |
SAN |
SI |
28 |
30.66 |
30.66 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8014A |
X |
|
G |
Zenmem 10 mg orodispergovateľné tablety |
tbl oro 60x10 mg (blis.PET/Al/PVC/Al/OPA) |
ZNT |
CZ |
30 |
32.86 |
32.86 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
95452 |
X |
|
O |
EBIXA 10 mg |
tbl flm 56x10 mg |
LUN |
DK |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
7546A |
X |
|
G |
Memabix 10 mg |
tbl oro 56x10 mg (blis. papier/PET/Al/PVC/Al/oPA) |
ADD |
PL |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
4667A |
X |
|
G |
MEMAMED 10 mg |
tbl flm 56x10 mg (blis.PVDC/AI) |
CRR |
SK |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
5222A |
X |
|
G |
Memantin Mylan 10 mg filmom obalené tablety |
tbl flm 56x10mg(blis. PVC/PVDC/Al) |
GENERICS |
UK |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
7668A |
X |
|
G |
Memantin Stada 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis.PVC/PE/PVDC/Al) |
STD |
DE |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8426A |
X |
|
G |
Memantine Accord 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis.PVC/PE/PVDC/Al) |
ACC |
GB |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
7998A |
X |
|
G |
Memantine Glenmark 10 mg |
tbl flm 56x10 mg (blis. PVC/Al) |
GLM - CZ |
CZ |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
6299A |
X |
|
G |
Memantine ratiopharm 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis.PVC/PVDC/Al) |
RAT |
DE |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8171A |
X |
|
G |
Memantine Vipharm 10 mg |
tbl flm 56x10 mg (blis.PVC/Al) |
VIH |
PL |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
5266A |
X |
|
G |
Nemdatine 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
28 |
30.67 |
30.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DX01 |
|
|
|
Memantín |
p.o. 10 mg (84-98 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
1.1000000000000001 |
|
|
|
5296A |
X |
|
G |
Marixino 10 mg filmom obalené tablety |
tbl flm 84x10 mg (blis.PVC/PVDC/Al) |
CNK-IE |
IE |
42 |
46 |
46 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
5268A |
X |
|
G |
Nemdatine 10 mg filmom obalené tablety |
tbl flm 98x10 mg (blis PVC/PVDC/Al) |
ACT-5 |
IS |
49 |
53.67 |
53.67 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DX01 |
|
|
|
Memantín |
p.o. 20 mg (28-30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
1.161 |
|
|
|
0999B |
X |
|
G |
MORYSA 20 mg filmom obalené tablety |
tbl flm 30x20 mg (fľ.HDPE) |
SVS |
CZ |
30 |
34.82 |
34.82 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
2849B |
X |
|
G |
MANTOMED 20 mg |
tbl flm 28x20 mg (blis.PVC/PE/PVDC/Al) |
MOE |
CY |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
5302A |
X |
|
G |
Marixino 20 mg filmom obalené tablety |
tbl flm 28x20 mg (blis.PVC/PVDC/Al) |
CNK-IE |
IE |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
7554A |
X |
|
G |
Memabix 20 mg |
tbl oro 28x20 mg (blis. papier/PET/Al/PVC/Al/oPA) |
ADD |
PL |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
4679A |
X |
|
G |
MEMAMED 20 mg |
tbl flm 28x20 mg (blis.PVDC/Al) |
CRR |
SK |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
5235A |
X |
|
G |
Memantin Mylan 20 mg filmom obalené tablety |
tbl flm 28x20mg(blis. PVC/PVDC/Al) |
GNC |
UK |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
7677A |
X |
|
G |
Memantin Stada 20 mg filmom obalené tablety |
tbl flm 28x20 mg (blis.PVC/PE/PVDC/Al) |
STD |
DE |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8430A |
X |
|
G |
Memantine Accord 20 mg filmom obalené tablety |
tbl flm 28x20 mg (blis.PVC/PE/PVDC/Al) |
ACC |
GB |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8005A |
X |
|
G |
Memantine Glenmark 20 mg |
tbl flm 28x20 mg (blis. PVC/Al) |
GLM |
CZ |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
6307A |
X |
|
G |
Memantine ratiopharm 20 mg filmom obalené tablety |
tbl flm 28x20 mg (blis.PVC/PVDC/Al) |
RAT |
DE |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8182A |
X |
|
G |
Memantine Vipharm 20 mg |
tbl flm 28x20 mg (blis.PVC/Al) |
VIH |
PL |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
5273A |
X |
|
G |
Nemdatine 20 mg filmom obalené tablety |
tbl flm 28x20 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
6007A |
X |
|
G |
Xapimant 20 mg filmom obalené tablety |
tbl flm 28x20 mg (blis.PVC/PVDC/Al) |
SAN |
SI |
28 |
32.5 |
32.5 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
7866A |
X |
|
G |
Memolan 20 mg filmom obalené tablety |
tbl flm 30x20 mg (blis.PVC/PE/PVDC/Al) |
GLH-2 |
AT |
30 |
34.83 |
34.83 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8018A |
X |
|
G |
Zenmem 20 mg orodispergovateľné tablety |
tbl oro 30x20 mg (blis.PET/Al/PVC/Al/OPA) |
ZNT |
CZ |
30 |
34.83 |
34.83 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DX01 |
|
|
|
Memantín |
p.o. 20 mg (56-60 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
1.161 |
|
|
|
5275A |
X |
|
G |
Nemdatine 20 mg filmom obalené tablety |
tbl flm 56x20 mg (blis PVC/PVDC/Al) |
ACT-5 |
IS |
56 |
65 |
65 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8186A |
X |
|
G |
Memantine Vipharm 20 mg |
tbl flm 56x20 mg (blis.PVC/Al) |
VIH |
PL |
56 |
65.010000000000005 |
65.010000000000005 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
8020A |
X |
|
G |
Zenmem 20 mg orodispergovateľné tablety |
tbl oro 60x20 mg (blis.PET/Al/PVC/Al/OPA) |
ZNT |
CZ |
60 |
69.66 |
69.66 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N06DX01 |
|
|
|
Memantín |
p.o. 20 mg (84-98 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
1.161 |
|
|
|
8189A |
X |
|
G |
Memantine Vipharm 20 mg |
tbl flm 98x20 mg (blis.PVC/Al) |
VIH |
PL |
98 |
113.76 |
113.76 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
5309A |
X |
|
G |
Marixino 20 mg filmom obalené tablety |
tbl flm 84x20 mg (blis.PVC/PVDC/Al) |
CNK-IE |
IE |
84 |
97.51 |
97.51 |
I |
0 |
0 |
0 |
NEU, PSY |
ind.obm. |
|
|
|
N07AA01 |
|
|
|
Neostigmín |
parent. 0,5 mg/ml |
2 |
mg |
|
|
|
|
|
|
|
|
1.208 |
|
|
|
00612 |
|
|
G |
SYNTOSTIGMIN |
inj 10x1 ml/0,5 mg |
HBS |
SK |
2.5 |
3.02 |
3.02 |
A |
0 |
0 |
0 |
|
|
|
|
|
N07AA02 |
|
|
|
Pyridostigmín |
p.o. 60 mg (150 ks) |
180 |
mg |
|
|
|
|
|
|
|
|
0.52200000000000002 |
|
|
|
91983 |
X |
|
G |
MESTINON |
tbl obd 150x60 mg |
MPH |
SK |
50 |
26.01 |
26.01 |
I |
0 |
0 |
0 |
NEU |
|
|
|
|
N07AA03 |
|
|
|
Distigmín |
p.o. 5 mg (50 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
0.1726 |
|
|
|
02130 |
X |
|
G |
UBRETID 5 mg |
tbl 50x5 mg |
NYC |
AT |
50 |
8.52 |
8.52 |
I |
0 |
0 |
0 |
NEU, URO |
|
|
|
|
N07CA01 |
|
|
|
Betahistín |
p.o. 24 mg (50-60 ks) |
24 |
mg |
|
|
|
|
|
|
|
|
0.10100000000000001 |
|
|
|
79375 |
X |
|
G |
Emperin 24 mg |
tbl 60x24 mg (blis. PVC/PVDC/AI) |
EGI |
HU |
60 |
6.02 |
6.02 |
I |
0 |
0 |
0 |
GER, INT, KLF, NEU, ORL |
|
|
|
|
53741 |
X |
|
G |
Betahistin Mylan 24mg |
tbl 50x24 mg |
GNC |
GB |
50 |
5.03 |
5.03 |
I |
0 |
0 |
0 |
GER, INT, KLF, NEU, ORL |
|
|
|
|
20379 |
X |
|
G |
Urutal 24 mg |
tbl 50x24 mg |
BLU |
SR |
50 |
5.04 |
5.04 |
I |
0 |
0 |
0 |
GER, INT, KLF, NEU, ORL |
|
|
|
|
N07CA01 |
|
|
|
Betahistín |
p.o. 24 mg (100 ks) |
24 |
mg |
|
|
|
|
|
|
|
|
0.10100000000000001 |
|
|
|
59465 |
X |
|
G |
Betahistin Actavis 24 mg |
tbl 100x24 mg (blis.PVC/PVDC/Al) |
ACT-5 |
IS |
100 |
10.029999999999999 |
10.029999999999999 |
I |
0 |
0 |
0 |
GER, INT, KLF, NEU, ORL |
|
|
|
|
N07XX09 |
|
|
|
Dimetylfumarát |
p.o. 120 mg (14 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
24.62 |
|
|
|
9681A |
|
|
O |
Tecfidera 120 mg tvrdé gastrorezistentné kapsuly. |
cps end 14x120 mg blis.PVC/PE/PVDC-PVC/alu |
BGI |
GB |
7 |
172.34 |
172.34 |
I |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
N07XX09 |
|
|
|
Dimetylfumarát |
p.o. 240 mg (56 ks) |
2 |
DF |
|
|
|
|
|
|
|
|
46.01 |
|
|
|
9682A |
|
|
O |
Tecfidera 240 mg tvrdé gastrorezistentné kapsuly. |
cps end 56x240 mg (blis.PVC/PE/PVDC-PVC/alu) |
BGI |
GB |
28 |
1288.28 |
1288.28 |
I |
0 |
0 |
0 |
NEU |
ind.obm., ZP |
|
|
|
R03AC02 |
|
|
|
Salbutamol |
inhal. sol. 5 mg/ml |
10 |
mg |
|
|
|
|
|
|
|
|
0.38100000000000001 |
|
|
|
94814 |
|
|
O |
Ventolin |
sol neb 20 ml/100 mg |
GWB |
GB |
12 |
3.7 |
3.7 |
A |
0 |
0 |
0 |
|
|
|
|
|
R03AC02 |
|
|
|
Salbutamol |
inhal. 100 mcg |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.111 |
|
|
|
15939 |
|
|
O |
Ventolin Inhaler N |
sus inh 1x200 ug/1 dávka |
GWP |
PL |
25 |
2.59 |
2.59 |
I |
0 |
0 |
0 |
|
|
|
|
|
R03AC13 |
|
|
|
Formoterol |
inhal. plv.12 mcg (60 dávok) |
24 |
µg |
|
|
|
|
|
|
|
|
0.47 |
|
|
|
97305 |
|
|
G |
FORMANO |
plv icd 60 x 12 µg + 1 x inhalátor |
TMP |
PL |
30 |
13.85 |
13.85 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
1566A |
|
|
G |
Formostad 12 mikrogramov inhalačný prášok v tvrdej kapsule |
plv icd 60x12µg (fľ.HDPE+inhalátor) |
STD |
DE |
30 |
13.85 |
13.85 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
41312 |
|
|
G |
Formoterol -ratiopharm 12 µg |
plv icd 60x12µg + inhalátor |
RAT |
DE |
30 |
13.85 |
13.85 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
3261A |
|
|
G |
Formoterol Sandoz 12 mikrogramov inhalačný prášok v tvrdej kapsule |
plv icd 1x60 (obal HDPE+inhalátor) |
SAN |
SI |
30 |
13.85 |
13.85 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
42979 |
|
|
G |
FORMOVENT 12µg |
plv icd 60x12 µg+inhalátor |
ITL |
IT |
30 |
13.85 |
13.85 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
R03AC13 |
|
|
|
Formoterol |
inhal. plv.12 mcg (120 dávok) |
24 |
µg |
|
|
|
|
|
|
|
|
0.47 |
|
|
|
1567A |
|
|
G |
Formostad 12 mikrogramov inhalačný prášok v tvrdej kapsule |
plv icd 120(2x60)x12µg (fľ.HDPE+2xinhalátor) |
STD |
DE |
60 |
27.69 |
27.69 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
R03AK07 |
|
|
|
Formoterol a iné antiastmatiká |
inhal. s beklometazónom 100/6 mcg |
4 |
DF |
|
|
|
|
|
|
|
|
1.0549999999999999 |
|
|
|
38996 |
|
|
O |
FOSTER |
sol inh 1x180 dávok |
CHS-AT |
AT |
45 |
47.47 |
47.47 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03BA02 |
|
|
|
Budezonid |
inhal. 100 mcg |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.46 |
|
|
|
62697 |
|
|
O |
PULMICORT TURBUHALER |
plv inh 200x100 ug |
AZC |
SE |
25 |
11.48 |
11.48 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
R03BA02 |
|
|
|
Budezonid |
inhal. 200 mcg |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.4 |
|
|
|
40585 |
|
|
O |
Budelin Novolizer 200 µg |
plv inh 200 dávok/2,18 g + aplikátor |
MPH |
SK |
50 |
19.28 |
19.28 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
R03BA02 |
|
|
|
Budezonid |
inhal. 200 mcg ( bezfreónový) |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.27800000000000002 |
|
|
|
R03BA02 |
|
|
|
Budezonid |
inhal. 200 mcg náplň |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.34300000000000003 |
|
|
|
40268 |
|
|
O |
Budelin Novolizer 200 µg |
plv inh 200 dávok/2,18 g |
MPH |
SK |
50 |
17.14 |
17.14 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
R03BA02 |
|
|
|
Budezonid |
inhal. 400 mcg |
0.8 |
mg |
|
|
|
|
|
|
|
|
0.38 |
|
|
|
33318 |
|
|
O |
MIFLONID 400 (BLIS.) |
plv inh 1x60x400ug |
PHM |
NL |
30 |
11.1 |
11.1 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
R03BA05 |
|
|
|
Flutikazón |
inhal. 50 mcg (bezfreónové) |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.87 |
|
|
|
13971 |
|
|
O |
Flixotide 50 Inhaler N |
sus inh 120x50 ug |
GWE |
FR |
10 |
8.56 |
8.56 |
I |
0 |
0 |
0 |
ALG,TRN |
|
|
|
|
R03BA05 |
|
|
|
Flutikazón |
inhal. 500 mcg |
0.6 |
mg |
|
|
|
|
|
|
|
|
0.57499999999999996 |
|
|
|
27961 |
|
|
O |
Flixotide Diskus 500 ug |
plv inh 1x60 dávok |
GWE |
FR |
50 |
28.73 |
28.73 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
R03BA07 |
|
|
|
Mometazón |
inhal. 400 mcg (60 dávok) |
0.4 |
mg |
|
|
|
|
|
|
|
|
0.55500000000000005 |
|
|
|
58165 |
|
|
O |
ASMANEX 400 µg |
plv inh 1x60 dávok |
MSD-NL |
NL |
60 |
33.1 |
33.1 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
R03BB01 |
|
|
|
Ipratrópiumbromid |
inhal. aerosol 20 mcg |
0.12 |
mg |
|
|
|
|
|
|
|
|
0.16 |
|
|
|
32992 |
|
|
O |
ATROVENT N 20 ug |
sol inh 10 ml (200 dávok) |
BOE |
DE |
33.332999999999998 |
5.27 |
5.27 |
I |
0 |
0 |
0 |
|
|
|
|
|
R03BC03 |
|
|
|
Nedokromil |
inhal. aerosol 2 mg |
8 |
mg |
|
|
|
|
|
|
|
|
0.37 |
|
|
|
56242 |
|
|
O |
TILADE MINT |
sus inh 2x112 dáv. |
FIS |
GB |
56 |
20.18 |
20.18 |
I |
0 |
0 |
0 |
ALG, TRN |
|
|
|
|
R03DA05 |
|
|
|
Aminofylín |
parent. 24 mg/ml |
0.6 |
g |
|
|
|
|
|
|
|
|
1.4539 |
|
|
|
00610 |
|
|
G |
SYNTOPHYLLIN |
inj 5x10 ml/240 mg |
HBS |
SK |
2 |
2.91 |
2.91 |
I |
0 |
0 |
0 |
|
|
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 4 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.45300000000000001 |
|
|
|
20458 |
X |
|
G |
Actamone 4 mg |
tbl mnd 28x4 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
11.2 |
5.07 |
5.07 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
2949A |
X |
|
G |
ASTMASAN 4mg žuvacie tablety |
tbl mnd 28x4 mg (blis.Al/Al) |
SAN |
SI |
11.2 |
5.07 |
5.07 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
05089 |
X |
|
G |
Monkasta 4mg |
tbl mnd 28x4mg |
KRK |
SI |
11.2 |
5.07 |
5.07 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
06003 |
X |
|
G |
Montelukast Mylan 4 mg, |
tbl mnd 28x4 mg (blis. Al/Al) |
GNS |
UK |
11.2 |
5.07 |
5.07 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
51861 |
X |
|
G |
Montelukast Teva 4 mg |
tbl mnd 28x4 mg |
TEV |
IL |
11.2 |
5.07 |
5.07 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
22047 |
X |
|
G |
Montexal 4 mg žuvacie tablety |
tbl mnd 28x4 mg (blis.OPA/Al/PVC/Al) |
MAP |
BG |
11.2 |
5.07 |
5.07 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
20356 |
X |
|
G |
SPIROMON 4 mg žuvacie tablety |
tbl mnd 28x4 mg (blis.nylon/Alu/PVC) |
ZNT |
CZ |
11.2 |
5.07 |
5.07 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
89461 |
X |
|
G |
Montelukast STADA 4 mg žuvacie tablety |
tbl mnd 30x4 mg (blis.nylon/Alu/PVC bez označenia dní) |
STD |
DE |
12 |
5.44 |
5.44 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 4 mg (98-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.45300000000000001 |
|
|
|
05097 |
X |
|
G |
Monkasta 4 mg žuvacie tablety |
tbl mnd 100x4mg |
KRK |
SL |
40 |
18.100000000000001 |
18.100000000000001 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 4 mg gra por (28 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
1.5349999999999999 |
|
|
|
09565 |
X |
|
G |
Montelukast Teva 4 mg granulát |
gra 28x4 mg (vre.ílov.sulf./LDPE/Al/surlyn) |
TEV-SK |
SK |
11.2 |
17.190000000000001 |
17.190000000000001 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
64444 |
X |
|
O |
SINGULAIR 4 mg granulát |
gro por 28 x 4 mg |
MSD |
NL |
11.2 |
17.190000000000001 |
17.190000000000001 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 5 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.55300000000000005 |
|
|
|
88874 |
X |
|
G |
Astmasan 5 mg žuvacie tablety |
tbl mnd 28x5 mg |
SAN |
SI |
14 |
7.73 |
7.73 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
51837 |
X |
|
G |
Montelukast Teva 5 mg |
tbl mnd 28x5 mg |
TEV |
IL |
14 |
7.73 |
7.73 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
20467 |
X |
|
G |
Actamone 5 mg |
tbl mnd 28x5 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
14 |
7.74 |
7.74 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
05108 |
X |
|
G |
Monkasta 5mg |
tbl mnd 28x5mg |
KRK |
SI |
14 |
7.74 |
7.74 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
22054 |
X |
|
G |
Montexal 5 mg žuvacie tablety |
tbl mnd 28x5 mg (blis.OPA/Al/PVC/Al) |
MAP |
BG |
14 |
7.74 |
7.74 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
20349 |
X |
|
G |
SPIROMON 5 mg žuvacie tablety |
tbl mnd 28x5 mg (blis.nylon/Alu/PVC) |
ZNT |
CZ |
14 |
7.74 |
7.74 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 5 mg (98-100 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.55300000000000005 |
|
|
|
05116 |
X |
|
G |
Monkasta 5mg žuvacie tablety |
tbl mnd 100x5mg |
KRK |
SL |
50 |
27.6 |
27.6 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
20471 |
X |
|
G |
Actamone 5 mg |
tbl mnd 98x5 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
49 |
27.1 |
27.1 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 10 mg (28-30 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.26300000000000001 |
|
|
|
20474 |
X |
|
G |
Actamone 10 mg |
tbl flm 28x10 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
28 |
7.36 |
7.36 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
82220 |
X |
|
G |
Astmasan 10 mg filmom obalené tablety |
tbl flm 28x10 mg |
SAN |
SI |
28 |
7.36 |
7.36 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
05053 |
X |
|
G |
Monkasta 10mg |
tbl flm 28x10mg |
KRK |
SI |
28 |
7.36 |
7.36 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
22467 |
X |
|
G |
Montelukast Mylan 10 mg |
tbl flm 28x10 mg |
GNS |
UK |
28 |
7.36 |
7.36 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
51849 |
X |
|
G |
Montelukast Teva 10 mg |
tbl flm 28x10 mg |
TEV |
IL |
28 |
7.36 |
7.36 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
20343 |
X |
|
G |
SPIROMON 10 mg filmom obalené tablety |
tbl flm 28x10 mg (blis.nylon/Alu/PVC) |
ZNT |
CZ |
28 |
7.36 |
7.36 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 10 mg (56 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.26300000000000001 |
|
|
|
20344 |
X |
|
G |
SPIROMON 10 mg filmom obalené tablety |
tbl flm 56x10 mg (blis.nylon/Alu/PVC) |
ZNT |
CZ |
56 |
14.72 |
14.72 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DC03 |
|
|
|
Montelukast |
p.o. 10 mg (98 ks) |
10 |
mg |
|
|
|
|
|
|
|
|
0.26300000000000001 |
|
|
|
20478 |
X |
|
G |
Actamone 10 mg |
tbl flm 98x10 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
98 |
25.76 |
25.76 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
05060 |
X |
|
G |
Monkasta 10 filmom obalené tablety |
tbl flm 98x10mg(blis.OPA/Al/PVC/Al) |
KRK |
SL |
98 |
25.76 |
25.76 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
20345 |
X |
|
G |
SPIROMON 10 mg filmom obalené tablety |
tbl flm 98x10 mg (blis.nylon/Alu/PVC) |
ZNT |
CZ |
98 |
25.76 |
25.76 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm. |
|
|
|
R03DX05 |
|
|
|
Omalizumab |
s.c. 150 mg/ml |
16 |
mg |
|
|
|
|
|
|
|
|
39.06 |
|
|
|
68695 |
|
|
O |
XOLAIR 150 mg |
sol inj 1 x 1 ml/150 mg |
NEH |
GB |
9.375 |
366.07 |
366.07 |
A |
0 |
0 |
0 |
ALG, DER, TRN |
ind.obm., ZP |
|
|
|
R05CB01 |
|
|
|
Acetylcysteín |
parent. 100 mg/ml |
0.5 |
g |
|
|
|
|
|
|
|
|
0.63670000000000004 |
|
|
|
88939 |
|
|
G |
ACC INJEKT |
sol inj 5x3 ml |
SAN-SLO-1 |
SI |
3 |
1.91 |
1.91 |
I |
0 |
0 |
0 |
GER, INT, KLF, PED, PLM, TRN |
|
|
|
|
R05CB13 |
|
|
|
Alfadornáza |
inhal. 1 mg/ml |
2.5 |
mg |
|
|
|
|
|
|
|
|
18.88 |
|
|
|
80404 |
|
|
O |
PULMOZYME |
sol inh 30x2,5 ml |
HLR-SK |
SK |
30 |
566.07000000000005 |
566.07000000000005 |
I |
0 |
0 |
0 |
ALG, TRN |
ind.obm., ZP |
|
|
|
R06AD02 |
|
|
|
Prometazín |
p.o. 25 mg (20 ks) |
25 |
mg |
|
|
|
|
|
|
|
|
0.11 |
|
|
|
33200 |
X |
|
G |
PROTHAZIN |
tbl flm 20x25 mg |
UCB |
BE |
20 |
2.12 |
2.12 |
I |
0 |
0 |
0 |
|
|
|
|
U50 |
R06AE09 |
|
|
|
Levocetirizín |
p.o. 5 mg (28-30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
76320 |
X |
|
G |
Levocetirizin Actavis 5 mg |
tbl flm 30x5 mg ( blis.PVC/PVDC/Al) |
ACT |
IS |
30 |
2.59 |
2.59 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
1263A |
X |
|
G |
Levocetirizin Dr. Max 5 mg filmom obalené tablety |
tbl flm 30x5 mg (blis.Al/OPA/Al/PVC) |
DMX |
GB |
30 |
2.59 |
2.59 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
R06AE09 |
|
|
|
Levocetirizín |
p.o. 5 mg (50-60 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
76322 |
X |
|
G |
Levocetirizin Actavis 5 mg |
tbl flm 50x5 mg ( blis.PVC/PVDC/Al) |
ACT |
IS |
50 |
4.3099999999999996 |
4.3099999999999996 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
1265A |
X |
|
G |
Levocetirizin Dr. Max 5 mg filmom obalené tablety |
tbl flm 50x5 mg (blis.Al/OPA/Al/PVC) |
DMX |
GB |
50 |
4.3099999999999996 |
4.3099999999999996 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
R06AE09 |
|
|
|
Levocetirizín |
p.o. 5 mg (90 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
50078 |
X |
|
G |
Cezera 5mg |
tbl flm 90x5 mg |
KRK |
SI |
90 |
7.76 |
7.76 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
76326 |
X |
|
G |
Levocetirizin Actavis 5 mg |
tbl flm 90x5 mg ( blis.PVC/PVDC/Al) |
ACT |
IS |
90 |
7.76 |
7.76 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
1269A |
X |
|
G |
Levocetirizin Dr. Max 5 mg filmom obalené tablety |
tbl flm 90x5 mg (blis.Al/OPA/Al/PVC) |
DMX |
GB |
90 |
7.76 |
7.76 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
80447 |
X |
|
G |
Zenaro 5 mg |
tbl flm 90x5 mg (blist. PVC/Aclar/PVC/Al) |
ZNT |
CZ |
90 |
7.76 |
7.76 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
R06AX |
|
|
|
Ostatné antihistaminiká na systémové použitie |
parent. bisulepin 0,5 mg/ml |
4 |
mg |
|
|
|
|
|
|
|
|
3.1202000000000001 |
|
|
|
04071 |
|
|
O |
DITHIADEN |
inj 10x2 ml |
ZNT |
CZ |
2.5 |
7.79 |
7.79 |
I |
0 |
0 |
0 |
|
|
|
|
|
R06AX27 |
|
|
|
Desloratadín |
p.o. 5 mg (10 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
13833 |
X |
|
G |
DESLOMED 5 mg filmom obalené tablety |
tbl flm 10x5 mg (blis.PVC/Aclar/Al) |
CRR |
SK |
10 |
0.86 |
0.86 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
R06AX27 |
|
|
|
Desloratadín |
p.o. 5 mg (30 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
31907 |
X |
|
G |
Desloratadine Actavis 5 mg filmom obalené tablety |
tbl flm 30x5 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
30 |
2.2999999999999998 |
2.2999999999999998 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
31831 |
X |
|
G |
LOTERA 5 mg filmom obalené tablety |
tbl flm 30x5 mg (blis.PVC/PE/PVDC/Al) |
SVS |
CZ |
30 |
2.31 |
2.31 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
30401 |
X |
|
G |
Dasselta 5mg |
tbl flm 30x5mg |
KRK |
SI |
30 |
2.59 |
2.59 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
13834 |
X |
|
G |
DESLOMED 5 mg filmom obalené tablety |
tbl flm 30x5 mg (blis.PVC/Aclar/Al) |
CRR |
SK |
30 |
2.59 |
2.59 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
1802A |
X |
|
G |
Desloratadin Saneca 5 mg |
tbl 30x5 mg (blis.OPA/Al/PVC/Al) |
SNC |
SK |
30 |
2.59 |
2.59 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
31035 |
X |
|
G |
DESLORATADIN ZENTIVA 5 mg filmom obalené tablety |
tbl flm 30x5 mg (blis.PCTFE/PVC/Al) |
ZNT |
CZ |
30 |
2.59 |
2.59 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
R06AX27 |
|
|
|
Desloratadín |
p.o. 5 mg (50-60 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
4237A |
X |
|
G |
DELESIT 5 mg filmom obalené tablety |
tbl flm 50x5 mg (blis.PVC/Aclar/Al) |
CIA-GB-1 |
UK |
50 |
4.09 |
4.09 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
31908 |
X |
|
G |
Desloratadine Actavis 5 mg filmom obalené tablety |
tbl flm 50x5 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
50 |
4.09 |
4.09 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
30403 |
X |
|
G |
Dasselta 5mg |
tbl flm 50x5mg |
KRK |
SI |
50 |
4.3099999999999996 |
4.3099999999999996 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
13835 |
X |
|
G |
DESLOMED 5 mg filmom obalené tablety |
tbl flm 50x5 mg (blis.PVC/Aclar/Al) |
CRR |
SK |
50 |
4.3099999999999996 |
4.3099999999999996 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
1803A |
X |
|
G |
Desloratadin Saneca 5 mg |
tbl 50x5 mg (blis.OPA/Al/PVC/Al) |
SNC |
SK |
50 |
4.3099999999999996 |
4.3099999999999996 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
31038 |
X |
|
G |
DESLORATADIN ZENTIVA 5 mg filmom obalené tablety |
tbl flm 50x5 mg (blis.PCTFE/PVC/Al) |
ZNT |
CZ |
50 |
4.3099999999999996 |
4.3099999999999996 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
R06AX27 |
|
|
|
Desloratadín |
p.o. 5 mg (90-100 ks) |
5 |
mg |
|
|
|
|
|
|
|
|
8.6199999999999999E-2 |
|
|
|
31833 |
X |
|
G |
LOTERA 5 mg filmom obalené tablety |
tbl flm 90x5 mg (blis.PVC/PE/PVDC/Al) |
SVS |
CZ |
90 |
6.93 |
6.93 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
4238A |
X |
|
G |
DELESIT 5 mg filmom obalené tablety |
tbl flm 100x5 mg (blis.PVC/Aclar/Al) |
CIA-GB-1 |
UK |
100 |
8.15 |
8.15 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
31910 |
X |
|
G |
Desloratadine Actavis 5 mg filmom obalené tablety |
tbl flm 100x5 mg (blis.OPA/Al/PVC/Al) |
ACT-5 |
IS |
100 |
8.18 |
8.18 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
30405 |
X |
|
G |
Dasselta 5mg |
tbl flm 100x5mg |
KRK |
SI |
100 |
8.57 |
8.57 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
31040 |
X |
|
G |
DESLORATADIN ZENTIVA 5 mg filmom obalené tablety |
tbl flm 100x5 mg (blis.PCTFE/PVC/Al) |
ZNT |
CZ |
100 |
8.57 |
8.57 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
13838 |
X |
|
G |
DESLOMED 5 mg filmom obalené tablety |
tbl flm 100x5 mg (blis.PVC/Aclar/Al) |
CRR |
SK |
100 |
8.6199999999999992 |
8.6199999999999992 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
1806A |
X |
|
G |
Desloratadin Saneca 5 mg |
tbl 100x5 mg (blis.OPA/Al/PVC/Al) |
SNC |
SK |
100 |
8.6199999999999992 |
8.6199999999999992 |
I |
0 |
0 |
0 |
|
|
|
|
U51 |
R06AX29 |
|
|
|
Bilastín |
p.o. 20 mg (30 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
0.27 |
|
|
|
04076 |
|
|
O |
Omarit |
tbl 30x20 mg (blis.PA/Al/PVC/Al) |
MNR |
LU |
30 |
8.06 |
8.06 |
I |
0 |
0 |
0 |
|
|
|
|
U52 |
S01BA01 |
|
|
|
Dexametazón |
loc. intravitreálny implantát |
700 |
µg |
|
|
|
|
|
|
|
|
1100.67 |
|
|
|
21707 |
|
|
O |
Ozurdex |
imp ivt 1x700 µg (vrecko s aplik.syst.) |
ALL |
IE |
1 |
1100.6600000000001 |
1100.6600000000001 |
A |
0 |
0 |
0 |
OPH |
ind.obm., ZP |
|
|
|
S01BC03 |
|
|
|
Diklofenak |
loc. 1 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.33529999999999999 |
|
|
|
33187 |
|
|
O |
UNICLOPHEN 0,1% |
int opo 1x10 ml (fľa PE) |
XUN |
SK |
10 |
3.35 |
3.35 |
I |
0 |
0 |
0 |
OPH |
|
|
|
|
S01EA05 |
|
|
|
Brimonidín |
loc. 2 mg/ml |
0.2 |
ml |
|
|
|
|
|
|
|
|
0.22 |
|
|
|
40457 |
|
|
G |
BRIMONAL 0,2% |
int opo 1x10 ml |
XUN |
SK |
50 |
10.79 |
10.79 |
I |
0 |
0 |
0 |
OPH |
ind.obm. |
|
|
|
S01EB01 |
|
|
|
Pilokarpín |
loc.10 mg/ml |
0.4 |
ml |
|
|
|
|
|
|
|
|
0.1095 |
|
|
|
33175 |
|
|
O |
PILOKARPIN 1% (PE) |
int opo 1x10 ml |
XUN |
SK |
25 |
2.73 |
2.73 |
I |
0 |
0 |
0 |
OPH |
|
|
|
|
S01ED01 |
|
|
|
Timolol |
loc. hypromelóza 5 mg/ml |
0.2 |
ml |
|
|
|
|
|
|
|
|
5.9700000000000003E-2 |
|
|
|
13206 |
|
|
O |
UNITIMOLOL 0,5% (PE.FĽ.) |
int opo 3x5 ml |
XUN |
SK |
73.8 |
4.1100000000000003 |
4.1100000000000003 |
I |
0 |
0 |
0 |
OPH |
|
|
|
|
13204 |
|
|
O |
UNITIMOLOL 0,5% (PE.FĽ.) |
int opo 1x10 ml |
XUN |
SK |
46.9 |
2.73 |
2.73 |
I |
0 |
0 |
0 |
OPH |
|
|
|
|
S01ED02 |
|
|
|
Betaxolol |
loc. 5 mg/ml |
0.2 |
ml |
|
|
|
|
|
|
|
|
0.12 |
|
|
|
90415 |
|
|
O |
BETALMIC 0,5% |
int opo 1x10 ml |
XUN |
SK |
50 |
5.8 |
5.8 |
I |
0 |
0 |
0 |
OPH |
|
|
|
U82 |
S01ED51 |
|
|
|
Timolol, kombinácie |
loc. dorzolamid int. oph. (1ks) |
0.2 |
ml |
|
|
|
|
|
|
|
|
0.35199999999999998 |
|
|
|
14684 |
|
|
O |
COSOPT |
int opo 1x5 ml |
LMK |
FR |
25 |
8.7799999999999994 |
8.7799999999999994 |
I |
0 |
0 |
0 |
OPH |
ind.obm. |
|
|
|
S01ED51 |
|
|
|
Timolol, kombinácie |
loc. dorzolamid int. oph. (3ks) |
0.2 |
ml |
|
|
|
|
|
|
|
|
0.35199999999999998 |
|
|
|
89721 |
|
|
O |
COSOPT |
int opo 3x5 ml |
MSD |
NL |
75 |
26.34 |
26.34 |
I |
0 |
0 |
0 |
OPH |
ind.obm. |
|
|
|
S01EE01 |
|
|
|
Latanoprost |
loc. 50 mcg/ml |
0.1 |
ml |
|
|
|
|
|
|
|
|
0.20300000000000001 |
|
|
|
4319A |
|
|
G |
MONOPOST 50 mikrogramov/ml |
int osd 30(6x5)x0,2 ml (obal LDPE jednodáv.) |
LTH |
FR |
60 |
12.16 |
12.16 |
I |
0 |
0 |
0 |
OPH |
ind.obm. |
|
|
U53 |
S01EE03 |
|
|
|
Bimatoprost |
loc. 0,3 mg/ml |
0.1 |
ml |
|
|
|
|
|
|
|
|
0.33100000000000002 |
|
|
|
8688A |
|
|
G |
Bimican 0,3 mg/ml |
int opo 3x3 ml (fľ.PE) |
PHC-2 |
PL |
90 |
29.77 |
29.77 |
I |
0 |
0 |
0 |
OPH |
ind.obm. |
|
|
|
S01GX09 |
|
|
|
Olopatadín |
loc. 1 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.84099999999999997 |
|
|
|
8694A |
|
|
G |
ALERPALUX 1 mg/ml |
int opo 1x5 ml (fľ.LDPE) |
PRW |
CZ |
5 |
4.2 |
4.2 |
I |
0 |
0 |
0 |
OPH, ALG |
|
|
|
|
S01HA02 |
|
|
|
Oxybuprokain |
loc.4 mg/ml |
1 |
ml |
|
|
|
|
|
|
|
|
0.28100000000000003 |
|
|
|
33232 |
|
|
O |
BENOXI |
int oph 1x10 ml (PE) |
XUN |
SK |
10 |
2.78 |
2.78 |
A |
0 |
0 |
0 |
OPH |
|
|
|
|
S01LA01 |
|
|
|
Verteporfin |
parent. plv. |
15 |
mg |
|
|
|
|
|
|
|
|
1127.96 |
|
|
|
13730 |
|
|
O |
VISUDYNE |
plv ifo 1x15 mg |
CBV |
CH |
1 |
1127.96 |
1127.96 |
A |
0 |
0 |
0 |
OPH |
ind.obm., ZP |
|
|
|
S01LA03 |
|
|
|
Pegaptanib |
loc. 0,3 mg |
0.3 |
mg |
|
|
|
|
|
|
|
|
558.99 |
|
|
|
97424 |
|
|
O |
MACUGEN 0,3 mg injekčný roztok |
sol inj 1x90 µl/0,3 mg (striek.naplnená+pripev.piest.tyčinkou, bez ihly) |
PRW |
CZ |
1 |
558.99 |
558.99 |
A |
0 |
0 |
0 |
OPH |
ind.obm., ZP |
|
|
|
S01LA04 |
|
|
|
Ranibizumab |
intravitreálne 10 mg/ml |
1 |
DF |
|
|
|
|
|
|
|
|
829.78 |
|
|
|
37085 |
|
|
O |
Lucentis |
sol inj 1x0,23 ml/2,3 mg |
NEH |
GB |
1 |
829.78 |
829.78 |
A |
0 |
0 |
0 |
OPH |
ind.obm., ZP |
|
|
|
9706A |
|
|
O |
Lucentis 10 mg/ml injekčný roztok v naplnenej injekčnej striekačke |
sol inj 1 x 0,165 ml/1,65 mg |
NEH |
GB |
1 |
829.78 |
829.78 |
A |
0 |
0 |
0 |
OPH |
ind.obm., ZP |
|
|
|
S01LA05 |
|
|
|
Aflibercept |
intravitreálne 40 mg/ml |
1 |
DF |
|
|
|
|
|
|
|
|
842.09 |
|
|
|
3407A |
|
|
O |
Eylea 40 mg/ml injekčný roztok v injekčnej liekovke |
sol inj 1x 0,1ml/4 mg (liek.inj.skl.) |
BYE |
DE |
1 |
842.09 |
842.09 |
A |
0 |
0 |
0 |
OPH |
ind.obm., ZP |
|
|
|
V01AA |
|
|
|
Extrakty alergénov |
parent. diagnostické alergény |
1 |
DF |
|
|
|
|
|
|
|
|
17.3 |
|
|
|
69225 |
|
|
O |
Soluprick SQ (DIAG.) |
sol inj 1x2 ml (alergén, kontrola) |
XLL |
AT |
1 |
16.78 |
16.78 |
A |
0 |
0 |
0 |
|
|
|
|
|
V01AA20 |
|
|
|
Extrakty alergénov |
parent. diagnostické alergény |
1 |
DF |
|
|
|
|
|
|
|
|
16.28 |
|
|
|
53626 |
|
|
O |
ALYOSTAL PRICK |
sol inj 1x3 ml |
SLG |
FR |
1 |
16.27 |
16.27 |
A |
0 |
0 |
0 |
ALG |
|
|
|
|
V03AC03 |
|
|
|
Deferasirox |
p.o. 250 mg (28 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
1 |
|
|
|
36482 |
|
|
O |
EXJADE 250 mg |
tbl dsp 28x250 mg |
NEH |
GB |
350 |
347.35 |
347.35 |
I |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
V03AC03 |
|
|
|
Deferasirox |
p.o. 500 mg (28 ks) |
20 |
mg |
|
|
|
|
|
|
|
|
0.95 |
|
|
|
36484 |
|
|
O |
EXJADE 500 mg |
tbl dsp 28x500 mg |
NEH |
GB |
700 |
659.16 |
659.16 |
I |
0 |
0 |
0 |
HEM |
ind.obm. |
|
|
|
V03AE01 |
|
|
|
Sulfonát polystyrénu |
p.o. 20 g (25 dávok) |
60 |
g |
|
|
|
|
|
|
|
|
3.03 |
|
|
|
39424 |
|
|
O |
Sorbisterit |
plu pre 1x500 g |
FMC |
DE |
8.3330000000000002 |
25.17 |
25.17 |
I |
0 |
0 |
0 |
NEF |
|
|
|
|
V03AE02 |
|
|
|
Sevelamer karbonát |
p.o. 800 mg (180 ks) |
6.4 |
g |
|
|
|
|
|
|
|
|
4.8920000000000003 |
|
|
|
77782 |
|
|
O |
Renvela |
tbl flm 180x 800 mg |
GZE |
NL |
22.5 |
110.06 |
110.06 |
I |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
0406B |
|
|
G |
Sevelamer carbonate Heaton 800 mg filmom obalené tablety |
tbl flm 180x800 mg (fľ.HDPE) |
|
|
22.5 |
110.06 |
110.06 |
I |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
0576B |
|
|
G |
Sevelamer carbonate Sandoz 800 mg |
tbl flm 180x800 mg (fľ.HDPE) |
SAN |
SI |
22.5 |
110.06 |
110.06 |
I |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
V03AE02 |
|
|
|
Sevelamer karbonát |
p.o. 2,4 g (90 ks) |
6.4 |
g |
|
|
|
|
|
|
|
|
7.9 |
|
|
|
77849 |
|
|
O |
Renvela |
plu por 90x 2,4 g |
GZE |
NL |
33.75 |
266.63 |
266.63 |
I |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
V03AE03 |
|
|
|
Hydrát uhličitanu lantanitého |
p.o. 500 mg (90 ks) |
2.25 |
g |
|
|
|
|
|
|
|
|
7.6 |
|
|
|
36379 |
|
|
O |
Fosrenol 500 mg žuvacie tablety |
tbl mnd 90x500 mg |
SHP |
GB |
20 |
151.84 |
151.84 |
I |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
V03AE03 |
|
|
|
Hydrát uhličitanu lantanitého |
p.o. 750 mg (90 ks) |
2.25 |
g |
|
|
|
|
|
|
|
|
7.2430000000000003 |
|
|
|
36386 |
|
|
O |
Fosrenol 750 mg žuvacie tablety |
tbl mnd 90x750 mg |
SHP |
GB |
30 |
217.29 |
217.29 |
I |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
V03AE04 |
|
|
|
Octan vápenatý a uhličitan horečnatý |
p.o. (180 ks) |
6 |
DF |
|
|
|
|
|
|
|
|
0.73 |
|
|
|
46292 |
|
|
O |
OsvaRen |
tbl flm 180 |
FMC-2 |
DE |
30 |
21.87 |
21.87 |
I |
0 |
0 |
0 |
NEF |
ind.obm. |
|
|
|
V03AF |
|
|
|
Levofolinát disodný |
parent. |
30 |
mg |
|
|
|
|
|
|
|
|
6.43 |
|
|
|
49598 |
|
|
G |
Levofolic |
sol ijf 1x9 ml/450 mg |
MCW |
DE |
15 |
83.79 |
83.79 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
49596 |
|
|
G |
Levofolic |
sol ijf 1x4 ml/200 mg |
MCW |
DE |
6.6669999999999998 |
40.39 |
40.39 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
49594 |
|
|
G |
Levofolic |
sol ijf 1x1ml/ 50 mg |
MCW |
DE |
1.667 |
10.72 |
10.72 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
V03AF01 |
|
|
|
Mesna |
parent. nad 200 mg |
0.2 |
g |
|
|
|
|
|
|
|
|
2.0539999999999998 |
|
|
|
0382B |
|
|
O |
Uromitexan 400 mg |
sol inj 10x4 ml/400 mg (ampl.skl.) |
XBT-1 |
DE |
20 |
41.07 |
41.07 |
A |
0 |
0 |
0 |
HEM, ONK |
|
|
|
|
V03AF02 |
|
|
|
Dexrazoxan |
parent. |
1 |
g |
|
|
|
|
|
|
|
|
164.79 |
|
|
|
08483 |
|
|
G |
Cyrdanax 20 mg/ml |
plv ifo 1x500 mg (liek.inj.skl.hnedá) |
PML |
AT |
0.5 |
82.39 |
82.39 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
V03AF03 |
|
|
|
Kalcium folinát |
parent. |
60 |
mg |
|
|
|
|
|
|
|
|
4.51 |
|
|
|
27030 |
|
|
G |
CALCIUMFOLINAT |
sol inj 1x10 ml/100 mg |
EBW |
AT |
1.667 |
7.5 |
7.5 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
49568 |
|
|
G |
Calciumfolinat "Ebewe" 10 mg/ml |
sol inj 1x30 ml/300 mg |
EBW |
AT |
5 |
22.5 |
22.5 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
96966 |
|
|
G |
CALCIUMFOLINAT |
sol inj 5x3 ml/30 mg |
EBW |
AT |
2.5 |
11.26 |
11.26 |
A |
0 |
0 |
0 |
ONK |
|
|
|
|
V04 |
|
|
|
Diagnostiká |
loc. Trolab komôrky + sety |
1 |
DF |
|
|
|
|
|
|
|
|
0.18099999999999999 |
|
|
|
24811 |
|
|
O |
TROLAB |
liq der 100x10 komôrok |
HEM |
DE |
1000 |
94.07 |
94.07 |
A |
0 |
0 |
0 |
ALG, DER |
|
|
|
|
V04 |
|
|
|
Diagnostiká |
loc. Trolab liq. |
1 |
ml |
|
|
|
|
|
|
|
|
3.07 |
|
|
|
15093 |
|
|
O |
TROLAB |
liq der 23x5 ml (set) |
HEM |
DE |
115 |
310.68 |
310.68 |
A |
0 |
0 |
0 |
ALG, DER |
|
|
|
|
24101 |
|
|
O |
TROLAB |
liq der 1x5 ml |
HEM |
DE |
5 |
15.3 |
15.3 |
A |
0 |
0 |
0 |
ALG, DER |
|
|
|
|
V04CX |
|
|
|
Iné diagnostické prípravky |
p.o. 45 mg |
1 |
DF |
|
|
|
|
|
|
|
|
21.04 |
|
|
|
40754 |
|
|
O |
Helicobacter Test INFAI pre deti vo veku 3-11 rokov, 45 mg prášok na perorálny roztok |
plv por 1x45 mg (fla. polyst./tuby) |
IFI |
DE |
1 |
21.03 |
21.03 |
I |
0 |
0 |
0 |
|
|
|
|
|
V04CX |
|
|
|
Iné diagnostické prípravky |
p.o. 75 mg |
1 |
DF |
|
|
|
|
|
|
|
|
27.68 |
|
|
|
54292 |
|
|
O |
Helicobacter Test INFAI 75 mg prášok na perorálny roztok |
plv por 1x75 mg (fla. polyst.) |
IFI |
DE |
1 |
27.68 |
27.68 |
I |
0 |
0 |
0 |
|
|
|
|
|
V06DD |
|
|
|
Aminokyseliny a kombinácie s polypeptidmi |
p.o. aminokyseliny a analógy tbl. |
5 |
DF |
|
|
|
|
|
|
|
|
2.5665 |
|
|
|
88115 |
|
|
O |
KETOSTERIL |
tbl obd 1x100 |
FRE |
DE |
20 |
50.46 |
50.46 |
I |
0 |
0 |
0 |
NEF |
|
|
|
|
V07AB |
|
|
|
Rozpúšťadlá a riedidlá vrátane irigačných rozt. |
parent. voda na injekcie |
100 |
ml |
|
|
|
|
|
|
|
|
0.23 |
|
|
|
97727 |
|
|
G |
WATER FOR INJECTION BIEFFE |
lif par 1x500 ml (sklo) |
BFF |
IT |
5 |
1.1299999999999999 |
1.1299999999999999 |
I |
0 |
0 |
0 |
|
|
|
|
|
V08AA01 |
|
|
|
Kyselina diatrizoová |
parent. |
10 |
ml |
|
|
|
|
|
|
|
|
2.31 |
|
|
|
25162 |
|
|
O |
UROGRAFIN 76% (amp.) |
sol inj 10x20 ml |
BAS |
DE |
20 |
35.79 |
35.79 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08AB02 |
|
|
|
Iohexol |
parent. 300 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
3.29 |
|
|
|
04330 |
|
|
G |
OMNIPAQUE 300 |
sol inj 10x50 ml (fľaša PP) |
NYE |
NO |
50 |
164.43 |
164.43 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08AB02 |
|
|
|
Iohexol |
parent. 350 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
2.88 |
|
|
|
39566 |
|
|
O |
OMNIPAQUE 350 |
sol inj 10x100 ml (fľaša PP) |
GHO |
NO |
100 |
287.94 |
287.94 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08AB04 |
|
|
|
Iopamidol |
parent. 300 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
4.99 |
|
|
|
40693 |
|
|
G |
SCANLUX 300 |
sol inj 10x100 ml |
SBA |
AT |
100 |
323.98 |
323.98 |
A |
0 |
0 |
0 |
|
|
|
|
|
40692 |
|
|
G |
SCANLUX 300 |
sol inj 10x50 ml |
SBA |
AT |
50 |
167.13 |
167.13 |
A |
0 |
0 |
0 |
|
|
|
|
|
87942 |
|
|
G |
Iopamigita 300 mg/ml injekčný a infúzny roztok |
sol ijf 10x100 ml/30 g (liek.inj.skl.-typ ll) |
ISG |
DE |
100 |
494.44 |
494.44 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08AB04 |
|
|
|
Iopamidol |
parent. 370 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
2.75 |
|
|
|
40694 |
|
|
G |
SCANLUX 370 |
sol inj 10x100 ml |
SBA |
AT |
100 |
274.56 |
274.56 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08AB05 |
|
|
|
Iopromid |
parent. 300 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
3.74 |
|
|
|
77017 |
|
|
O |
ULTRAVIST-300 |
sol inj 10x100 ml |
BAS |
DE |
100 |
372.8 |
372.8 |
A |
0 |
0 |
0 |
|
|
|
|
|
77024 |
|
|
O |
ULTRAVIST-300 |
sol inj 10x20 ml |
BAS |
DE |
20 |
74.56 |
74.56 |
A |
0 |
0 |
0 |
|
|
|
|
|
77016 |
|
|
O |
ULTRAVIST-300 |
sol inj 10x50 ml |
BAS |
DE |
50 |
186.4 |
186.4 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08AB05 |
|
|
|
Iopromid |
parent. 370 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
3.29 |
|
|
|
77019 |
|
|
O |
ULTRAVIST-370 |
sol inj 10x100 ml |
BAS |
DE |
100 |
328.7 |
328.7 |
A |
0 |
0 |
0 |
|
|
|
|
|
93626 |
|
|
O |
ULTRAVIST-370 |
sol inj 1x200 ml |
BAS |
DE |
20 |
65.739999999999995 |
65.739999999999995 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08AB07 |
|
|
|
Ioversol |
parent. 240 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
3.66 |
|
|
|
98298 |
|
|
O |
OPTIRAY 240 |
sol inj 10x50 ml (fľašky) |
MAL-DE |
DE |
50 |
182.97 |
182.97 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08AB07 |
|
|
|
Ioversol |
parent. 300 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
3.2629999999999999 |
|
|
|
92367 |
|
|
O |
OPTIRAY 300 |
sol inj 10x100 ml (fľašky) |
MAL-DE |
DE |
100 |
324.89 |
324.89 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08AB07 |
|
|
|
Ioversol |
parent. 350 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
3.45 |
|
|
|
92371 |
|
|
O |
OPTIRAY 350 |
sol inj 10x200 ml (fľašky) |
MAL-DE |
DE |
200 |
689.94 |
689.94 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08AB10 |
|
|
|
Iomeprol |
parent. 350 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
4.6509999999999998 |
|
|
|
87281 |
|
|
O |
IOMERON 350 |
sol inj 10x200 ml |
BCC |
DE |
200 |
930.2 |
930.2 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08AB10 |
|
|
|
Iomeprol |
parent. 400 mg/ml |
10 |
ml |
|
|
|
|
|
|
|
|
6.85 |
|
|
|
87287 |
|
|
O |
IOMERON 400 |
sol inj 10x200 ml |
BCC |
DE |
200 |
1370 |
1370 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08BA01 |
|
|
|
Síran barnatý so suspendujúcou latkou |
p.o. alebo p. rect. (1ks) |
1 |
DF |
|
|
|
|
|
|
|
|
7.62 |
|
|
|
94489 |
|
|
O |
MICROPAQUE CT |
sus pre 1x150 ml |
GUT |
FR |
1 |
7.62 |
7.62 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08CA02 |
|
|
|
Kyselina gadoterová |
parent. 0,5 mmol/ml (10 ml) |
15 |
ml |
|
|
|
|
|
|
|
|
55.697000000000003 |
|
|
|
8497A |
|
|
O |
DOTAREM 0,5 mmol/ml injekčný roztok v injekčných liekovkách |
sol inj 1x10 ml (liek.inj.skl.) |
GUT-2 |
FR |
0.66700000000000004 |
37.15 |
37.15 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08CA02 |
|
|
|
Kyselina gadoterová |
parent. 0,5 mmol/ml (15 ml) |
15 |
ml |
|
|
|
|
|
|
|
|
49.44 |
|
|
|
8498A |
|
|
O |
DOTAREM 0,5 mmol/ml injekčný roztok v injekčných liekovkách |
sol inj 1x15 ml (liek.inj.skl.) |
GUT-2 |
FR |
1 |
49.44 |
49.44 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08CA02 |
|
|
|
Kyselina gadoterová |
parent. 0,5 mmol/ml (20 ml) |
15 |
ml |
|
|
|
|
|
|
|
|
46.698999999999998 |
|
|
|
8499A |
|
|
O |
DOTAREM 0,5 mmol/ml injekčný roztok v injekčných liekovkách |
sol inj 1x20 ml (liek.inj.skl.) |
GUT-2 |
FR |
1.333 |
62.25 |
62.25 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08CA03 |
|
|
|
Gadodiamid |
parent. 0,5 mmol/ml |
10 |
ml |
|
|
|
|
|
|
|
|
32.17 |
|
|
|
78817 |
|
|
O |
OMNISCAN 0,5MMOL/ML (INJ.LIEK.) |
sol inj 10x20 ml |
NYI |
NO |
20 |
565 |
565 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08CA04 |
|
|
|
Gadoteridol |
parent. 0,5 mmol/ml |
1 |
ml |
|
|
|
|
|
|
|
|
3.86 |
|
|
|
54254 |
|
|
O |
PROHANCE |
sol inj 1x15 ml(fľaš.) |
BGL |
DE |
15 |
57.69 |
57.69 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08CA06 |
|
|
|
Gadoversetamid |
parent. 0,5 mmol/ml |
1 |
ml |
|
|
|
|
|
|
|
|
2.8820000000000001 |
|
|
|
44619 |
|
|
O |
Optimark 500 mikromolov/ml injekčný roztok v injekčnej liekovke |
sol inj 10x15 ml (liek.inj.skl.) |
MAL-DE |
DE |
150 |
432.28 |
432.28 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08CA09 |
|
|
|
Gadobutrol |
parent. 1 mmol/ml |
15 |
ml |
|
|
|
|
|
|
|
|
94.094999999999999 |
|
|
|
03132 |
|
|
O |
Gadovist 1,0 mmol/ml |
sol inj 1x15 ml (inj. liek.) |
BAS |
DE |
1 |
94.09 |
94.09 |
A |
0 |
0 |
0 |
|
|
|
|
|
03134 |
|
|
O |
GADOVIST 1,0 mmol/ ml |
sol inj 5x7,5 ml (napl.inj.striek.) |
BAS |
DE |
2.5 |
235.24 |
235.24 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08CA10 |
|
|
|
Kyselina gadoxetová |
parent. 0,25 mmol/ml |
10 |
ml |
|
|
|
|
|
|
|
|
139.93 |
|
|
|
41543 |
|
|
O |
Primovist 0,25 mmol/ml, injekčný roztok, naplnená injekčná striekačka |
sol inj 1x10ml |
BAS |
DE |
1 |
139.93 |
139.93 |
A |
0 |
0 |
0 |
|
|
|
|
|
V08DA05 |
|
|
|
Mikrobubliny síranu hexafluoridu |
parent. 8 mcl/ml |
1 |
DF |
|
|
|
|
|
|
|
|
69.39 |
|
|
|
99442 |
|
|
O |
SonoVue |
plv iud 1x8 µl/ ml+5 ml solv.+oddel.prenos. systém MiniSpike |
BBV |
NL |
1 |
69.39 |
69.39 |
A |
0 |
0 |
0 |
GIT, KAR, NEU, RAT, URO |
|
|
|
|
V10XX02 |
|
|
|
Ibritumomabtiuxetán |
parent. 1,6 mg/ml (2 ml) |
1 |
DF |
|
|
|
|
|
|
|
|
9728.09 |
|
|
|
40792 |
|
|
O |
ZEVALIN |
kit rad 1x3,2 mg |
SPE |
NL |
1 |
9728.09 |
9728.09 |
A |
0 |
0 |
0 |
HEM, ONK |
ind.obm. |
|
|
|
9
55
600
600
95
2503
3
472
False
False